NCT ID,Disease,Drug Name
NCT07094204,Pancreatic ductal adenocarcinoma,ASP5834
NCT07094204,Pancreatic ductal adenocarcinoma,panitumumab
NCT07047001,Nonpapillary renal cell carcinoma,Vorolanib Tablets
NCT07047001,Nonpapillary renal cell carcinoma,Vorolanib + Toripalimab
NCT06854601,Attention deficit-hyperactivity disorder,Mexidol
NCT06894901,Dengue disease,Biological (Male Wolbachia-infected Aedes aegypti)
NCT06836401,Periodontal disorder,Topical Gel
NCT07104604,Rectal carcinoma,Liposomal Irinotecan
NCT06770504,Autoimmune hemolytic anemia,YTS109
NCT06611501,Endometriosis,metformin hydrochloride
NCT06785272,Asthma,magnesium sulfate
NCT07107672,Gastroesophageal reflux disease,[14C]X842
NCT06574204,Dermatitis,erythromycin
NCT06574204,Dermatitis,azithromycin
NCT07028801,Rabies,Freeze-dried human rabies vaccine (human diploid cells)
NCT07028801,Rabies,Freeze-dried human rabies vaccine (human diploid cells)
NCT07028801,Rabies,Freeze-dried human rabies vaccine (human diploid cells)
NCT07028801,Rabies,Freeze-dried human rabies vaccine (human diploid cells)
NCT07028801,Rabies,Freeze-dried human rabies vaccine (human diploid cells)
NCT06956001,EGFR,Firmonertinib Mesilate Tablets
NCT06956001,EGFR,Pemetrexed Disodium for Injection
NCT06956001,EGFR,Cisplatin for injection
NCT06956001,EGFR,Carboplatin Injection
NCT06956001,Non-small cell lung carcinoma,Firmonertinib Mesilate Tablets
NCT06956001,Non-small cell lung carcinoma,Pemetrexed Disodium for Injection
NCT06956001,Non-small cell lung carcinoma,Cisplatin for injection
NCT06956001,Non-small cell lung carcinoma,Carboplatin Injection
NCT06619301,Gestational diabetes,insulin glargine
NCT06619301,Gestational diabetes,insulin NPH
NCT06619301,Type 2 diabetes mellitus,insulin glargine
NCT06619301,Type 2 diabetes mellitus,insulin NPH
NCT07048704,Cystic fibrosis,Intravenous Bacteriophage Cocktail plus Standard IV Antibiotics
NCT06835101,Obesity disorder,Midazolam (sedative)
NCT06991101,Adult glioblastoma,ruxolitinib
NCT06991101,Adult glioblastoma,temozolomide
NCT06991101,Glioma susceptibility 1,ruxolitinib
NCT06991101,Glioma susceptibility 1,temozolomide
NCT07080801,Amyotrophic lateral sclerosis,RAG-21
NCT06609304,Lymphoma,axicabtagene ciloleucel
NCT07104201,Primary biliary cholangitis,fenofibrate
NCT07082972,Myofascial pain syndrome,Botulinum toxin injection
NCT06893172,Postherpetic neuralgia,gabapentin
NCT07037472,Dermatomyositis,Drug treatment
NCT06955104,Inherited lipid metabolism disorder,JW0108 + C2407
NCT06719804,Epilepsy,propranolol
NCT06596772,Rheumatoid arthritis,MB04 (proposed biosimilar to etanercept)
NCT06596772,Rheumatoid arthritis,Enbrel (etanercept)
NCT06899204,Atopic eczema,abrocitinib
NCT06899204,Dermatitis,abrocitinib
NCT06701201,Cancer,SynKIR-110
NCT06701201,Cancer,SynKIR-310
NCT06878404,Arthritic joint disease,Icotrokinra
NCT06878404,Arthritic joint disease,Active reference comparator
NCT07085572,Adrenal cortex carcinoma,cemiplimab
NCT06597201,End stage renal failure,amino acid (15) peritoneal dialysis solution
NCT06597201,End stage renal failure,glucose peritoneal dialysis solution
NCT07114601,Prostate neoplasm,LY4257496
NCT07114601,Prostate neoplasm,Standard of Care Anticancer Therapies
NCT06758401,Carcinoma,Sigvotatug Vedotin
NCT06758401,Carcinoma,pembrolizumab
NCT06758401,Non-small cell lung carcinoma,Sigvotatug Vedotin
NCT06758401,Non-small cell lung carcinoma,pembrolizumab
NCT07108504,Malignant pancreatic neoplasm,gemcitabine
NCT07108504,Malignant pancreatic neoplasm,LM-302
NCT06588504,Diabetes mellitus,dasiglucagon
NCT06588504,Diabetes mellitus,glucagon
NCT06675201,Esophageal squamous cell carcinoma,neoantigen-loaded dendritic cell vaccine (NeoDC-Vac)
NCT07037004,Nonpapillary renal cell carcinoma,Clostridium butyricum CBM
NCT07037004,Nonpapillary renal cell carcinoma,pembrolizumab
NCT06922604,Primary central nervous system lymphoma,glofitamab
NCT06922604,Primary central nervous system lymphoma,obinutuzumab
NCT07022704,"COPD, severe early onset",doxapram
NCT06917001,Dengue disease,Resomelagon
NCT06920901,Asthma,APG777
NCT06694701,Sepsis,Emapalumab-Izsg
NCT06694701,Sepsis,Emapalumab-Izsg
NCT06645301,Malignant pancreatic neoplasm,Group A
NCT06645301,Malignant pancreatic neoplasm,Group B
NCT06917404,Osteoarthritis,Pentosan Polysulfate Sodium twice weekly
NCT07102901,Gastroesophageal junction adenocarcinoma,SHR2554 Tablets
NCT07102901,Gastroesophageal junction adenocarcinoma,SHR-A1811 Injection
NCT07102901,Gastroesophageal junction adenocarcinoma,SHR-A1904 Injection
NCT07102901,Gastroesophageal junction adenocarcinoma,SHR-1701 Injection
NCT06601101,Keratoconus,Insulin
NCT06959004,Migraine disorder,Substance P
NCT06640504,Sepsis,Blood Lactate
NCT06990204,Hypertensive disorder,Azilsartan medoxomil
NCT06990204,Hypertensive disorder,Edarbi®
NCT07035301,Respiratory system disorder,Lidocaine Intravenous Infusion
NCT07035301,Respiratory system disorder,Remimazolam Tosilate
NCT07035301,Respiratory system disorder,remifentanil
NCT07035301,Respiratory system disorder,Rocuronium (0.15mg/kg/body mass)
NCT07037901,Atopic eczema,IMG-007
NCT06966401,Endogenous depression,NBI-1065845
NCT06954467,Hepatocellular carcinoma,JS207
NCT06954467,Hepatocellular carcinoma,JS007
NCT06969001,Wet macular degeneration,SCAI-005
NCT06969001,Wet macular degeneration,SCAI-005
NCT06969001,Wet macular degeneration,SCAI-005
NCT06997367,Tuberculosis,MTBVAC
NCT06997367,Tuberculosis,BCG Sii
NCT07106372,Atopic eczema,Stapokibatrt
NCT06853444,Autoimmune thrombocytopenic purpura,ESG206
NCT06853444,Autoimmune thrombocytopenic purpura,ESG206
NCT06853444,Autoimmune thrombocytopenic purpura,ESG206
NCT06853444,Autoimmune thrombocytopenic purpura,ESG206
NCT06919744,Pseudotumor cerebri,Best medical care
NCT06871644,Systemic sclerosis,T cell injection targeting CD7 chimeric antigen receptor
NCT06824844,Dry eye syndrome,artificial tear eyedrops
NCT06824844,Dry eye syndrome,0.05% cyclosporine eyedrops
NCT06816901,Lactation,Depo Medroxyprogesterone acetate
NCT07087067,Preeclampsia,Aspirin
NCT06839144,Ovarian cancer,Propranolol (Beta-Blocker) and Etodolac (COX-2 Inhibitor)
NCT07082192,Amyotrophic lateral sclerosis,Test drug CB03-154
NCT07082192,Amyotrophic lateral sclerosis,Test drug CB03-154
NCT07082192,Amyotrophic lateral sclerosis,Test drug CB03-154
NCT07089992,Sarcoma,pembrolizumab
NCT06602492,Nicotine dependence,Lower nicotine e-liquid
NCT06602492,Nicotine dependence,Higher nicotine eliquid
NCT06975644,Triple-negative breast carcinoma,"nab-paclitaxel, carboplatin, and bemotuzumab"
NCT06975644,Triple-negative breast carcinoma,"epirubicin, cyclophosphamide, and bemotuzumab"
NCT06911944,Down syndrome,donanemab
NCT06789744,Hernia,Intravenous Patient-Controlled Analgesia (PCA) (fentanyl)
NCT06612840,Non-small cell lung carcinoma,GNC-077
NCT07000344,Ovarian cancer,Cohort
NCT07000344,Ovarian cancer,Cohort
NCT06830044,Endogenous depression,Milsaperidone
NCT06879340,B-cell non-Hodgkin lymphoma,DuoCAR20.19.22-D95
NCT06879340,B-cell non-Hodgkin lymphoma,Fludarabine (Conditional therapy)
NCT06879340,B-cell non-Hodgkin lymphoma,Cyclophosphamide (Conditional therapy)
NCT06879340,Precursor B-cell acute lymphoblastic leukemia,DuoCAR20.19.22-D95
NCT06879340,Precursor B-cell acute lymphoblastic leukemia,Fludarabine (Conditional therapy)
NCT06879340,Precursor B-cell acute lymphoblastic leukemia,Cyclophosphamide (Conditional therapy)
NCT07065240,Endogenous depression,SPT-300
NCT06755944,Cerebrovascular disorder,XY03-EA
NCT06941844,Endogenous depression,MM120 (LSD D-Tartrate)
NCT06751589,Endometrial cancer,tirzepatide
NCT06973889,Digestive system disorder,Helicobacter pylori eradication therapy
NCT06816992,Non-small cell lung carcinoma,ORIC-114 Dose
NCT06816992,Non-small cell lung carcinoma,ORIC-114 Dose
NCT06816992,Non-small cell lung carcinoma,ORIC-114 Dose
NCT06705192,Dementia,VES001
NCT06705192,Frontotemporal dementia,VES001
NCT06776289,Periapical periodontitis,Platelet rich fibrin
NCT06997289,Insomnia,Group that is receiving treatment.
NCT06967389,Weight loss,Ozempic®
NCT06761989,Pain,Intrathecal morphine injection
NCT06903689,Kidney failure,Pentoxifylline
NCT06566989,Metastatic prostate carcinoma,[¹⁴C]Opevesostat
NCT06566989,Metastatic prostate carcinoma,prednisone
NCT06566989,Metastatic prostate carcinoma,fludrocortisone
NCT06641089,Arthritic joint disease,Sonelokimab
NCT06641089,Arthritic joint disease,risankizumab
NCT06840392,Hidradenitis suppurativa,Remibrutinib Dose A
NCT06840392,Hidradenitis suppurativa,Remibrutinib Dose B
NCT07000292,Lupus nephritis,Injection of MSC303
NCT07064889,Autoimmune thrombocytopenic purpura,dexamethasone
NCT07064889,Autoimmune thrombocytopenic purpura,upadacitinib
NCT06694389,COVID-19,mRNA-1083
NCT06694389,COVID-19,Licensed Influenza Vaccine
NCT06694389,COVID-19,SARS-CoV-2 Vaccine
NCT06694389,Influenza,mRNA-1083
NCT06694389,Influenza,Licensed Influenza Vaccine
NCT06694389,Influenza,SARS-CoV-2 Vaccine
NCT06651229,Leukemia,JNJ-90189892
NCT06902844,Lupus nephritis,Equecabtagene Autoleucel Injection
NCT06902844,Systemic lupus erythematosus,Equecabtagene Autoleucel Injection
NCT06980792,Pancreatic ductal adenocarcinoma,Chemotherapy
NCT06917092,Endometrial cancer,QL1706 combined with chemotherapy ± Bevacizumab
NCT07021989,Classic Hodgkin lymphoma,pembrolizumab
NCT07021989,Classic Hodgkin lymphoma,gemcitabine
NCT07021989,Classic Hodgkin lymphoma,vinorelbine
NCT07021989,Classic Hodgkin lymphoma,Liposomal Doxorubicin
NCT07021989,Classic Hodgkin lymphoma,pegfilgrastim
NCT07021989,Hodgkins lymphoma,pembrolizumab
NCT07021989,Hodgkins lymphoma,gemcitabine
NCT07021989,Hodgkins lymphoma,vinorelbine
NCT07021989,Hodgkins lymphoma,Liposomal Doxorubicin
NCT07021989,Hodgkins lymphoma,pegfilgrastim
NCT06626789,Borderline personality disorder,Amygdala neurofeedback
NCT06591429,Multiple sclerosis,anti-CD20 MS treatment
NCT06987292,Psoriasis,IL-17i
NCT06900192,Multiple sclerosis,Orca-Q
NCT06900192,Multiple sclerosis,myeloablative regimen
NCT06715592,Vulvar carcinoma,Bleomicina
NCT06928389,Non-small cell lung carcinoma,"Ivonescimab, docetaxel"
NCT07004192,Infertility disorder,HCG injection
NCT06958692,Endogenous depression,Dextromethorphan and Bupropion Sustained-Release Tablets
NCT06898489,Systemic lupus erythematosus,Conventional pharmacotherapy
NCT06948292,Diabetic kidney disease,QRX-3
NCT06703892,Follicular lymphoma,GF-CART01
NCT06703892,Follicular lymphoma,GF-CART01
NCT06703892,Follicular lymphoma,GF-CART01
NCT06703892,High grade B-cell lymphoma,GF-CART01
NCT06703892,High grade B-cell lymphoma,GF-CART01
NCT06703892,High grade B-cell lymphoma,GF-CART01
NCT06979492,Sickle cell disease,Prophylactic Transfusion Intervention group: Transfusion
NCT06619392,Pain,HRS-2129
NCT06934889,Adult glioblastoma,ERAS-801
NCT06934889,Adult glioblastoma,ABBV-637
NCT06934889,Adult glioblastoma,ABBV-155
NCT06934889,Adult glioblastoma,temozolomide
NCT06607692,Medulloblastoma,Olaparib
NCT06607692,Meningioma,Olaparib
NCT06842992,Endogenous depression,NH102
NCT06842992,Endogenous depression,NH102
NCT06842992,Endogenous depression,NH102
NCT06842992,Endogenous depression,Duloxetine Hydrochloride Enteric-coated Capsule
NCT06978192,Herpes zoster,dexmedetomidine nasal spray group
NCT06723392,Pregnancy disorder with abortive outcome,Oral nitrofurantoin monohydrate/macrocrystals
NCT07011589,Epidermolysis bullosa,Efgartigimod
NCT06872892,Bronchiectasis,BI
NCT06783192,Human immunodeficiency virus,MK-8527
NCT06783192,Human immunodeficiency virus,LNG/EE
NCT06634589,B-cell non-Hodgkin lymphoma,BGB-16673
NCT06634589,B-cell non-Hodgkin lymphoma,Sonrotoclax
NCT06634589,B-cell non-Hodgkin lymphoma,zanubrutinib
NCT06634589,B-cell non-Hodgkin lymphoma,mosunetuzumab
NCT06634589,B-cell non-Hodgkin lymphoma,glofitamab
NCT06634589,B-cell non-Hodgkin lymphoma,obinutuzumab
NCT06877689,Proximal spinal muscular atrophy,Apitegromab
NCT07090044,Diabetic retinopathy,Bromfenac Sodium
NCT07090044,Diabetic retinopathy,Loteprednol Etabonate
NCT07090044,Diabetic retinopathy,Propylene Glycol Preservative-free Artificial Tears
NCT07090044,Macular retinal edema,Bromfenac Sodium
NCT07090044,Macular retinal edema,Loteprednol Etabonate
NCT07090044,Macular retinal edema,Propylene Glycol Preservative-free Artificial Tears
NCT06993792,Obesity disorder,Orforglipron
NCT06993792,Type 2 diabetes mellitus,Orforglipron
NCT06780592,Adult glioblastoma,Vebreltinib + Temozolomide
NCT06780592,Adult glioblastoma,temozolomide
NCT06761092,Delirium,Nebulized Dexmedetomidine for Post-Anesthesia Delirium in Preschool Children
NCT06941792,Coronary artery disorder,inclisiran sodium injection
NCT06604689,Non-small cell lung carcinoma,third-generation EGFR TKIs (Almonertinib/Furmonertinib/Osimertinib)
NCT06872489,Malignant pancreatic neoplasm,SL-28.
NCT06872489,Neuroblastoma,SL-28.
NCT06852092,Paroxysmal nocturnal hemoglobinuria,Carbon-14 labeled HSK39297
NCT06620692,Psoriasis,5% GM-XANTHO [GM-XAN003]
NCT06710704,Epicondylitis,Methylprednisolone and mepacaine
NCT06710704,Pain,Methylprednisolone and mepacaine
NCT06913101,Type 2 diabetes mellitus,Trelagliptin
NCT06913101,Type 2 diabetes mellitus,Vildagliptin
NCT06735001,Atrial fibrillation,Lab test
NCT07052201,Bronchopulmonary dysplasia,dexamethasone
NCT07052201,Bronchopulmonary dysplasia,dexamethasone
NCT07052201,Bronchopulmonary dysplasia,Dexametasone
NCT06879301,Diabetic macular edema,Intravitreal injection of aflibercept
NCT06623201,Basal cell carcinoma,aminolevulinic acid HCL (ALA)
NCT06618001,Leukemia,JNJ-89853413
NCT06902467,Ovarian cancer,Following
NCT06962267,Malignant pancreatic neoplasm,TQB2916 Injection
NCT06962267,Malignant pancreatic neoplasm,Chemotherapy
NCT06826001,Androgenetic alopecia,topical finasteride
NCT06826001,Androgenetic alopecia,Topical minoxidil
NCT06786767,Asthma,"BDP/FF/G (Beclomethasone diprprionate, formoterol fumarate, glycopyrronium bromide)"
NCT06781567,Adrenal cortex carcinoma,HG146
NCT07000201,Anxiety,"One hour prior to admission to the operating room, patients will receive the study medication (as premedication) by mouth with a sip of water"
NCT06863467,Kidney failure,Intravenous Gemini
NCT06604767,Respiratory syncytial virus infectious disease,parainfluenza virus type
NCT06604767,Respiratory syncytial virus infectious disease,RSV/hMPV/PIV3 vaccine
NCT06604767,Respiratory syncytial virus infectious disease,RSV/hMPV vaccine
NCT06604767,Respiratory syncytial virus infectious disease,RSV vaccine
NCT06604767,Respiratory syncytial virus infectious disease,RSV vaccine
NCT06801067,Diarrheal disease,SER-155
NCT07041801,Systemic lupus erythematosus,hUC-MSCs treatment (low dose)
NCT07041801,Systemic lupus erythematosus,hUC-MSCs treatment (medium dose)
NCT07041801,Systemic lupus erythematosus,hUC-MSCs treatment (high dose)
NCT07041801,Systemic lupus erythematosus,hUC-MSCs treatment （Double dose）
NCT06637501,B-cell chronic lymphocytic leukemia,Sonrotoclax
NCT06637501,B-cell chronic lymphocytic leukemia,zanubrutinib
NCT06778967,Type 2 diabetes mellitus,GZR18
NCT06778967,Type 2 diabetes mellitus,semaglutide
NCT06989567,Sickle cell disease,L-citrulline
NCT06759701,Diabetes mellitus,tirzepatide
NCT06759701,Prostate cancer,tirzepatide
NCT06942767,Gastric adenocarcinoma,QLS31905 for Injection
NCT06942767,Gastric adenocarcinoma,QL2107 Injection
NCT06942767,Gastric adenocarcinoma,oxaliplatin Injection
NCT06942767,Gastric adenocarcinoma,Capecitabine Tablets
NCT06942767,Gastroesophageal junction adenocarcinoma,QLS31905 for Injection
NCT06942767,Gastroesophageal junction adenocarcinoma,QL2107 Injection
NCT06942767,Gastroesophageal junction adenocarcinoma,oxaliplatin Injection
NCT06942767,Gastroesophageal junction adenocarcinoma,Capecitabine Tablets
NCT06915701,Rheumatoid arthritis,Will take
NCT06906367,Fabry disease,migalastat HCl
NCT06906367,Fabry disease,ERT
NCT06989840,Acne,TVB-3567
NCT06592144,Muscle weakness,Testosterone cypionate (200mg/3ml)
NCT07119840,Gingivitis,Listerine Mouthwash Product
NCT07119840,Gingivitis,chlorhexidine Mouthwash
NCT06788444,Irritable bowel syndrome,esketamine
NCT06659744,Diabetes mellitus,New use of semaglutide injection
NCT06659744,Diabetes mellitus,New initiation of sitagliptin
NCT06811844,Chemotherapy,Two-cycle induction chemotherapy + immunotherapy
NCT06811844,Chemotherapy,Three-cycle induction chemotherapy + immunotherapy
NCT06979544,Depressive disorder,LPCN
NCT06979544,Postpartum depression,LPCN
NCT06612944,Myelodysplastic syndrome,Prophylactic Intervention for Relapse Prevention Post-Allogeneic Transplantation
NCT07104344,Systemic lupus erythematosus,CM355
NCT06995144,Edema,Extended Release Torsemide Tablets
NCT06995144,Edema,Immedate Release Torsemide Tablets
NCT06995144,Heart failure,Extended Release Torsemide Tablets
NCT06995144,Heart failure,Immedate Release Torsemide Tablets
NCT06754644,Non-small cell lung carcinoma,QL2107
NCT06754644,Non-small cell lung carcinoma,pemetrexed
NCT06754644,Non-small cell lung carcinoma,carboplatin
NCT06754644,Non-small cell lung carcinoma,Keytruda®
NCT07047144,Proximal spinal muscular atrophy,Apitegromab
NCT07047144,Proximal spinal muscular atrophy,nusinersen
NCT07047144,Proximal spinal muscular atrophy,risdiplam
NCT07014644,Opiate dependence,0.9g Naltrexone Implant +
NCT07014644,Opiate dependence,1.5g Naltrexone Implant
NCT06758544,Malignant pancreatic neoplasm,Oncolytic virus VRT106
NCT06758544,Malignant pancreatic neoplasm,Chemotherapy
NCT07044544,Hematopoietic and lymphoid cell neoplasm,G-CSF
NCT07044544,Hematopoietic and lymphoid cell neoplasm,decitabine
NCT07044544,Hematopoietic and lymphoid cell neoplasm,venetoclax
NCT07044544,Myelodysplastic syndrome,G-CSF
NCT07044544,Myelodysplastic syndrome,decitabine
NCT07044544,Myelodysplastic syndrome,venetoclax
NCT07044544,Myeloid neoplasm,G-CSF
NCT07044544,Myeloid neoplasm,decitabine
NCT07044544,Myeloid neoplasm,venetoclax
NCT06794944,Inflammatory bowel disease,Vancomycin (POC)
NCT06794944,Inflammatory bowel disease,fidaxomicin
NCT06982040,IgA glomerulonephritis,NTQ5082 capsules
NCT06982040,IgA glomerulonephritis,NTQ5082 capsules
NCT06982040,IgA glomerulonephritis,NTQ5082 capsules
NCT06768840,Vitiligo-associated multiple autoimmune disease susceptibility 1,baricitinib
NCT06768840,Vitiligo-associated multiple autoimmune disease susceptibility 1,oral mini pulse
NCT06971744,Ovarian cancer,hydroxychloroquine
NCT06971744,Ovarian cancer,nelfinavir
NCT06971744,Ovarian cancer,bevacizumab
NCT07025044,Overactive bladder,onabotulinum toxin type a
NCT06861101,Allergic rhinitis,JT002 Nasal spray
NCT06660667,Wet macular degeneration,SAR402663
NCT06660667,Wet macular degeneration,Diluent
NCT06667167,Non-small cell lung carcinoma,Induction Carboplatin
NCT07131501,Hepatocellular carcinoma,Iparomlimab and Tuvonralimab Injection (QL1706)
NCT07131501,Hepatocellular carcinoma,lenvatinib
NCT06677801,Systemic lupus erythematosus,Telitacicept
NCT06754267,Precursor B-cell acute lymphoblastic leukemia,venetoclax
NCT06754267,Precursor B-cell acute lymphoblastic leukemia,Olverembatinib
NCT06754267,Precursor B-cell acute lymphoblastic leukemia,Predinisone
NCT06846567,Diabetes mellitus,BM2216 Extended-Release tablets（5.5mg）
NCT06846567,Diabetes mellitus,Mirogabalin Besilate Tablets
NCT06846567,Diabetes mellitus,BM2216 Extended-Release Tablets(11mg)
NCT06846567,Diabetes mellitus,BM2216 Extended-Release Tablets(16.5mg)
NCT06810167,Constipation disorder,tenapanor
NCT06810167,Cystic fibrosis,tenapanor
NCT07070167,Newborn respiratory distress syndrome,Intratracheal administration of surfactant
NCT07067801,Sudden sensorineural hearing loss,prednisone - oral corticosteroid
NCT06883240,Von Willebrand disease (hereditary or acquired),Von Willebrand Factor Concentrates
NCT06883240,Von Willebrand disease (hereditary or acquired),Von Willebrand Factor Concentrates and Factor VIII Concentrates
NCT06883240,Von Willebrand disease (hereditary or acquired),Factor VIII Concentrates
NCT06883240,Von Willebrand disease (hereditary or acquired),Recombinant Activated Factor VII
NCT06883240,Von Willebrand disease (hereditary or acquired),Activated Prothrombin Complex Concentrate
NCT06885840,Non-small cell lung carcinoma,MCLA-129
NCT06580301,Precursor B-cell acute lymphoblastic leukemia,YK012
NCT06847867,Myelodysplastic syndrome,momelotinib
NCT06832267,Primary central nervous system lymphoma,Rituximab-Methotrexate-Temozolomide-Thiotepa (RMTT)
NCT06758167,Major depressive disorder,XingpiJieyu formula
NCT06758167,Major depressive disorder,escitalopram
NCT06594640,Diffuse large B-cell lymphoma,Mitoxantrone Hydrochloride Liposome
NCT06594640,Diffuse large B-cell lymphoma,Rituximab (R)
NCT06594640,Diffuse large B-cell lymphoma,Cyclophosphamide (CTX)
NCT06594640,Diffuse large B-cell lymphoma,Vincristin
NCT06594640,Diffuse large B-cell lymphoma,prednisolone
NCT06716567,Influenza,Influenza vaccine
NCT07054567,Cervical carcinoma,BL-B01D1
NCT07054567,Cervical carcinoma,pembrolizumab
NCT07054567,Cervical carcinoma,bevacizumab
NCT07054567,Endometrial cancer,BL-B01D1
NCT07054567,Endometrial cancer,pembrolizumab
NCT07054567,Endometrial cancer,bevacizumab
NCT07123701,COVID-19,Tanshinone capsules
NCT07033767,Obesity disorder,genistein
NCT06937567,Biliary tract cancer,CDH17 CAR-T
NCT06937567,Gastric carcinoma,CDH17 CAR-T
NCT06937567,Pancreatic adenocarcinoma,CDH17 CAR-T
NCT07080567,Cerebrovascular disorder,maraviroc
NCT07080567,Cerebrovascular disorder,mannitol
NCT07080567,Ischemic stroke,maraviroc
NCT07080567,Ischemic stroke,mannitol
NCT07101367,Coronary artery disorder,dexmedetomidine
NCT07101367,Coronary artery disorder,methylprednisolone
NCT06934967,Paroxysmal nocturnal hemoglobinuria,LNP023
NCT06793189,Marginal zone lymphoma,Obinutuzumab and Orelabrutinib
NCT06793189,Marginal zone lymphoma,"Obinutuzumab, Orelabrutinib and Lenalidomide"
NCT06793189,Marginal zone lymphoma,Orelabrutinib
NCT06793189,Marginal zone lymphoma,Orelabrutinib
NCT06857240,Dermatomyositis,ruxolitinib Topical Cream
NCT07025889,Gastric carcinoma,IBI343
NCT07025889,Gastric carcinoma,Sintilimab
NCT07025889,Gastric carcinoma,oxaliplatin
NCT07025889,Gastric carcinoma,S-1
NCT06976229,Spinal cord injury,Allogeneic Human Induced Pluripotent Stem Cell (iPSC)-Derived Motor Neuron Progenitor Cells
NCT06846489,Mantle cell lymphoma,acalabrutinib
NCT06846489,Mantle cell lymphoma,rituximab
NCT07015489,Esophageal squamous cell carcinoma,induction chemotherapy and immunotherapy
NCT07014189,HIV infectious disease,Neviparine (NVP)/ Lamivudine (3TC)
NCT07116889,Asthma,GB-0895 (SC)
NCT07116889,Asthma,GB-0895 (SC)
NCT07116889,"COPD, severe early onset",GB-0895 (SC)
NCT07116889,"COPD, severe early onset",GB-0895 (SC)
NCT06629389,Parkinson disease,cannabidiol
NCT06629389,Parkinson disease,cannabidiol
NCT06629389,Parkinson disease,Cannabidiol
NCT06779929,Type 2 diabetes mellitus,tirzepatide
NCT06779929,Type 2 diabetes mellitus,dulaglutide
NCT06703840,Erectile dysfunction,LIB-01
NCT07101744,Nasopharyngeal carcinoma,Iparomlimab and Tuvonralimab
NCT06742840,Pain,HRS-2129
NCT07101640,Bronchopulmonary dysplasia,montelukast
NCT06671444,Insomnia,YZJ-1139
NCT06623240,Juvenile idiopathic arthritis,allogeneic Hope Biosciences adipose-derived mesenchymal stem cells
NCT07117240,Diabetes mellitus,lixisenatide + glargine
NCT07117240,Diabetes mellitus,Insulin Therapy
NCT06946940,Fibromyalgia,Cannabis Oil (5% THC/5% CBD)
NCT06728644,Polycystic ovary syndrome,L-arginine intervention
NCT06649240,Cholesterol,Statins and/or Ezetimibe
NCT06649240,Cholesterol,PCSK9 inhibitor
NCT06649240,Ischemic stroke,Statins and/or Ezetimibe
NCT06649240,Ischemic stroke,PCSK9 inhibitor
NCT06671340,Diabetes mellitus,Dorzagliatin
NCT06739044,Type 2 diabetes mellitus,Ozempic®
NCT06739044,Type 2 diabetes mellitus,HDG1901
NCT06947967,Lymphoma,"CHOP (cyclophosphamide, hydroxydaunorubicin [doxorubicin], Oncovin [vincristine], prednisone)"
NCT06947967,Lymphoma,Tucidinostat
NCT07132567,Mycosis fungoides,Poteligeo
NCT07001540,Diffuse large B-cell lymphoma,"Polatuzumab Vedotin combined with Rituximab, Gemcitabine, and Oxaliplatin (Pola-R- GemOx)"
NCT06614140,Cancer,Personalized Neoantigen Peptide Vaccine with Poly-ICLC and Checkpoint Inhibitors
NCT07105267,Autism,FMT Protocol
NCT06993740,Thrombotic disease,NaCl
NCT06993740,Thrombotic disease,dexmedetomidine
NCT06783881,Hypertriglyceridemia,Kylo-12
NCT06730581,Cholangiocarcinoma,Utidelone Capsule
NCT06730581,Cholangiocarcinoma,Utidelone capsule
NCT06730581,Cholangiocarcinoma,Utidelone Capsule
NCT06730581,Ovarian cancer,Utidelone Capsule
NCT06730581,Ovarian cancer,Utidelone capsule
NCT06730581,Ovarian cancer,Utidelone Capsule
NCT06807281,Atopic eczema,abrocitinib
NCT06924710,Non-small cell lung carcinoma,Standard Therapy
NCT07030881,Asthma,pMDI Triple Inhaler and Spacer
NCT07030881,Asthma,pMDI Triple Inhaler Only
NCT06776510,Autoimmune thrombocytopenic purpura,nicotinamide adenine dinucleotid/nicotinamide mononucleotide
NCT06719310,Infectious disease,ACC017+FTC/TAF
NCT07000110,Systemic lupus erythematosus,anifrolumab
NCT06778395,Gastroesophageal reflux disease,dexlansoprazole
NCT06778395,Gastroesophageal reflux disease,Vonoprazan
NCT06621095,Malignant pancreatic neoplasm,anlotinib + benmelstobart + nab-paclitaxel + gemcitabine
NCT06621095,Malignant pancreatic neoplasm,nab-paclitaxel + gemcitabine
NCT06859281,Pharyngitis,Grammidin neo
NCT06859281,Pharyngitis,"Grammidin, a metered dose topical spray"
NCT07019181,Esophageal cancer,tislelizumab
NCT07019181,Esophageal cancer,albumin-bound paclitaxel
NCT07019181,Esophageal cancer,Nedaplatin
NCT06833281,Alzheimer disease,SPG302
NCT06630481,Malignant pancreatic neoplasm,neoadjuvant therapy
NCT07041281,"Hypertension, pregnancy-induced",spironolactone
NCT07041281,Preeclampsia,spironolactone
NCT06628310,Esophageal adenocarcinoma,ABBV-400
NCT06628310,Esophageal adenocarcinoma,Budigalimab
NCT06628310,Esophageal adenocarcinoma,fluorouracil
NCT06628310,Esophageal adenocarcinoma,leucovorin
NCT06628310,Esophageal adenocarcinoma,oxaliplatin
NCT06628310,Gastroesophageal junction adenocarcinoma,ABBV-400
NCT06628310,Gastroesophageal junction adenocarcinoma,Budigalimab
NCT06628310,Gastroesophageal junction adenocarcinoma,fluorouracil
NCT06628310,Gastroesophageal junction adenocarcinoma,leucovorin
NCT06628310,Gastroesophageal junction adenocarcinoma,oxaliplatin
NCT06983210,Renal pelvis/ureter urothelial carcinoma,"Add-on effect of adding tamivarotene (AM80) to gemcitabine, cisplatin, and nivolumab combination therapy"
NCT07066995,Exocrine pancreatic carcinoma,Mesothelin and Claudin
NCT07066995,Malignant pancreatic neoplasm,Mesothelin and Claudin
NCT06690281,Cholangiocarcinoma,KRAS TCR-Transduced PBL
NCT06690281,Cholangiocarcinoma,aldesleukin
NCT06690281,Cholangiocarcinoma,fludarabine
NCT06690281,Cholangiocarcinoma,cyclophosphamide
NCT06690281,Malignant pancreatic neoplasm,KRAS TCR-Transduced PBL
NCT06690281,Malignant pancreatic neoplasm,aldesleukin
NCT06690281,Malignant pancreatic neoplasm,fludarabine
NCT06690281,Malignant pancreatic neoplasm,cyclophosphamide
NCT06690281,Pediatric hepatocellular carcinoma,KRAS TCR-Transduced PBL
NCT06690281,Pediatric hepatocellular carcinoma,aldesleukin
NCT06690281,Pediatric hepatocellular carcinoma,fludarabine
NCT06690281,Pediatric hepatocellular carcinoma,cyclophosphamide
NCT06772610,Non-small cell lung carcinoma,Ensartinib group
NCT06643910,Non-small cell lung carcinoma,Single drug group A
NCT06643910,Non-small cell lung carcinoma,Combined treatment group B
NCT07085195,Parkinson disease,clozapine
NCT06714981,Obesity disorder,Opioid Free Anaesthesia
NCT06714981,Obesity disorder,Opioid based Anesthesia
NCT06685081,Pain,dexmedetomidine
NCT06685081,Pain,dexmedetomidine
NCT06685081,Pain,dexmedetomidine
NCT06685081,Pain,dexmedetomidine
NCT06685081,Pain,lidocaine and triamcinolone
NCT07108881,Hypotensive disorder,C
NCT07108881,Hypotensive disorder,T
NCT07052981,IgA glomerulonephritis,Telitacicept
NCT07128381,Myelofibrosis,Axatilimab (SNDX-6352)
NCT07128381,Myelofibrosis,ruxolitinib
NCT06905210,Acne,Experimental drug
NCT06581081,Precursor B-cell acute lymphoblastic leukemia,Senl_B19 autologous CAR-T (S1904) treatment
NCT07059910,Autoimmune thrombocytopenic purpura,Steroid and eltrombopage
NCT06822881,Systemic lupus erythematosus,CAR-T Therapy
NCT06822881,Systemic sclerosis,CAR-T Therapy
NCT06586281,Psoriatic arthritis,guselkumab
NCT06903910,Parkinson disease,Donepezil (Aricept)
NCT06932081,Congenital heart disease,SGLT2 inhibitors
NCT06932081,Tetralogy of fallot,SGLT2 inhibitors
NCT06913881,Type 2 diabetes mellitus,GLP-1
NCT07072910,Migraine disorder,cabergoline
NCT07072910,Migraine disorder,Cabergoline
NCT06875310,Carcinoma,adagrasib
NCT06875310,Carcinoma,pembrolizumab
NCT06875310,Carcinoma,carboplatin
NCT06875310,Carcinoma,pemetrexed
NCT06875310,Carcinoma,cisplatin
NCT06762769,Smoldering plasma cell myeloma,isatuximab
NCT06762769,Smoldering plasma cell myeloma,Iberdomide
NCT06762769,Smoldering plasma cell myeloma,dexamethasone
NCT06656169,Arthritic joint disease,Subcutaneous polyvidone collagen
NCT07108868,B-cell chronic lymphocytic leukemia,CAR-T cells targeting CD19 and CD22
NCT07108868,Lymphoma,CAR-T cells targeting CD19 and CD22
NCT06820268,B-cell non-Hodgkin lymphoma,XS-04 tablet
NCT06820268,Childhood myelodysplastic syndrome,XS-04 tablet
NCT07077668,Amyotrophic lateral sclerosis,A sterile aqueous solution of RAG -
NCT06783569,Gastric carcinoma,JR8603
NCT07089368,Acne,Zn(II)-phthalocyanine gel
NCT06738368,Precursor B-cell acute lymphoblastic leukemia,ASPARAGINASE ERWINIA CHRYSANTHEMI
NCT06738368,Precursor B-cell acute lymphoblastic leukemia,cyclophosphamide
NCT06738368,Precursor B-cell acute lymphoblastic leukemia,doxorubicin
NCT06738368,Precursor B-cell acute lymphoblastic leukemia,etoposide
NCT06738368,Precursor B-cell acute lymphoblastic leukemia,filgrastim
NCT06738368,Precursor B-cell acute lymphoblastic leukemia,pegfilgrastim
NCT06738368,Precursor B-cell acute lymphoblastic leukemia,prednisone
NCT06738368,Precursor B-cell acute lymphoblastic leukemia,rituximab
NCT06738368,Precursor B-cell acute lymphoblastic leukemia,vincristine
NCT07025369,Prostate adenocarcinoma,relugolix
NCT06634069,Intracranial hypertension,sodium lactate
NCT06634069,Intracranial hypertension,3% NaCl
NCT06660069,Gingivitis,Stannous Fluoride Toothpaste (Parodontax Complete Protection Toothpaste)
NCT06660069,Gingivitis,CPC Mouthwash (Parodontax Active Gum Health Mouthwash)
NCT06660069,Gingivitis,Regular Fluoride Toothpaste (Crest Cavity Protection)
NCT06660069,Gingivitis,Stannous Fluoride Toothpaste (Parodontax Complete Protection Toothpaste)
NCT06765668,Parkinson disease,CREXONT ER
NCT06591468,Primary biliary cholangitis,prednisone
NCT06591468,Primary biliary cholangitis,UDCA (Ursodeoxycholic acid)
NCT07103668,Gastric adenocarcinoma,CAR T cells
NCT07103668,Gastric adenocarcinoma,Control
NCT06612268,Sickle cell disease,Etavopivat
NCT06673069,Down syndrome,ION269
NCT06994169,Large B-cell lymphoma,glofitamab
NCT06862869,Carcinoma,alectinib
NCT06647069,Barrett esophagus,DR-0201
NCT06647069,Dermatomyositis,DR-0201
NCT06647069,Scleroderma,DR-0201
NCT06647069,Sjogren syndrome,DR-0201
NCT06647069,Systemic lupus erythematosus,DR-0201
NCT06647069,Systemic sclerosis,DR-0201
NCT07111468,Bronchitis,YHP2401
NCT07111468,Bronchitis,YHR2402
NCT07111468,Bronchitis,YHR2403
NCT06672068,Non-small cell lung carcinoma,TY-9591
NCT06672068,Non-small cell lung carcinoma,TY-9591
NCT06783868,Atrial fibrillation,"Market-approved AVNB, OAC and AAD"
NCT06783868,Cerebrovascular disorder,"Market-approved AVNB, OAC and AAD"
NCT06792968,Maturity-onset diabetes of the young type 1,Empagliflozin + Metformin hydrochloride
NCT06792968,Maturity-onset diabetes of the young type 1,Synjardy
NCT06976268,Parkinson disease,BHV-8000
NCT06976268,Parkinson disease,BHV-8000
NCT06933368,Gingivitis,Crest Cavity Protection Toothpaste
NCT06933368,Gingivitis,Experimental Mouthwash
NCT06790368,Allergic disease,VENOX
NCT06851468,Helicobacter pylori,Keverprazan
NCT06851468,Helicobacter pylori,esomeprazole
NCT06851468,Helicobacter pylori,amoxicillin
NCT06644768,Non-small cell lung carcinoma,valemetostat tosylate
NCT06644768,Non-small cell lung carcinoma,pembrolizumab
NCT07030868,Obesity disorder,LY6249492
NCT07030868,Type 2 diabetes mellitus,LY6249492
NCT06824168,Leukemia,Quizartinib High Dose
NCT06824168,Leukemia,Quizartinib Low Dose
NCT06830668,HIV infectious disease,Regimen：BIC+FTC+TAF
NCT07068568,Basal cell carcinoma,sonidegib
NCT06794268,Follicular lymphoma,lisocabtagene maraleucel
NCT06835569,Cancer,ALTA3263
NCT06835569,Non-small cell lung carcinoma,ALTA3263
NCT07041268,Diabetes mellitus,rituximab
NCT06748872,Ovarian carcinoma,Lymphodepletion
NCT06748872,Ovarian carcinoma,TCR-T cells (MDG1015)
NCT06748872,Soft tissue sarcoma,Lymphodepletion
NCT06748872,Soft tissue sarcoma,TCR-T cells (MDG1015)
NCT06609668,Polymyalgia rheumatica,Additional blood samples
NCT06609668,Temporal arteritis,Additional blood samples
NCT06984146,Hodgkins lymphoma,nivolumab
NCT06984146,Hodgkins lymphoma,doxorubicin
NCT06984146,Hodgkins lymphoma,vinblastine
NCT06984146,Hodgkins lymphoma,dacarbazine
NCT07121569,Ischemic stroke,Oral lumbrokinase DLBS1033
NCT07077369,Hepatocellular carcinoma,WGc-0201 injection
NCT07077369,Hepatocellular carcinoma,tislelizumab
NCT06972069,Kidney failure,"Conditioning Regimen (Rituxan, Siplizumab, Cyclophosphamide, Tegoprubart)"
NCT06968546,Pain,Intranasal Sufentanil
NCT06968546,Pain,Intranasal Ketamine (IN)
NCT06886269,Pain,14C-VX-993
NCT07064668,Hepatocellular carcinoma,TUDCA (Tauroursodeoxycholic Acid) Supplementation
NCT07064668,Hepatocellular carcinoma,Immune checkpoint inhibitor (ICI)
NCT07121946,Diffuse large B-cell lymphoma,LTZ-301
NCT07121946,Diffuse large B-cell lymphoma,LTZ-301
NCT07121946,Diffuse large B-cell lymphoma,LTZ-301
NCT07121946,Follicular lymphoma,LTZ-301
NCT07121946,Follicular lymphoma,LTZ-301
NCT07121946,Follicular lymphoma,LTZ-301
NCT07121946,Mantle cell lymphoma,LTZ-301
NCT07121946,Mantle cell lymphoma,LTZ-301
NCT07121946,Mantle cell lymphoma,LTZ-301
NCT07121946,Marginal zone lymphoma,LTZ-301
NCT07121946,Marginal zone lymphoma,LTZ-301
NCT07121946,Marginal zone lymphoma,LTZ-301
NCT06736769,Anorexia nervosa,Ketamine infusion
NCT07073768,Maturity-onset diabetes of the young type 1,Trelagliptin
NCT07073768,Maturity-onset diabetes of the young type 1,Sitagliptin
NCT07115069,Obesity disorder,GLP-1 receptor agonist
NCT06718569,Arthritic joint disease,Biological or targeted synthetic DMARD
NCT06718569,Spondyloarthropathy,Biological or targeted synthetic DMARD
NCT06665568,Anxiety,Intranasal ketamine hydrochloride
NCT07082868,Primary central nervous system lymphoma,ibrutinib
NCT07082868,Primary central nervous system lymphoma,epcoritamab
NCT06972446,Rheumatoid arthritis,Lutikizumab
NCT06972446,Rheumatoid arthritis,Ravagalimab
NCT07086469,Esophageal squamous cell carcinoma,Neoadjuvant immunochemotherapy
NCT07086469,Esophageal squamous cell carcinoma,Surufatinib Administration
NCT07086469,Esophageal squamous cell carcinoma,Concurrent Chemotherapy
NCT06590246,Hepatocellular carcinoma,Armored and GPC3-targeted autologous CAR T-cell
NCT06711146,Systemic lupus erythematosus,Metabolically Armed CD19 CAR-T cells
NCT07019246,Hypertensive disorder,EP mixture
NCT07019246,Hypertensive disorder,propofol
NCT06812546,Heart failure,vericiguat
NCT06609369,Insomnia,varenicline
NCT06797869,Diabetes mellitus,CagriSema (Cagrilintide B and Semaglutide I)
NCT06617169,Childhood bladder carcinoma,MNPR-101-PCTA-177Lu
NCT06617169,Gastric carcinoma,MNPR-101-PCTA-177Lu
NCT06617169,Malignant pancreatic neoplasm,MNPR-101-PCTA-177Lu
NCT06617169,Ovarian cancer,MNPR-101-PCTA-177Lu
NCT06617169,Triple-negative breast carcinoma,MNPR-101-PCTA-177Lu
NCT06617169,Urothelial carcinoma,MNPR-101-PCTA-177Lu
NCT06680869,Cardiac arrest,amiodarone hydrochloride Injection
NCT06752746,Acquired polycythemia vera,9MW3011
NCT06984068,Rotator cuff syndrome,vitamin D
NCT06608368,Dentin sensitivity,Test Dentifrice (Sensodyne Repair and Protect Original Mint)
NCT06608368,Dentin sensitivity,Positive Control Dentifrice (Sensodyne Fresh Mint)
NCT06608368,Dentin sensitivity,Reference Dentifrice (Crest Cavity Protection Regular)
NCT06867146,Malignant pancreatic neoplasm,Three-drug chemotherapy group
NCT06867146,Malignant pancreatic neoplasm,two-drug chemotherapy group
NCT07030569,HER2 positive breast carcinoma,Trastuzumab deruxtecan (DS-8201a)
NCT06919510,Rectum adenocarcinoma,lvonescimab
NCT06919510,Rectum adenocarcinoma,CAPOX (oxaliplatin/capecitabine)
NCT06952712,Preeclampsia,Aspirin
NCT06952712,Preeclampsia,Aspirin
NCT06853912,Post-traumatic stress disorder,Psilocybin
NCT06608212,Type 2 diabetes mellitus,"Finerenone (Kerendia, BAY948862)"
NCT06608212,Type 2 diabetes mellitus,Others except finerenone
NCT06957210,Post-traumatic stress disorder,SSRIs
NCT06785012,Depressive disorder,JNJ-89495120
NCT06787612,Ovarian cancer,Ubamatamab
NCT06787612,Ovarian cancer,bevacizumab
NCT06787612,Ovarian cancer,cemiplimab
NCT06787612,Ovarian cancer,Fianlimab
NCT06787612,Ovarian cancer,PLD
NCT06787612,Ovarian cancer,sarilumab
NCT06735781,Non-small cell lung carcinoma,nivolumab
NCT06620510,Hepatocellular carcinoma,Immuncell-LC
NCT06620510,Hepatocellular carcinoma,No Interventions
NCT06918912,Diffuse large B-cell lymphoma,Loncastuximab Tesirine (Anti-CD19 Antibody-Drug Conjugate)
NCT06918912,High grade B-cell lymphoma,Loncastuximab Tesirine (Anti-CD19 Antibody-Drug Conjugate)
NCT06833112,Ankylosing spondylitis,secukinumab
NCT06833112,Ankylosing spondylitis,adalimumab
NCT06802081,Atrial fibrillation,tirzepatide
NCT06802081,Obesity disorder,tirzepatide
NCT07085481,Cataract,room temperature Bupivacaine
NCT07085481,Cataract,warm Bupivacaine
NCT06830395,IgA glomerulonephritis,CM313
NCT06970795,Small cell lung carcinoma,SYS6040 for injection
NCT06643481,Amyotrophic lateral sclerosis,VHB937
NCT06757881,Hepatocellular carcinoma,Gene modified anti-IL1RAP Chimeric Antigen Receptor T Cells :1.0×10^8(First dose group)
NCT06757881,Hepatocellular carcinoma,Gene modified anti-IL1RAP Chimeric Antigen Receptor T Cells :2.5×10^8(Second dose group)
NCT06757881,Hepatocellular carcinoma,Gene modified anti-IL1RAP Chimeric Antigen Receptor T Cells :5.0×10^8（Third dose group）
NCT06687681,Malignant glioma,NK cell therapy
NCT06831981,Rectal carcinoma,Chemotherapy with
NCT06831981,Rectal carcinoma,Consolidation chemotherapy with FOLFOX
NCT06773481,Malignant glioma,BC008-1A
NCT06773481,Malignant glioma,BC008-1A
NCT06910072,Triple-negative breast carcinoma,paclitaxel polymeric micelles + carboplatin + iparomilimab and tuvonralimab
NCT06975072,Pain,Magnesium sulfate administration
NCT07043972,Urothelial carcinoma,gemcitabine
NCT07043972,Urothelial carcinoma,carboplatin
NCT06841172,Hepatocellular carcinoma,Systemic therapy (Continuation of current first-line systemic therapy)
NCT06841172,Hepatocellular carcinoma,Systemic therapy (Early switch to second-line systemic therapy)
NCT06695572,Type 2 diabetes mellitus,CKD-383
NCT06669169,Heart failure,Low dose Jia Shen Tablet
NCT06669169,Heart failure,High dose Jia Shen Tablet
NCT06885268,Hypotensive disorder,noradrenaline infusion for management blood pressure
NCT06995872,Neuroblastoma,rhIL-15
NCT06995872,Neuroblastoma,Dinituximab
NCT06995872,Neuroblastoma,temozolomide
NCT06995872,Neuroblastoma,irinotecan hydrochloride
NCT06859268,Obesity disorder,Retatrutide
NCT06607172,Gingivitis,Cetylpyridinium Chloride (CPC)
NCT06949072,Dental caries,Test Dentifrice
NCT06949072,Dental caries,Reference Dentifrice
NCT06949072,Dental caries,Negative Control Dentifrice
NCT07072572,Ascites,Lower albumin dosage
NCT07072572,Cirrhosis of liver,Lower albumin dosage
NCT06807268,Atopic eczema,abrocitinib
NCT06796868,Endogenous depression,GW117 Tablets
NCT06796868,Endogenous depression,GW117 Tablets
NCT06796868,Endogenous depression,GW117 Tablets
NCT06703268,Type 2 diabetes mellitus,HSK7653
NCT06703268,Type 2 diabetes mellitus,Daily DPP-4 inhibitor
NCT06972472,Obesity disorder,Orforglipron
NCT06972472,Type 2 diabetes mellitus,Orforglipron
NCT06976372,Obesity disorder,AMG
NCT06943872,B-cell chronic lymphocytic leukemia,Sonrotoclax
NCT06943872,B-cell chronic lymphocytic leukemia,obinutuzumab
NCT06943872,B-cell chronic lymphocytic leukemia,rituximab
NCT06943872,B-cell chronic lymphocytic leukemia,venetoclax
NCT06864104,Hypertensive disorder,Tonlamarsen
NCT07085104,Lupus nephritis,Cyclophophamide
NCT07085104,Systemic lupus erythematosus,Cyclophophamide
NCT07085104,Systemic sclerosis,Cyclophophamide
NCT06835504,Abdominal pain,ketamine hydrochloride
NCT06835504,Abdominal pain,Morphine sulphate
NCT06835504,Pain,ketamine hydrochloride
NCT06835504,Pain,Morphine sulphate
NCT06757504,Autism,TTYP01 Tablets (12mg or
NCT06754501,Cancer,atezolizumab
NCT06754501,Cancer,Tiragolumab
NCT07030101,Hypertensive disorder,TCA108
NCT07030101,Hypertensive disorder,Bramicar HCT
NCT06718101,Atopic eczema,Lutikizumab
NCT06789172,Non-small cell lung carcinoma,OKN4395
NCT06789172,Non-small cell lung carcinoma,H2 Receptor Antagonist
NCT06789172,Pancreatic adenocarcinoma,OKN4395
NCT06789172,Pancreatic adenocarcinoma,H2 Receptor Antagonist
NCT06789172,Sarcoma,OKN4395
NCT06789172,Sarcoma,H2 Receptor Antagonist
NCT06952504,Endometrial cancer,pembrolizumab
NCT06952504,Endometrial cancer,carboplatin
NCT06952504,Endometrial cancer,paclitaxel
NCT06952504,Endometrial cancer,docetaxel
NCT06952504,Endometrial cancer,Sacituzumab Tirumotecan
NCT06947304,Metabolic dysfunction-associated steatohepatitis,Miricorilant
NCT06947304,Metabolic dysfunction-associated steatotic liver disease,Miricorilant
NCT06881472,Type 1 diabetes mellitus,Glucose-dependent Insulinotropic Polypeptide (GIP)
NCT06881472,Type 1 diabetes mellitus,alanine
NCT07107204,Leukemia,BT02
NCT07107204,Lymphoma,BT02
NCT06699472,Ewing sarcoma,Chemotherapy
NCT06699472,Ewing sarcoma,trilaciclib Injection [Cosela]
NCT06838104,Psychotic disorder,melatonin
NCT06851104,Hepatocellular carcinoma,Cadonilimab (AK104)
NCT06725004,Polycystic ovary syndrome,oxytocin
NCT06725004,Polycystic ovary syndrome,human chorionic gonadotropin
NCT06764004,Periapical periodontitis,Bleeding and clots
NCT06769204,Infertility disorder,EMLA SPRAY
NCT06943404,Post-traumatic stress disorder,BXCL501 (dexmedetomidine HCl)
NCT06657404,Atrial fibrillation,"use Amiodarone, Bisoprolol and Digoxin"
NCT06940401,Non-small cell lung carcinoma,JS111 capsules (AP-L1898)
NCT07098104,Gastric carcinoma,Immunotherapy
NCT06939504,Pulmonary fibrosis,HRS-9813 Capsule
NCT06939504,Pulmonary fibrosis,HRS-9813 Tablet
NCT06826872,Hypertensive disorder,SPC
NCT06826872,Hypertensive disorder,SPC
NCT06826872,Hypertensive disorder,SPC
NCT06826872,Hypertensive disorder,SPC
NCT06957704,Depressive disorder,ketamine
NCT06957704,Depressive disorder,midazolam
NCT06941272,Childhood malignant neoplasm,Patritumab Deruxtecan
NCT06717204,Myocardial infarction,vericiguat Oral Tablet [Verquvo]
NCT06717204,Myocardial infarction,Prescription Drugs
NCT06800404,Multiple sclerosis,Autologous HB-adMSCs
NCT06727604,Graves disease,IMVT-1402
NCT06727604,Graves disease,IMVT-1402
NCT06942104,Malignant glioma,18F-TRX
NCT06731504,Hematopoietic and lymphoid cell neoplasm,abatacept
NCT06712472,Endometrial cancer,Olaparib (300 mg BID)
NCT06682572,Ovarian cancer,Avutometinib (VS-6766) + Defactinib (VS-6063)
NCT06640972,Cholesterol,RDX-002
NCT06712004,Cerebrovascular disorder,Bevifibatide citrate injection
NCT06712004,Ischemic stroke,Bevifibatide citrate injection
NCT06908304,Carcinoma,6-Thio-2'-Deoxyguanosine
NCT06908304,Carcinoma,cemiplimab
NCT06908304,Carcinoma,docetaxel
NCT06908304,Carcinoma,vinorelbine
NCT06908304,Carcinoma,Gemcitabine alone
NCT06973772,Chikungunya,DENGUE: Dengue
NCT06973772,Chikungunya,DENGUE: Dengue
NCT06973772,Chikungunya,Chikungunya (CHIKV) live attenuated vaccine (VLA1555)
NCT06973772,Dengue disease,DENGUE: Dengue
NCT06973772,Dengue disease,DENGUE: Dengue
NCT06973772,Dengue disease,Chikungunya (CHIKV) live attenuated vaccine (VLA1555)
NCT06823804,"Familial acute respiratory distress syndrome, ANLN-related, dog",10ml of
NCT07115004,Von Willebrand disease (hereditary or acquired),VGA039
NCT06642272,Diabetes mellitus,empagliflozin
NCT06642272,Diabetes mellitus,dapagliflozin
NCT06642272,Heart failure,empagliflozin
NCT06642272,Heart failure,dapagliflozin
NCT06998004,Rabies,AVX70120 low dose level
NCT06998004,Rabies,AVX70120 middle dose level
NCT06998004,Rabies,AVX70120 high dose level
NCT06998004,Rabies,AVX70481 low dose level
NCT06998004,Rabies,AVX70481 middle dose level
NCT06998004,Rabies,AVX70481 high dose level
NCT07038369,Endometrial cancer,ATV-1601
NCT07038369,Endometrial carcinoma,ATV-1601
NCT07038369,Ovarian cancer,ATV-1601
NCT07038369,Ovarian carcinoma,ATV-1601
NCT07038369,Prostate carcinoma,ATV-1601
NCT07038369,Suppressor of tumorigenicity 3,ATV-1601
NCT07038369,Tumor of uterus,ATV-1601
NCT06990568,Diarrheal disease,Lacidofil
NCT06990568,Pneumonia,Lacidofil
NCT06974968,Spinal cord injury,Allogeneic Human Induced Pluripotent Stem Cell (iPSC)-Derived Motor Neuron Progenitor Cells
NCT06961968,Schizophrenia,iloperidone
NCT06933472,End stage renal failure,AP301
NCT06933472,End stage renal failure,AP301 Low Dose
NCT06772168,Inherited lipid metabolism disorder,CMG190303(Dapagliflozin/Rosuvastatin)
NCT06772168,Inherited lipid metabolism disorder,Comparator
NCT06772168,Type 2 diabetes mellitus,CMG190303(Dapagliflozin/Rosuvastatin)
NCT06772168,Type 2 diabetes mellitus,Comparator
NCT06734572,Childhood malignant neoplasm,18F-FAPIBiotin
NCT06907472,Type 2 diabetes mellitus,Protocol-based treatment
NCT06865768,Prostate carcinoma,Flotufolastat F-18 Gallium
NCT06841068,Multiple sclerosis,Amniotic fluid or placental CD117 stem cells
NCT06945068,Systemic lupus erythematosus,GB261
NCT06822868,B-cell non-Hodgkin lymphoma,CAR T cells
NCT06594068,Systemic lupus erythematosus,anifrolumab
NCT07015268,Endometriosis,KLH-2109
NCT07015268,Endometriosis,Leuprorelin acetate
NCT06791772,Systemic lupus erythematosus,CM313 injection
NCT06791772,Systemic lupus erythematosus,CM313 injection
NCT06592768,Allergic asthma,Briquilimab
NCT06847568,ST-elevation myocardial infarction,Adrenaline
NCT06777472,Asthma,"The specific drug comes from ""GINA (2024)"""
NCT06626568,Frozen shoulder,Compound betamethasone Injection(Gluteal muscle injection)
NCT06626568,Frozen shoulder,Compound betamethasone Injection(Subacromial Ultrasound Guided injection)
NCT07055568,Malignant pancreatic neoplasm,iNKT
NCT06987968,Hepatic encephalopathy,VS-01 on top of SOC (Active Treatment Group)
NCT06987968,Hepatic encephalopathy,SOC
NCT06673368,Attention deficit-hyperactivity disorder,"NRCT-101SR, NRCT-202XR"
NCT06569368,Rectum adenocarcinoma,metronidazole
NCT06717672,Pain,Lidocaine
NCT06911372,Gestational diabetes,Intradermal Microdialysis
NCT06569472,Juvenile dermatomyositis,CD19-targetd CAR-T
NCT06839872,B-cell chronic lymphocytic leukemia,pirtobrutinib
NCT06839872,B-cell chronic lymphocytic leukemia,acalabrutinib
NCT06891872,Chickenpox,Vaicella Vaccine+DTaP on Day
NCT06891872,Chickenpox,Varicella vaccine+MMR on Day
NCT06891872,Chickenpox,Varicella Vaccine
NCT06834672,Fallopian tube carcinoma,IBI354
NCT06834672,Fallopian tube carcinoma,paclitaxel/Gemcitabine/Liposomal doxorubicin
NCT06882772,Congenital heart disease,2 mL SunButyrate-TG
NCT06882772,Congenital heart disease,4 mL SunButyrate-TG
NCT07112872,Type 2 diabetes mellitus,RO7795081
NCT07112872,Type 2 diabetes mellitus,semaglutide
NCT07128472,Psoriasis,Humira
NCT06672172,Type 2 diabetes mellitus,HRS-7535 tablet
NCT06672172,Type 2 diabetes mellitus,HRS-7535 tablet
NCT06672172,Type 2 diabetes mellitus,HRS-7535 tablet
NCT06594172,Cognitive impairment,memantine Oral Tablet
NCT06594172,Cognitive impairment,Pioglitazone
NCT06669572,Carcinoma,pembrolizumab
NCT06669572,Carcinoma,lenvatinib
NCT07065968,Autoimmune thrombocytopenic purpura,teriflunomide
NCT07065968,Autoimmune thrombocytopenic purpura,dexamethasone
NCT06826768,Prostate cancer,REGN5678
NCT06826768,Prostate cancer,cemiplimab
NCT06894472,Bruxism,Pharmacotherapy
NCT06616168,Bacterial vaginosis,"Antibiotic therapy after the results of antibiotic sensitivity test (Mostly Oxacillin, Benzylpenicillin, Ceftriaxone, Doxycycline, Clindamycin)"
NCT06616168,Bacterial vaginosis,"Antifungal therapy (Mostly Fluconazole, Nystatin, Amphotericin B)"
NCT07042672,Binge eating disorder,GLP-1
NCT07119372,Anemia,BCD-131 (pegdarbepoetin beta)
NCT07119372,Anemia,Mircera (methoxypolyethylene glycol-epoetin beta)
NCT06994572,Hepatocellular carcinoma,CT-01
NCT06994572,Hepatocellular carcinoma,everolimus
NCT06781372,Adult glioblastoma,Development and characterization of PDOs
NCT06781372,Adult glioblastoma,Evaluation of the effects of epigenetic and splicing inhibitors on viability and gene expression signatures of GBM PDOs and GSCs
NCT06781372,Glioma susceptibility 1,Development and characterization of PDOs
NCT06781372,Glioma susceptibility 1,Evaluation of the effects of epigenetic and splicing inhibitors on viability and gene expression signatures of GBM PDOs and GSCs
NCT06974110,Endometrial cancer,MOMA-341
NCT06974110,Endometrial cancer,irinotecan
NCT06974110,Endometrial cancer,Immunotherapy
NCT06974110,Gastric carcinoma,MOMA-341
NCT06974110,Gastric carcinoma,irinotecan
NCT06974110,Gastric carcinoma,Immunotherapy
NCT06677710,Multiple sclerosis,IDP-023
NCT06677710,Multiple sclerosis,ocrelizumab
NCT06677710,Multiple sclerosis,Interleukin-2
NCT06677710,Multiple sclerosis,cyclophosphamide
NCT06677710,Multiple sclerosis,fludarabine
NCT06677710,Multiple sclerosis,mesna
NCT06677710,Secondary progressive multiple sclerosis,IDP-023
NCT06677710,Secondary progressive multiple sclerosis,ocrelizumab
NCT06677710,Secondary progressive multiple sclerosis,Interleukin-2
NCT06677710,Secondary progressive multiple sclerosis,cyclophosphamide
NCT06677710,Secondary progressive multiple sclerosis,fludarabine
NCT06677710,Secondary progressive multiple sclerosis,mesna
NCT06963112,Anxiety,midazolam
NCT06963112,Delirium,midazolam
NCT06728410,Intrahepatic cholangiocarcinoma,pemigatinib
NCT06728410,Intrahepatic cholangiocarcinoma,durvalumab
NCT07096310,Sepsis,Meropenem I.V.
NCT07096310,Sepsis,Tazocin (pipercillin/tazobactam)
NCT06859710,Pain,THC
NCT06859710,Pain,CBD
NCT06859710,Pain,CBD
NCT06859710,Pain,CBD
NCT06896110,Adult glioblastoma,nivolumab
NCT06896110,Adult glioblastoma,Azacitidine (AZA)
NCT06896110,Glioma susceptibility 1,nivolumab
NCT06896110,Glioma susceptibility 1,Azacitidine (AZA)
NCT06592612,Hepatocellular carcinoma,Second-line systemic therapy
NCT06585410,Skin squamous cell carcinoma,cemiplimab
NCT07041112,Psoriasis,Biologic therapy for psoriasis
NCT07041112,Psoriatic arthritis,Biologic therapy for psoriasis
NCT07116746,Gout,AR882
NCT07116746,Gout,XOI Low Dose
NCT07116746,Gout,XOI High Dose
NCT07116746,Hyperuricemia,AR882
NCT07116746,Hyperuricemia,XOI Low Dose
NCT07116746,Hyperuricemia,XOI High Dose
NCT06666712,Malignant glioma,topotecan
NCT06652412,Malignant colon neoplasm,Ultrafractionated RT and CGA Guided systemic treatment.
NCT06652412,Malignant colon neoplasm,Sintilimab
NCT06652412,Malignant colon neoplasm,fluorouracil
NCT06652412,Malignant colon neoplasm,Raltitrexed
NCT06652412,Malignant colon neoplasm,oxaliplatin
NCT06652412,Malignant colon neoplasm,Irinotecan (CPT-11)
NCT06652412,Rectal carcinoma,Ultrafractionated RT and CGA Guided systemic treatment.
NCT06652412,Rectal carcinoma,Sintilimab
NCT06652412,Rectal carcinoma,fluorouracil
NCT06652412,Rectal carcinoma,Raltitrexed
NCT06652412,Rectal carcinoma,oxaliplatin
NCT06652412,Rectal carcinoma,Irinotecan (CPT-11)
NCT06996912,Atopic eczema,HSK44459
NCT07077512,Follicular lymphoma,Autoleucel (Relmacabtagene Autoleucel)
NCT07077512,Follicular lymphoma,Sintilimab (PD-1 inhibitor)
NCT07077512,Mantle cell lymphoma,Autoleucel (Relmacabtagene Autoleucel)
NCT07077512,Mantle cell lymphoma,Sintilimab (PD-1 inhibitor)
NCT07063212,Hypopharynx squamous cell carcinoma,sacituzumab govitecan
NCT07063212,Hypopharynx squamous cell carcinoma,cetuximab
NCT07063212,Laryngeal squamous cell carcinoma,sacituzumab govitecan
NCT07063212,Laryngeal squamous cell carcinoma,cetuximab
NCT07063212,Oropharynx squamous cell carcinoma,sacituzumab govitecan
NCT07063212,Oropharynx squamous cell carcinoma,cetuximab
NCT06775912,Acquired idiopathic inflammatory myopathy,RD06-05 CART Cell Injection
NCT06775912,Myasthenia gravis,RD06-05 CART Cell Injection
NCT06775912,Systemic lupus erythematosus,RD06-05 CART Cell Injection
NCT06775912,Systemic sclerosis,RD06-05 CART Cell Injection
NCT07019012,Type 2 diabetes mellitus,SGLT2i+Metformin+Cofrogliptin
NCT07019012,Type 2 diabetes mellitus,SGLT2i+Metformin+Linagliptin
NCT06989112,Endometrial cancer,trastuzumab deruxtecan
NCT06989112,Endometrial cancer,Rilvegostomig
NCT06989112,Endometrial cancer,pembrolizumab
NCT06989112,Endometrial cancer,carboplatin
NCT06989112,Endometrial cancer,paclitaxel
NCT06989112,Endometrial cancer,docetaxel
NCT07084610,Non-small cell lung carcinoma,Nivolumab
NCT07057310,Menopause,semaglutide or tirzepatide
NCT07057310,Obesity disorder,semaglutide or tirzepatide
NCT06584812,Ischemic stroke,Tiprogrel
NCT06584812,Ischemic stroke,Tiprogrel
NCT06584812,Ischemic stroke,clopidogrel
NCT06584812,Ischemic stroke,ticagrelor
NCT06748612,Poliomyelitis,Pentavalent vaccine
NCT06748612,Poliomyelitis,Hexavalent vaccine
NCT06748612,Poliomyelitis,Inactivated poliovirus vaccine (IPV)
NCT06748612,Poliomyelitis,Bivalent oral polio vaccine (bOPV)
NCT06748612,Poliomyelitis,Fractional IPV( fIPV)
NCT06651112,Metabolic disease,Antipsychotic drugs
NCT07025512,Anemia,177Lu-PSMA-617
NCT07025512,Thrombocytopenia,177Lu-PSMA-617
NCT06889012,Essential hypertension,BR1018
NCT06889012,Essential hypertension,BR1018A
NCT06889012,Essential hypertension,BR1018B
NCT06709612,Hernia,AMT-143 hydrogel containing containing ropivacaine
NCT06709612,Hernia,ropivacaine
NCT06635746,Fetal alcohol syndrome,Vinpocetine
NCT06993610,Hidradenitis suppurativa,Tibulizumab Dose A
NCT06993610,Hidradenitis suppurativa,Tibulizumab Dose B
NCT06790212,Malignant colon neoplasm,Ivonescimab
NCT06790212,Malignant colon neoplasm,oxaliplatin
NCT06790212,Malignant colon neoplasm,capecitabine
NCT06800612,Endometrial cancer,Oncologic drugs administered for treatment of breast cancer
NCT06800612,Endometrial cancer,Oncologic drug administered for treatment of gynecologic cancer
NCT06800612,Ovarian cancer,Oncologic drugs administered for treatment of breast cancer
NCT06800612,Ovarian cancer,Oncologic drug administered for treatment of gynecologic cancer
NCT06800612,Suppressor of tumorigenicity 3,Oncologic drugs administered for treatment of breast cancer
NCT06800612,Suppressor of tumorigenicity 3,Oncologic drug administered for treatment of gynecologic cancer
NCT06811012,Tuberculosis,Contezolid
NCT06811012,Tuberculosis,Linezolid (LZD)
NCT06845410,Coronary artery disorder,Secondary prevention for atherosclerotic coronary artery disease
NCT06845410,Coronary artery disorder,Immunosuppressive Therapy
NCT06845410,Coronary artery disorder,Supportive therapies
NCT06922110,Endogenous depression,Azetukalner
NCT06911710,Lymphoma,"CAR-T Cells infusion（CAR2219,CAR2019, CAR19 etc）"
NCT06911710,Precursor B-cell acute lymphoblastic leukemia,"CAR-T Cells infusion（CAR2219,CAR2019, CAR19 etc）"
NCT06794710,Dilated cardiomyopathy,"diuretics, ACEIs/ARBs, beta blockers, positive inotropic drugs, MRAs, SGLT2i, retinoids"
NCT06794710,Hypertrophic cardiomyopathy,"diuretics, ACEIs/ARBs, beta blockers, positive inotropic drugs, MRAs, SGLT2i, retinoids"
NCT07087912,Acquired idiopathic inflammatory myopathy,Dengue
NCT07087912,Antiphospholipid syndrome,Dengue
NCT07087912,Juvenile idiopathic arthritis,Dengue
NCT07087912,Psoriatic arthritis,Dengue
NCT07087912,Rheumatoid arthritis,Dengue
NCT07087912,Systemic lupus erythematosus,Dengue
NCT07087912,Systemic sclerosis,Dengue
NCT07087912,Takayasu arteritis,Dengue
NCT06774846,Pneumonia,Acetylsalicylic acid/Aspirin (100 mg)
NCT07004712,Small cell lung carcinoma,Adebelizumab combined with irinotecan liposome as second-line therapy
NCT06911112,Endogenous depression,NBI-1065845
NCT06600412,Diabetic kidney disease,R3R01
NCT06591312,Ischemic stroke,ticagrelor
NCT06591312,Ischemic stroke,clopidogrel
NCT06707012,Depressive disorder,metformin hydrochloride
NCT06773312,Gastroesophageal junction adenocarcinoma,BC001+Sintilimab+XELOX
NCT07024212,Metabolic dysfunction-associated steatotic liver disease,DR10624 Injection
NCT06781112,Nasopharyngeal carcinoma,"albumin paclitaxel (200mg/m2), cisplatin (60mg/m2, infused over"
NCT07095712,Amyotrophic lateral sclerosis,nL-TARD-001
NCT06747312,Antiphospholipid syndrome,Belimumab+SOC
NCT06747312,Antiphospholipid syndrome,SOC
NCT06701812,Medulloblastoma,digoxin
NCT07003646,Pulmonary embolism,alteplase
NCT07110246,Low grade glioma,dabrafenib
NCT07110246,Low grade glioma,trametinib
NCT07067346,Neuroblastoma,IR-101
NCT06798246,Renal pelvis/ureter urothelial carcinoma,Chemotherapy
NCT06798246,Renal pelvis/ureter urothelial carcinoma,Immunotherapy
NCT06798246,Renal pelvis/ureter urothelial carcinoma,ADC
NCT06798246,Renal pelvis/ureter urothelial carcinoma,Chemotherapy combined with immunotherapy
NCT06799169,Tinnitus,nortriptyline
NCT06799169,Tinnitus,topiramate
NCT06799169,Tinnitus,paroxetine
NCT06799169,Tinnitus,verapamil
NCT06767046,Non-small cell lung carcinoma,KRAS-specific Autologous TCR-T cell injection
NCT06683846,Neuroendocrine carcinoma,Ivocizumab
NCT06683846,Penile carcinoma,Ivocizumab
NCT06683846,Renal carcinoma,Ivocizumab
NCT06683846,Rhabdomyosarcoma,Ivocizumab
NCT06683846,Sarcoma,Ivocizumab
NCT06683846,Urothelial carcinoma,Ivocizumab
NCT06964269,Dry eye syndrome,CORTICOTROPIN
NCT06964269,Neurotrophic keratopathy,CORTICOTROPIN
NCT06613269,Nonpapillary renal cell carcinoma,68Ga-NY104 PET/CT
NCT06613269,Nonpapillary renal cell carcinoma,18F-FDG PET/CT
NCT06613269,Nonpapillary renal cell carcinoma,Systemic therapy
NCT06791746,Stomatitis,compound Staphylococcal lysostaphin mouthrinse
NCT06791746,Stomatitis,chlorhexidine mouthrinse
NCT06819046,Glaucoma,Rocklatan
NCT06819046,Glaucoma,Systane Ultra
NCT06621069,Osteoporosis,Bisphosphonates
NCT06855069,Ovarian cancer,HS-20089
NCT06855069,Ovarian cancer,paclitaxel
NCT06855069,Ovarian cancer,doxorubicin
NCT06855069,Ovarian cancer,topotecan
NCT06974669,Vitiligo-associated multiple autoimmune disease susceptibility 1,oral steroid-dexamethasone
NCT06782646,Hyperlipidemia,Berberine
NCT06645769,Diabetes mellitus,sodium phenylbutyrate
NCT06701669,"Familial acute respiratory distress syndrome, ANLN-related, dog",Cohort B: paridiprubart
NCT07008469,Myotonic dystrophy,Del-desiran (AOC
NCT06920069,Poliomyelitis,sIPV
NCT06920069,Poliomyelitis,DTaP
NCT06920069,Poliomyelitis,bOPV
NCT06920069,Poliomyelitis,MMR Vaccine
NCT06629246,Heart failure,Conventional heart failure treatment
NCT06629246,Heart failure,Pogejiuxin decoction combined with conventional heart failure treatment
NCT07072169,B-cell non-Hodgkin lymphoma,ABO2203 Injection
NCT06767969,Ischemic stroke,acetaminophen
NCT06653946,Ischemic stroke,alteplase
NCT06653946,Ischemic stroke,alteplase
NCT06976346,Parkinson disease,"HRG2010 Capsule, Sinemet®, Madopar®"
NCT06903546,Maturity-onset diabetes of the young type 1,Propolis drops
NCT06848569,Classic Hodgkin lymphoma,Sintilimab in combination with AVD chemotherapy
NCT06902246,Hepatocellular carcinoma,regorafenib
NCT07075146,Obesity disorder,DOR/3TC/TDF
NCT07075146,Obesity disorder,BIC/FTC/TAF
NCT06982846,Type 2 diabetes mellitus,Retatrutide
NCT07038746,Allergic disease,Inhaled Epinephrine
NCT06598969,Myelodysplastic syndrome,Total bone marrow and lymphoid irradiation/cyclophosphamide/etoposide
NCT06682169,Graft versus host disease,Rovadicitinib
NCT06682169,Graft versus host disease,imatinib
NCT06682169,Graft versus host disease,methotrexate
NCT06682169,Graft versus host disease,mycophenolate mofetil
NCT06682169,Graft versus host disease,rituximab
NCT07103369,Atopic eczema,SM17 for injection
NCT06763146,Type 2 diabetes mellitus,"Finerenone (Kerendia, BAY948862)"
NCT06825169,Interstitial lung disease,NCR101 injection
NCT06915246,Hodgkins lymphoma,VI-0609
NCT06915246,Hodgkins lymphoma,BiCNU
NCT06915246,Lymphoma,VI-0609
NCT06915246,Lymphoma,BiCNU
NCT06915246,Non-Hodgkin lymphoma,VI-0609
NCT06915246,Non-Hodgkin lymphoma,BiCNU
NCT06761846,Gastric adenocarcinoma,Sintilimab plus Chemotherapy
NCT06761846,Gastroesophageal junction adenocarcinoma,Sintilimab plus Chemotherapy
NCT07054346,Prostate cancer,177 Lutetium Prostate-Specific Membrane Antigen
NCT07054346,Prostate cancer,Actinium-225 Prostate-Specific Membrane Antigen
NCT06936046,Adult glioblastoma,Dual antibody A
NCT06936046,Adult glioblastoma,Dual antibody B
NCT06936046,Adult glioblastoma,Stupp protocol
NCT07027969,Atrial fibrillation,Anti-Obesity Medication (AOM) treatment
NCT07012746,Hearing loss disorder,TJ0113 capsules
NCT07080346,Behcet disease,upadacitinib
NCT06928246,Atopic eczema,Onabotulinum Toxin Type A - Phase
NCT06928246,Atopic eczema,Onabotulinum Toxin Type A - Phase
NCT07116681,Pulmonary hypertension,Inhaled treprostinil
NCT06742281,COVID-19,CVXGA (CVXGA50)
NCT06742281,COVID-19,COMIRNATY®
NCT07026981,Malignant pancreatic neoplasm,[Ga-68]MTP220 PET/CT Scan
NCT06681181,Colitis,GSK4528287
NCT06731595,Atrial fibrillation,colchicine
NCT06651281,Colitis,Tulisokibart
NCT06577181,Paroxysmal familial ventricular fibrillation,hCG + estradiol
NCT06648681,Delirium,lemborexant
NCT06648681,Sleep,lemborexant
NCT06896981,Obesity disorder,Metformin with Semaglutide
NCT06977581,Asthma,PF-07275315
NCT06679881,Hereditary angioedema,Deucrictibant
NCT06854250,Metastatic prostate carcinoma,Cyclophosphamide (CTX)
NCT06971250,Pain,Capsaicin only (7.6 ng)
NCT06971250,Pain,Capsaicin + Flupirtine
NCT06971250,Pain,Capsaicin + Flupirtine
NCT06971250,Pain,Capsaicin + Flupirtine
NCT06971250,Pain,Capsaicin + Flupirtine
NCT06971250,Pain,Room Temperature Injection (Control)
NCT06971250,Pain,Heated injection without Flupirtine
NCT06971250,Pain,Heated Injection with Flupirtine
NCT07115043,Cutaneous neuroendocrine carcinoma,AZD6750
NCT07115043,Cutaneous neuroendocrine carcinoma,rilvegostomig
NCT07115043,Melanoma,AZD6750
NCT07115043,Melanoma,rilvegostomig
NCT07115043,Non-small cell lung carcinoma,AZD6750
NCT07115043,Non-small cell lung carcinoma,rilvegostomig
NCT07115043,Nonpapillary renal cell carcinoma,AZD6750
NCT07115043,Nonpapillary renal cell carcinoma,rilvegostomig
NCT07115043,Squamous cell carcinoma,AZD6750
NCT07115043,Squamous cell carcinoma,rilvegostomig
NCT07070050,Analgesic,Ibuprofen continuous infusion
NCT07070050,Analgesic,Ibuprofen bolus injection
NCT06683950,Age-related macular degeneration,Aflibercept
NCT06989203,Obesity disorder,semaglutide
NCT06989203,Weight loss,semaglutide
NCT06768138,Cerebrovascular disorder,Intra-arterial infusion of Alteplase
NCT06786338,IgA glomerulonephritis,SGB-9768
NCT06942143,Melanoma,Super1 TCR-T
NCT06942143,Sarcoma,Super1 TCR-T
NCT06652243,Hepatocellular carcinoma,SN301A
NCT06810050,Atopic eczema,CGB-500 with
NCT06810050,Atopic eczema,CGB-500 Ointment with
NCT06601595,Inflammatory bowel disease,TNF inhibitors
NCT06601595,Inflammatory bowel disease,conventional ibd medical treatment
NCT06649695,AL amyloidosis,teclistamab
NCT06756295,Melanoma,individualized tumor FAST vaccine combination (including adjuvant)
NCT07012395,Colitis,SPY001
NCT07012395,Colitis,SPY002
NCT07012395,Colitis,SPY003
NCT07007195,Nicotine dependence,Nicotine replacement therapy (NRT)
NCT07076095,Small cell lung carcinoma,IBB0979
NCT07076095,Small cell lung carcinoma,topotecan hydrochloride for injection
NCT06644781,Esophageal squamous cell carcinoma,Ifinatamab deruxtecan
NCT06644781,Esophageal squamous cell carcinoma,docetaxel
NCT06644781,Esophageal squamous cell carcinoma,paclitaxel
NCT06644781,Esophageal squamous cell carcinoma,Irinotecan hydrochloride (HCl)
NCT06981195,Insomnia,lemborexant
NCT06818981,Obstructive sleep apnea syndrome,8mg dexamethasone
NCT06789081,Alveolar soft part sarcoma,GCAR1
NCT06898814,Anemia,ferric derisomaltose
NCT06627595,Melanoma,Immunotherapy
NCT07078695,Psoriasis,SHR-1139 Injection
NCT07078695,Psoriasis,SHR-1139 Injection
NCT07078695,Psoriasis,SHR-1139 Injection
NCT06585995,COVID-19,vitamin D (cholecalciferol) supplementation
NCT07091695,Melanoma,Nivolumab + relatlimab
NCT07091695,Melanoma,Nivolumab + ipilimumab
NCT07011043,Systemic lupus erythematosus,Budoprutug
NCT06861543,Non-small cell lung carcinoma,TMT101 Injection
NCT06817343,Wet macular degeneration,Aflibercept (2.0 mg)
NCT07014943,Primary central nervous system lymphoma,"High dose Gemcitabine, Busulfan, and Thiotepa as conditioning therapy"
NCT06925243,Gastric carcinoma,Neoadjuvant apatinib combined with sintilimab and perioperative SOX
NCT06925243,Gastric carcinoma,Neoadjuvant sintilimab combined with perioperative SOX
NCT06818643,Childhood malignant neoplasm,MK-3120
NCT06998043,Cystic fibrosis,BX004
NCT06775743,Non-small cell lung carcinoma,ORIENT-31 regimen
NCT06673043,Lupus erythematosus,anifrolumab
NCT06999343,"COPD, severe early onset",Metformin
NCT06609343,End stage renal failure,bupropion hydrochloride
NCT06756243,Allergic rhinitis,Budesonide Nasal Spray therapy
NCT06655246,Gastrointestinal stromal tumor,ziftomenib
NCT06655246,Gastrointestinal stromal tumor,Imatinib Mesylate
NCT07043946,Autoimmune thrombocytopenic purpura,Budoprutug
NCT06617312,Nicotine dependence,Cytisinicline
NCT06969612,Non-small cell lung carcinoma,tislelizumab
NCT06969612,Non-small cell lung carcinoma,pemetrexed
NCT06969612,Non-small cell lung carcinoma,cisplatin
NCT06969612,Non-small cell lung carcinoma,carboplatin
NCT06969612,Non-small cell lung carcinoma,paclitaxel
NCT06969612,Non-small cell lung carcinoma,Albumin Paclitaxel
NCT06969612,Non-small cell lung carcinoma,Golidocitinib
NCT06717412,Exudative vitreoretinopathy 1,Conbercept
NCT06861712,Oropharynx squamous cell carcinoma,"Docetaxel, Cisplatin, Toripalimab"
NCT06963346,Childhood bladder carcinoma,romidepsin
NCT06963346,Childhood bladder carcinoma,durvalumab
NCT07006246,HIV infectious disease,Tenofovir disoproxil fumarate + lamivudine/emtricitabine (TDF+3TC /FTC)
NCT06737146,Malignant glioma,MT027 cells suspension
NCT07081646,AL amyloidosis,AZD0120
NCT07081646,Amyloidosis,AZD0120
NCT06947746,Rheumatoid arthritis,hiSCs
NCT06670846,Anxiety,distraction using intranasal Midazolam
NCT07000695,Atherosclerotic cardiovascular disease,Pelacarsen
NCT06788314,Pain,enalapril
NCT06936995,Pain,Preemptive Multimodal Intravenous Analgesia
NCT06819514,Fabry disease,EXG110 Injection
NCT07068295,Diabetes mellitus,NNC0471-0119 H
NCT07068295,Diabetes mellitus,"insulin aspart, human"
NCT06960395,EGFR,VIR-5525
NCT06960395,EGFR,pembrolizumab
NCT07122895,Schizophrenia,NMDAE
NCT06709495,Osteosarcoma,PEEL-224
NCT06709495,Osteosarcoma,temozolomide
NCT06709495,Osteosarcoma,vincristine
NCT06709495,Osteosarcoma,pegfilgrastim
NCT06709495,Osteosarcoma,filgrastim
NCT06709495,Rhabdomyosarcoma,PEEL-224
NCT06709495,Rhabdomyosarcoma,temozolomide
NCT06709495,Rhabdomyosarcoma,vincristine
NCT06709495,Rhabdomyosarcoma,pegfilgrastim
NCT06709495,Rhabdomyosarcoma,filgrastim
NCT06709495,Sarcoma,PEEL-224
NCT06709495,Sarcoma,temozolomide
NCT06709495,Sarcoma,vincristine
NCT06709495,Sarcoma,pegfilgrastim
NCT06709495,Sarcoma,filgrastim
NCT06987695,Obesity disorder,Maridebart cafraglutide
NCT06929143,Diabetic macular edema,"Aflibercept (Eylea, BAY86-5321)"
NCT06929143,Wet macular degeneration,"Aflibercept (Eylea, BAY86-5321)"
NCT07050043,Non-small cell lung carcinoma,Nivolumab
NCT07050043,Non-small cell lung carcinoma,"Cisplatin, Carboplatin, Pemetrexed, Gemcitabine, Paclitaxel, Docetaxel"
NCT06936943,Richter syndrome,ONO-4538
NCT07032038,Sensorineural hearing loss disorder,Otic neural progenitors
NCT06624943,Type 1 diabetes mellitus,biosimilar insulin glargine
NCT06895538,Leukemia,Rabbit Anti-Human T-Lymphocyte Immunoglobulin (ATLG)
NCT06895538,Lymphoma,Rabbit Anti-Human T-Lymphocyte Immunoglobulin (ATLG)
NCT06895538,Myelodysplastic syndrome,Rabbit Anti-Human T-Lymphocyte Immunoglobulin (ATLG)
NCT06838143,Systemic-onset juvenile idiopathic arthritis,Ilaris
NCT06876038,Lip and oral cavity carcinoma,5-Amino Levulinic Acid
NCT06814938,Obesity disorder,semaglutide
NCT06718543,Rectal carcinoma,AK112 with SCRT and CapeOX
NCT06718543,Rectal carcinoma,AK112 with SCRT
NCT07029438,Gingivitis,Mouthwash
NCT07029438,Gingivitis,Toothpaste
NCT06571708,Childhood bladder carcinoma,gemcitabine
NCT06571708,Childhood bladder carcinoma,cisplatin
NCT06571708,Childhood bladder carcinoma,cemiplimab
NCT06571708,Childhood bladder carcinoma,Fianlimab
NCT06719908,Alcohol,"AFA-281 is a small molecule, orally available"
NCT06885723,Sudden sensorineural hearing loss,local anesthetic cream
NCT06885723,Sudden sensorineural hearing loss,lidocaine spray
NCT06653023,Hepatocellular carcinoma,Universal CAR-T cells injection for treating HCC and NSCLC
NCT06653023,Non-small cell lung carcinoma,Universal CAR-T cells injection for treating HCC and NSCLC
NCT06714123,Pulmonary fibrosis,Senicapoc
NCT06987123,Nasopharyngeal carcinoma,toripalimab
NCT06987123,Nasopharyngeal carcinoma,capecitabine
NCT07076550,Uveal melanoma,[225Ac]Ac-A9-3408
NCT06653608,Dental pulp necrosis,Nano-reinforced calcium hydroxide medicament
NCT06653608,Dental pulp necrosis,Calcium hydroxide without nanoparicles
NCT06710223,Hepatocellular carcinoma,SD-101
NCT06710223,Hepatocellular carcinoma,tremelimumab
NCT06710223,Hepatocellular carcinoma,durvalumab
NCT06842823,Hereditary angioedema,navenibart
NCT06732323,Triple-negative breast carcinoma,ESG401
NCT06732323,Triple-negative breast carcinoma,Investigator's Choice Chemotherapy
NCT06712823,Congenital adrenal hyperplasia,atumelnant (CRN04894)
NCT06681623,Multiple sclerosis,ublituximab
NCT06869850,Cognitive impairment,amoxicillin
NCT06869850,Cognitive impairment,Sulfadoxine (12.5 mg)/Pyrimethamine (250 mg)
NCT06869850,Cognitive impairment,Artemether+Lumefantrine
NCT06933329,Non-small cell lung carcinoma,Zelenectide pevedotin (BT8009)
NCT06855589,Prostate cancer,6 months of Eligard
NCT06855589,Prostate cancer,12 months of Eligard
NCT06713889,Aortic valve stenosis,Biocollection
NCT06850740,Hernia,Ondansetron
NCT06884540,Pain,dexmedetomidine
NCT06884540,Pain,lidocaine
NCT06650540,Paroxysmal familial ventricular fibrillation,Levofloxacin Plus Metronidazole Suppositories
NCT06650540,Paroxysmal familial ventricular fibrillation,Levofloxacin co-administered with Metronidazole tablets
NCT06673329,Female reproductive organ cancer,brodalumab
NCT06673329,Gastric carcinoma,brodalumab
NCT06673329,Lip and oral cavity carcinoma,brodalumab
NCT06673329,Malignant colon neoplasm,brodalumab
NCT06673329,Malignant pancreatic neoplasm,brodalumab
NCT06673329,Prostate cancer,brodalumab
NCT06673329,Rectal carcinoma,brodalumab
NCT06673329,Renal carcinoma,brodalumab
NCT06673329,Skin cancer,brodalumab
NCT06673329,Testicular cancer,brodalumab
NCT06783829,Prostate cancer,SHR4394
NCT06623929,Ankle injury,Etofenamat
NCT06623929,Ankle injury,diclofenac
NCT06620029,Endometrial cancer,BMX-001
NCT06620029,Endometrial cancer,Paclitaxel (Taxol)
NCT07101029,Periapical periodontitis,Bio-C Temp Intracanal Medication
NCT07101029,Periapical periodontitis,Calcium Hydroxide Intracanal medication
NCT07063329,Non-small cell lung carcinoma,PLB1004
NCT07063329,Non-small cell lung carcinoma,PLB1004
NCT07063329,Non-small cell lung carcinoma,RP2D of PLB1004 oral once daily Combined with Platinum-Based Chemotherapy
NCT07063329,Non-small cell lung carcinoma,RP2D of PLB1004 oral once daily Combined with Platinum-Based Chemotherapy
NCT06960629,Glaucoma,Netarsudil
NCT07023029,Sickle cell disease,Etavopivat
NCT07023029,Sickle cell disease,moxifloxacin
NCT07023029,Thalassemia,Etavopivat
NCT07023029,Thalassemia,moxifloxacin
NCT07011095,Atrial fibrillation,VKA
NCT07011095,Atrial fibrillation,Direct Oral Anticoagulant (DOAC)
NCT07011095,Cerebrovascular disorder,VKA
NCT07011095,Cerebrovascular disorder,Direct Oral Anticoagulant (DOAC)
NCT07055295,Rabies,"Rabies Vaccine (Serum-free Vero Cell), Freeze-dried"
NCT07055295,Rabies,Verorab®
NCT06914895,Obesity disorder,tirzepatide
NCT06914895,Type 1 diabetes mellitus,tirzepatide
NCT06621043,Rett syndrome,NTI164
NCT06970743,B-cell chronic lymphocytic leukemia,BGB-16673
NCT06970743,B-cell chronic lymphocytic leukemia,bendamustine
NCT06970743,B-cell chronic lymphocytic leukemia,rituximab
NCT06970743,B-cell chronic lymphocytic leukemia,methylprednisolone
NCT07001150,Parkinson disease,levodopa-carbidopa
NCT07001150,Parkinson disease,Silymarin
NCT06975150,Sclerosing cholangitis,HK-660S
NCT06975150,Sclerosing cholangitis,HK-660S
NCT06947850,Dry eye syndrome,cenegermin Ophthalmic Solution [Oxervate]
NCT06947850,Neurotrophic keratopathy,cenegermin Ophthalmic Solution [Oxervate]
NCT06611150,Nasopharyngeal carcinoma,Nab-paclitaxel
NCT06860594,Glioma susceptibility 1,Triapine
NCT06863194,Kidney disorder,Probiotic Supplementation (Lactobacillus plantarum)
NCT06863194,Kidney failure,Probiotic Supplementation (Lactobacillus plantarum)
NCT07111494,Psoriatic arthritis,GLP-1 agonists
NCT06896994,Postherpetic neuralgia,esketamine group
NCT06896994,Postherpetic neuralgia,control group
NCT07043894,Hematopoietic and lymphoid cell neoplasm,Romiplostim N01
NCT07073794,Metastatic prostate carcinoma,Cancer Therapeutic Procedure
NCT07073794,Metastatic prostate carcinoma,Cancer Therapeutic Procedure
NCT06950294,Pneumonia,High dose inhaled nitric oxide
NCT07078994,Crohn disease,"anti-TL1A monoclonal antibody, low dose"
NCT07078994,Crohn disease,"anti-TL1A monoclonal antibody, medium dose"
NCT07078994,Crohn disease,"anti-TL1A monoclonal antibody, high dose"
NCT06648876,Diabetes mellitus,YG1699
NCT06648876,Kidney failure,YG1699
NCT07077473,Familial Mediterranean fever,real word drugs
NCT06946927,Non-small cell lung carcinoma,JMKX001899
NCT06946927,Non-small cell lung carcinoma,IN10018
NCT06946927,Non-small cell lung carcinoma,Chemotherapy: Pemetrexed
NCT06946927,Non-small cell lung carcinoma,carboplatin
NCT06924827,Dravet syndrome,CANNABIDIOL
NCT06852573,Systemic lupus erythematosus,ZM001 Injection
NCT06596876,Parkinson disease,HRG2010
NCT07038876,Schizophrenia,ML-007C-MA BID
NCT07038876,Schizophrenia,ML-007C-MA QD
NCT06984627,Graves disease,Rilzabrutinib dose
NCT06984627,Graves disease,Rilzabrutinib dose
NCT06972576,Non-small cell lung carcinoma,EphA2-targeted CAR-T Cells
NCT06972576,Non-small cell lung carcinoma,EphA2-targeted CAR-DCs
NCT06599827,Rectal carcinoma,chemotherapy
NCT06599827,Rectal carcinoma,immunotherapy
NCT06697327,Leukemia,"(Daunorubicin, Cytarabine, Venetoclax)"
NCT06697327,Leukemia,"(Daunorubicin, Cytarabine)"
NCT07108127,Rectal carcinoma,Trastuzumab biosimilars and pertuzumab biosimilars plus XELOX
NCT06712927,Melanoma,ipilimumab
NCT06712927,Melanoma,Nivolumab + Relatlimab FDC
NCT06618573,Systemic lupus erythematosus,Isoniazid/Pyridoxine
NCT06618573,Systemic lupus erythematosus,Saccharum Lactis
NCT06618573,Tuberculosis,Isoniazid/Pyridoxine
NCT06618573,Tuberculosis,Saccharum Lactis
NCT06699576,Osteosarcoma,HS-20093
NCT06699576,Osteosarcoma,Anlotinib
NCT06699576,Osteosarcoma,epirubicin
NCT06699576,Osteosarcoma,Adebrelimab
NCT06699576,Soft tissue sarcoma,HS-20093
NCT06699576,Soft tissue sarcoma,Anlotinib
NCT06699576,Soft tissue sarcoma,epirubicin
NCT06699576,Soft tissue sarcoma,Adebrelimab
NCT06771427,Dry eye syndrome,Chinese herbal tea TBDESJS
NCT06771427,Sjogren syndrome,Chinese herbal tea TBDESJS
NCT07100873,Rheumatoid arthritis,ADI-001
NCT07100873,Rheumatoid arthritis,fludarabine
NCT07100873,Rheumatoid arthritis,cyclophosphamide
NCT06931327,Hypercholesterolemia,Test Drug
NCT06931327,Hypercholesterolemia,Reference Drug
NCT06836973,Myasthenia gravis,blinatumomab
NCT06903273,Biliary tract cancer,tislelizumab
NCT06903273,Cholangiocarcinoma,tislelizumab
NCT07064473,Diabetes mellitus,Vicadrostat
NCT07064473,Diabetes mellitus,empagliflozin
NCT07064473,Hypertensive disorder,Vicadrostat
NCT07064473,Hypertensive disorder,empagliflozin
NCT06823427,Renal pelvis/ureter urothelial carcinoma,9MW2821
NCT06823427,Renal pelvis/ureter urothelial carcinoma,Toripalimab (JS001 )
NCT06823427,Urothelial carcinoma,9MW2821
NCT06823427,Urothelial carcinoma,Toripalimab (JS001 )
NCT06697522,Myopia,atropine sulfate
NCT06792422,Glaucoma,Oral semaglutide
NCT07101822,Penile carcinoma,cemiplimab
NCT06672939,Obesity disorder,Orforglipron
NCT06760039,Diffuse large B-cell lymphoma,R-CMOP Regimen
NCT06760039,Diffuse large B-cell lymphoma,R-CHOP Regimen
NCT06780839,Non-small cell lung carcinoma,ensartinib
NCT06927739,Heart disorder,Orticumab
NCT06927739,Myocardial infarction,Orticumab
NCT06997939,Ischemic stroke,ABMSC
NCT06997939,Ischemic stroke,ABMSC
NCT06997939,Ischemic stroke,ABMSC
NCT06759922,Type 2 diabetes mellitus,Tab Metformin + Tab Glimepiride
NCT06759922,Type 2 diabetes mellitus,Tab Metformin + Tab Empagliflozin
NCT06759922,Type 2 diabetes mellitus,Tab Metformin +Tab Sitagliptin
NCT06759922,Type 2 diabetes mellitus,Tab Metformin + Tab Empagliflozin + Tab Sitagliptin
NCT06787222,Acne,tretinoin
NCT06787222,Acne,tretinoin
NCT06568939,Non-small cell lung carcinoma,TELISOTUZUMAB VEDOTIN
NCT06861439,Obesity disorder,tirzepatide
NCT07064525,Hypertensive disorder,SPC1001 Low
NCT07064525,Hypertensive disorder,SPC5002
NCT07064525,Hypertensive disorder,SPC5003
NCT07064525,Hypertensive disorder,SPC5004
NCT06850922,Diabetic macular edema,RO7446603
NCT06850922,Diabetic macular edema,aflibercept
NCT06850922,Diabetic macular edema,faricimab
NCT06672822,Dermatomyositis,Sodium Thiosulfate (STS)
NCT06672822,Systemic sclerosis,Sodium Thiosulfate (STS)
NCT06813339,Atherosclerotic cardiovascular disease,UDP-003
NCT07111325,Epicondylitis,iEV
NCT07111325,Epicondylitis,PRP
NCT06808425,Attention deficit-hyperactivity disorder,Intervention B
NCT06808425,Sleep,Intervention B
NCT06896422,Chemotherapy,glutathione
NCT06896422,Chemotherapy,PD1 Inhibitor
NCT06896422,Chemotherapy,Chemotherapy
NCT06896422,Non-small cell lung carcinoma,glutathione
NCT06896422,Non-small cell lung carcinoma,PD1 Inhibitor
NCT06896422,Non-small cell lung carcinoma,Chemotherapy
NCT07048522,Pain,nimodipine
NCT06843239,Scleroderma,Tibulizumab
NCT06843239,Systemic sclerosis,Tibulizumab
NCT06799039,Inflammatory bowel disease,xylitol
NCT06817239,Delirium,esketamine
NCT06817239,Pain,esketamine
NCT06926439,Poisoning,Long chain lipid emulsion
NCT07097922,Dry eye syndrome,3% Diquafosol Sodium Eye Drops
NCT07097922,Dry eye syndrome,0.1% hyaluronic acid
NCT07001839,Systemic lupus erythematosus,QLS4131 for Injection.
NCT06578039,Primary ovarian failure,umbilical cord-derived mesenchymal stem cell
NCT07124039,Type 2 diabetes mellitus,"Finerenone (Kerendia, BAY948862)"
NCT06732622,Bell's palsy,Steroids
NCT06942039,Medulloblastoma,Cytarabine IT
NCT06942039,Medulloblastoma,hydrocortisone
NCT06942039,Medulloblastoma,cisplatin
NCT06942039,Medulloblastoma,vincristine
NCT06942039,Medulloblastoma,etoposide
NCT06942039,Medulloblastoma,cyclophosphamide
NCT06942039,Medulloblastoma,mesna
NCT06942039,Medulloblastoma,filgrastim
NCT06942039,Medulloblastoma,carboplatin
NCT06942039,Medulloblastoma,thiotepa
NCT06942039,Medulloblastoma,Topotecan IT
NCT06942039,Medulloblastoma,tamoxifen
NCT06942039,Medulloblastoma,isotretinoin
NCT06942039,Medulloblastoma,celecoxib
NCT06942039,Medulloblastoma,etoposide phosphate
NCT06942039,Medulloblastoma,temozolomide
NCT06942039,Neuroblastoma,Cytarabine IT
NCT06942039,Neuroblastoma,hydrocortisone
NCT06942039,Neuroblastoma,cisplatin
NCT06942039,Neuroblastoma,vincristine
NCT06942039,Neuroblastoma,etoposide
NCT06942039,Neuroblastoma,cyclophosphamide
NCT06942039,Neuroblastoma,mesna
NCT06942039,Neuroblastoma,filgrastim
NCT06942039,Neuroblastoma,carboplatin
NCT06942039,Neuroblastoma,thiotepa
NCT06942039,Neuroblastoma,Topotecan IT
NCT06942039,Neuroblastoma,tamoxifen
NCT06942039,Neuroblastoma,isotretinoin
NCT06942039,Neuroblastoma,celecoxib
NCT06942039,Neuroblastoma,etoposide phosphate
NCT06942039,Neuroblastoma,temozolomide
NCT07026539,Type 2 diabetes mellitus,Finerenone (BAY
NCT06995339,Gout,Febuxostat Tablets
NCT06995339,Gout,metformin
NCT06958939,Myasthenia gravis,Dose level
NCT06958939,Myasthenia gravis,Dose level
NCT06958939,Myasthenia gravis,Dose level
NCT06958939,Myasthenia gravis,Dose level
NCT06869486,Insomnia,blood sampling
NCT06869486,Metabolic disease,blood sampling
NCT06905873,Vitiligo-associated multiple autoimmune disease susceptibility 1,FB102
NCT06644573,Anxiety,"Diprivan (propofol), Astra-Zeneca"
NCT06644573,Circadian rhythm,"Diprivan (propofol), Astra-Zeneca"
NCT06644573,Depressive disorder,"Diprivan (propofol), Astra-Zeneca"
NCT06644573,Insomnia,"Diprivan (propofol), Astra-Zeneca"
NCT06644573,Pain,"Diprivan (propofol), Astra-Zeneca"
NCT06644573,Post-traumatic stress disorder,"Diprivan (propofol), Astra-Zeneca"
NCT06644573,REM sleep behavior disorder,"Diprivan (propofol), Astra-Zeneca"
NCT06644573,Sleep,"Diprivan (propofol), Astra-Zeneca"
NCT06829173,Malignant glioma,XRD-0394
NCT07000682,Systemic sclerosis,UTAA91 injection
NCT06768320,Obesity disorder,Lomaira
NCT06768320,Weight loss,Lomaira
NCT06578520,Heart failure,dapagliflozin
NCT06973174,Sepsis,Premature neonates with invasive infection caused by Bacillus cereus
NCT06848374,Bursitis,40 mg Methylprednisolone
NCT06848374,Bursitis,80 mg Methylprednisolone
NCT06964620,Diabetes mellitus,Sanggua tablets
NCT06813274,Cognitive impairment,hypoglycemic treatment
NCT06813274,Cognitive impairment,Tangshen'an Granules
NCT06813274,Cognitive impairment,Ginkgo Leaf Tablets
NCT06813274,Cognitive impairment,Mecobalamin Tablets
NCT06813274,Diabetes mellitus,hypoglycemic treatment
NCT06813274,Diabetes mellitus,Tangshen'an Granules
NCT06813274,Diabetes mellitus,Ginkgo Leaf Tablets
NCT06813274,Diabetes mellitus,Mecobalamin Tablets
NCT06813274,Diabetic retinopathy,hypoglycemic treatment
NCT06813274,Diabetic retinopathy,Tangshen'an Granules
NCT06813274,Diabetic retinopathy,Ginkgo Leaf Tablets
NCT06813274,Diabetic retinopathy,Mecobalamin Tablets
NCT06906874,End stage renal failure,activated charcoal
NCT06906874,End stage renal failure,Phosphate Binders
NCT06937931,Cervical dystonia,IPN10200
NCT06922331,Inflammatory bowel disease,upadacitinib
NCT07109882,Bruxism,chlorzoxazone
NCT07109882,Bruxism,orphenadrine citrate
NCT06593782,Nausea and vomiting,HSK21542
NCT06593782,Nausea and vomiting,HSK21542
NCT06593782,Nausea and vomiting,dolasetron
NCT06825182,Type 2 diabetes mellitus,Outpatient newly diagnosed type
NCT06825182,Type 2 diabetes mellitus,Inpatient newly diagnosed type
NCT07065682,Benign prostatic hyperplasia,Aloevera + dutasteride
NCT07065682,Benign prostatic hyperplasia,Dutasteride (0.5mg)
NCT06828120,"COPD, severe early onset",Taneasy
NCT06828120,"COPD, severe early onset",Fluimucil
NCT07030920,Human immunodeficiency virus,fostemsavir
NCT06741020,Hepatocellular carcinoma,"Adebrelimab, Oxaliplatin, Fluorouracil,Leucovorin"
NCT07047820,Depressive disorder,zuranolone
NCT06978920,Parkinson disease,Allogeneic dopaminergic neural precursor cell(NCR201)
NCT06785974,Atherosclerosis,atorvastatin
NCT06785974,Melanoma,atorvastatin
NCT06790420,Lymphoma,Rituximab Pfizer
NCT06790420,Lymphoma,Rituxan
NCT07112274,Heart failure,empagliflozin
NCT06808074,Cirrhosis of liver,Inhaled amikacin
NCT06808074,Hepatic encephalopathy,Inhaled amikacin
NCT06664320,Mitral valve insufficiency,hydroxyethyl starch (HES
NCT06664320,Tricuspid valve insufficiency,hydroxyethyl starch (HES
NCT06833320,Congenital heart disease,propranolol hydrochloride
NCT07111520,Non-small cell lung carcinoma,BNT326
NCT07111520,Non-small cell lung carcinoma,BNT327
NCT07111520,Non-small cell lung carcinoma,pembrolizumab
NCT07111520,Non-small cell lung carcinoma,SoC
NCT07114120,Bronchiectasis,Bailing Capsules in combination Guben Kechuan Granules
NCT07114120,"COPD, severe early onset",Bailing Capsules in combination Guben Kechuan Granules
NCT07081074,Radiodermatitis,Amino acid-derived lipids
NCT07099274,Hepatocellular carcinoma,lparomlimab and Tuvonralimab Injection in Combination with TACE and Lenvatinib
NCT06680466,Pain,YZJ-4729
NCT06680466,Pain,morphine
NCT06680466,Pain,YZJ-4729
NCT06680466,Pain,YZJ-4729
NCT06680466,Pain,YZJ-4729
NCT06605326,Heart failure,Subcutaneous Treprostinil
NCT06605326,Pulmonary hypertension,Subcutaneous Treprostinil
NCT06662526,Bipolar disorder,Trace lithium dose plus treatment as usual
NCT06662526,Dementia,Trace lithium dose plus treatment as usual
NCT06662526,Depressive disorder,Trace lithium dose plus treatment as usual
NCT06891157,Diffuse large B-cell lymphoma,Chidamide plus R-CHOP
NCT06787066,Menopause,propranolol hydrochloride
NCT06787066,Menopause,phentolamine Injection
NCT06870266,Paroxysmal familial ventricular fibrillation,Nafarelin nasal spray
NCT06870266,Paroxysmal familial ventricular fibrillation,Utrogestan®
NCT07066826,Alzheimer disease,Huperzine A Controlled-Release Tablets
NCT07066826,Alzheimer disease,Donepezil hydrochloride tablets
NCT06582966,Sexually transmitted disease,Doxycyclin
NCT06742866,Atrial fibrillation,amiodarone Injection
NCT06742866,Atrial fibrillation,Sodium Chloride Injection
NCT06640166,Colon adenocarcinoma,encorafenib + cetuximab + FOLFIRI
NCT06640166,Colon carcinoma,encorafenib + cetuximab + FOLFIRI
NCT06640166,Malignant colon neoplasm,encorafenib + cetuximab + FOLFIRI
NCT06928766,Obstructive sleep apnea syndrome,eszopiclone
NCT06928766,Obstructive sleep apnea syndrome,Lemborexant
NCT06890026,Wet macular degeneration,faricimab Injection [Vabysmo]
NCT07061626,Glioma susceptibility 1,Rhenium-186 Nanoliposome
NCT06654726,Sclerosing cholangitis,aldafermin
NCT06901466,Mitral valve insufficiency,Experimental: Rivaroxaban monotherapy
NCT06901466,Mitral valve insufficiency,Active Comparator: Rivaroxaban+Aspirin
NCT06767566,Pain,Ketamine (Ketalar)
NCT06767566,Postpartum depression,Ketamine (Ketalar)
NCT06602466,Gingivitis,Test toothpaste
NCT06602466,Gingivitis,Colgate Cavity Protection Toothpaste
NCT06809166,Obesity disorder,Contrave
NCT06809166,Weight loss,Contrave
NCT07025226,Malignant glioma,dasatinib
NCT07025226,Malignant glioma,Fisetin
NCT07025226,Malignant glioma,Fluorodopa F
NCT07025226,Malignant glioma,quercetin
NCT07025226,Malignant glioma,temozolomide
NCT06695026,Hepatocellular carcinoma,RZ-001 Dose
NCT06695026,Hepatocellular carcinoma,RZ-001 Dose
NCT06695026,Hepatocellular carcinoma,RZ-001 Dose
NCT06919926,Dementia,AGB101
NCT06883526,Lymphoma,ZG005 for Injection
NCT06883526,Lymphoma,Gecacitinib Hydrochloride Tablets
NCT06948357,Presbyopia,BRIMOCHOL PF eye drops
NCT06837857,Pain,Opioid
NCT06659757,Cystic fibrosis,KIT2014
NCT06844357,Hepatocellular carcinoma,tirapazamine
NCT06764966,Cirrhosis of liver,atorvastatin
NCT07113366,Atopic eczema,FAE cream
NCT06979726,Heart failure,Lasix ONYU
NCT07049926,Nonpapillary renal cell carcinoma,belzutifan
NCT07049926,Nonpapillary renal cell carcinoma,Zanzalintinib
NCT06932757,Uveal melanoma,Quisinostat
NCT06904066,Cancer,aldesleukin
NCT06904066,Cancer,cyclophosphamide
NCT06904066,Cancer,fludarabine phosphate
NCT06904066,Cancer,Individual Patient TCR-Transduced PBL
NCT06904066,Hematopoietic and lymphoid system neoplasm,aldesleukin
NCT06904066,Hematopoietic and lymphoid system neoplasm,cyclophosphamide
NCT06904066,Hematopoietic and lymphoid system neoplasm,fludarabine phosphate
NCT06904066,Hematopoietic and lymphoid system neoplasm,Individual Patient TCR-Transduced PBL
NCT06904066,Leukemia,aldesleukin
NCT06904066,Leukemia,cyclophosphamide
NCT06904066,Leukemia,fludarabine phosphate
NCT06904066,Leukemia,Individual Patient TCR-Transduced PBL
NCT06939166,Autoimmune encephalitis,UCAR T-cell
NCT06939166,Multiple sclerosis,UCAR T-cell
NCT06939166,Myasthenia gravis,UCAR T-cell
NCT06805266,Parkinson disease,Vortioxetine (tablet)
NCT06698666,Endogenous depression,Rosuvastatin
NCT06698666,Endogenous depression,sertraline Pill
NCT06698666,Mal de Debarquement,Rosuvastatin
NCT06698666,Mal de Debarquement,sertraline Pill
NCT07034326,Non-small cell lung carcinoma,Zilongjin tablet combined with immunotherapy
NCT07034326,Non-small cell lung carcinoma,Immunotherapy
NCT06720025,Anemia,SAL-0951 tablets
NCT06720025,Anemia,rHuEPO injection
NCT07006025,Myelodysplastic syndrome,decitabine
NCT06733025,Cerebrovascular disorder,BoNT Injections
NCT06733025,Spinal cord injury,BoNT Injections
NCT06812325,Endocrine exophthalmos,VRDN-003
NCT07072325,Childhood malignant neoplasm,CD-001
NCT06948825,Weight loss,Metformin Hcl
NCT06811025,Meningitis,Contezolid
NCT06811025,Meningitis,Linezolid (LZD)
NCT06811025,Tuberculosis,Contezolid
NCT06811025,Tuberculosis,Linezolid (LZD)
NCT06706622,Multiple system atrophy,Lu AF82422
NCT06974422,Cardiovascular disorder,Regular oral anti-diabetic medications.
NCT06715839,Cancer,[68Ga]Ga-DOTA-H2D3
NCT06715839,Cancer,[18F]F-RESCA-RB14
NCT06715839,Cancer,[68Ga]Ga-NOTA-T4
NCT06715839,Cancer,[18F]F-RESCA-T4
NCT06715839,Cancer,[68Ga]Ga-NOTA-G5
NCT06715839,Cancer,[18F]F-RESCA-G5
NCT06715839,Cancer,[68Ga]Ga-NOTA-WWH347
NCT06715839,Cancer,[18F]F-RESCA-WWH347
NCT06715839,Cancer,[68Ga]Ga-NOTA-RND20
NCT06715839,Cancer,[18F]F-RESCA-RND20
NCT06715839,Esophageal cancer,[68Ga]Ga-DOTA-H2D3
NCT06715839,Esophageal cancer,[18F]F-RESCA-RB14
NCT06715839,Esophageal cancer,[68Ga]Ga-NOTA-T4
NCT06715839,Esophageal cancer,[18F]F-RESCA-T4
NCT06715839,Esophageal cancer,[68Ga]Ga-NOTA-G5
NCT06715839,Esophageal cancer,[18F]F-RESCA-G5
NCT06715839,Esophageal cancer,[68Ga]Ga-NOTA-WWH347
NCT06715839,Esophageal cancer,[18F]F-RESCA-WWH347
NCT06715839,Esophageal cancer,[68Ga]Ga-NOTA-RND20
NCT06715839,Esophageal cancer,[18F]F-RESCA-RND20
NCT06715839,Gastric carcinoma,[68Ga]Ga-DOTA-H2D3
NCT06715839,Gastric carcinoma,[18F]F-RESCA-RB14
NCT06715839,Gastric carcinoma,[68Ga]Ga-NOTA-T4
NCT06715839,Gastric carcinoma,[18F]F-RESCA-T4
NCT06715839,Gastric carcinoma,[68Ga]Ga-NOTA-G5
NCT06715839,Gastric carcinoma,[18F]F-RESCA-G5
NCT06715839,Gastric carcinoma,[68Ga]Ga-NOTA-WWH347
NCT06715839,Gastric carcinoma,[18F]F-RESCA-WWH347
NCT06715839,Gastric carcinoma,[68Ga]Ga-NOTA-RND20
NCT06715839,Gastric carcinoma,[18F]F-RESCA-RND20
NCT06715839,Malignant colon neoplasm,[68Ga]Ga-DOTA-H2D3
NCT06715839,Malignant colon neoplasm,[18F]F-RESCA-RB14
NCT06715839,Malignant colon neoplasm,[68Ga]Ga-NOTA-T4
NCT06715839,Malignant colon neoplasm,[18F]F-RESCA-T4
NCT06715839,Malignant colon neoplasm,[68Ga]Ga-NOTA-G5
NCT06715839,Malignant colon neoplasm,[18F]F-RESCA-G5
NCT06715839,Malignant colon neoplasm,[68Ga]Ga-NOTA-WWH347
NCT06715839,Malignant colon neoplasm,[18F]F-RESCA-WWH347
NCT06715839,Malignant colon neoplasm,[68Ga]Ga-NOTA-RND20
NCT06715839,Malignant colon neoplasm,[18F]F-RESCA-RND20
NCT06715839,Malignant pancreatic neoplasm,[68Ga]Ga-DOTA-H2D3
NCT06715839,Malignant pancreatic neoplasm,[18F]F-RESCA-RB14
NCT06715839,Malignant pancreatic neoplasm,[68Ga]Ga-NOTA-T4
NCT06715839,Malignant pancreatic neoplasm,[18F]F-RESCA-T4
NCT06715839,Malignant pancreatic neoplasm,[68Ga]Ga-NOTA-G5
NCT06715839,Malignant pancreatic neoplasm,[18F]F-RESCA-G5
NCT06715839,Malignant pancreatic neoplasm,[68Ga]Ga-NOTA-WWH347
NCT06715839,Malignant pancreatic neoplasm,[18F]F-RESCA-WWH347
NCT06715839,Malignant pancreatic neoplasm,[68Ga]Ga-NOTA-RND20
NCT06715839,Malignant pancreatic neoplasm,[18F]F-RESCA-RND20
NCT06715839,Rectal cancer,[68Ga]Ga-DOTA-H2D3
NCT06715839,Rectal cancer,[18F]F-RESCA-RB14
NCT06715839,Rectal cancer,[68Ga]Ga-NOTA-T4
NCT06715839,Rectal cancer,[18F]F-RESCA-T4
NCT06715839,Rectal cancer,[68Ga]Ga-NOTA-G5
NCT06715839,Rectal cancer,[18F]F-RESCA-G5
NCT06715839,Rectal cancer,[68Ga]Ga-NOTA-WWH347
NCT06715839,Rectal cancer,[18F]F-RESCA-WWH347
NCT06715839,Rectal cancer,[68Ga]Ga-NOTA-RND20
NCT06715839,Rectal cancer,[18F]F-RESCA-RND20
NCT06829225,Colitis,Tulisokibart
NCT06694025,Influenza,Efluelda Tetra Pre-filled syringe
NCT06788522,Insomnia,suvorexant
NCT06788522,Post-traumatic stress disorder,suvorexant
NCT06749925,Adult glioblastoma,Dendritic Cell Vaccine
NCT07058025,Bronchopulmonary dysplasia,Human Allogenic Umbilical Cord Mesenchymal Stromal Cells
NCT07004322,Diabetes mellitus,NNC0519-0130
NCT07004322,Obesity disorder,NNC0519-0130
NCT06705322,Cervical carcinoma,Cnidium Monnieri Detoxification Formula
NCT06705322,Human papilloma virus infection,Cnidium Monnieri Detoxification Formula
NCT06844422,Malignant pancreatic neoplasm,Ivonescimab
NCT06981325,Basal cell carcinoma,cemiplimab
NCT06627322,Type 2 diabetes mellitus,Dual-combination therapy
NCT06627322,Type 2 diabetes mellitus,Triple-combination therapy
NCT06919939,Large B-cell lymphoma,epcoritamab
NCT06919939,Large B-cell lymphoma,loncastuximab tesirine
NCT06978439,Mucocutaneous lymph node syndrome,Rivaroxaban (Xarelto)
NCT06688825,Obesity disorder,Blood draw
NCT06795022,Hepatocellular carcinoma,AZD9793 Intravenous (IV) monotherapy
NCT06795022,Hepatocellular carcinoma,AZD9793 Subcutaneous (SC) monotherapy)
NCT06921525,Dry eye syndrome,Tea Tree Oil Topical Application Oil
NCT06921525,Dry eye syndrome,azithromycin Ophthalmic Solution
NCT07105722,Pneumonia,Pn-MAPS30plus
NCT06904222,Respiratory syncytial virus infectious disease,Low dose antigen of LYB005 without A01B adjuvant
NCT06904222,Respiratory syncytial virus infectious disease,Low dose antigen of LYB005 with A01B adjuvant
NCT06904222,Respiratory syncytial virus infectious disease,Middle dose antigen of LYB005 without A01B adjuvant
NCT06904222,Respiratory syncytial virus infectious disease,Middle dose antigen of LYB005 with A01B adjuvant
NCT06904222,Respiratory syncytial virus infectious disease,High dose antigen of LYB005 without A01B adjuvant
NCT06904222,Respiratory syncytial virus infectious disease,High dose antigen of LYB005 with A01B adjuvant
NCT06974825,Type 2 diabetes mellitus,BGM0504 Administered SC
NCT06974825,Type 2 diabetes mellitus,BGM0504 Administered SC
NCT06974825,Type 2 diabetes mellitus,BGM0504 Administered SC
NCT06974825,Type 2 diabetes mellitus,Semaglutide Administered SC
NCT07070622,Rectal carcinoma,patients were assigned to receive TNT or iTNT management
NCT07034222,Alzheimer disease,Administer Leqemi
NCT06835322,Glomerulonephritis,finerenone
NCT07004725,Rheumatoid arthritis,niacin sustained release capsules
NCT06946225,Cutaneous melanoma,IMA203
NCT06946225,Cutaneous melanoma,mRNA-4203
NCT06600425,Primary ciliary dyskinesia,RCT1100
NCT06905522,Pulmonary tuberculosis,Bedaquiline (B)
NCT06905522,Pulmonary tuberculosis,Sitafloxacin (S)
NCT06905522,Pulmonary tuberculosis,Linezolid (L)
NCT06905522,Pulmonary tuberculosis,Pyrazinamide (Z)
NCT06905522,Pulmonary tuberculosis,Isoniazid (H)
NCT06905522,Pulmonary tuberculosis,Rifampicin (R)
NCT06905522,Pulmonary tuberculosis,Ethambutol (E)
NCT06905522,Pulmonary tuberculosis,Moxifloxacin (M)
NCT06905522,Pulmonary tuberculosis,Pretomanid (Pa)
NCT06592339,Hypercholesterolemia,MK-0616
NCT06608186,Polycystic ovary syndrome,Cetrorelix drug
NCT06608186,Polycystic ovary syndrome,Drospirenone drug
NCT06846463,Diffuse large B-cell lymphoma,zanubrutinib
NCT07105839,Obesity disorder,Intraoperative rescue analgesia
NCT07105839,Obesity disorder,Intraoperative rescue analgesia
NCT06609239,Asthma,Lunsekimig
NCT06839586,Diarrheal disease,CMTS4520 (dietary fiber and probiotics)
NCT06781086,Malignant pancreatic neoplasm,Nimotuzumab
NCT06781086,Malignant pancreatic neoplasm,AG regimen
NCT06953986,Gastroesophageal reflux disease,vonoprazan
NCT06953986,Gastroesophageal reflux disease,Esomeprazole
NCT06890039,Cirrhosis of liver,TAK-242
NCT06890039,Cirrhosis of liver,G-CSF (Filgrastim)
NCT06992739,EGFR,Trilaciclib and Sacituzumab Tirumotecan
NCT06992739,Non-small cell lung carcinoma,Trilaciclib and Sacituzumab Tirumotecan
NCT07116239,Hypoalbuminemia,edoxaban
NCT07116239,Hypoalbuminemia,Enoxaparin
NCT07116239,Nephrotic syndrome,edoxaban
NCT07116239,Nephrotic syndrome,Enoxaparin
NCT07109986,Lupus nephritis,UB-VV410
NCT07109986,Systemic lupus erythematosus,UB-VV410
NCT07090486,COVID-19,nirmatrelvir-ritonavir
NCT06799286,Small cell lung carcinoma,BMS-986489
NCT06824363,Esophageal adenocarcinoma,tremelimumab
NCT06824363,Esophageal adenocarcinoma,durvalumab
NCT06824363,Gastric adenocarcinoma,tremelimumab
NCT06824363,Gastric adenocarcinoma,durvalumab
NCT07064863,Childhood bladder carcinoma,Gemcitabine + BCG
NCT07064863,Childhood bladder carcinoma,BCG (TICE strain)
NCT06688539,Nicotine dependence,varenicline Pill
NCT07065539,Adenomyosis,GnRH-a-1M
NCT07065539,Adenomyosis,GnRH-a-2M
NCT07065539,Adenomyosis,GnRH-a+LE-1M
NCT07065539,Adenomyosis,GnRH-a+LE-2M
NCT06693986,Pancreatic adenocarcinoma,Replicative Adenovirus Vector (RGDCRAdCOX2F)
NCT06890286,Type 2 diabetes mellitus,BR3006
NCT06890286,Type 2 diabetes mellitus,BR3006A
NCT06890286,Type 2 diabetes mellitus,BR3006B
NCT06890286,Type 2 diabetes mellitus,BR3006C
NCT07011186,Myeloid neoplasm,TQB3909 Tablets + Azacitidine
NCT06617286,Classic Hodgkin lymphoma,CD30 CAR T-cell
NCT06643039,Nosocomial infection,Nasopharyngeal swab
NCT06566586,B-cell non-Hodgkin lymphoma,TQB3702 tablets+Chemotherapy regimen
NCT07074886,Multiple sclerosis,Ocrelizumab Test Formulation
NCT07074886,Multiple sclerosis,Ocrelizumab Reference Formulation
NCT07062263,Biliary tract cancer,trastuzumab
NCT07062263,Biliary tract cancer,Chemotherapy
NCT06779539,Non-small cell lung carcinoma,ensartinib
NCT07095686,Amyotrophic lateral sclerosis,nL-CHCHD-001
NCT06684639,Neuroblastoma,GD2-CAR-T cell
NCT06612086,Pulmonary hypertension,Dapagliflozin (Forxiga)
NCT07081022,B-cell non-Hodgkin lymphoma,JS203 in combination with gemcitabine and oxaliplatin
NCT07081022,B-cell non-Hodgkin lymphoma,"JS203 in combination with ifosfamide, carboplatin and etoposide"
NCT07081022,B-cell non-Hodgkin lymphoma,"JS203 in combination with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone"
NCT07081022,B-cell non-Hodgkin lymphoma,JS203 combined with lenalidomide
NCT06858839,Obesity disorder,Maridebart Cafraglutide
NCT06857786,Gastric adenocarcinoma,Drug: CT041 autologous CAR T-cell injection
NCT06857786,Gastroesophageal junction adenocarcinoma,Drug: CT041 autologous CAR T-cell injection
NCT06800339,Non-small cell lung carcinoma,nivolumab
NCT06800339,Non-small cell lung carcinoma,Chemotherapy
NCT06827886,Alveolar soft part sarcoma,GCAR1
NCT07012486,Androgenetic alopecia,Oral DHA + Topical minoxidil
NCT07012486,Androgenetic alopecia,Topical Minoxidil
NCT06831539,Cancer,PEGLyte bowel preparation
NCT06961786,Metastatic melanoma,TILT-123
NCT06961786,Metastatic melanoma,TIL
NCT06961786,Metastatic melanoma,cyclophosphamide
NCT06961786,Metastatic melanoma,fludarabine
NCT06846086,Cardiomyopathy,melatonin
NCT06926322,Dental pulp necrosis,Conventional double antibiotic paste of Metronidazole
NCT06926322,Dental pulp necrosis,Double antibiotic paste of Metronidazole and Ciprofloxacin loaded chitosan-coated silver nanoparticles
NCT06926322,Dental pulp necrosis,chitosan-coated silver nanoparticles
NCT06926322,Pain,Conventional double antibiotic paste of Metronidazole
NCT06926322,Pain,Double antibiotic paste of Metronidazole and Ciprofloxacin loaded chitosan-coated silver nanoparticles
NCT06926322,Pain,chitosan-coated silver nanoparticles
NCT06926322,Root resorption,Conventional double antibiotic paste of Metronidazole
NCT06926322,Root resorption,Double antibiotic paste of Metronidazole and Ciprofloxacin loaded chitosan-coated silver nanoparticles
NCT06926322,Root resorption,chitosan-coated silver nanoparticles
NCT06883539,Hepatocellular carcinoma,LXP1788 is administered intravenously via Port-A
NCT06883539,Malignant pancreatic neoplasm,LXP1788 is administered intravenously via Port-A
NCT07047339,Colitis,Probiotics
NCT07047339,Inflammatory bowel disease,Probiotics
NCT06940739,Metastatic melanoma,IOV-3001
NCT06865339,Non-small cell lung carcinoma,cemiplimab
NCT06865339,Non-small cell lung carcinoma,Fianlimab
NCT06865339,Non-small cell lung carcinoma,Platinum Doublet Chemotherapy (PDC)
NCT06895486,Poliomyelitis,Novel Oral Polio Vaccine Type
NCT06895486,Poliomyelitis,Novel Oral Polio Vaccine Type
NCT07010822,Poliomyelitis,nOPV2
NCT06623422,Carcinoma,pembrolizumab
NCT06623422,Carcinoma,cisplatin
NCT06623422,Carcinoma,carboplatin
NCT06623422,Carcinoma,pemetrexed
NCT06623422,Carcinoma,gemcitabine
NCT06623422,Carcinoma,paclitaxel
NCT06623422,Carcinoma,Intismeran autogene
NCT07055386,Type 2 diabetes mellitus,GZR102
NCT07055386,Type 2 diabetes mellitus,GZR18
NCT06906822,Melanoma,ENFORTUMAB VEDOTIN
NCT06906822,Melanoma,pembrolizumab
NCT06662539,Obesity disorder,Petrelintide
NCT06788639,B-cell chronic lymphocytic leukemia,lisocabtagene maraleucel
NCT06744439,Essential hypertension,BR1015
NCT06744439,Essential hypertension,BR1015-2
NCT06744439,Essential hypertension,BR1015-3
NCT06962839,Macular retinal edema,BI
NCT07113522,Crohn disease,MT-501
NCT07113522,Inflammatory bowel disease,MT-501
NCT07112339,Diabetes mellitus,Insulin icodec
NCT07112339,Diabetes mellitus,Basal insulin analogues
NCT06903286,Amyotrophic lateral sclerosis,SPG302
NCT06809530,Neoplastic meningitis,QL1706 (bispecific antibody targeting PD-1 and CLTA-4)
NCT06809530,Neoplastic meningitis,Pemetrexed (Alimta)
NCT06964230,Alzheimer disease,T3D-959
NCT06740630,Chickenpox,Investigational varicella vaccine_Lot
NCT06740630,Chickenpox,Investigational varicella vaccine_Lot
NCT06740630,Chickenpox,Investigational varicella vaccine_Lot
NCT06740630,Chickenpox,Marketed varicella vaccine_Lot
NCT06740630,Chickenpox,Marketed varicella vaccine_Lot
NCT06740630,Chickenpox,MMR vaccine
NCT06740630,Chickenpox,Hepatitis A vaccine
NCT06740630,Chickenpox,PCV (pneumococcal conjugate vaccine)
NCT06740630,Chickenpox,PCV
NCT06740630,Chickenpox,Vaxneuvance
NCT06608030,Depressive disorder,esketamine
NCT06758830,Chemotherapy,Chemoradiotherapy
NCT06758830,Chemotherapy,Consolidation Chemotherapy
NCT06758830,Rectal carcinoma,Chemoradiotherapy
NCT06758830,Rectal carcinoma,Consolidation Chemotherapy
NCT06805825,Adrenal cortex carcinoma,NN3201
NCT06805825,Gastrointestinal stromal tumor,NN3201
NCT06805825,Nonpapillary renal cell carcinoma,NN3201
NCT06805825,Uveal melanoma,NN3201
NCT06762730,Osteopenia,Zoledronic Acid
NCT06883630,Non-small cell lung carcinoma,RC148 plus Carboplatin and Paclitaxel/pemetrexed
NCT06883630,Non-small cell lung carcinoma,RC148
NCT06772766,Beta-thalassemia HBB/LCRB,9MW3011
NCT06672666,Anxiety,Hemp Derived Cannabidiol Extract
NCT07070466,Esophageal cancer,Ivonescimab
NCT07070466,Esophageal cancer,5-Fluorouracil
NCT07070466,Esophageal cancer,oxaliplatin
NCT07070466,Esophageal cancer,leucovorin
NCT07070466,Gastric carcinoma,Ivonescimab
NCT07070466,Gastric carcinoma,5-Fluorouracil
NCT07070466,Gastric carcinoma,oxaliplatin
NCT07070466,Gastric carcinoma,leucovorin
NCT06956066,Anxiety,shotblocker
NCT06956066,Pain,shotblocker
NCT07114666,Malignant pancreatic neoplasm,XH001
NCT07114666,Malignant pancreatic neoplasm,Chemotherapy
NCT06603974,Gastric carcinoma,Benmelstobart
NCT06603974,Gastric carcinoma,tegafur
NCT06603974,Gastric carcinoma,oxaliplatin
NCT06603974,Gastric carcinoma,albumin paclitaxel
NCT07113574,Kidney failure,meropenem
NCT07113574,Kidney failure,aztreonam
NCT06805565,Social phobia,ONO-1110
NCT06866665,Atrial fibrillation,Anticoagulation Monotherapy
NCT06866665,Atrial fibrillation,Combination therapy
NCT06866665,Coronary artery disorder,Anticoagulation Monotherapy
NCT06866665,Coronary artery disorder,Combination therapy
NCT06699966,Endogenous depression,celecoxib
NCT06699966,Endogenous depression,minocycline
NCT07101666,Gastric carcinoma,Standard of care neoadjuvant chemotherapy
NCT06683066,Prostate cancer,Triprorelin for injection
NCT06683066,Prostate cancer,Diphereline
NCT06872866,Erectile dysfunction,ASP-001.1
NCT06962865,Non-small cell lung carcinoma,RC108
NCT06962865,Non-small cell lung carcinoma,Furmonertinib Mesilate Tablets Monotherapy
NCT06594965,Anemia,HS-20106
NCT06594965,Myelodysplastic syndrome,HS-20106
NCT06674291,Tuberculosis,No intervention (observational study)
NCT07073729,Neurotrophic keratopathy,Cenergermin
NCT06618391,Non-small cell lung carcinoma,Envafolimab
NCT06618391,Non-small cell lung carcinoma,Recombinant human endostatin
NCT06618391,Non-small cell lung carcinoma,recombinant human adenovirus type
NCT06943794,Gastric carcinoma,recommendations for eradication treatment
NCT06890494,Leukemia,BiTE-EV
NCT06930794,Non-small cell lung carcinoma,Vebreltinib combined with platinum-based doublet chemotherapy.
NCT06930794,Non-small cell lung carcinoma,platinum-based doublet chemotherapy.
NCT06975891,Dry eye syndrome,Systane PRO
NCT06975891,Dry eye syndrome,Refresh Optive MEGA-3
NCT06586294,Gastric adenocarcinoma,Drug: AK129 Drug：oxaliplatin Drug：capecitabine
NCT06586294,Gastric adenocarcinoma,Drug: AK129 Drug：cadonilimab Drug：oxaliplatin Drug：capecitabine
NCT06586294,Gastroesophageal junction adenocarcinoma,Drug: AK129 Drug：oxaliplatin Drug：capecitabine
NCT06586294,Gastroesophageal junction adenocarcinoma,Drug: AK129 Drug：cadonilimab Drug：oxaliplatin Drug：capecitabine
NCT06922591,Non-small cell lung carcinoma,TNG462
NCT06922591,Non-small cell lung carcinoma,RMC-9805
NCT06922591,Non-small cell lung carcinoma,RMC-6236
NCT06922591,Thoracic cancer,TNG462
NCT06922591,Thoracic cancer,RMC-9805
NCT06922591,Thoracic cancer,RMC-6236
NCT06866691,Traumatic brain injury,levetiracetam
NCT06866691,Traumatic brain injury,lacosamide
NCT07036991,Carotid stenosis,Evolocumab (biweekly injections) + Rosuvastatin/Atorvastatin ± Ezetimibe
NCT07036991,Carotid stenosis,Rosuvastatin/Atorvastatin ± Ezetimibe
NCT06999694,Hepatocellular carcinoma,tremelimumab
NCT06999694,Hepatocellular carcinoma,durvalumab
NCT07091994,Ischemic stroke,edaravone dexborneol injection
NCT07091994,Ischemic stroke,Standard therapeutic protocol
NCT06861894,Esophageal squamous cell carcinoma,Adebrelimab and nab-paclitaxel and carboplatin
NCT06723691,Type 2 diabetes mellitus,acetaminophen
NCT06723691,Type 2 diabetes mellitus,metformin
NCT06723691,Type 2 diabetes mellitus,warfarin
NCT06723691,Type 2 diabetes mellitus,atorvastatin
NCT06723691,Type 2 diabetes mellitus,digoxin
NCT06723691,Type 2 diabetes mellitus,HRS9531
NCT07059494,Hepatocellular carcinoma,atezolizumab
NCT07059494,Hepatocellular carcinoma,bevacizumab
NCT07026994,ACys amyloidosis,Colchicine
NCT07096063,Type 2 diabetes mellitus,tirzepatide
NCT07096063,Type 2 diabetes mellitus,dulaglutide
NCT07096063,Type 2 diabetes mellitus,semaglutide
NCT07096063,Type 2 diabetes mellitus,sitagliptin
NCT06869863,Azoospermia,"Medicinal product MediReg® (Human Mesenchymal Stromal Cell Secretome), lyophilizate for preparation of solution for injection in patients with severe spermatogenesis disorders"
NCT06787586,Atopic eczema,ATTO-1310
NCT06637163,Esophageal squamous cell carcinoma,Benmelstobart+ Paclitaxel + Carboplatin+ Radiotherapy
NCT06637163,Esophageal squamous cell carcinoma,Paclitaxel + Carboplatin + Radiotherapy
NCT07114263,Analgesic,Group F (fentanyl group)
NCT07114263,Analgesic,Group D :Dexmedetomidine group
NCT07114263,Analgesic,Group DF :Fentanyl and Dexmedetomidine group
NCT06889363,Dental caries,MTA
NCT06889363,Dental caries,PRF
NCT06729463,Psoriasis,Humira
NCT06729463,Psoriatic arthritis,Humira
NCT07132463,Rectal carcinoma,Tislelizumab combined with the CAPOX regimen
NCT07132463,Rectal carcinoma,CAPOX regimen
NCT07050563,Cancer,Compound Ciwujia Granules
NCT06618963,Food allergy,omalizumab Injection
NCT06708663,Biliary tract cancer,HX009+IN10018
NCT06708663,Melanoma,HX009+IN10018
NCT07021963,Hypertrophic cardiomyopathy,HRS-1893 Tablet
NCT06774963,Biliary tract cancer,LNCB74
NCT06774963,Endometrial cancer,LNCB74
NCT06774963,Non-small cell lung carcinoma,LNCB74
NCT06774963,Ovarian cancer,LNCB74
NCT06942663,Gastric carcinoma,Adjuvant Chemotherapy
NCT06795048,Wet macular degeneration,faricimab
NCT06995430,Meningitis,rMenB+OMV NZ vaccine
NCT06718257,Cholangiocarcinoma,Gemcitabine combined with cisplatin or oxaliplatin
NCT06718257,Cholangiocarcinoma,"Gemcitabine combined with cisplatin or oxaliplatin, PD-1/L1 and TKI inhibitors"
NCT06991348,Gastroesophageal reflux disease,Tegoprazan
NCT06991348,Gastroesophageal reflux disease,pantoprazole
NCT06901648,Type 2 diabetes mellitus,HS-20094
NCT06901648,Type 2 diabetes mellitus,dulaglutide
NCT06901648,Type 2 diabetes mellitus,Palcebo
NCT06698848,Depressive disorder,ketamin
NCT06714448,Epilepsy,Sodium valporate
NCT07064330,Skin squamous cell carcinoma,cemiplimab
NCT06765330,Dental caries,CHX disinfection
NCT06843148,Metabolic dysfunction-associated steatotic liver disease,Niacin (250mg)
NCT06840548,Nonpapillary renal cell carcinoma,[68Ga]Ga-OncoCAIX
NCT06747130,Dengue disease,montelukast
NCT06674148,Interstitial lung disease,Qifangfeixian granules
NCT06801730,Malignant glioma,Irinotecan liposome combined with bevacizumab
NCT07012057,Dermatomyositis,Deucravacitinb
NCT07012057,Juvenile dermatomyositis,Deucravacitinb
NCT06802848,Psoriatic arthritis,Xeligekimab injection
NCT07070648,Diffuse large B-cell lymphoma,POLA-R-CHP
NCT07049848,Soft tissue sarcoma,atezolizumab
NCT07049848,Soft tissue sarcoma,doxorubicin hydrochloride
NCT06791148,Gastric carcinoma,albumin-bound paclitaxel
NCT06791148,Gastric carcinoma,AK112
NCT07001748,Gastric adenocarcinoma,Standard of Care Chemotherapy
NCT07001748,Gastric adenocarcinoma,Intraperitoneal Paclitaxel
NCT07001748,Gastroesophageal junction adenocarcinoma,Standard of Care Chemotherapy
NCT07001748,Gastroesophageal junction adenocarcinoma,Intraperitoneal Paclitaxel
NCT07040930,Rheumatoid arthritis,GenSci120
NCT07030257,Childhood bladder carcinoma,CP-383
NCT07030257,Malignant pancreatic neoplasm,CP-383
NCT07030257,Non-small cell lung carcinoma,CP-383
NCT07030257,Small cell lung carcinoma,CP-383
NCT07038330,Anemia,Sucrosomial Iron
NCT06701357,Diffuse large B-cell lymphoma,CR-CHOP+PD1 inhibitor
NCT06701357,Diffuse large B-cell lymphoma,CR-CHOP + Orelabrutinib
NCT06701357,Diffuse large B-cell lymphoma,CR-CHOP + decitabine
NCT06806657,Hereditary angioedema,garadacimab
NCT07023848,Gastric carcinoma,89Zr-LNCab104
NCT07023848,Gastric carcinoma,89Zr-LNCab103
NCT07023848,Gastric carcinoma,18F-FDG
NCT07023848,Urothelial carcinoma,89Zr-LNCab104
NCT07023848,Urothelial carcinoma,89Zr-LNCab103
NCT07023848,Urothelial carcinoma,18F-FDG
NCT06789848,Biliary tract cancer,Ligufalimab
NCT06789848,Biliary tract cancer,Cadonilimab
NCT06945848,Pseudotumor cerebri,acetazolamide
NCT06693648,Osteoarthritis,AMZ001 Diclofenac gel
NCT06593548,Metastatic malignant neoplasm,Ivosidenib (AK112)
NCT06834230,Hypertensive disorder,Dotinurad
NCT06834230,Hypertensive disorder,febuxostat
NCT06767748,Diabetes mellitus,GZR4
NCT06767748,Diabetes mellitus,insulin degludec
NCT06723548,Myasthenia gravis,Telitacicept
NCT07132957,Small cell lung carcinoma,14C-labeled AL8326
NCT06961357,Melanoma,cyclophosphamide
NCT06961357,Melanoma,fludarabine
NCT06961357,Melanoma,Interleukin-2
NCT06961357,Melanoma,TIL Product
NCT06676748,Pharyngitis,Benzydamine Hydrochloride
NCT06648057,Biliary tract cancer,lenvatinib plus pembrolizumab
NCT06648057,Cholangiocarcinoma,lenvatinib plus pembrolizumab
NCT06643130,Hypertensive disorder,JW0104+C2402
NCT06643130,Hypertensive disorder,JW0104+C2403
NCT06643130,Hypertensive disorder,C2402
NCT06643130,Inherited lipid metabolism disorder,JW0104+C2402
NCT06643130,Inherited lipid metabolism disorder,JW0104+C2403
NCT06643130,Inherited lipid metabolism disorder,C2402
NCT06682130,Diffuse large B-cell lymphoma,Group A：Patients with PR or ctDNA positivity after salvage treatment
NCT06682130,Diffuse large B-cell lymphoma,Group C: Patients with SD/PD after posterior treatment
NCT06620848,Biliary tract cancer,HRS-4642 monotherapy
NCT06620848,Biliary tract cancer,HRS-4642 and adebrelimab combination therapy
NCT06821048,Gastric carcinoma,Intraperitoneal infusion of FAST CEA-targeted CAR-T
NCT06821048,Malignant pancreatic neoplasm,Intraperitoneal infusion of FAST CEA-targeted CAR-T
NCT06821048,Metastatic malignant neoplasm,Intraperitoneal infusion of FAST CEA-targeted CAR-T
NCT06653348,Ischemic stroke,Ticagrelor
NCT06653348,Ischemic stroke,Ticagrelor
NCT06653348,Transient ischemic attack,Ticagrelor
NCT06653348,Transient ischemic attack,Ticagrelor
NCT06770257,Leukemia,"daunorubicin, cytarabine liposomes"
NCT06770257,Leukemia,azacitidine
NCT06770257,Leukemia,venetoclax
NCT06789757,Hepatocellular carcinoma,memantine hydrochloride
NCT06789757,Hepatocellular carcinoma,bevacizumab
NCT06789757,Hepatocellular carcinoma,atezolizumab
NCT07000357,Cardiovascular disorder,AZD0780
NCT06949748,Cardiomyopathy,Flecainide (monotherapy)
NCT07027748,Neuroblastoma,naxitamab
NCT07027748,Neuroblastoma,irinotecan
NCT07027748,Neuroblastoma,temozolomide
NCT07027748,Neuroblastoma,Sargramostim granulocyte-macrophage colony stimulating factor
NCT06735248,Multiple sclerosis,mRNA-1195
NCT06717425,Obesity disorder,PF-07976016
NCT06983548,Chikungunya,"semen, blood and urine tests"
NCT06916130,Gastroesophageal reflux disease,AD-120A
NCT06916130,Gastroesophageal reflux disease,AD-120
NCT06680830,Parkinson disease,NEU-411
NCT07022730,Sepsis,Noradrenaline
NCT07052448,Hepatocellular carcinoma,sequential radiotherapy after the combination of transcatheter arterial chemoembolization (TACE) combined with lenvatinib and anti-PD-1 antibodies
NCT06925048,Non-small cell lung carcinoma,PD-1 inhbitor+SHR0302
NCT06925048,Non-small cell lung carcinoma,PD-L1 inhibitor+SHR0302
NCT06955130,Obesity disorder,Glycerol
NCT06955130,Obesity disorder,lactate
NCT06955130,Obesity disorder,glucose
NCT06955130,Type 2 diabetes mellitus,Glycerol
NCT06955130,Type 2 diabetes mellitus,lactate
NCT06955130,Type 2 diabetes mellitus,glucose
NCT07112430,Exudative vitreoretinopathy 1,Fentanyl Citrate (Intranasal)
NCT06966830,Epilepsy,Lacosamide (LCM)
NCT06880848,Carcinoma,Sonidegib Phosphate Capsules
NCT06826248,Hypothyroidism,Darqeen Capsule
NCT07118930,Coronary artery disorder,Sivelestat Sodium injection
NCT06640530,Melanoma,BCD-263
NCT06640530,Melanoma,Opdivo
NCT06735430,Appendicitis,Ciprofol
NCT06735430,Appendicitis,propofol
NCT06588530,Diphtheria,Tenivac
NCT06588530,Tetanus,Tenivac
NCT06627530,Prostate cancer,darolutamide Oral Tablet
NCT06627530,Prostate cancer,leuprorelin
NCT06787430,ST-elevation myocardial infarction,nicorandil
NCT06727630,Melanoma,PRJ1-3024
NCT06601530,Pain,tramadol
NCT06617325,Systemic lupus erythematosus,DZP
NCT06610825,Metastatic prostate carcinoma,Enhertu
NCT06610825,Prostate cancer,Enhertu
NCT06696248,Hypertensive disorder,Carvedilol and alverine
NCT07007325,Small cell lung carcinoma,[68Ga]Ga-PentixaFor
NCT07001930,Nicotine dependence,Epidiolex
NCT06705530,Non-Hodgkin lymphoma,Hem101
NCT06902025,Precursor B-cell acute lymphoblastic leukemia,JY231 Injection
NCT06745622,Paroxysmal nocturnal hemoglobinuria,HSK39297 tablets
NCT06852222,Leukemia,Bleximenib
NCT06852222,Leukemia,Venetoclax (VEN)
NCT06852222,Leukemia,Azacitidine (AZA)
NCT06900725,Atrial fibrillation,edoxaban
NCT06900725,Atrial fibrillation,edoxaban
NCT06900725,Ischemic stroke,edoxaban
NCT06900725,Ischemic stroke,edoxaban
NCT06727422,Superficial epidermolytic ichthyosis,rifaximin
NCT06727422,Superficial epidermolytic ichthyosis,RNIB21 containing rifaximin
NCT06806930,Carcinoma,Neoadjuvant endocrine therapy
NCT06806930,Carcinoma,Neoadjuvant endocrine therapy
NCT06806930,Carcinoma,Neoadjuvant endocrine therapy
NCT06665230,Narcolepsy,MK-6552
NCT06665230,Narcolepsy,modafinil
NCT07051525,Leukemia,Early antibiotic cessation alert
NCT06657222,Non-small cell lung carcinoma,TUB-030
NCT06657222,Small cell lung carcinoma,TUB-030
NCT06602622,Weight loss,Integrase inhibitor
NCT06602622,Weight loss,Doravirine + tenofovir DF + lamivudine
NCT06675422,Systemic lupus erythematosus,JY231 injection
NCT06958822,Anemia,Ferric Carboxymaltose (FCM)
NCT06619522,Myelofibrosis,ruxolitinib
NCT06619522,Myelofibrosis,INCB57643
NCT06792825,Follicular lymphoma,tafasitamab
NCT06792825,Follicular lymphoma,rituximab
NCT06792825,Follicular lymphoma,lenalidomide
NCT06792825,Marginal zone lymphoma,tafasitamab
NCT06792825,Marginal zone lymphoma,rituximab
NCT06792825,Marginal zone lymphoma,lenalidomide
NCT06648525,Intrahepatic cholangiocarcinoma,Adebrelimab
NCT06648525,Intrahepatic cholangiocarcinoma,Irinotecan liposomes
NCT06648525,Intrahepatic cholangiocarcinoma,lenvatinib
NCT06648525,Intrahepatic cholangiocarcinoma,5-Fluorouracil (5-FU)
NCT06648525,Intrahepatic cholangiocarcinoma,Calcium Folinate
NCT06740422,Constipation disorder,Xuanhuang Runtong Tablet
NCT06740422,Constipation disorder,Xuanhuang Runtong Tablet Simulator
NCT06681922,Graft versus host disease,"Cyclophosphamide, Bortezomib, Abatacept"
NCT06915025,Fallopian tube carcinoma,IMNN-001 (IL-12 Plasmid Formulated with PEG-PEI-Cholesterol Lipopolymer)
NCT06915025,Fallopian tube carcinoma,paclitaxel
NCT06915025,Fallopian tube carcinoma,carboplatin
NCT06915025,Fallopian tube carcinoma,olaparib
NCT06915025,Fallopian tube carcinoma,niraparib
NCT06915025,Ovarian cancer,IMNN-001 (IL-12 Plasmid Formulated with PEG-PEI-Cholesterol Lipopolymer)
NCT06915025,Ovarian cancer,paclitaxel
NCT06915025,Ovarian cancer,carboplatin
NCT06915025,Ovarian cancer,olaparib
NCT06915025,Ovarian cancer,niraparib
NCT06915025,Ovarian carcinoma,IMNN-001 (IL-12 Plasmid Formulated with PEG-PEI-Cholesterol Lipopolymer)
NCT06915025,Ovarian carcinoma,paclitaxel
NCT06915025,Ovarian carcinoma,carboplatin
NCT06915025,Ovarian carcinoma,olaparib
NCT06915025,Ovarian carcinoma,niraparib
NCT06915025,Primary peritoneal carcinoma,IMNN-001 (IL-12 Plasmid Formulated with PEG-PEI-Cholesterol Lipopolymer)
NCT06915025,Primary peritoneal carcinoma,paclitaxel
NCT06915025,Primary peritoneal carcinoma,carboplatin
NCT06915025,Primary peritoneal carcinoma,olaparib
NCT06915025,Primary peritoneal carcinoma,niraparib
NCT07086222,COVID-19,"SARS-CoV-2 (COVID-19) vaccine, protein NVX-CoV2705"
NCT06813222,Anemia,Dapagliflozin (DAPA)
NCT07099222,Constipation disorder,"Low, non-weight based dose of Dexamethasone and Dexmedetomidine in peripheral nerve blocks"
NCT07099222,Constipation disorder,"Ropivacaine with low, non weight based Dexamethasone additive"
NCT07099222,Nausea and vomiting,"Low, non-weight based dose of Dexamethasone and Dexmedetomidine in peripheral nerve blocks"
NCT07099222,Nausea and vomiting,"Ropivacaine with low, non weight based Dexamethasone additive"
NCT07028125,Nonpapillary renal cell carcinoma,cabozantinib and nivolumab
NCT06948422,Hypertensive disorder,Orforglipron
NCT06882122,Migraine disorder,atogepant
NCT06684873,Non-small cell lung carcinoma,AK112 Injection
NCT06788431,Atherosclerosis,IMC-001
NCT06788431,Atherosclerosis,Optimal medical treatment
NCT06788431,Atherosclerosis,Optimal medical treatment
NCT06930573,Hepatocellular carcinoma,AK112
NCT06888973,Ankylosing spondylitis,Mesenchymal Stem Cells
NCT06888973,Juvenile idiopathic arthritis,Mesenchymal Stem Cells
NCT06888973,Rheumatoid arthritis,Mesenchymal Stem Cells
NCT06888973,Systemic lupus erythematosus,Mesenchymal Stem Cells
NCT06888973,Systemic sclerosis,Mesenchymal Stem Cells
NCT07085273,Gastric carcinoma,Irinotecan Liposomal
NCT06649773,Type 2 diabetes mellitus,Noiiglutide Injection
NCT06878573,Age-related macular degeneration,Intravitreal Aflibercept Injection
NCT06878573,Diabetic macular edema,Intravitreal Aflibercept Injection
NCT06813573,Diffuse large B-cell lymphoma,blood sampling
NCT06813573,Follicular lymphoma,blood sampling
NCT06859931,Systemic lupus erythematosus,TQB3702 Tablets
NCT06693973,B-cell non-Hodgkin lymphoma,AcNK-Sup003 cell injection solution
NCT07065331,Asthma,AZD8630
NCT06982131,Obesity disorder,RO7795081
NCT06982131,Obesity disorder,rosuvastatin
NCT06982131,Obesity disorder,pitavastatin
NCT06963827,Kidney disorder,Mezagitamab
NCT07106827,Cholangiocarcinoma,GV20-0251
NCT07106827,Endometrial cancer,GV20-0251
NCT07106827,Hepatocellular carcinoma,GV20-0251
NCT07106827,Melanoma,GV20-0251
NCT07106827,Non-small cell lung carcinoma,GV20-0251
NCT07106827,Pancreatic ductal adenocarcinoma,GV20-0251
NCT07106827,Testicular cancer,GV20-0251
NCT06859073,Hyperuricemia,NNC4004-0002
NCT06693531,Eosinophilic esophagitis,dupilumab
NCT07110831,Depressive disorder,fluoxetine
NCT07115927,Endometrial cancer,dostarlimab
NCT06969027,Non-small cell lung carcinoma,JS207
NCT06969027,Non-small cell lung carcinoma,pemetrexed Injection
NCT06969027,Non-small cell lung carcinoma,Platinum
NCT06969027,Non-small cell lung carcinoma,paclitaxel
NCT06601127,Ischemic stroke,Tiprogrel
NCT06601127,Ischemic stroke,Tiprogrel
NCT06601127,Ischemic stroke,clopidogrel
NCT06871527,Gastric adenocarcinoma,fruquintinib + tislelizumab + FOLFOX
NCT06871527,Gastric carcinoma,fruquintinib + tislelizumab + FOLFOX
NCT07028827,Myopia,0.05% atropine eye drops
NCT07028827,Myopia,0.025% atropine eye drops
NCT06813027,Vitiligo-associated multiple autoimmune disease susceptibility 1,EV
NCT06684327,Penile carcinoma,Albumin-paclitaxel Injection
NCT06684327,Rhabdomyosarcoma,Albumin-paclitaxel Injection
NCT06684327,Testicular cancer,Albumin-paclitaxel Injection
NCT06908473,Cardiovascular disorder,Participants will receive Tongmai Jiangtang Capsule (TJC) in addition to standard treatment.
NCT06908473,Cerebrovascular disorder,Participants will receive Tongmai Jiangtang Capsule (TJC) in addition to standard treatment.
NCT06939127,Non-small cell lung carcinoma,Neoadjuvant Cryoablation Combined with Tislelizumab and Chemotherapy
NCT06939127,Non-small cell lung carcinoma,Adjuvant tislelizumab
NCT07006727,Small cell lung carcinoma,225Ac-ETN029
NCT07006727,Small cell lung carcinoma,111In-ETN029
NCT06744127,Essential hypertension,BR1015
NCT06744127,Essential hypertension,BR1015-1
NCT06744127,Essential hypertension,BR1015-2
NCT06740526,IgA glomerulonephritis,Sibeprenlimab
NCT07098026,Gastric carcinoma,Shenqi Fuwei Mixture
NCT07069166,Periodontitis,Para-probiotic oral care
NCT07069166,Periodontitis,Chlorhexidine oral care
NCT07069166,Type 2 diabetes mellitus,Para-probiotic oral care
NCT07069166,Type 2 diabetes mellitus,Chlorhexidine oral care
NCT06577766,Obesity disorder,NNC0638-0355
NCT06878066,Cerebrovascular disorder,thrombolysis therapy
NCT06878066,Ischemic stroke,thrombolysis therapy
NCT06609226,Sickle cell disease,Etavopivat A
NCT06609226,Sickle cell disease,Etavopivat B
NCT06616766,Non-small cell lung carcinoma,YH42946
NCT07047066,Adult glioblastoma,Fluzoparib with Temozolomide
NCT06738966,Endometrial cancer,BL0175
NCT06738966,Ovarian cancer,BL0175
NCT07021066,Biliary tract cancer,BL-M05D1
NCT07021066,Esophageal adenocarcinoma,BL-M05D1
NCT07021066,Gastric adenocarcinoma,BL-M05D1
NCT06832566,Hypotensive disorder,Fludrocortisone
NCT07092566,Renal carcinoma,Ropivacaine HCL
NCT07092566,Renal carcinoma,Exparel
NCT07092566,Renal carcinoma,epinephrine
NCT07092566,Renal carcinoma,Clonidine HCL
NCT07092566,Renal carcinoma,ketorolac
NCT06697366,Gastric carcinoma,Irinotecan liposome injection Ⅱ
NCT06697366,Gastric carcinoma,Sintilimab
NCT07129629,Tuberculosis,Bedaquiline (B)
NCT07129629,Tuberculosis,moxifloxacin
NCT07129629,Tuberculosis,Pyrazinamide (PZA)
NCT07129629,Tuberculosis,Delamanid (D)
NCT07129629,Tuberculosis,Isoniazid (H)
NCT07129629,Tuberculosis,Rifampicin (R)
NCT07129629,Tuberculosis,Ethambutol (E)
NCT06940180,Squamous cell carcinoma,toripalimab
NCT06940180,Squamous cell carcinoma,carboplatin
NCT06940180,Squamous cell carcinoma,docetaxel
NCT06940180,Squamous cell carcinoma,cisplatin
NCT06581380,Small cell lung carcinoma,JK-1201I
NCT06581380,Small cell lung carcinoma,topotecan
NCT06970080,Asthma,Inhaled corticosteroid (ICS)
NCT06970080,Asthma,Oral Corticosteroid (OCS)
NCT06619080,Osteoarthritis,Genicular nerve block with bupivacaine and corticosteroids
NCT06619080,Osteoarthritis,Genicular nerve block with bupivacaine
NCT06785129,Endometriosis,Hormonal assessment
NCT06785129,Migraine disorder,Hormonal assessment
NCT06600529,Autism,Autologous PRP
NCT06600529,Autism,Exosome Therapy
NCT07051629,Epilepsy,SIF001
NCT06635629,Cushing syndrome,desmopressin
NCT06635629,Cushing syndrome,dexamethasone
NCT06694129,Non-small cell lung carcinoma,entrectinib
NCT06947980,Atopic eczema,CM512
NCT06635980,Triple-negative breast carcinoma,Chemotherapy
NCT07040280,Melanoma,Sulforaphane (broccoli sprout extract)
NCT06786429,Cervical carcinoma,Gardasil
NCT06786429,Cervical carcinoma,Hepatitis B Virus Vaccine(HBV)
NCT06786429,Depressive disorder,Gardasil
NCT06786429,Depressive disorder,Hepatitis B Virus Vaccine(HBV)
NCT06722729,Parkinson disease,KDT-3594
NCT06957080,Diabetic macular edema,EYE103
NCT06957080,Diabetic macular edema,ranibizumab
NCT07121829,Malignant pancreatic neoplasm,tovorafenib
NCT07121829,Malignant pancreatic neoplasm,Tovorafenib Drug: Pimasertib
NCT07121829,Melanoma,tovorafenib
NCT07121829,Melanoma,Tovorafenib Drug: Pimasertib
NCT06973629,Amyotrophic lateral sclerosis,Debamestrocel - MSC-NTF (NurOwn)
NCT06717529,Osteoarthritis,methylprednisolone acetate Injection
NCT06570980,Type 2 diabetes mellitus,"sulfonylurease with metformin, DPP4 inhibitors with Metformin"
NCT06946680,Malignant glioma,Ex-Vivo expanded autologous IL-8 receptor (CXCR2) modified CD70 CAR (8R-70CAR) T cells
NCT06938529,Obesity disorder,VCT220
NCT06847880,Root resorption,1: Vitamin C Supplementation
NCT06847880,Root resorption,Vitamin E Supplementation
NCT06607380,Tetanus,TNM002
NCT06607380,Tetanus,Adsorbed tetanus vaccine
NCT06607380,Tetanus,TNM002 + adsorbed tetanus vaccine
NCT07020429,Primary ovarian failure,Huanjingjian decoction
NCT07020429,Primary ovarian failure,Hormone replacement therapy
NCT06889948,Glomerulonephritis,daratumumab
NCT06889948,Kidney failure,daratumumab
NCT06634030,Wound healing,RhPDGF-BB
NCT06576830,Pain,methadone
NCT06576830,Pain,Fentanyl/Hydromorphone
NCT06579430,Hypoparathyroidism,Indocyanine Green near infrared fluorescence imaging
NCT06579430,Hypoparathyroidism,Indocyanine Green near infrared fluorescence imaging
NCT06611930,Type 2 diabetes mellitus,CK-0045
NCT06773130,Pancreatic ductal adenocarcinoma,HRS-4642
NCT06773130,Pancreatic ductal adenocarcinoma,Nimotuzumab
NCT06636825,Hypercapnia,caffeine
NCT06754930,Non-small cell lung carcinoma,SHR-1826
NCT06754930,Non-small cell lung carcinoma,SHR-1316
NCT06754930,Non-small cell lung carcinoma,SHR-9839
NCT06754930,Non-small cell lung carcinoma,SHR-8068
NCT06754930,Non-small cell lung carcinoma,Ametinib mesylate
NCT06754930,Non-small cell lung carcinoma,BP-102
NCT06754930,Non-small cell lung carcinoma,carboplatin
NCT06991530,Paroxysmal familial ventricular fibrillation,Low Molecular Weight Heparine
NCT06952530,Hypertensive disorder,Orforglipron
NCT06597422,Neurotrophic keratopathy,STSP-0902 ophthalmic solution
NCT06597422,Neurotrophic keratopathy,STSP-0902 ophthalmic solution
NCT06597422,Neurotrophic keratopathy,STSP-0902 ophthalmic solution
NCT06597422,Neurotrophic keratopathy,STSP-0902 ophthalmic solution
NCT06649422,Leukemia,blinatumomab
NCT06984822,Blindness (disorder),Anti-VEGF treatment
NCT06984822,Diabetes mellitus,Anti-VEGF treatment
NCT06984822,Diabetic macular edema,Anti-VEGF treatment
NCT06872125,Dravet syndrome,zorevunersen
NCT06698822,Primary cutaneous T-cell non-Hodgkin lymphoma,tofacitinib
NCT06833125,Nosocomial infection,Garlic powder standardized to allicin
NCT07077122,Periodontitis,antibiotic prophylaxis
NCT06922825,Cancer,68Ga-FAPI-46
NCT06817525,Triple-negative breast carcinoma,6*Nab-P (d
NCT06817525,Triple-negative breast carcinoma,6*Nab-P (d
NCT06817525,Triple-negative breast carcinoma,6*Nab-P (d
NCT06817525,Triple-negative breast carcinoma,6*Nab-P (d
NCT07003425,Atopic eczema,APG777
NCT07003425,Atopic eczema,APG777
NCT07003425,Atopic eczema,APG777
NCT06821425,Periodontal disorder,Melatonin gel mixed with xenograft
NCT07076225,Pulmonary tuberculosis,Bedaquiline (B)
NCT07076225,Pulmonary tuberculosis,Sitafloxacin (S)
NCT07076225,Pulmonary tuberculosis,Linezolid (L)
NCT07076225,Pulmonary tuberculosis,Pyrazinamide (Z)
NCT07076225,Pulmonary tuberculosis,Isoniazid (H)
NCT07076225,Pulmonary tuberculosis,Rifampicin (R)
NCT07076225,Pulmonary tuberculosis,Ethambutol (E)
NCT06739122,Type 2 diabetes mellitus,dulaglutide
NCT06766591,Chemotherapy,Ivonescimab combined with chemotherapy
NCT06766591,Non-small cell lung carcinoma,Ivonescimab combined with chemotherapy
NCT06923891,Schizophrenia,Xanomeline/Trospium
NCT06765694,Epicondylitis,Botulinum toxin injection
NCT06933394,Neuroblastoma,arsenic trioxide
NCT06933394,Neuroblastoma,MAPK inhibitors
NCT06933394,Neuroblastoma,Chemotherapy
NCT07066891,Diabetes mellitus,CSII in the prediction model group
NCT07066891,Diabetes mellitus,CSII in the empirical group
NCT07066891,Type 2 diabetes mellitus,CSII in the prediction model group
NCT07066891,Type 2 diabetes mellitus,CSII in the empirical group
NCT07128394,Infertility disorder,Recombinant Luteinizing Hormone (rLH)
NCT07128394,Infertility disorder,Recombinant Follicle-Stimulating Hormone (rFSH)
NCT07128394,Infertility disorder,Gonadotropin-Releasing Hormone Agonist (GnRH-a)
NCT06699394,AL amyloidosis,Teclistamab (Tec)
NCT06923540,Mobility,IV Acetaminophen
NCT06719791,Epilepsy,sirolimus
NCT06666491,Malaria,tafenoquine
NCT06666491,Malaria,primaquine
NCT06666491,Malaria,chloroquine
NCT06566391,Melanoma,ipilimumab
NCT07099794,Biliary tract cancer,Liposomal irinotecan+5-FU/LV+Lenvatinib
NCT07099794,Biliary tract cancer,NALIRI
NCT06830694,Small cell lung carcinoma,"Atezolizumab, Etoposide, Carboplatin, Tarlatamab"
NCT06993194,Agitation,haloperidol
NCT06993194,Agitation,dexmedetomidine
NCT06993194,Delirium,haloperidol
NCT06993194,Delirium,dexmedetomidine
NCT06993194,Traumatic brain injury,haloperidol
NCT06993194,Traumatic brain injury,dexmedetomidine
NCT06859294,Rheumatoid arthritis,LY3541860
NCT07116694,Bipolar I disorder,BXCL501 Sublingual Film
NCT07116694,Bipolar II disorder,BXCL501 Sublingual Film
NCT07116694,Schizophrenia,BXCL501 Sublingual Film
NCT06952660,Cervical carcinoma,Tivdak
NCT06886360,Sclerosing cholangitis,norucholic acid
NCT06585891,HIV infectious disease,VRC-HIVMAB0121-00-AB
NCT06812260,Small cell lung carcinoma,HLX10+chemo
NCT06878560,End stage renal failure,10 GE Xenokidney
NCT06937060,Psoriasis,semaglutide
NCT07117760,Prostate cancer,225Ac-LNC1011
NCT07117760,Prostate cancer,68Ga-PSMA-11
NCT06875960,Systemic lupus erythematosus,BMS-986165
NCT06656494,Myelodysplastic syndrome,ICP-248
NCT06656494,Myelodysplastic syndrome,azacitidine
NCT06662994,Diabetic macular edema,Aflibercept
NCT06890260,Allergic rhinitis,Cetirizine hydrochloride tablets combined with nasal budesonide spray.
NCT06632860,Meningioma,68Ga-TATE-RGD
NCT06632860,Meningioma,18-FDG
NCT06568094,Prostate cancer,HRS-5041 tablets
NCT06568094,Prostate cancer,Abiraterone Acetate tablets（II）
NCT06568094,Prostate cancer,Prednisone Acetate tablets
NCT06568094,Prostate cancer,docetaxel Injection
NCT06568094,Prostate cancer,HRS-1167 tablets
NCT06568094,Prostate cancer,SHR2554 tablets
NCT06947460,Systemic sclerosis,CD19-BCMA CAR-T cells infusion
NCT06681194,Wound healing,silver nitrate
NCT06681194,Wound healing,triamcinolone
NCT06681194,Wound healing,Silver nitrate + triamcinolone
NCT07046494,Bipolar I disorder,RAP-219
NCT06775860,Atopic eczema,ICP-332 Tablets
NCT06747260,Perinatal asphyxia,Intranasal breast milk
NCT06940960,Precursor B-cell acute lymphoblastic leukemia,JY231 Injection
NCT06762158,Esophageal squamous cell carcinoma,neoadjuvant immunotherapy
NCT06762158,Esophageal squamous cell carcinoma,adjuvant immunotherapy
NCT06907316,Syphilis,Cefixime
NCT06907316,Syphilis,Benzathine penicillin
NCT06764316,Hepatocellular carcinoma,BAY
NCT06764316,Hepatocellular carcinoma,BAY
NCT06747858,Cystic fibrosis,ARCT-032
NCT06599658,Inflammatory bowel disease,Inactivated influenza vaccine (IIV) at baseline
NCT06599658,Inflammatory bowel disease,COVID-19 Vaccines at a
NCT06599658,Inflammatory bowel disease,Inactivated influenza vaccine at Month
NCT06599658,Inflammatory bowel disease,COVID-19 Vaccines at a
NCT06599658,Influenza,Inactivated influenza vaccine (IIV) at baseline
NCT06599658,Influenza,COVID-19 Vaccines at a
NCT06599658,Influenza,Inactivated influenza vaccine at Month
NCT06599658,Influenza,COVID-19 Vaccines at a
NCT06599658,Rheumatoid arthritis,Inactivated influenza vaccine (IIV) at baseline
NCT06599658,Rheumatoid arthritis,COVID-19 Vaccines at a
NCT06599658,Rheumatoid arthritis,Inactivated influenza vaccine at Month
NCT06599658,Rheumatoid arthritis,COVID-19 Vaccines at a
NCT06854458,Myocardial ischemia,Gadavist
NCT06854458,Myocardial ischemia,Vasodilator
NCT06620796,Small cell lung carcinoma,Arm
NCT06620796,Small cell lung carcinoma,second-line group
NCT06952296,Endometriosis,Dydrogesterone
NCT06722196,Atrial fibrillation,topical amiodarone
NCT06664996,Hepatocellular carcinoma,Sintilimab (approved)
NCT06670196,Non-small cell lung carcinoma,SKB264
NCT06670196,Non-small cell lung carcinoma,osimertinib
NCT06837896,Prostate cancer,QLG1080
NCT06654596,IgA glomerulonephritis,Telitacicept
NCT06654596,IgA glomerulonephritis,Glucocorticoid
NCT07118696,Pulmonary tuberculosis,Extra
NCT06671496,Psoriatic arthritis,Zasocitinib
NCT06817096,Influenza,Nitazoxanide
NCT06717958,Myelodysplastic syndrome,Ivosidenib
NCT06782958,Amyotrophic lateral sclerosis,50mg FHND1002
NCT06782958,Amyotrophic lateral sclerosis,100mg FHND1002
NCT06782958,Amyotrophic lateral sclerosis,150 mg FHND1002
NCT06782958,Amyotrophic lateral sclerosis,200 mg FHND1002（fasting）
NCT06782958,Amyotrophic lateral sclerosis,250mg FHND1002
NCT06782958,Amyotrophic lateral sclerosis,200mg FHND1002(postprandial)
NCT06804096,Pneumonia,Faropenem
NCT06804096,Pneumonia,Co-amoxiclav
NCT06804096,Pneumonia,clarithromycin
NCT06866158,Diabetic kidney disease,Dendritic cell immunotherapy
NCT06603558,Migraine disorder,atogepant
NCT06948396,Asthma,tezepelumab
NCT06939296,Obesity disorder,VCT220
NCT06779396,Pain,The triamcinolone acetonide plus ropivacaine group
NCT06779396,Pain,The ropivacaine group
NCT07079696,Autism,ATRA
NCT06838416,Type 2 diabetes mellitus,finerenone
NCT06924658,Gout,metformin
NCT06676696,Kidney failure,Continue low dose calcineurin inhibitor (CNI)
NCT06676696,Kidney failure,Calcineurin inhibitor withdrawal at
NCT06590558,Invasive breast carcinoma,eriBULin mesylate
NCT06590558,Invasive breast carcinoma,Tolinapant
NCT06890858,Ovarian cancer,Fasudil Hydrochloride
NCT06750458,Malignant glioma,DexamethasoneGroup III (n=25) (Dexamethasone group)
NCT06967558,Prediabetes syndrome,Exendin
NCT07008196,Rheumatoid arthritis,Telitacicept
NCT06998758,Weight loss,megestrol acetate
NCT06689358,Pain,0.4 ml/kg of
NCT06703658,Type 2 diabetes mellitus,AZD5004(Part A)
NCT06703658,Type 2 diabetes mellitus,AZD5004(Part B)
NCT06860958,Depressive disorder,fluoxetine
NCT06860958,Depressive disorder,roflumilast
NCT06871358,ST-elevation myocardial infarction,Atorvastatin
NCT06742996,Mantle cell lymphoma,Sonrotoclax
NCT06742996,Mantle cell lymphoma,zanubrutinib
NCT06714396,Amyotrophic lateral sclerosis,QRL-101
NCT06814496,Cervical carcinoma,tarlatamab
NCT06814496,Childhood bladder carcinoma,tarlatamab
NCT06814496,Cutaneous neuroendocrine carcinoma,tarlatamab
NCT06814496,Glioma susceptibility 1,tarlatamab
NCT06814496,Melanoma,tarlatamab
NCT06814496,Testicular cancer,tarlatamab
NCT06575296,Childhood acute lymphoblastic leukemia,revumenib
NCT06681324,Crohn disease,AZD7798
NCT07033234,Psoriasis,HS-20118
NCT06961617,Hepatocellular carcinoma,"LioCyx-M, HBV antigen-specific TCR-redirected T cells"
NCT06803524,Pertussis,Pertagen® vaccine
NCT06803524,Pertussis,Adacel® vaccine
NCT06846424,Fallopian tube carcinoma,SCT-001 CAR-T cells
NCT06846424,Ovarian cancer,SCT-001 CAR-T cells
NCT06791824,Aplastic anemia,CM313(SC) injection
NCT06791824,Aplastic anemia,CM313(SC) injection
NCT06791824,Aplastic anemia,CM313(SC) injection
NCT06608134,Osteoarthritis,Umbilical Cord Wharton's Jelly Allograft Intra-articular Knee Injection
NCT07025824,Myelodysplastic syndrome,Treosulfan (Treo)
NCT07025824,Myelodysplastic syndrome,Melphalan (Mel)
NCT07025824,Myelodysplastic syndrome,Fludarabine (Flud)
NCT06881017,Gastric carcinoma,trastuzumab
NCT06881017,Gastric carcinoma,Adebrelimab
NCT06881017,Gastric carcinoma,Apatinib
NCT06881017,Gastric carcinoma,S-1
NCT06881017,Gastric carcinoma,capecitabine
NCT06881017,Gastric carcinoma,oxaliplatin
NCT06881017,Gastric carcinoma,zolbetuximab
NCT06881017,Gastric carcinoma,SHR-A1811
NCT06881017,Gastric carcinoma,SHR-A1904
NCT06881017,Gastric carcinoma,SHR-1701
NCT06582017,Hepatocellular carcinoma,QXL138AM Injection every
NCT06582017,Malignant pancreatic neoplasm,QXL138AM Injection every
NCT06582017,Nonpapillary renal cell carcinoma,QXL138AM Injection every
NCT06582017,Ovarian cancer,QXL138AM Injection every
NCT06582017,Prostate cancer,QXL138AM Injection every
NCT06582017,Urothelial carcinoma,QXL138AM Injection every
NCT06743334,COVID-19,Tozinameran (BNT162b2)
NCT06743334,COVID-19,Tozinameran (BNT162b2) / Riltozinameran (BNT162b2 OMI BA.1)
NCT06743334,COVID-19,Tozinameran (BNT162b2) / Famtozinameran (BNT162b2 OMI BA.4-5)
NCT06809517,Neoplastic meningitis,AK112
NCT06809517,Neoplastic meningitis,Pemetrexed (Alimta)
NCT06720324,Hematopoietic and lymphoid cell neoplasm,Fludarabine + Cyclophosphamide + CD7-specific CAR-T Cells
NCT07057934,Cholelithiasis,Standard Systemic Analgesia
NCT06630234,Gastrointestinal stromal tumor,DCC-3009
NCT07055724,AL amyloidosis,Eque-cel CAR-T Therapy
NCT06654934,Sarcoidosis,prednisolone
NCT06654934,Sarcoidosis,prednisolone
NCT07098234,Hyperbilirubinemia,Vitamin D3
NCT06827717,Ewing sarcoma,irinotecan liposome (II) + temozolomide + fluzoparib
NCT06680817,Diabetic macular edema,faricimab
NCT06680817,Wet macular degeneration,faricimab
NCT06822517,Parkinson disease,VENT-02
NCT06975917,Biliary tract cancer,Chemotherapy
NCT06782217,Allergic disease,VENOX
NCT06912035,Maturity-onset diabetes of the young type 1,Diacerein
NCT06964958,Nonpapillary renal cell carcinoma,177Lu-PSMA-617
NCT06964958,Renal carcinoma,177Lu-PSMA-617
NCT07087158,Nonpapillary renal cell carcinoma,IBR854
NCT07087158,Nonpapillary renal cell carcinoma,pazopanib
NCT06756035,Ovarian carcinoma,CT-95
NCT06777758,Constipation disorder,remimazolam
NCT06777758,Constipation disorder,propofol
NCT06777758,Vomiting,remimazolam
NCT06777758,Vomiting,propofol
NCT07127458,Polycystic ovary syndrome,Adolescent PCOS group receiving oral contraceptives
NCT06788158,Pain,Incobotulinum Toxin A
NCT06788158,Pain,Glucocorticoid
NCT06798558,Prostate adenocarcinoma,Lu-17-PSMA-617
NCT06785558,Overactive bladder,Anticholinergic therapy
NCT07112586,Androgenetic alopecia,Plasma derived exosomes
NCT06753786,Intracerebral hemorrhage,Venous thromboembolism prophylaxis with unfractionated heparin or low molecular weight heparin starting within the first
NCT06753786,Intracerebral hemorrhage,Venous thromboembolism prophylaxis with unfractionated heparin or low molecular weight heparin starting on the
NCT06753786,Pulmonary embolism,Venous thromboembolism prophylaxis with unfractionated heparin or low molecular weight heparin starting within the first
NCT06753786,Pulmonary embolism,Venous thromboembolism prophylaxis with unfractionated heparin or low molecular weight heparin starting on the
NCT06792435,Biliary tract cancer,XNW27011
NCT06792435,Biliary tract cancer,XNW27011
NCT06792435,Gastric carcinoma,XNW27011
NCT06792435,Gastric carcinoma,XNW27011
NCT06792435,Gastroesophageal junction adenocarcinoma,XNW27011
NCT06792435,Gastroesophageal junction adenocarcinoma,XNW27011
NCT06792435,Ovarian cancer,XNW27011
NCT06792435,Ovarian cancer,XNW27011
NCT07022535,Fallopian tube carcinoma,Carboplatin plus Paclitaxel
NCT07022535,Ovarian cancer,Carboplatin plus Paclitaxel
NCT07022535,Peritoneum cancer,Carboplatin plus Paclitaxel
NCT06879158,Type 2 diabetes mellitus,BR3409
NCT06879158,Type 2 diabetes mellitus,BR3409-1
NCT06879158,Type 2 diabetes mellitus,BR3409-2
NCT06576635,Non-small cell lung carcinoma,docetaxel
NCT06576635,Non-small cell lung carcinoma,paclitaxel
NCT06576635,Non-small cell lung carcinoma,gemcitabine
NCT06576635,Non-small cell lung carcinoma,pemetrexed
NCT06576635,Non-small cell lung carcinoma,vinorelbine
NCT06772558,Benign prostatic hyperplasia,Desflurane Inhalation
NCT06772558,Cholecystitis,Desflurane Inhalation
NCT06772558,Coronary artery disorder,Desflurane Inhalation
NCT06602258,Alzheimer disease,E2814
NCT06602258,Alzheimer disease,lecanemab
NCT07055958,Parkinson disease,metformin
NCT06655896,Scleroderma,rapcabtagene autoleucel
NCT06655896,Scleroderma,rituximab
NCT06961435,Colitis,vedolizumab
NCT06851858,Diabetes mellitus,AZD6234
NCT06851858,Obesity disorder,AZD6234
NCT06979596,Childhood malignant neoplasm,MK-5684
NCT06979596,Childhood malignant neoplasm,Fludrocortisone/ Fludrocortisone acetate
NCT06979596,Childhood malignant neoplasm,Dexamethasone/Dexamethasone acetate
NCT06979596,Childhood malignant neoplasm,Rescue Medications
NCT06979596,Childhood malignant neoplasm,fulvestrant
NCT06979596,Childhood malignant neoplasm,exemestane
NCT06979596,Childhood malignant neoplasm,Megestrol acetate/Medroxyprogesterone acetate
NCT06979596,Childhood malignant neoplasm,tamoxifen
NCT06979596,Childhood malignant neoplasm,letrozole
NCT06982196,Psoriasis,Sulodexide
NCT06945458,Atopic eczema,KT-621
NCT06845358,Tuberculosis,BCG TICE strain
NCT06973096,Adult glioblastoma,CART-EGFR-IL13Ra2 cells
NCT06612996,Hernia,tramadol
NCT06612996,Hernia,Magnesium sulphate
NCT07122596,Sepsis,Meropenem Infusion
NCT06615596,Atrial fibrillation,Anticoagulant drugs
NCT06902558,Autosomal dominant polycystic kidney disease,ABBV-CLS-628
NCT06663358,Fabry disease,Pegunigalsidase-alfa
NCT06902896,Dilated cardiomyopathy,FAP immunosuppressive CAR-DC
NCT06902896,Heart failure,FAP immunosuppressive CAR-DC
NCT07123896,Cardiac rhythm disease,Drug Treatment
NCT07038096,Neuroendocrine carcinoma,ZG006
NCT07038096,Neuroendocrine carcinoma,ZG005
NCT07038096,Small cell lung carcinoma,ZG006
NCT07038096,Small cell lung carcinoma,ZG005
NCT06785116,"Hypertension, pregnancy-induced",Dapagliflozin
NCT06785116,Preeclampsia,Dapagliflozin
NCT06574516,Pain,ibuprofen
NCT06574516,Pain,paracetamol
NCT06958796,Cytomegalovirus,Cytomegalovirus Immune Globulin Intravenous (Human) monthly for three months
NCT07106996,Polycystic ovary syndrome,red yeast rice，RYR
NCT07092696,Cervical carcinoma,toripalimab
NCT07036796,Diabetic neuropathy,melatonin
NCT06916416,Classic Hodgkin lymphoma,pembrolizumab
NCT06588296,Obesity disorder,ixekizumab
NCT06588296,Obesity disorder,tirzepatide
NCT06588296,Psoriatic arthritis,ixekizumab
NCT06588296,Psoriatic arthritis,tirzepatide
NCT06730516,Glaucoma,Latanoprost (Xalatan)
NCT06730516,Glaucoma,Brimonidine
NCT06729996,Diabetes mellitus,Pioglitazone (PIO)
NCT06729996,Diabetes mellitus,Empagliflozin (EMPA)
NCT06729996,Pancreatitis,Pioglitazone (PIO)
NCT06729996,Pancreatitis,Empagliflozin (EMPA)
NCT07045896,Arthritic joint disease,Fucoidan
NCT07045896,Arthritic joint disease,corn starch
NCT06579196,Non-small cell lung carcinoma,Trabedersen
NCT06579196,Non-small cell lung carcinoma,pembrolizumab
NCT06726096,Rheumatoid arthritis,Recombinant Humanized Anti-interleukin-6 Receptor Monoclonal Antibody Injection
NCT06740916,Myeloproliferative neoplasm,81-mg aspirin once daily
NCT06740916,Myeloproliferative neoplasm,81-mg aspirin twice daily
NCT07119996,Childhood bladder carcinoma,"Tislelizumab, Cisplatin, Gemcitabine and Vitamin B3"
NCT06618196,Diphtheria,LR20062
NCT06618196,Diphtheria,DTaP-HepB-IPV-Hib vaccine
NCT06618196,Pertussis,LR20062
NCT06618196,Pertussis,DTaP-HepB-IPV-Hib vaccine
NCT06618196,Poliomyelitis,LR20062
NCT06618196,Poliomyelitis,DTaP-HepB-IPV-Hib vaccine
NCT06618196,Tetanus,LR20062
NCT06618196,Tetanus,DTaP-HepB-IPV-Hib vaccine
NCT06623396,Diabetes mellitus,M28z1XXPD1DNR CAR
NCT06623396,Esophageal adenocarcinoma,M28z1XXPD1DNR CAR
NCT06623396,Gastroesophageal junction adenocarcinoma,M28z1XXPD1DNR CAR
NCT06947616,Cardiogenic shock,Mild therapeutic hypothermia
NCT06704516,Menopause,Menopausal hormone therapy
NCT06840496,Rett syndrome,Bionetide
NCT07022496,Migraine disorder,Caffeine (200 mg)
NCT07022496,Migraine disorder,triptans
NCT07022496,Migraine disorder,NSAID (Nonsteroidal anti-inflammatory drugs)
NCT07022496,Migraine disorder,Paracetamol (acetaminophen)
NCT06708416,Postherpetic neuralgia,ONO-1110
NCT06722235,Autoimmune thrombocytopenic purpura,Mezagitamab
NCT06665035,Dengue disease,TDV
NCT06713135,Duchenne muscular dystrophy,vamorolone
NCT06823258,Non-small cell lung carcinoma,HS-10365
NCT06863558,Intracerebral hemorrhage,PPA Intervention
NCT06620835,Non-small cell lung carcinoma,Blood samples for Hematology
NCT06620835,Non-small cell lung carcinoma,Blood samples for Chemistry
NCT06620835,Non-small cell lung carcinoma,Blood sample for liver function tests
NCT06620835,Non-small cell lung carcinoma,Pregnancy test
NCT07069335,Ovarian cancer,olaparib
NCT06897735,Lip and oral cavity carcinoma,Afatinib Dimaleat
NCT06897735,Lip and oral cavity carcinoma,inhalation of afatinib dimaleate
NCT06897735,Melanoma,Afatinib Dimaleat
NCT06897735,Melanoma,inhalation of afatinib dimaleate
NCT06834386,Delirium,suvorexant
NCT06834386,Insomnia,suvorexant
NCT06604286,Pain,"In this group, patients received"
NCT06604286,Pain,8 mg IM dexamethasone injection into the pterygoid cavity after impacted tooth surgery.
NCT06912763,Lymphedema,Pravastatin (drug)
NCT06912763,Lymphedema,pentoxifylline
NCT06912763,Lymphedema,ketoprofen
NCT06912763,Lymphedema,Pirfenidoneone
NCT06912763,Lymphedema,tocopherol
NCT06933563,Myasthenia gravis,UCAR T-cell group
NCT07053735,Childhood bladder carcinoma,Nimotuzumab and Radiotherapy
NCT06870435,Nasopharyngeal carcinoma,"Blood, nasopharyngeal swab and saliva"
NCT07112235,"COPD, severe early onset",Rhinovirus-A16
NCT07099235,Depressive disorder,ketamine hydrochloride
NCT06636435,Hepatocellular carcinoma,CBA-1205
NCT06636435,Hepatocellular carcinoma,CBA-1205
NCT06636435,Hepatocellular carcinoma,CBA-1205
NCT06812858,Hodgkins lymphoma,"Nivolumab, Pembrolizumab"
NCT06680258,Hepatocellular carcinoma,TPST-1120
NCT06680258,Hepatocellular carcinoma,atezolizumab
NCT06680258,Hepatocellular carcinoma,bevacizumab
NCT06811363,Osteoporosis,Anti-resorptive agents
NCT06811363,Osteoporosis,Anabolic Agents
NCT06685835,Hidradenitis suppurativa,Brensocatib
NCT06825858,Age-related macular degeneration,KH658
NCT06840158,Cerebral palsy,Miotox (Botulinum toxin type A is a hemagglutinin complex)
NCT06840158,Cerebral palsy,BOTOX®
NCT06966635,Nephrolithiasis,Sodium Bicarbonate Oral Capsule
NCT06966635,Nephrolithiasis,Potassium Citrate Tablets
NCT06966635,Nephrolithiasis,uric-acid-lowering drug
NCT06723535,Kidney failure,BMS-986278
NCT06716658,Lymphoma,JAK1 Inhibitor
NCT06716658,Mycosis fungoides,JAK1 Inhibitor
NCT06716658,Primary cutaneous T-cell non-Hodgkin lymphoma,JAK1 Inhibitor
NCT06602063,Fallopian tube carcinoma,Iparomlimab/Tuvonralimab
NCT06602063,Ovarian carcinoma,Iparomlimab/Tuvonralimab
NCT06602063,Primary peritoneal carcinoma,Iparomlimab/Tuvonralimab
NCT06627335,Atopic eczema,Ruxolitinib Cream
NCT06627335,Atopic eczema,TCS
NCT06944496,Gastric carcinoma,Disitamab Vedotin+Tislelizumab+Oxaliplatin+Capecitabine
NCT06944496,Gastric carcinoma,Tislelizumab+Oxaliplatin+Capecitabine
NCT06716216,Type 2 diabetes mellitus,Drug
NCT06716216,Type 2 diabetes mellitus,Drug:10 mg BGM0504 Administered SC
NCT06716216,Type 2 diabetes mellitus,Drug: Semaglutide Administered SC
NCT06893796,Preeclampsia,Telpegfilgrastim Injection
NCT06893796,Preeclampsia,Telpegfilgrastim Injection
NCT06893796,Preeclampsia,Telpegfilgrastim Injection
NCT06777316,Cholangiocarcinoma,CGT4859
NCT06777316,Intrahepatic cholangiocarcinoma,CGT4859
NCT07008716,Small cell lung carcinoma,Etoposide + carboplatin
NCT06617416,Non-small cell lung carcinoma,Cadonilimab (AK104)
NCT06617416,Non-small cell lung carcinoma,Sugemalimab
NCT07082816,Ocular hypertension,Netarsudil
NCT07082816,Ocular hypertension,Netarsudil
NCT06956196,Atopic eczema,Stapokibatrt
NCT06584916,Obesity disorder,Orforglipron
NCT07113496,Precursor B-cell acute lymphoblastic leukemia,Allogeneic CAR-T
NCT06820216,Hiatus hernia,Rectointercostal facial plane block using bupivacaine
NCT06925516,Intrahepatic cholangiocarcinoma,Apatinib and Adebrelimab in Combination With chemotherapy
NCT07083063,Pancreatitis,Nitroglycerin (NTG)
NCT07031063,HIV infectious disease,DTG/3TC
NCT07031063,HIV infectious disease,Bictegravir (BIC) plus Emtricitabine (FTC) plus Tenofovir Alafenamide (TAF)
NCT06752616,Agitation,Sublingual Dexmedetomidine
NCT06752616,Agitation,Buccal midazolam
NCT06752616,Agitation,Oral lorazepam
NCT07130916,Non-small cell lung carcinoma,Aumolertinib
NCT07036016,Non-small cell lung carcinoma,EGFR-TKI
NCT07036016,Non-small cell lung carcinoma,PD-1/PD-L1 inhibitor
NCT07036016,Non-small cell lung carcinoma,EGFR-TKI combined with PD-1/PD-L1
NCT06698796,Dermatomyositis,Dazukibart
NCT06648096,Fanconi anemia,afatinib
NCT06713616,Depressive disorder,Racemic ketamine
NCT06713616,Depressive disorder,Spravato (Esketamine)
NCT07016516,Migraine disorder,PRT-064040 nasal spray
NCT07016516,Migraine disorder,PRT-064040 nasal spray
NCT06659016,Urinary tract infection,Fosfomycin
NCT06659016,Urinary tract infection,Combination of dietary supplement and fosfomycin
NCT06679816,Pituitary gland adenoma,Hormone replacement therapy
NCT07002216,Hodgkins lymphoma,brentuximab vedotin
NCT07002216,Hodgkins lymphoma,etoposide
NCT07002216,Hodgkins lymphoma,cyclophosphamide
NCT07002216,Hodgkins lymphoma,doxorubicin
NCT07002216,Hodgkins lymphoma,dacarbazine
NCT07002216,Hodgkins lymphoma,dexamethasone
NCT06837116,Dengue disease,Vaccine
NCT06668389,Congenital heart disease,SGLT2 inhibitor (Dapagliflozin
NCT06821529,Parkinson disease,ICA07 therapy
NCT06841640,"COPD, severe early onset",AERO-001
NCT06841640,"COPD, severe early onset",AERO-002
NCT06841640,"COPD, severe early onset",AERO-007
NCT06709040,Maturity-onset diabetes of the young type 1,somapacitan
NCT07030140,Cholangiocarcinoma,tislelizumab
NCT07030140,Cholangiocarcinoma,gemcitabine
NCT07030140,Cholangiocarcinoma,Cisplatin or Oxaliplatin
NCT07059429,Ketamine,ketamine
NCT07059429,Ketamine,Standard Analgesia
NCT06659029,Systemic lupus erythematosus,anifrolumab
NCT06924229,Dry eye syndrome,Hormonal treatment
NCT07055529,Vitiligo-associated multiple autoimmune disease susceptibility 1,Group A recieving PUVA therapy
NCT07055529,Vitiligo-associated multiple autoimmune disease susceptibility 1,Group B receiving Tablet Tofacitinib
NCT06652529,Mesothelioma,AROG4-01
NCT06652529,Mesothelioma,AROG4-01
NCT06652529,Non-small cell lung carcinoma,AROG4-01
NCT06652529,Non-small cell lung carcinoma,AROG4-01
NCT06652529,Ovarian cancer,AROG4-01
NCT06652529,Ovarian cancer,AROG4-01
NCT06968429,Migraine disorder,NBP Softgel Capsules
NCT07115329,Endogenous depression,Zelquistinel
NCT07126938,Poisoning,Alcoholic beverage
NCT06978738,Anti-neutrophil cytoplasmic antibody-associated vasculitis,universal allogeneic anti-CD19/BCMA CAR T-cells
NCT06978738,Autoimmune hemolytic anemia,universal allogeneic anti-CD19/BCMA CAR T-cells
NCT06978738,Inclusion body myositis,universal allogeneic anti-CD19/BCMA CAR T-cells
NCT06978738,Myasthenia gravis,universal allogeneic anti-CD19/BCMA CAR T-cells
NCT06978738,Systemic lupus erythematosus,universal allogeneic anti-CD19/BCMA CAR T-cells
NCT06978738,Systemic sclerosis,universal allogeneic anti-CD19/BCMA CAR T-cells
NCT06862908,Obesity disorder,IBI362
NCT06748508,Gastric carcinoma,"Sintilimab, oxalipaltin"
NCT06917690,Epidermolysis bullosa,Oleogel-S10
NCT06917690,Rheumatic disorder,Oleogel-S10
NCT06930703,Sickle cell disease,cannabidiol
NCT07021703,Rabies,"Freeze-dried Human Rabies Vaccine（Human Diploid Cell）, Essen"
NCT07021703,Rabies,Freeze-dried Human Rabies Vaccine（Human Diploid Cell），Zagreb
NCT06607003,Malaria,P. vivax challenge agent derived from PvHMB-CCE001
NCT06607003,Malaria,P. vivax challenge agent derived from PvHMB-CCE002
NCT06957938,Laryngeal carcinoma,Neoadjuvant Chemotherapy (NACT)
NCT06957938,Laryngeal carcinoma,Neoadjuvant and maintenance Tislelizumab
NCT07100938,Rheumatoid arthritis,BGB-45035
NCT06738108,Pulmonary embolism,ECOS
NCT06738108,Pulmonary embolism,Control group
NCT06709638,Coronary artery disorder,Zhilong Huoxue Tongyu capsule
NCT07090538,Neuroblastoma,eliglustat
NCT06591338,Ischemic stroke,ticagrelor
NCT06591338,Ischemic stroke,clopidogrel
NCT06671938,Multiple system atrophy,exidavnemab
NCT06671938,Parkinson disease,exidavnemab
NCT06700408,Hypercholesterolemia,Dachaihu Decoction combined Erzhiwan with variation
NCT06667908,Carcinoma,JNJ-90301900
NCT06667908,Carcinoma,durvalumab
NCT06667908,Carcinoma,Concurrent Chemo/Radiation Therapy (cCRT): Carboplatin
NCT06667908,Carcinoma,Concurrent Chemo/Radiation Therapy (cCRT): Paclitaxel
NCT06614608,Osteoarthritis,5% ASKC200
NCT06614608,Osteoarthritis,1% ASKC200
NCT06614608,Pain,5% ASKC200
NCT06614608,Pain,1% ASKC200
NCT06692738,Non-small cell lung carcinoma,Rilvegostomig
NCT06692738,Non-small cell lung carcinoma,pembrolizumab
NCT06692738,Non-small cell lung carcinoma,carboplatin
NCT06692738,Non-small cell lung carcinoma,paclitaxel
NCT06692738,Non-small cell lung carcinoma,Nab-paclitaxel
NCT06756308,T-cell non-Hodgkin lymphoma,enasidenib
NCT06756308,T-cell non-Hodgkin lymphoma,rituximab
NCT06658938,Precursor B-cell acute lymphoblastic leukemia,blinatumomab
NCT06643208,Intrahepatic cholangiocarcinoma,"TACE-HAIC, Envafolimab and Lenvatinib"
NCT07086638,Radiodermatitis,Photo-responsive nanozyme
NCT06635538,Infertility disorder,Corifollitropin alfa (CFA)
NCT06635538,Infertility disorder,Clomiphene Citrate (CC)
NCT06868238,Ductal breast carcinoma in situ,Magtrace
NCT07098338,Non-small cell lung carcinoma,Rilvegostomig
NCT07098338,Non-small cell lung carcinoma,ramucirumab
NCT07098338,Non-small cell lung carcinoma,Dato-DXd
NCT07074938,Traumatic brain injury,Jianmin Daopeng Angong Niuhuang Wan
NCT07074938,Traumatic brain injury,Tongrentang Angong Niuhuang Wan
NCT06727838,Diabetes mellitus,HRS-7535 tablets
NCT06727838,Diabetes mellitus,Metformin Hydrochloride Extended-release Tablets
NCT06727838,Diabetes mellitus,Metformin Hydrochloride Tablets
NCT06676579,IgA glomerulonephritis,avacopan
NCT06676579,IgA glomerulonephritis,prednisone
NCT06676579,IgA glomerulonephritis,Methylprednisolone (drug)
NCT06676579,IgA glomerulonephritis,prednisolone
NCT07035379,Diffuse large B-cell lymphoma,TRS005
NCT07035379,Diffuse large B-cell lymphoma,cyclophosphamide
NCT07035379,Diffuse large B-cell lymphoma,doxorubicin
NCT07035379,Diffuse large B-cell lymphoma,prednisolone
NCT06958484,Hepatocellular carcinoma,Iparomlimab and Tuvonralimab Injection (QL1706) plus bevacizumab
NCT06648902,Renal carcinoma,meldonium
NCT06691802,Asthma,Shu Fei Tie
NCT06922084,Cataract,Clareon PanOptix PRO
NCT06922084,Cataract,Mix-and-Match PanOptix/Vivity
NCT06587802,Adrenal cortex carcinoma,Triprolizumab
NCT06697184,B-cell chronic lymphocytic leukemia,Sonrotoclax
NCT06697184,B-cell chronic lymphocytic leukemia,zanubrutinib
NCT06794502,Tuberculosis,Herbal medicine
NCT06730802,Coronary artery disorder,PCSK9 inhibitor
NCT06730802,Coronary artery disorder,Statin
NCT07014202,Non-small cell lung carcinoma,Immunotherapy (with or without chemotherapy) maintenance therapy
NCT06644079,Skin squamous cell carcinoma,tranexamic acid
NCT06916884,Allergic rhinitis,Desloratadine / Betamethasone in fixed dose
NCT06916884,Allergic rhinitis,desloratadine
NCT06825702,Macular retinal edema,KIO-104
NCT06922279,Gastroesophageal cancer,Standard systemic therapy (chemotherapy)
NCT06736379,Squamous cell carcinoma,VRP-encapsulated saRNA encoding IL-12 (1 x
NCT06736379,Squamous cell carcinoma,Pembrolizumab (KEYTRUDA®)
NCT06736379,Squamous cell carcinoma,VRP-encapsulated saRNA encoding IL-12 (3 x
NCT06755684,EGFR,Befotertinib combined Bevacizumab
NCT06755684,EGFR,Befotertinib combined platinum-based double chemotherapy
NCT06755684,Non-small cell lung carcinoma,Befotertinib combined Bevacizumab
NCT06755684,Non-small cell lung carcinoma,Befotertinib combined platinum-based double chemotherapy
NCT06641284,Heart failure,spironolactone
NCT06863402,B-cell chronic lymphocytic leukemia,Nemtabrutinib
NCT06863402,B-cell chronic lymphocytic leukemia,pembrolizumab
NCT06863402,Richter syndrome,Nemtabrutinib
NCT06863402,Richter syndrome,pembrolizumab
NCT06945679,Dengue disease,CPLE
NCT06801379,Insomnia,Inhaled Melatonin (100 μg)
NCT06801379,Insomnia,Oral Melatonin (4 mg)
NCT06884384,Antiphospholipid syndrome,Additional blood collection during routine blood sampling at the inclusion (33.9 ml) and at the thrombotic recurrence (between
NCT07024784,Fallopian tube carcinoma,IMGN151
NCT07024784,Fallopian tube carcinoma,carboplatin
NCT07024784,Fallopian tube carcinoma,bevacizumab
NCT07024784,Fallopian tube carcinoma,olaparib
NCT07024784,Primary peritoneal carcinoma,IMGN151
NCT07024784,Primary peritoneal carcinoma,carboplatin
NCT07024784,Primary peritoneal carcinoma,bevacizumab
NCT07024784,Primary peritoneal carcinoma,olaparib
NCT07102979,Cirrhosis of liver,Ursodeoxycholic Acid (URSO)
NCT07102979,Cirrhosis of liver,simvastatin
NCT06745284,Obesity disorder,Survodutide
NCT06745284,Obesity disorder,semaglutide
NCT06862102,Cervical squamous intraepithelial neoplasia,HPV vaccine
NCT06657079,"Familial acute respiratory distress syndrome, ANLN-related, dog",combined standard aerosolized doses of budesonide (0.5 mg/2 mL) every
NCT07091279,Autism,propranolol
NCT06632379,"Hypertension, pregnancy-induced",atorvastatin
NCT06632379,Preeclampsia,atorvastatin
NCT06690684,Heart failure,Hematological indicators
NCT06690684,Heart failure,Serological indicators in patients with myocardial infarction
NCT06690684,Heart failure,Levels of biomarkers in blood of patients with acute myocardial infarction
NCT06690684,Myocardial ischemia,Hematological indicators
NCT06690684,Myocardial ischemia,Serological indicators in patients with myocardial infarction
NCT06690684,Myocardial ischemia,Levels of biomarkers in blood of patients with acute myocardial infarction
NCT06801184,Irritable bowel syndrome,Plasma Sample
NCT06801184,Irritable bowel syndrome,Stool Sample
NCT06676384,IgA glomerulonephritis,Oral prednisolone and SoC
NCT06676384,IgA glomerulonephritis,Gut-directed budesonide and SoC
NCT06676384,IgA glomerulonephritis,Mycophenolate mofetil (MMF) and SoC
NCT06676384,IgA glomerulonephritis,Hydroxychloroquine and SoC
NCT06676384,IgA glomerulonephritis,Non-steroidal mineralocorticoid receptor antagonist and SoC
NCT06676384,IgA glomerulonephritis,SoC defined as maximal labelled or tolerated dose of angiotensin-converting enzyme inhibitor/ angiotensin receptor blocker (ACEi/ARB) & steady dose of sodium-glucose cotransporter-2 inhibitor (SGLT2i)
NCT06676384,Kidney failure,Oral prednisolone and SoC
NCT06676384,Kidney failure,Gut-directed budesonide and SoC
NCT06676384,Kidney failure,Mycophenolate mofetil (MMF) and SoC
NCT06676384,Kidney failure,Hydroxychloroquine and SoC
NCT06676384,Kidney failure,Non-steroidal mineralocorticoid receptor antagonist and SoC
NCT06676384,Kidney failure,SoC defined as maximal labelled or tolerated dose of angiotensin-converting enzyme inhibitor/ angiotensin receptor blocker (ACEi/ARB) & steady dose of sodium-glucose cotransporter-2 inhibitor (SGLT2i)
NCT07076784,Acne,Icariin
NCT06910384,Amyotrophic lateral sclerosis,STR04
NCT06586684,Hyperlipidemia,inclisiran
NCT06706284,Type 2 diabetes mellitus,semaglutide Injectable Product
NCT06959784,Cerebrovascular disorder,semaglutide
NCT06959784,Cerebrovascular disorder,metformin
NCT06959784,Diabetes mellitus,semaglutide
NCT06959784,Diabetes mellitus,metformin
NCT06615050,Graft versus host disease,Tacrolimus (Tac)
NCT06615050,Graft versus host disease,Methotrexate (MTX)
NCT06615050,Graft versus host disease,Ruxolitinib (Rux)
NCT06615050,Graft versus host disease,cyclophosphamide
NCT06615050,Graft versus host disease,Mycophenolate mofetil (MMF)
NCT06565650,Dry eye syndrome,Miebo
NCT06613750,Type 2 diabetes mellitus,Sitagliptin and Gliclazide
NCT06613750,Type 2 diabetes mellitus,metformin
NCT07082114,Type 2 diabetes mellitus,HDM1002
NCT07082114,Type 2 diabetes mellitus,HDM1002
NCT07082114,Type 2 diabetes mellitus,HDM1002
NCT07082114,Type 2 diabetes mellitus,Dapagliflozin (DAPA)
NCT07117214,Carcinoma,[68Ga]Ga-DWJ155
NCT06991114,Acquired idiopathic inflammatory myopathy,Allogeneic NK Cells
NCT06991114,Juvenile dermatomyositis,Allogeneic NK Cells
NCT06991114,Scleroderma,Allogeneic NK Cells
NCT06991114,Sjogren syndrome,Allogeneic NK Cells
NCT06991114,Systemic sclerosis,Allogeneic NK Cells
NCT07058155,Morbid obesity,Anti-Obesity Pharmacotherapy (Class Effect)
NCT06857955,Hypertensive disorder,QCZ484
NCT06873555,Ovarian cancer,DC05F01
NCT06873555,Small cell lung carcinoma,DC05F01
NCT06670755,Tuberculosis,ID93/GLA-SE
NCT06670755,Tuberculosis,BCG Danish
NCT07006714,Osteoarthritis,Vitamin D3
NCT06706414,Infertility disorder,Denosumab (Prolia)
NCT06706414,Infertility disorder,Letrozole (Aromatase Inhibitors)
NCT07047014,Cerebrovascular disorder,Tenecteplase (0.25mg/kg)
NCT07047014,Cerebrovascular disorder,Standard medical treatment
NCT06683014,Borderline personality disorder,MDMA
NCT06844214,Myotonic dystrophy,SAR446268
NCT07029295,Infective endocarditis,Determination of beta-hydroxybutyrate (BHB) in capillary blood
NCT06763055,Intracerebral hemorrhage,colchicine
NCT06763055,Intracerebral hemorrhage,DEFEROXAMINE MESYLATE
NCT06689514,Benign prostatic hyperplasia,alpha receptor antagonist
NCT06689514,Benign prostatic hyperplasia,Low dose Tranilast
NCT06689514,Benign prostatic hyperplasia,High dose Tranilast
NCT06892314,Type 2 diabetes mellitus,Exposure to hyperglycemia (type
NCT06591455,Primary biliary cholangitis,fenofibrate
NCT06591455,Primary biliary cholangitis,UDCA (Ursodeoxycholic acid)
NCT06650514,Osteosarcoma,OMO-103
NCT06933914,Paroxysmal nocturnal hemoglobinuria,MY008211A tablets
NCT07060950,Cancer,Blood sampling C1
NCT06614855,Adult glioblastoma,C134
NCT06614855,Adult glioblastoma,C134
NCT06614855,Glioma susceptibility 1,C134
NCT06614855,Glioma susceptibility 1,C134
NCT06567314,Skin squamous cell carcinoma,Ivonescimab
NCT07076914,Small cell lung carcinoma,Experimental (Health Canada Approved Proton Pump Inhibitors)
NCT06675214,Nasopharyngeal carcinoma,Full course of PD-1/PD-L1 blockades
NCT06675214,Nasopharyngeal carcinoma,Cisplatin-based induction chemotherapy
NCT06675214,Nasopharyngeal carcinoma,Concurrent Chemotherapy
NCT06649214,Schizophrenia,Olanzapine-samidorphan；
NCT06649214,Schizophrenia,olanzapine
NCT07005414,Autism,bumetanide
NCT06799195,Graft versus host disease,Attenuated-dose Cyclophosphamide
NCT06799195,Graft versus host disease,High-dose Cyclophosphamide
NCT06799195,Graft versus host disease,sirolimus
NCT06799195,Graft versus host disease,Mycophenolate Mofetil (MMF)
NCT06790095,Traumatic brain injury,Cyclosporine (CsA)
NCT07052214,Prostate cancer,68Ga-PSMA-11
NCT07052214,Prostate carcinoma,68Ga-PSMA-11
NCT07099014,Cardiogenic shock,Inahled Isoflurane
NCT07099014,Cardiogenic shock,"Propofol, midazolam"
NCT06956495,Insomnia,Tasipimidine
NCT07048314,Erectile dysfunction,Allogeneic adipose-derived mesenchymal stem cells (HB-adMSCs) at the doctor's office
NCT07048314,Erectile dysfunction,Allogeneic adipose-derived mesenchymal stem cells (HB-adMSCs) in the OR
NCT07048314,Prostate cancer,Allogeneic adipose-derived mesenchymal stem cells (HB-adMSCs) at the doctor's office
NCT07048314,Prostate cancer,Allogeneic adipose-derived mesenchymal stem cells (HB-adMSCs) in the OR
NCT06854614,Obesity disorder,Phentermine-Topiramate
NCT06854614,Obesity disorder,Naltrexone-Bupropion Combination
NCT06854614,Obesity disorder,orlistat
NCT06773195,Myelofibrosis,Ulixertinib
NCT06773195,Myelofibrosis,ruxolitinib
NCT06815003,Childhood myelodysplastic syndrome,cyclophosphamide
NCT06815003,Childhood myelodysplastic syndrome,fludarabine
NCT06815003,Childhood myelodysplastic syndrome,melphalan
NCT06815003,Childhood myelodysplastic syndrome,tacrolimus
NCT06815003,Childhood myelodysplastic syndrome,vedolizumab
NCT06815003,Graft versus host disease,cyclophosphamide
NCT06815003,Graft versus host disease,fludarabine
NCT06815003,Graft versus host disease,melphalan
NCT06815003,Graft versus host disease,tacrolimus
NCT06815003,Graft versus host disease,vedolizumab
NCT06815003,Myeloproliferative neoplasm,cyclophosphamide
NCT06815003,Myeloproliferative neoplasm,fludarabine
NCT06815003,Myeloproliferative neoplasm,melphalan
NCT06815003,Myeloproliferative neoplasm,tacrolimus
NCT06815003,Myeloproliferative neoplasm,vedolizumab
NCT07103603,Hepatic steatosis,Menopausal hormone therapy
NCT07103603,Menopause,Menopausal hormone therapy
NCT06731803,Gastroesophageal junction adenocarcinoma,Trastuzumab deruxtecan +
NCT06731803,Gastroesophageal junction adenocarcinoma,Trastuzumab deruxtecan + FLO
NCT06707103,Injury,TR987
NCT06574503,Influenza,GP681
NCT06574503,Influenza,GP681 Simulant
NCT06743503,Large B-cell lymphoma,Rapamycin
NCT07110103,Small cell lung carcinoma,golidocitinib with PD-1 inhibitors
NCT06717243,Small cell lung carcinoma,Carboplatin/Cisplatin -Etoposide - Atezolizumab
NCT06792903,Dry eye syndrome,CG101 high dose + artificial tear
NCT06792903,Dry eye syndrome,CG101 low dose + artificial tear
NCT07082803,Lymphoma,TLN-121
NCT07082803,Lymphoma,TLN-254
NCT07082803,Lymphoma,TLN-121
NCT06716203,Type 2 diabetes mellitus,Drug
NCT06716203,Type 2 diabetes mellitus,Drug
NCT06891443,Blindness (disorder),sepofarsen
NCT06686043,Suppressor of tumorigenicity 3,"HPV vaccine, Imiquimod, and metformin combination therapy"
NCT06686043,Vaginal carcinoma,"HPV vaccine, Imiquimod, and metformin combination therapy"
NCT06686043,Vulvar carcinoma,"HPV vaccine, Imiquimod, and metformin combination therapy"
NCT06822790,Hypertriglyceridemia,Plozasiran Injection
NCT07056803,Maturity-onset diabetes of the young type 1,Oral semaglutide
NCT07056803,Maturity-onset diabetes of the young type 1,subcutaneous semaglutide
NCT06695143,Leishmaniasis,Fusidic Acid
NCT06689943,Strabismus,Tylenol
NCT06961643,Diabetes mellitus,HRS-7535 Tables
NCT07129343,Von Willebrand disease (hereditary or acquired),Vonvendi
NCT07129343,Von Willebrand disease (hereditary or acquired),Advate
NCT06777238,Type 2 diabetes mellitus,GZR18
NCT06788743,Diabetes mellitus,TIVA ( anesthesia with propofol and remifentanil)
NCT06788743,Diabetes mellitus,VA（anesthesia with sevoflurane and remifentanil）
NCT06852638,Follicular lymphoma,[18F]F-RESCA-RCCB6
NCT06852638,Follicular lymphoma,[18F]F-RESCA-R8B4
NCT06852638,Follicular lymphoma,[18F]F-RESCA-RD06
NCT06852638,Follicular lymphoma,[68Ga]Ga-NOTA-R8B4
NCT06852638,Follicular lymphoma,[68Ga]Ga-NOTA-RD06
NCT06852638,Follicular lymphoma,[89Zr]Zr-DFO-RB6
NCT06852638,Follicular lymphoma,[89Zr]Zr-DFO-R8B4
NCT06852638,Follicular lymphoma,[89Zr]Zr-DFO-RD06
NCT06852638,Lymphoma,[18F]F-RESCA-RCCB6
NCT06852638,Lymphoma,[18F]F-RESCA-R8B4
NCT06852638,Lymphoma,[18F]F-RESCA-RD06
NCT06852638,Lymphoma,[68Ga]Ga-NOTA-R8B4
NCT06852638,Lymphoma,[68Ga]Ga-NOTA-RD06
NCT06852638,Lymphoma,[89Zr]Zr-DFO-RB6
NCT06852638,Lymphoma,[89Zr]Zr-DFO-R8B4
NCT06852638,Lymphoma,[89Zr]Zr-DFO-RD06
NCT06852638,Mantle cell lymphoma,[18F]F-RESCA-RCCB6
NCT06852638,Mantle cell lymphoma,[18F]F-RESCA-R8B4
NCT06852638,Mantle cell lymphoma,[18F]F-RESCA-RD06
NCT06852638,Mantle cell lymphoma,[68Ga]Ga-NOTA-R8B4
NCT06852638,Mantle cell lymphoma,[68Ga]Ga-NOTA-RD06
NCT06852638,Mantle cell lymphoma,[89Zr]Zr-DFO-RB6
NCT06852638,Mantle cell lymphoma,[89Zr]Zr-DFO-R8B4
NCT06852638,Mantle cell lymphoma,[89Zr]Zr-DFO-RD06
NCT06852638,Nasopharyngeal carcinoma,[18F]F-RESCA-RCCB6
NCT06852638,Nasopharyngeal carcinoma,[18F]F-RESCA-R8B4
NCT06852638,Nasopharyngeal carcinoma,[18F]F-RESCA-RD06
NCT06852638,Nasopharyngeal carcinoma,[68Ga]Ga-NOTA-R8B4
NCT06852638,Nasopharyngeal carcinoma,[68Ga]Ga-NOTA-RD06
NCT06852638,Nasopharyngeal carcinoma,[89Zr]Zr-DFO-RB6
NCT06852638,Nasopharyngeal carcinoma,[89Zr]Zr-DFO-R8B4
NCT06852638,Nasopharyngeal carcinoma,[89Zr]Zr-DFO-RD06
NCT06852638,Renal carcinoma,[18F]F-RESCA-RCCB6
NCT06852638,Renal carcinoma,[18F]F-RESCA-R8B4
NCT06852638,Renal carcinoma,[18F]F-RESCA-RD06
NCT06852638,Renal carcinoma,[68Ga]Ga-NOTA-R8B4
NCT06852638,Renal carcinoma,[68Ga]Ga-NOTA-RD06
NCT06852638,Renal carcinoma,[89Zr]Zr-DFO-RB6
NCT06852638,Renal carcinoma,[89Zr]Zr-DFO-R8B4
NCT06852638,Renal carcinoma,[89Zr]Zr-DFO-RD06
NCT06653738,Nephrolithiasis,empagliflozin
NCT06653738,Urolithiasis,empagliflozin
NCT06740903,Cholecystitis,inj. dexmedetomidine infusion @
NCT06740903,Cholecystitis,inj. lignocaine infusion @1-2 mg/kg/h
NCT07090343,Aortic valve stenosis,Wegovy ®
NCT07090343,Heart failure,Wegovy ®
NCT06967038,Lymphoma,CAR-NK cell
NCT07013838,Takayasu arteritis,deucravacitinib
NCT07013838,Takayasu arteritis,adalimumab
NCT06726538,Female sexual dysfunction,"Intravenous administration of Autologous, adipose-derived mesenchymal stem cells"
NCT06667050,Gastric adenocarcinoma,Chemotherapy plus sintilimab and bevacizumab
NCT06841055,Non-small cell lung carcinoma,BNT327
NCT06841055,Non-small cell lung carcinoma,docetaxel
NCT07114055,Irritable bowel syndrome,ebastine
NCT06715514,Menopause,GLP-1 Receptor Agonist
NCT06715514,Menopause,Menopausal Hormone Therapy
NCT06715514,Type 2 diabetes mellitus,GLP-1 Receptor Agonist
NCT06715514,Type 2 diabetes mellitus,Menopausal Hormone Therapy
NCT06580314,Ovarian carcinoma,bevacizumab
NCT06580314,Ovarian carcinoma,olaparib
NCT06773455,Atopic eczema,tralokinumab
NCT06742255,Bell's palsy,Stellate Ganglion Block
NCT06574555,Cardiac rhythm disease,norepinephrine
NCT06574555,Hypertensive disorder,norepinephrine
NCT06574555,Hypotensive disorder,norepinephrine
NCT06574555,Pain,norepinephrine
NCT06764355,Esophageal squamous cell carcinoma,tislelizumab
NCT06764355,Esophageal squamous cell carcinoma,paclitaxel
NCT06764355,Esophageal squamous cell carcinoma,cisplatin
NCT06740214,Pain,0.5% standard bupivacaine only
NCT06740214,Pain,1.33% liposomal bupivacaine with
NCT06740214,Pain,1.33% liposomal bupivacaine only
NCT07035314,Obstructive sleep apnea syndrome,NSAIDs
NCT07035314,Obstructive sleep apnea syndrome,Control (Standard treatment)
NCT06911255,Hepatocellular carcinoma,Tremelimumab Plus Durvalumab (MEDI4736)
NCT06704555,Follicular lymphoma,Tiselizumab
NCT06704555,Follicular lymphoma,rituximab
NCT06704555,Follicular lymphoma,cyclophosphamide
NCT06704555,Follicular lymphoma,doxorubicin
NCT06704555,Follicular lymphoma,vincristine
NCT06704555,Follicular lymphoma,prednisone
NCT06708455,Melanoma,RAPA-201 Rapamycin Resistant T Cells
NCT06708455,Melanoma,Chemotherapy Prior to RAPA-201 Therapy
NCT07093255,Exudative vitreoretinopathy 1,FLQ-101
NCT07093814,Adult glioblastoma,VRT106
NCT06775314,Acne,Cleanser
NCT06775314,Acne,Combination cream
NCT06775314,Acne,spot cream
NCT06775314,Acne,Adapalene
NCT06971055,Dental caries,Sodium Hypochlorite
NCT06971055,Dental caries,Moringa Oleifera Leaf Extract
NCT06971055,Dental pulp necrosis,Sodium Hypochlorite
NCT06971055,Dental pulp necrosis,Moringa Oleifera Leaf Extract
NCT06780150,Multiple sclerosis,ocrelizumab
NCT06635850,Interstitial lung disease,Mosliciguat
NCT06635850,Pulmonary hypertension,Mosliciguat
NCT06916650,Frozen shoulder,Ultrasound-Guided Intra-articular Corticosteroid Injection
NCT06786650,Migraine disorder,Tenoxicam Injectable Product
NCT06786650,Migraine disorder,ibuprofen
NCT07029555,Rheumatoid arthritis,PIT565
NCT06569355,Obesity disorder,VCT220
NCT06683755,Melanoma,nivolumab
NCT06683755,Melanoma,relatlimab
NCT06683755,Melanoma,ipilimumab
NCT07131514,Malignant pancreatic neoplasm,HRS-4642+AG +Adebrelimab
NCT06881290,Lupus erythematosus,Vunakizumab (IL-17A inhibitor)
NCT07128290,Intrahepatic cholangiocarcinoma,CISGEM + Rilvegostomig
NCT06592703,Multiple sclerosis,Adipose tissue-derived Mesenchymal Stromal Cells
NCT06669403,Sepsis,OPT101
NCT06824103,Graft versus host disease,ruxolitinib
NCT06938503,Malignant pancreatic neoplasm,AG regimen
NCT06938503,Malignant pancreatic neoplasm,Nimotuzumab
NCT06911203,Obesity disorder,BGM0504
NCT06911203,Obesity disorder,tirzepatide
NCT06887803,Myelofibrosis,Roginolisib
NCT06902103,Pain,Nabufine Hydrochloride Injection
NCT06902103,Pain,Nabufine Hydrochloride Injection
NCT06976203,Alzheimer disease,KarXT
NCT06976203,Alzheimer disease,KarX-EC
NCT06738303,Metastatic prostate carcinoma,Cabazitaxel and carboplatin
NCT06738303,Metastatic prostate carcinoma,Lu-PSMA-617
NCT06926543,Invasive breast carcinoma,Chemoradiation
NCT06926543,Invasive breast carcinoma,Chemoradiation
NCT06753864,Osteoporosis,Test (T)
NCT06753864,Osteoporosis,Reference (R)
NCT07098403,Asthma,SHR-1905 Injection
NCT06581003,Traumatic brain injury,oxygen
NCT06581003,Traumatic brain injury,oxygen
NCT06700603,Malignant pancreatic neoplasm,Irinotecan liposome (Nal-IRI) in combination with
NCT06932003,Hidradenitis suppurativa,LT-002-158 Tablets
NCT06698003,Lymphoma,mogamulizumab
NCT06610890,Psoriasis,Hemay005
NCT06610890,Psoriasis,Midazolam maleate
NCT07123090,Nonpapillary renal cell carcinoma,Sasanlimab
NCT07123090,Nonpapillary renal cell carcinoma,palbociclib
NCT07123090,Nonpapillary renal cell carcinoma,axitinib
NCT07123090,Renal carcinoma,Sasanlimab
NCT07123090,Renal carcinoma,palbociclib
NCT07123090,Renal carcinoma,axitinib
NCT06864143,COVID-19,mRNA-1083 Composition
NCT06864143,COVID-19,mRNA-1083 Composition
NCT06864143,COVID-19,mRNA-1083 Composition
NCT06864143,COVID-19,mRNA-1083 Composition
NCT06864143,COVID-19,mRNA-1083 Composition
NCT06864143,COVID-19,mRNA-1083 Composition
NCT06864143,COVID-19,mRNA-1083 Composition
NCT06864143,COVID-19,mRNA-1083 Composition
NCT06864143,COVID-19,Influenza Vaccine
NCT06864143,COVID-19,COVID-19 Vaccine
NCT06864143,COVID-19,Investigational Influenza Vaccine
NCT06864143,COVID-19,Investigational COVID-19 Vaccine Lot A
NCT06864143,COVID-19,Investigational COVID-19 Vaccine Lot B
NCT06864143,Influenza,mRNA-1083 Composition
NCT06864143,Influenza,mRNA-1083 Composition
NCT06864143,Influenza,mRNA-1083 Composition
NCT06864143,Influenza,mRNA-1083 Composition
NCT06864143,Influenza,mRNA-1083 Composition
NCT06864143,Influenza,mRNA-1083 Composition
NCT06864143,Influenza,mRNA-1083 Composition
NCT06864143,Influenza,mRNA-1083 Composition
NCT06864143,Influenza,Influenza Vaccine
NCT06864143,Influenza,COVID-19 Vaccine
NCT06864143,Influenza,Investigational Influenza Vaccine
NCT06864143,Influenza,Investigational COVID-19 Vaccine Lot A
NCT06864143,Influenza,Investigational COVID-19 Vaccine Lot B
NCT06643390,Systemic sclerosis,MK-2225
NCT06703190,COVID-19,Pfizer-BioNTech BNT162b2 COVID-19 Vaccinated
NCT06703190,COVID-19,Not vaccinated with
NCT06785090,Cataract,bromfenac
NCT06785090,Cataract,Moxifloxacin
NCT06785090,Cataract,Dexamethasone phosphate
NCT06804603,Obesity disorder,Tradipitant
NCT06605703,Obesity disorder,Bupropion-Naltrexone
NCT06605703,Obesity disorder,Bupropion-Naltrexone-Metformin
NCT07116343,Coronary artery disorder,ropivacaine
NCT07116343,Coronary artery disorder,0.9 % NaCl
NCT06757764,Cerebrovascular disorder,aspirin
NCT06757764,Cerebrovascular disorder,clopidogrel
NCT06757764,Cerebrovascular disorder,cilostazol
NCT07115550,Hepatocellular carcinoma,Iparomlimab and Tuvonralimab Injection (QL1706) in combination with Regorafenib
NCT06675955,Multiple sclerosis,ocrelizumab
NCT06703255,Malignant glioma,HX301+/Temozolomide
NCT06828055,Weight loss,VK2735
NCT06857214,Systemic lupus erythematosus,GNC-038
NCT06954155,Cerebrovascular disorder,Tenecteplase (0.25mg/kg)
NCT06954155,Cerebrovascular disorder,Standard medical treatment
NCT06753955,Autoimmune encephalitis,ART5803
NCT06753955,Autoimmune encephalitis,Intravenous immunoglobulin (IVIG)
NCT06825455,Peritoneum cancer,fludarabine
NCT06825455,Peritoneum cancer,cyclophosphamide
NCT06825455,Peritoneum cancer,B7H3 CAR-γδT cells
NCT06728514,Hypertensive disorder,Inj Bupivacaine
NCT06678555,Carcinoma,lorlatinib
NCT06769555,AL amyloidosis,CM-336 BCMA/CD3 bispecific antibody
NCT06904014,Hepatocellular carcinoma,Sintilimab
NCT06904014,Hepatocellular carcinoma,lenvatinib
NCT07057050,Cerebrovascular disorder,The Botulinum toxin injection
NCT06696755,Bipolar I disorder,Icalcaprant
NCT06696755,Bipolar II disorder,Icalcaprant
NCT07108855,Gastric carcinoma,Indocyanine Green (IC-Green)
NCT06885814,Esophageal squamous cell carcinoma,Adebrelimab
NCT07033455,Hypertrophic cardiomyopathy,HRS-1893
NCT06776055,Cervical carcinoma,HPV-16/18 vaccine
NCT06776055,Cervical squamous intraepithelial neoplasia,HPV-16/18 vaccine
NCT06776055,Human papilloma virus infection,HPV-16/18 vaccine
NCT06776055,Vaginal carcinoma,HPV-16/18 vaccine
NCT06776055,Vulvar carcinoma,HPV-16/18 vaccine
NCT06581055,Myelodysplastic syndrome,luspatercept
NCT06581055,Myelodysplastic syndrome,epoetin alfa
NCT07078955,Dry eye syndrome,BRM421 Ophthalmic Solution
NCT07078955,Dry eye syndrome,BRM421 Ophthalmic Solution
NCT07067255,Ovarian cancer,GPC3 CD146 CAR-T cells
NCT07067255,Ovarian carcinoma,GPC3 CD146 CAR-T cells
NCT06579755,Dengue disease,TDV
NCT06617455,Ductal breast carcinoma in situ,fezolinetant
NCT06666855,Ocular hypertension,DE-117B Eye Drops
NCT06666855,Ocular hypertension,latanoprost
NCT06647550,Type 2 diabetes mellitus,HD-6277
NCT06647550,Type 2 diabetes mellitus,HD-6277
NCT06647550,Type 2 diabetes mellitus,HD-6277
NCT06672055,COVID-19,VXA-CoV2-3.1
NCT06672055,COVID-19,COMIRNATY®
NCT06672055,COVID-19,VXA-CoV2-3.3
NCT07062055,Hepatocellular carcinoma,Anti-VEGF
NCT07062055,Hepatocellular carcinoma,Immunotherapy
NCT07049055,Malignant pancreatic neoplasm,E-EDV-D682
NCT07049055,Malignant pancreatic neoplasm,EDV-GC
NCT07049055,Malignant pancreatic neoplasm,gemcitabine
NCT07049055,Malignant pancreatic neoplasm,Nab paclitaxel.
NCT06644755,Sarcoma,DS-2243a
NCT07000955,Obesity disorder,tirzepatide
NCT07000955,Obesity disorder,IBI362
NCT06767514,Non-small cell lung carcinoma,Ivonescimab Injection
NCT06767514,Non-small cell lung carcinoma,pembrolizumab Injection
NCT06921395,Female infertility,Fang Le Shu (Follitrope)
NCT06921395,Female infertility,Guo Na Fen (Gonal-F)
NCT06965114,Hairy cell leukemia,cladribine
NCT06965114,Hairy cell leukemia,rituximab
NCT06965114,Hairy cell leukemia,tovorafenib
NCT06608914,Osteoarthritis,Nandrolone decanoate
NCT06798714,Atrial fibrillation,NSAID
NCT06798714,Atrial fibrillation,colchicine
NCT06798714,Coronary artery disorder,NSAID
NCT06798714,Coronary artery disorder,colchicine
NCT06693895,Chickenpox,Investigational varicella vaccine
NCT06693895,Chickenpox,Marketed varicella vaccine
NCT06693895,Chickenpox,"Measles, mumps, and rubella vaccine"
NCT06693895,Chickenpox,Hepatitis A vaccine
NCT06693895,Chickenpox,PCV (pneumococcal conjugate vaccine)
NCT06693895,Chickenpox,PCV
NCT06693895,Chickenpox,Vaxneuvance
NCT07030595,End stage renal failure,AP301
NCT07030595,End stage renal failure,Sevelamer carbonate (Renvela®)
NCT07030595,End stage renal failure,AP301 Low Dose
NCT06762314,Diabetes mellitus,Insulin
NCT06762314,Diabetes mellitus,semaglutide
NCT06762314,Diabetes mellitus,empagliflozin
NCT06637514,Phenylketonuria,JNT-517 Tablet
NCT06637514,Phenylketonuria,JNT-517 Tablet
NCT06983795,Ischemic stroke,Medical management
NCT06724614,Androgenetic alopecia,VDPHL01
NCT06597695,Depressive disorder,Ketamine-assisted psychotherapy
NCT06883695,Rheumatoid arthritis,SHR-3045 Injection
NCT06748014,Hemorrhoid,Aescin in Horse Chestnut
NCT06748014,Hemorrhoid,MPFF
NCT07130214,Pulpitis,Biodentine
NCT06645314,Hepatocellular carcinoma,Group A
NCT06645314,Hepatocellular carcinoma,Group B
NCT06585514,Lupus nephritis,CD19 CAR-T cells
NCT06585514,Systemic lupus erythematosus,CD19 CAR-T cells
NCT06770114,Gingivitis,Cetylpyridinium Chloride and Zinc Lactate Mouthwash
NCT06770114,Gingivitis,PhosFlur Mouthwash
NCT07052695,B-cell chronic lymphocytic leukemia,mosunetuzumab
NCT07052695,B-cell chronic lymphocytic leukemia,ibrutinib
NCT07052695,B-cell chronic lymphocytic leukemia,acalabrutinib
NCT07052695,B-cell chronic lymphocytic leukemia,zanubrutinib
NCT07052695,B-cell chronic lymphocytic leukemia,pirtobrutinib
NCT07052695,Leukemia,mosunetuzumab
NCT07052695,Leukemia,ibrutinib
NCT07052695,Leukemia,acalabrutinib
NCT07052695,Leukemia,zanubrutinib
NCT07052695,Leukemia,pirtobrutinib
NCT07052695,Lymphoma,mosunetuzumab
NCT07052695,Lymphoma,ibrutinib
NCT07052695,Lymphoma,acalabrutinib
NCT07052695,Lymphoma,zanubrutinib
NCT07052695,Lymphoma,pirtobrutinib
NCT07087795,Diabetes mellitus,NNC0194-0499
NCT07087795,Diabetes mellitus,semaglutide
NCT07041814,Turner syndrome,Oral estradiol valerate
NCT07041814,Turner syndrome,Transdermal
NCT06590714,Rotator cuff syndrome,Experimental(Acelex cap m2mg)
NCT06590714,Rotator cuff syndrome,Active Comparator(NSAIDs-excluded non-opioid or opioid analgesics)
NCT06705595,Pharyngitis,Tracheo-Spray
NCT06705595,Pharyngitis,Lidocaine Spray on DLT
NCT06926595,Graft versus host disease,Cyclophosphamide (primary intervention for GVHD prophylaxis)
NCT07056595,IgA glomerulonephritis,finerenone
NCT07001995,Small cell lung carcinoma,limertinib
NCT07001995,Small cell lung carcinoma,etoposide and carboplatin
NCT06937203,Diabetes mellitus,ARO-ALK7
NCT06937203,Obesity disorder,ARO-ALK7
NCT06986603,Hypoglycemia,Glucagon for Injection (Fresenius Kabi USA)
NCT06916403,Fibromyalgia,Intravenous Ketamine Infusions
NCT06764303,Paroxysmal nocturnal hemoglobinuria,NTQ5082
NCT07055243,Anemia,mitapivat
NCT06610643,COVID-19,combination therapy
NCT06610643,COVID-19,SOC
NCT06990503,Ovarian cancer,SHR-A1811
NCT06990503,Ovarian cancer,Chemotherapy
NCT07024303,Autism,Psychotropic medication (at discretion of psychiatrist)
NCT06777303,Periodontitis,curcurmin loaded on chitosan nano-particles
NCT06777303,Periodontitis,hyaluronic acid loaded on chitosan nano-particles
NCT06777303,Periodontitis,chitosan nano-particles
NCT06795503,Triple-negative breast carcinoma,Docetaxel plus cyclophosphamide
NCT06795503,Triple-negative breast carcinoma,"Epirubicin, cyclophosphamide plus paclitaxel"
NCT07007143,Mitral valve insufficiency,Experimental: Aspirin monotherapy
NCT07007143,Mitral valve insufficiency,Active Comparator: Aspirin+Clopidogrel
NCT06784843,Cataract,Dexmedetomidine as an adjuvant to local anesthesia for peribulbar block
NCT06784843,Cataract,Midazolam as an adjuvant to local anesthesia for peribulbar block
NCT07085143,Depressive disorder,Compound Ciwujia Granules
NCT06773143,Insomnia,Esketamine at low dose
NCT06738043,Obesity disorder,Dexmedetomidine infusion
NCT06738043,Obesity disorder,Ketamine infusion
NCT07057843,Malignant pancreatic neoplasm,Enteral Nutrition Emulsion
NCT06622603,Gout,febuxostat
NCT06922903,Prostate cancer,INR101
NCT06752850,Hemophilia,"antihemophilic factor (recombinant), Fc-VWF-XTEN fusion protein"
NCT06737250,Primary central nervous system lymphoma,R2P -> RP
NCT07082855,Retinitis pigmentosa,Minocycline
NCT07082855,Retinitis pigmentosa,Minocycline
NCT06782555,Metastatic prostate carcinoma,Evofosfamide
NCT06782555,Metastatic prostate carcinoma,Zalifrelimab
NCT06782555,Metastatic prostate carcinoma,Balstilimab
NCT07103655,Hypertrophic cardiomyopathy,mavacamten
NCT07103655,Hypertrophic cardiomyopathy,"Beta Blocker (BB) - metoprolol, bisoprolol, carvedilol"
NCT07103655,Hypertrophic cardiomyopathy,diltiazem
NCT06930755,Ovarian cancer,NMS-03305293
NCT06930755,Ovarian cancer,topotecan
NCT07119450,Obesity disorder,GZR18 injection、[14C]GZR18 injection
NCT07071155,Myelodysplastic syndrome,momelotinib
NCT07071155,Myelodysplastic syndrome,azacitidine
NCT07071155,Myelodysplastic syndrome,decitabine
NCT07059650,Diffuse large B-cell lymphoma,DZD8586+R-CHOP
NCT07059650,Diffuse large B-cell lymphoma,DZD8586+R-GemOx
NCT07059650,Diffuse large B-cell lymphoma,DZD8586+BR
NCT06595355,Diabetic macular edema,bevacizumab with oral curcumin
NCT06595355,Macular retinal edema,bevacizumab with oral curcumin
NCT06781255,Diabetic macular edema,Kamuvudine-9
NCT07023484,Fallopian tube carcinoma,Carboplatin plus Paclitaxel
NCT07023484,Ovarian cancer,Carboplatin plus Paclitaxel
NCT07023484,Primary peritoneal carcinoma,Carboplatin plus Paclitaxel
NCT06860802,Appendicitis,cefoxitin
NCT07076121,Pancreatic ductal adenocarcinoma,BMS-986504
NCT07076121,Pancreatic ductal adenocarcinoma,gemcitabine
NCT07076121,Pancreatic ductal adenocarcinoma,Nab-paclitaxel
NCT07020221,Pancreatic ductal adenocarcinoma,VS-7375
NCT07020221,Pancreatic ductal adenocarcinoma,cetuximab
NCT06957002,Temporal arteritis,bosentan
NCT06957002,Temporal arteritis,Glucocorticoids
NCT06798402,Cutaneous leishmaniasis,Ciprofloxacin (BAYO9867)
NCT06798402,Cutaneous leishmaniasis,sodium stibogluconate (Pentostam)
NCT06662721,Takayasu arteritis,baricitinib
NCT06631521,Prostate cancer,darolutamide
NCT06631521,Prostate cancer,relugolix
NCT06731621,Autism,Psilocybin
NCT06699602,Nonpapillary renal cell carcinoma,cemiplimab
NCT06699602,Nonpapillary renal cell carcinoma,Fianlimab
NCT07122102,Type 2 diabetes mellitus,Cofrogliptin
NCT07122102,Type 2 diabetes mellitus,acarbose
NCT06911502,Follicular lymphoma,Golcadomide
NCT06911502,Follicular lymphoma,rituximab
NCT06911502,Follicular lymphoma,lenalidomide
NCT06911502,Follicular lymphoma,cyclophosphamide
NCT06911502,Follicular lymphoma,doxorubicin
NCT06911502,Follicular lymphoma,vincristine
NCT06911502,Follicular lymphoma,Prednisone/Prednisolone
NCT06911502,Follicular lymphoma,bendamustine
NCT06670521,Dysphagia,methylprednisolone
NCT07061184,Irritable bowel syndrome,FLCWK
NCT06611202,Dementia,clonazepam
NCT07035821,Childhood malignant neoplasm,Olanzapine Tablets
NCT07104721,Anti-neutrophil cytoplasmic antibody-associated vasculitis,YTS109 cell
NCT07104721,Antiphospholipid syndrome,YTS109 cell
NCT07104721,Inclusion body myositis,YTS109 cell
NCT07104721,Lupus nephritis,YTS109 cell
NCT07104721,Systemic lupus erythematosus,YTS109 cell
NCT07104721,Systemic sclerosis,YTS109 cell
NCT06789302,Type 2 diabetes mellitus,DT2-SCT intravenous infusion
NCT07064902,Nasopharyngeal carcinoma,Ivonescimab（AK112，a PD-1/VEGF bispecific antibody）
NCT06951802,Endometriosis,ketamine
NCT06951802,Endometriosis,propofol
NCT07128121,Respiratory syncytial virus infectious disease,Respiratory Syncytial Virus IN006 Bivalent mRNA Vaccine (IN006)
NCT07050121,Cancer,Ciwujia capsules
NCT07050121,Insomnia,Ciwujia capsules
NCT06701721,Diabetic macular edema,THN391 MAD
NCT06701721,Diabetic retinopathy,THN391 MAD
NCT06664502,Diabetic macular edema,EYE201
NCT06664502,Wet macular degeneration,EYE201
NCT06687421,Prostate cancer,Androgen deprivation therapy
NCT06725121,Hepatocellular carcinoma,Atezolizumab & Bevacizumab
NCT06725121,Hepatocellular carcinoma,Yttrium-90 (Y-90)
NCT06957821,Peripheral arterial disease,PEGULICIANINE
NCT07016321,Dengue disease,Emetine Hydrochloride
NCT07016321,Dengue disease,Emetine Hydrochloride
NCT06897202,Type 2 diabetes mellitus,MET097 Injection
NCT06656702,Amyotrophic lateral sclerosis,Psilocybin
NCT07120321,Dental caries,Mineral Trioxide Aggregate (MTA)
NCT07120321,Dental caries,Biodentine
NCT07120321,Dental caries,ferric sulfate
NCT07120321,Dental caries,Sodium hypochlorite gel application
NCT07120321,Pulpitis,Mineral Trioxide Aggregate (MTA)
NCT07120321,Pulpitis,Biodentine
NCT07120321,Pulpitis,ferric sulfate
NCT07120321,Pulpitis,Sodium hypochlorite gel application
NCT07089121,Anti-neutrophil cytoplasmic antibody-associated vasculitis,Descartes-08
NCT07089121,Juvenile dermatomyositis,Descartes-08
NCT06681402,Pneumonia,FLAMOD
NCT06585202,Atopic eczema,ATI-2138
NCT06708702,Stomatitis,Copaíba mouthwash
NCT06699121,Sclerosing cholangitis,LB-P8 low-dose
NCT06699121,Sclerosing cholangitis,LB-P8 high-dose
NCT07116421,Epilepsy,2-phenylethanol rose scent
NCT06873321,Peripheral arterial disease,rivaroxaban
NCT06873321,Peripheral arterial disease,clopidogrel
NCT07007221,Depressive disorder,metformin
NCT07007221,Depressive disorder,metformin
NCT07007221,Depressive disorder,metformin
NCT07007221,Depressive disorder,metformin
NCT07007221,Depressive disorder,fluoxetine
NCT07007221,Depressive disorder,Metformin+Fluoxetine
NCT06940102,Cachexia,Nano-crystalline Megestrol Acetate Oral Suspension
NCT06940102,Cachexia,TKI-Based Therapy
NCT06940102,Gastric carcinoma,Nano-crystalline Megestrol Acetate Oral Suspension
NCT06940102,Gastric carcinoma,TKI-Based Therapy
NCT06940102,Hepatocellular carcinoma,Nano-crystalline Megestrol Acetate Oral Suspension
NCT06940102,Hepatocellular carcinoma,TKI-Based Therapy
NCT07121621,Attention deficit-hyperactivity disorder,PHArmacoKinetics of methYLphenidate in adult patients with ADHD: comparison between patients with and without OBesity.
NCT07121621,Obesity disorder,PHArmacoKinetics of methYLphenidate in adult patients with ADHD: comparison between patients with and without OBesity.
NCT06888921,Ovarian cancer,COM701
NCT06731764,Hypothyroidism,levothyroxine
NCT06731764,Hypothyroidism,Levothyroxine/Liothyronine once daily
NCT06731764,Hypothyroidism,Levothyroxine/Liothyronine twice daily
NCT06867302,Agitation,Dexmedetomidine in
NCT06867302,Agitation,dexmedetomidine Injection [Precedex]
NCT06635902,Sickle cell disease,L-citrulline
NCT06635902,Sickle cell disease,L-citrulline
NCT06963021,Endogenous depression,NBI-1065845
NCT06943521,Biliary tract cancer,MT-4561
NCT06943521,Cervical carcinoma,MT-4561
NCT06943521,Endometrial cancer,MT-4561
NCT06943521,Gastric carcinoma,MT-4561
NCT06943521,Neuroendocrine carcinoma,MT-4561
NCT06943521,Neuroendocrine neoplasm,MT-4561
NCT06943521,Non-small cell lung carcinoma,MT-4561
NCT06943521,Ovarian cancer,MT-4561
NCT06943521,Pancreatic ductal adenocarcinoma,MT-4561
NCT06943521,Prostate cancer,MT-4561
NCT06943521,Soft tissue sarcoma,MT-4561
NCT06943521,Urothelial carcinoma,MT-4561
NCT06865664,Rhabdomyosarcoma,fludarabine
NCT06865664,Rhabdomyosarcoma,cyclophosphamide
NCT06865664,Rhabdomyosarcoma,cetuximab
NCT06865664,Rhabdomyosarcoma,FGFR4-CAR T Cells
NCT06839664,Obesity disorder,HS-20094 injection
NCT06787664,Chordoma,BL-B01D1
NCT07021521,Preeclampsia,0 mg/kg Midazolam (Control Group)
NCT07021521,Preeclampsia,0.01 mg/kg Midazolam Group
NCT07021521,Preeclampsia,0.02 mg/kg Midazolam Group
NCT07021521,Preeclampsia,0.03 mg/kg Midazolam Group
NCT06900764,Systemic lupus erythematosus,CAR-T cell
NCT06593821,Bruxism,Botulinum toxin
NCT06952621,Esophageal squamous cell carcinoma,3 cycles (Toripalimab + chemotherapy)
NCT06952621,Esophageal squamous cell carcinoma,3 cycles（DCF）
NCT06727864,Pulmonary tuberculosis,4-month regimen (2HERZ/2HRE)
NCT06727864,Pulmonary tuberculosis,6-month (2HERZ/4HRE)
NCT06995521,Graft versus host disease,vorinostat
NCT07047521,Dengue disease,Tetravalent Dengue Vaccine (TDV)
NCT06649721,Pulmonary tuberculosis,bedaquiline
NCT06649721,Pulmonary tuberculosis,delamanid
NCT06649721,Pulmonary tuberculosis,linezolid
NCT06649721,Pulmonary tuberculosis,levofloxacin
NCT06649721,Pulmonary tuberculosis,Clofazimine
NCT06656221,Mantle cell lymphoma,obinutuzumab
NCT06656221,Mantle cell lymphoma,glofitamab
NCT06656221,Mantle cell lymphoma,bortezomib
NCT06656221,Mantle cell lymphoma,Orelabrutinib
NCT07115121,Anemia,Intravenous Ferric Carboxymaltose
NCT07115121,Anemia,Intravenous Iron Sucrose
NCT06972264,Androgenetic alopecia,VDPHL01
NCT06598202,Amyotrophic lateral sclerosis,exosomes derived from human umbilical cord blood mesenchymal stem cells for nasal drop
NCT06855121,AL amyloidosis,teclistamab
NCT06855121,AL amyloidosis,elranatamab
NCT06855121,AL amyloidosis,ciltacabtagene autoleucel
NCT06855121,AL amyloidosis,talquetamab
NCT06855121,AL amyloidosis,idecabtagene vicleucel
NCT06735664,Richter syndrome,Odronextamab
NCT06735664,Richter syndrome,zanubrutinib
NCT06790602,Pancreatic ductal adenocarcinoma,Cemiplimab Plus Gemcitabine
NCT06963502,Non-small cell lung carcinoma,HS-10370
NCT06963502,Non-small cell lung carcinoma,HS-20117
NCT06963502,Non-small cell lung carcinoma,Adebrelimab
NCT06963502,Non-small cell lung carcinoma,capecitabine
NCT06963502,Non-small cell lung carcinoma,oxaliplatin
NCT06963502,Non-small cell lung carcinoma,"Folinic Acid, Fluorouracil and Oxaliplatin/Irinotecan"
NCT06963502,Non-small cell lung carcinoma,HS-20093
NCT06963502,Non-small cell lung carcinoma,platinum (cisplatin or carboplatin)
NCT06890884,Lymphoma,Zilovertamab vedotin
NCT06890884,Lymphoma,rituximab
NCT06890884,Lymphoma,cyclophosphamide
NCT06890884,Lymphoma,doxorubicin
NCT06890884,Lymphoma,Rituximab Biosimilar
NCT06890884,Lymphoma,prednisone
NCT06890884,Lymphoma,prednisolone
NCT06890884,Lymphoma,polatuzumab vedotin
NCT06890884,Lymphoma,Rescue Medication
NCT06736184,Hyperkalemia,Sodium Zirconium Cyclosilicate (SZC)
NCT06760702,Ovarian cancer,AUR109
NCT06760702,Ovarian cancer,AUR109
NCT06760702,Ovarian cancer,AUR109
NCT06760702,Renal carcinoma,AUR109
NCT06760702,Renal carcinoma,AUR109
NCT06760702,Renal carcinoma,AUR109
NCT06892002,Type 1 diabetes mellitus,teplizumab
NCT06583902,Infective endocarditis,Intravenous iron
NCT06606821,Coronary artery disorder,tirzepatide
NCT06733402,Acne,Trifarotene Cream
NCT06733402,Acne,AKLIEF® Cream (Trifarotene
NCT06733402,Acne,AKLIEF® Cream (Trifarotene
NCT06637384,Diabetes mellitus,Hyaluronic Acid (HA)
NCT06637384,Diabetes mellitus,Corticosteroid Injection
NCT06914102,Diabetes mellitus,semaglutide
NCT06671002,Pain,NSAID
NCT06671002,Pain,Opioid
NCT06671002,Pain,acetaminophen
NCT06671002,Pain,ibuprofen
NCT07072884,Systemic sclerosis,GC012F injection
NCT06615284,Coronary artery disorder,Atorvo+™ (Arm1)
NCT06615284,Coronary artery disorder,Atorvo+™ +CBD (Arm
NCT06615284,Coronary artery disorder,Atorvo+™ +CBD (Arm
NCT07087002,Medulloblastoma,GPC2-CAR T cells
NCT07087002,Medulloblastoma,fludarabine
NCT07087002,Medulloblastoma,cyclophosphamide
NCT06661902,Prostate cancer,Buffered Lidocaine (1% Lidocaine +
NCT06661902,Prostate cancer,lidocaine
NCT06997484,Parkinson disease,HL-400
NCT07092202,Neoplastic meningitis,Firmonertinib
NCT07092202,Neoplastic meningitis,Intrathecal injection of pemetrexed
NCT07092202,Non-small cell lung carcinoma,Firmonertinib
NCT07092202,Non-small cell lung carcinoma,Intrathecal injection of pemetrexed
NCT06869902,Ankyloglossia,Colostrum
NCT06869902,Pain,Colostrum
NCT07075484,Autoimmune hemolytic anemia,YTS109 cell
NCT07002502,Cancer,PRaG-1(cordycepin tablet)
NCT06702202,Peripheral arterial disease,Mixture of local anesthetics
NCT06702202,Peripheral arterial disease,0.5% hyperbaric bupivacaine
NCT06990802,Postpartum depression,Treatment as Usual (TAU)
NCT07015684,Sickle cell disease,131I-apamistmab
NCT07015684,Sickle cell disease,sirolimus
NCT07015684,Sickle cell disease,Campath
NCT07015684,Sickle cell disease,Total Body Irradiation
NCT06840002,Ovarian cancer,SHR-A1811
NCT06840002,Ovarian cancer,carboplatin
NCT06840002,Ovarian cancer,bevacizumab
NCT06769984,Endocrine exophthalmos,SCTT11
NCT06677502,Cognitive impairment,Cerebrolysin
NCT06809621,Diabetes mellitus,NNC0471-0119 H
NCT06809621,Diabetes mellitus,"insulin aspart, human"
NCT06808321,Hypertensive disorder,Benidipine Hydrochloride
NCT06645821,Hidradenitis suppurativa,EVO101
NCT06914921,Irritable bowel syndrome,A standard antispasmodic
NCT06938321,Biliary tract cancer,AK112
NCT06938321,Biliary tract cancer,AK130
NCT06726421,Nonpapillary renal cell carcinoma,"axitinib ± immune checkpoint inhibitors (ICIs), lenvatinib ± ICIs, cabozantinib ± ICIs, sunitinib and pazopanib"
NCT06778564,Psychotic disorder,CBD
NCT06630221,Myelodysplastic syndrome,Eltrombopag (EPAG)
NCT07119021,Ischemic stroke,Intravenous thrombolysis + edaravone
NCT06706921,Metastatic prostate carcinoma,18F-Fluciclovine PET/CT Scan
NCT06946264,Bronchiolitis,Albuterol Sulfate
NCT06946264,Bronchiolitis,Sodium Chloride
NCT07074002,Essential tremor,BP1.4979
NCT06727721,Diabetes mellitus,mesenchymal stem cells with OCN-19
NCT06727721,Diabetes mellitus,Mesenchymal stem cells
NCT06727721,Diabetes mellitus,albumin injection
NCT06727721,Type 2 diabetes mellitus,mesenchymal stem cells with OCN-19
NCT06727721,Type 2 diabetes mellitus,Mesenchymal stem cells
NCT06727721,Type 2 diabetes mellitus,albumin injection
NCT06664021,Intrahepatic cholangiocarcinoma,Tislelizumab combined with S-1
NCT07082621,Stomatitis,N-acetylcysteine (NAC) spray
NCT07082621,Stomatitis,Conventional treatment
NCT07072221,Mature T-cell and NK-cell non-Hodgkin lymphoma,BCL regimen
NCT07072221,Mature T-cell and NK-cell non-Hodgkin lymphoma,Cohort
NCT06798064,Parkinson disease,Allogeneic bone marrow-derived mesenchymal stem cells
NCT07081984,Cervical carcinoma,therapeutic tumor vaccine
NCT07089784,Diabetes mellitus,MK-2828
NCT07077902,Hidradenitis suppurativa,Topical roflumilast
NCT06778902,Diffuse large B-cell lymphoma,azacytidine
NCT06778902,Diffuse large B-cell lymphoma,R-GemOx
NCT07108621,Infertility disorder,Choriongonadotropin alfa (hCG)
NCT07046221,Esophageal cancer,tislelizumab
NCT07046221,Esophageal cancer,Albumin-Bound Paclitaxel
NCT07046221,Esophageal cancer,cis-platinum
NCT07046221,Esophageal cancer,Nedaplatin
NCT07046221,Esophageal cancer,carboplatin
NCT06686121,Peripheral arterial disease,Nitrate Rich Beetroot Juice
NCT07088302,Premature,lactase administration
NCT06618521,"Hypertension, pregnancy-induced",Anti-hypertensive drug (Methyldopa
NCT06808984,Agitation,BMS-986368
NCT07054684,IgA glomerulonephritis,BHV-1400
NCT07002684,Endogenous depression,esketamine
NCT06810284,Perinatal asphyxia,Sildenafil Citrate (IV)
NCT06696079,Atrial fibrillation,Early Resumption of Oral Anticoagulation Therapy
NCT06696079,Atrial fibrillation,Late Resumption of Oral Anticoagulation Therapy
NCT06919679,Hodgkins lymphoma,BrECADD
NCT07105579,Leukemia,BITE and DLI
NCT06599684,Diabetic retinopathy,INV-102
NCT07120984,Malignant glioma,L19TNF
NCT07120984,Malignant glioma,L19TNF and TMZ
NCT07120984,Malignant glioma,L19TNF and CCNU
NCT07120984,Malignant glioma,L19TNF monotherapy
NCT07120984,Malignant glioma,L19TNF and TMZ in recurrent astrocytoma
NCT07120984,Malignant glioma,L19TNF and CCNU in recurrent astrocytoma
NCT07120984,Malignant glioma,L19TNF monothery in recurrent oligodendroglioma
NCT06829784,Asthma,TQC2731 injection
NCT06581679,Adenomyosis,triptorelin
NCT06568484,Tuberculosis,bedaquiline
NCT06568484,Tuberculosis,levofloxacin
NCT07083479,Pancreatic ductal adenocarcinoma,ELI-002
NCT06954584,Ovarian cancer,bevacizumab
NCT06954584,Ovarian cancer,Fluzoparib Monotherapy
NCT07082179,Non-small cell lung carcinoma,Iparomlimab and Tuvonralimab combined with paclitaxel polymer micelles and Platinum (cisplatin/carboplatin)
NCT07057479,Type 2 diabetes mellitus,Fixed-dose combination of SGLT2 inhibitor and thiazolidinedione
NCT07057479,Type 2 diabetes mellitus,Control Group
NCT07057479,Type 2 diabetes mellitus,Control Group
NCT07057479,Type 2 diabetes mellitus,Background Therapy (All Groups) - Metformin
NCT06735079,Endogenous depression,REL1017 (esmethadone HCI) (active drug)
NCT06951464,Non-small cell lung carcinoma,BL-B01D1
NCT06951464,Non-small cell lung carcinoma,Almonertinib
NCT06657703,Systemic lupus erythematosus,HC022
NCT06613490,Rheumatoid arthritis,anti CD19 CAR NK cells
NCT06587503,COVID-19,BioNTech - Pfizer COVID-19 vaccine
NCT06587503,COVID-19,rVSV∆G-ZEBOV-GP
NCT06981390,Coronary artery disorder,Ticagrelor + Aspirin for
NCT06981390,Coronary artery disorder,Ticagrelor + Aspirin for
NCT06981390,Coronary artery disorder,Ticagrelor + Aspirin for
NCT06807190,Diabetes mellitus,Insulin Icodec
NCT06952803,Prostate cancer,Saruparib
NCT06952803,Prostate cancer,Abiraterone + Prednisolone/Prednisone
NCT06952803,Prostate cancer,Androgen Deprivation Therapy (ADT)
NCT06760403,Wound healing,hypochlorous acid
NCT06931990,Atopic eczema,LT-002-158 tablets
NCT06854003,Lymphoma,bendamustine
NCT06854003,Lymphoma,rituximab
NCT06854003,Lymphoma,cytarabine
NCT06854003,Lymphoma,zanubrutinib
NCT06854003,Lymphoma,Sonrotoclax
NCT06854003,Mantle cell lymphoma,bendamustine
NCT06854003,Mantle cell lymphoma,rituximab
NCT06854003,Mantle cell lymphoma,cytarabine
NCT06854003,Mantle cell lymphoma,zanubrutinib
NCT06854003,Mantle cell lymphoma,Sonrotoclax
NCT06697990,Carcinoma,Iruplinalib
NCT06625190,Alveolar soft part sarcoma,zoledronic acid
NCT06625190,Chordoma,zoledronic acid
NCT06625190,Ewing sarcoma,zoledronic acid
NCT06625190,Neuroblastoma,zoledronic acid
NCT06625190,Osteosarcoma,zoledronic acid
NCT06625190,Rhabdomyosarcoma,zoledronic acid
NCT06896890,Non-small cell lung carcinoma,CIS-DPI
NCT07068490,Coronary artery disorder,Routine use of P-CAB on DAPT
NCT07068490,Coronary artery disorder,Guideline Directed Medical Therapy
NCT07076290,"COPD, severe early onset",R-3750
NCT06778603,Osteosarcoma,a targeted probe B7H3-IRDye800CW
NCT07120503,Asthma,WIN378
NCT06922890,Spinal cord injury,STUP-001
NCT06899464,Cerebrovascular disorder,14-day Cerebrolysin treatment
NCT06899464,Intracerebral hemorrhage,14-day Cerebrolysin treatment
NCT06639984,Irritable bowel syndrome,Psyllium (0.7 g/year of age per day)
NCT06639984,Irritable bowel syndrome,Psyllium (0.5 g/year of age per day)
NCT06580002,Female reproductive organ cancer,riluzole
NCT06580002,Gastric carcinoma,riluzole
NCT06580002,Ovarian cancer,riluzole
NCT06580002,Sarcoma,riluzole
NCT07042802,Ovarian cancer,LBL-024 Injection
NCT07042802,Ovarian cancer,paclitaxel Injection
NCT06965621,Heart failure,18F-metaFluorobenzylguanidine
NCT06965621,Heart failure,Rubidium-82
NCT07111221,Cirrhosis of liver,Non-selective beta-blockers
NCT06851364,Dry eye syndrome,0.38% Sodium Hyaluronate (SH) Eye Drops
NCT06851364,Dry eye syndrome,0.18% Sodium Hyaluronate Eye Drops
NCT06659679,Diabetes mellitus,New use of oral semaglutide
NCT06659679,Diabetes mellitus,New initiation of sitagliptin
NCT06711679,Childhood acute lymphoblastic leukemia,Low-dose ropivacaine
NCT06711679,Childhood acute lymphoblastic leukemia,Medium-dose of ropivacaine
NCT06711679,Childhood acute lymphoblastic leukemia,High-dose ropivacaine
NCT06859684,Intrahepatic cholangiocarcinoma,durvalumab
NCT06859684,Intrahepatic cholangiocarcinoma,hepatic arterial infusion chemotherapy (HAIC)
NCT06859684,Intrahepatic cholangiocarcinoma,lenvatinib
NCT06790784,Proliferative diabetic retinopathy,faricimab
NCT06813079,Pancreatic ductal adenocarcinoma,cobimetinib
NCT06813079,Pancreatic ductal adenocarcinoma,ponatinib
NCT06813079,Pancreatic ductal adenocarcinoma,brigatinib
NCT06813079,Pancreatic ductal adenocarcinoma,colchicine
NCT06813079,Pancreatic ductal adenocarcinoma,selinexor
NCT06813079,Pancreatic ductal adenocarcinoma,abemaciclib
NCT06813079,Pancreatic ductal adenocarcinoma,neratinib
NCT06813079,Pancreatic ductal adenocarcinoma,doxorubicin
NCT06813079,Pancreatic ductal adenocarcinoma,etoposide
NCT06813079,Pancreatic ductal adenocarcinoma,ceritinib
NCT07087379,Aortic valve stenosis,Intensive statin treatment
NCT06818279,Cirrhosis of liver,dabigatran
NCT06818279,Cirrhosis of liver,enoxaparin
NCT06881784,Non-small cell lung carcinoma,daraxonrasib
NCT06881784,Non-small cell lung carcinoma,docetaxel
NCT06948864,Anemia,Ferric Carboxymaltose (FCM)
NCT06774664,IgA glomerulonephritis,SCTC21C
NCT07003464,B-cell chronic lymphocytic leukemia,zanubrutinib
NCT07003464,B-cell chronic lymphocytic leukemia,obinutuzumab
NCT07003464,B-cell chronic lymphocytic leukemia,bendamustine
NCT07047690,Systemic sclerosis,nemolizumab
NCT06870890,Asthma,Dosage
NCT06870890,Dyspnea,Dosage
NCT06671990,Heart failure,vericiguat
NCT06812390,Cirrhosis of liver,Albumin infusion (25% albumin)
NCT07110090,Cancer,Umbilical Cord Blood Megakaryocyte Injection (XJ-MK-002)
NCT07110090,Thrombocytopenia,Umbilical Cord Blood Megakaryocyte Injection (XJ-MK-002)
NCT07035990,Cystic fibrosis,SION-451
NCT07035990,Cystic fibrosis,SION-2222
NCT07035990,Cystic fibrosis,SION-109
NCT06590090,Rheumatoid arthritis,Natrunix
NCT06590090,Rheumatoid arthritis,Methotrexate (MTX)
NCT06677190,Ovarian cancer,belzutifan
NCT06677190,Ovarian carcinoma,belzutifan
NCT06857890,Pharyngitis,Grammidin with anesthetic neo
NCT06857890,Pharyngitis,"Grammidin with anesthetic, a metered dose topical spray"
NCT06859190,Cancer,estazolam
NCT06859190,Insomnia,estazolam
NCT06752590,Fibromyalgia,ONO-1110
NCT06622590,Influenza,QIV
NCT06622590,Influenza,QIV control
NCT06747390,Oropharyngeal carcinoma,Lidocaine
NCT06747390,Oropharynx squamous cell carcinoma,Lidocaine
NCT06747390,Squamous cell carcinoma,Lidocaine
NCT07058090,Tuberculosis,Silymarin
NCT07058090,Tuberculosis,N Acetyl Cysteine
NCT07058090,Tuberculosis,Rifampicin (RMP) Ethambutol (E) Isoniazid (H) Pyrazinamid (Z)
NCT06902090,Pain,"Meloxicam Nanocrystal Injection(Yangtze River Pharmaceutical Group Co., Ltd.)"
NCT06902090,Pain,Meloxicam Nanocrystal Injection (ANJESO®)
NCT06610903,Psoriasis,Hemay005
NCT06765603,Myopia,Atropine
NCT06934590,Non-small cell lung carcinoma,RX001
NCT07080190,Poisoning,Early N-Acetylcysteine
NCT07080190,Poisoning,Late N-Acetylcysteine
NCT06614790,Ovarian cancer,Niraparib
NCT06591390,Ischemic stroke,ticagrelor
NCT06591390,Ischemic stroke,cilostazol
NCT06956690,Melanoma,ENV-501
NCT07032103,Lymphoma,Immunochemotherapy
NCT07073690,Myelodysplastic syndrome,luspatercept
NCT07015190,Uveal melanoma,Darovasertib
NCT06860490,Hepatocellular carcinoma,Sintilimab
NCT06860490,Hepatocellular carcinoma,Bevacizumab Biosimilar
NCT06669390,Stomatitis,NG11-2
NCT07039890,Type 2 diabetes mellitus,Empagliflozin + Linagliptin filmcoated tablets
NCT07039890,Type 2 diabetes mellitus,Glyxambi film-coated tablets
NCT06746064,Pulmonary fibrosis,CHF10073 (Part
NCT06746064,Pulmonary fibrosis,CHF10073 (Part
NCT06746064,Pulmonary fibrosis,CHF10073 (Part
NCT06746064,Pulmonary fibrosis,itraconazole (Part
NCT06746064,Pulmonary fibrosis,CHF10073 (Part
NCT06876064,Rheumatoid arthritis,Blood test
NCT06876064,Rheumatoid arthritis,Urine test
NCT06809179,Social phobia,Fasedienol Nasal Spray - Fasedienol Nasal Spray
NCT06828484,Allergic rhinitis,Allergenic Extract Standardized Cat Hair Acetone-Precipitated (AP)
NCT07128979,Hemorrhoid,Neoven
NCT06815679,Pneumonia,salbutamol
NCT06815679,Respiratory failure,salbutamol
NCT06602479,Migraine disorder,MEDI0618
NCT06917079,Non-small cell lung carcinoma,BBO-11818
NCT06917079,Non-small cell lung carcinoma,pembrolizumab
NCT06917079,Non-small cell lung carcinoma,Platinum chemotherapy (cisplatin or carboplatin)
NCT06917079,Non-small cell lung carcinoma,pemetrexed
NCT06917079,Non-small cell lung carcinoma,cetuximab
NCT06738979,Obesity disorder,TQF3510 (Semaglutide Injection)
NCT06738979,Obesity disorder,Wegovy®
NCT06771479,Monkeypox,MVA strain monkeypox attenuated live vaccine (low dose)
NCT06771479,Monkeypox,MVA strain monkeypox attenuated live vaccine (high dose)
NCT06826079,Gastric carcinoma,sorbitol
NCT06627179,Retinitis pigmentosa,Intravitreal Injection of Ultevursen
NCT06784479,Obstructive sleep apnea syndrome,Remimazolam and Propofol
NCT06784479,Obstructive sleep apnea syndrome,propofol
NCT06784479,Obstructive sleep apnea syndrome,Midazolam and propofol
NCT07123779,Pulmonary hypertension,HS235
NCT06789679,Pancreatic adenocarcinoma,"Gemcitabine, albumin-bound paclitaxel, S-1"
NCT06789679,Pancreatic adenocarcinoma,"Gemcitabine, albumin-bound paclitaxel"
NCT06775379,Endogenous depression,Azetukalner
NCT06647979,Beta-thalassemia HBB/LCRB,autologous bone marrow derived CD34+ HSPCs electroporated with BCL11A enhancer targeting Cas9 ribonucleoprotein
NCT06647979,Sickle cell disease,autologous bone marrow derived CD34+ HSPCs electroporated with BCL11A enhancer targeting Cas9 ribonucleoprotein
NCT06671379,Non-small cell lung carcinoma,SHR-A2009 monotherapy
NCT06671379,Non-small cell lung carcinoma,platinum-based dual-agent chemotherapy
NCT06802679,End stage renal failure,Urokinase
NCT06802679,End stage renal failure,Urokinase
NCT06684379,COVID-19,PRS CK STORM
NCT06684379,COVID-19,PRS CK STORM
NCT06684379,Influenza,PRS CK STORM
NCT06684379,Influenza,PRS CK STORM
NCT06684379,Newborn respiratory distress syndrome,PRS CK STORM
NCT06684379,Newborn respiratory distress syndrome,PRS CK STORM
NCT06823479,Skin squamous cell carcinoma,nivolumab
NCT06823479,Skin squamous cell carcinoma,Ipilumimab
NCT06716021,Atrial fibrillation,Etripamil
NCT06889064,Essential hypertension,BR1400-1
NCT06889064,Essential hypertension,BR1400-2
NCT06889064,Essential hypertension,BR1400-3
NCT06987864,Paroxysmal nocturnal hemoglobinuria,eculizumab
NCT07121764,Hypospadias,Bupivacaine %0.25 (isobaric)
NCT07121764,Hypospadias,Dexmedetomidine & Bupivacaine.
NCT06658964,Autosomal dominant polycystic kidney disease,Cohort
NCT06658964,Autosomal dominant polycystic kidney disease,Cohort
NCT06713421,Gastric carcinoma,Dimethicone+Pronase
NCT06713421,Gastric carcinoma,dimethicone
NCT06571864,Amyloidosis,Anti-CD38 Monoclonal Antibody
NCT06692764,Atherosclerotic cardiovascular disease,AZD0780
NCT06643221,Leukemia,isoproterenol
NCT06643221,Leukemia,Bisoprolol Fumarate Tablet
NCT06643221,Leukemia,Nadolol (1 x
NCT06643221,Leukemia,Carvedilol
NCT06643221,Leukemia,roflumilast
NCT06643221,Lymphoma,isoproterenol
NCT06643221,Lymphoma,Bisoprolol Fumarate Tablet
NCT06643221,Lymphoma,Nadolol (1 x
NCT06643221,Lymphoma,Carvedilol
NCT06643221,Lymphoma,roflumilast
NCT06628921,Migraine disorder,Eptinezumab
NCT06759064,Ascites,zoledronic acid plus Sintilimab intraperitoneal injection
NCT06759064,Gastric carcinoma,zoledronic acid plus Sintilimab intraperitoneal injection
NCT06866964,Testicular cancer,Low-dose ASA
NCT06917664,Coronary artery disorder,sacubitril/valsartan
NCT06964464,Cardiomyopathy,metoprolol succinate
NCT06964464,Cardiomyopathy,carvedilol
NCT06964464,Ventricular arrhythmia,metoprolol succinate
NCT06964464,Ventricular arrhythmia,carvedilol
NCT06925464,T-cell non-Hodgkin lymphoma,CD7 CAR-T cells infusion
NCT06883864,Atrial fibrillation,Medication
NCT06592664,Exocrine pancreatic carcinoma,certepetide
NCT06592664,Exocrine pancreatic carcinoma,nab-paclitaxel
NCT06592664,Exocrine pancreatic carcinoma,gemcitabine
NCT06592664,Exocrine pancreatic carcinoma,certepetide
NCT06592664,Malignant pancreatic neoplasm,certepetide
NCT06592664,Malignant pancreatic neoplasm,nab-paclitaxel
NCT06592664,Malignant pancreatic neoplasm,gemcitabine
NCT06592664,Malignant pancreatic neoplasm,certepetide
NCT06592664,Pancreatic adenocarcinoma,certepetide
NCT06592664,Pancreatic adenocarcinoma,nab-paclitaxel
NCT06592664,Pancreatic adenocarcinoma,gemcitabine
NCT06592664,Pancreatic adenocarcinoma,certepetide
NCT06592664,Pancreatic ductal adenocarcinoma,certepetide
NCT06592664,Pancreatic ductal adenocarcinoma,nab-paclitaxel
NCT06592664,Pancreatic ductal adenocarcinoma,gemcitabine
NCT06592664,Pancreatic ductal adenocarcinoma,certepetide
NCT06957964,Injury,Standard Antibiotic Treatment
NCT07051564,Type 1 diabetes mellitus,CNK-UT009 cell injection
NCT07022964,T-cell non-Hodgkin lymphoma,CD5 CAR-T cells infusion
NCT06668064,Wet macular degeneration,EYP-1901
NCT06668064,Wet macular degeneration,Aflibercept (2.0 mg)
NCT07077538,Diabetes mellitus,Amino acid peritoneal dialysis solution
NCT06592638,Small cell lung carcinoma,ZG006
NCT07060508,Malaria,Single dose of
NCT06971523,Lymphoma,CTS3497
NCT07096908,Obesity disorder,tirzepatide
NCT06690723,Obstructive sleep apnea syndrome,Dapagliflozin (Forxiga)
NCT06690723,Obstructive sleep apnea syndrome,Vitamin D3 ( Colecalciferol)
NCT06690723,Obstructive sleep apnea syndrome,Vitamin D3 plus Dapagliflozin
NCT06957223,Endogenous depression,Dextromethorphan-Bupropion
NCT06957223,Endogenous depression,SSRIs
NCT07000123,Cardiovascular disorder,AZD0780
NCT06683638,Syphilis,Doxycycline
NCT06890338,Fallopian tube carcinoma,carboplatin
NCT06890338,Fallopian tube carcinoma,mirvetuximab soravtansine
NCT06890338,Fallopian tube carcinoma,bevacizumab
NCT06890338,Ovarian carcinoma,carboplatin
NCT06890338,Ovarian carcinoma,mirvetuximab soravtansine
NCT06890338,Ovarian carcinoma,bevacizumab
NCT06890338,Primary peritoneal carcinoma,carboplatin
NCT06890338,Primary peritoneal carcinoma,mirvetuximab soravtansine
NCT06890338,Primary peritoneal carcinoma,bevacizumab
NCT06645808,Adult glioblastoma,89Zr-DFO-N-Suc-F8scFv
NCT06645808,Adult glioblastoma,89Zr-DFO-N-Suc-C9scFv
NCT06645808,Colon carcinoma,89Zr-DFO-N-Suc-F8scFv
NCT06645808,Colon carcinoma,89Zr-DFO-N-Suc-C9scFv
NCT06645808,Exocrine pancreatic carcinoma,89Zr-DFO-N-Suc-F8scFv
NCT06645808,Exocrine pancreatic carcinoma,89Zr-DFO-N-Suc-C9scFv
NCT06645808,Gastric carcinoma,89Zr-DFO-N-Suc-F8scFv
NCT06645808,Gastric carcinoma,89Zr-DFO-N-Suc-C9scFv
NCT06645808,Osteosarcoma,89Zr-DFO-N-Suc-F8scFv
NCT06645808,Osteosarcoma,89Zr-DFO-N-Suc-C9scFv
NCT06645808,Rectal carcinoma,89Zr-DFO-N-Suc-F8scFv
NCT06645808,Rectal carcinoma,89Zr-DFO-N-Suc-C9scFv
NCT06963008,Cystic fibrosis,inhaled BMD003(CFTR mRNA)
NCT07113808,Ascites,SonoVue®
NCT07034508,Diffuse large B-cell lymphoma,polatuzumab vedotin
NCT07034508,Diffuse large B-cell lymphoma,rituximab
NCT07034508,Diffuse large B-cell lymphoma,cyclophosphamide
NCT07034508,Diffuse large B-cell lymphoma,doxorubicin
NCT07034508,Diffuse large B-cell lymphoma,prednisone
NCT06601608,Periodontitis,Herbal therapy
NCT06705608,Multiple sclerosis,fingolimod
NCT06705608,Multiple sclerosis,natalizumab
NCT06705608,Multiple sclerosis,Dimethyl fumarate (DMF)
NCT06705608,Multiple sclerosis,alemtuzumab
NCT06705608,Multiple sclerosis,teriflunomide
NCT06705608,Skin cancer,fingolimod
NCT06705608,Skin cancer,natalizumab
NCT06705608,Skin cancer,Dimethyl fumarate (DMF)
NCT06705608,Skin cancer,alemtuzumab
NCT06705608,Skin cancer,teriflunomide
NCT06816823,Malignant pancreatic neoplasm,CL-NK-001
NCT07020923,IgA glomerulonephritis,Atacicept
NCT07020923,"IgA nephropathy, susceptibility to, 1",Atacicept
NCT07018323,Graves disease,IMVT-1402
NCT07018323,Graves disease,IMVT-1402
NCT06683508,Obesity disorder,LY3549492
NCT07043608,Metastatic malignant neoplasm,Zanzalintinib
NCT07043608,Metastatic malignant neoplasm,Investigator Choice of Bone Strengthening Agents (BSA)
NCT07043608,Nonpapillary renal cell carcinoma,Zanzalintinib
NCT07043608,Nonpapillary renal cell carcinoma,Investigator Choice of Bone Strengthening Agents (BSA)
NCT06794008,Anti-neutrophil cytoplasmic antibody-associated vasculitis,BCMA-CD19 CAR-T therapy
NCT06794008,Antiphospholipid syndrome,BCMA-CD19 CAR-T therapy
NCT06794008,Behcet disease,BCMA-CD19 CAR-T therapy
NCT06794008,Inclusion body myositis,BCMA-CD19 CAR-T therapy
NCT06794008,Sjogren syndrome,BCMA-CD19 CAR-T therapy
NCT06794008,Systemic lupus erythematosus,BCMA-CD19 CAR-T therapy
NCT06794008,Systemic sclerosis,BCMA-CD19 CAR-T therapy
NCT06892223,Myelodysplastic syndrome,Monalizumab (anti-NKG2A monoclonal antibody)
NCT06892223,Myeloproliferative neoplasm,Monalizumab (anti-NKG2A monoclonal antibody)
NCT07071623,Human immunodeficiency virus,MK-8527
NCT07071623,Human immunodeficiency virus,Emtricitabine/tenofovir disoproxil (FTC/TDF)
NCT06645223,Diabetes mellitus,No Interventions
NCT07046923,Carcinoma,LY4175408
NCT07046923,Small cell lung carcinoma,LY4175408
NCT06762743,Epilepsy,Brivaracetam Oral Solution (Test Formulation)
NCT06762743,Epilepsy,Brivaracetam Oral Solution (Reference Formulation)
NCT06920043,Metabolic dysfunction-associated steatohepatitis,Efimosfermin
NCT06715943,Paroxysmal nocturnal hemoglobinuria,HRS-5965 capsule
NCT06969664,Endometriosis,SHR7280 Tablet
NCT06725264,Sarcoidosis,deucravacitinib
NCT06947408,Asthma,IBI3002
NCT07093008,Eosinophilic esophagitis,AQ280 Capsule
NCT07093008,Eosinophilic esophagitis,AQ280 Tablet for Oral Suspension
NCT07022223,Marginal zone lymphoma,orelabrutinib combined with rituximab regimen
NCT06617923,Fallopian tube carcinoma,Senaparib
NCT06617923,Fallopian tube carcinoma,temozolomide
NCT06617923,Ovarian cancer,Senaparib
NCT06617923,Ovarian cancer,temozolomide
NCT06603623,Migraine disorder,BHV-2100
NCT06603623,Migraine disorder,BHV-2100
NCT06881823,Prostate cancer,AAA602
NCT06881823,Prostate cancer,AAA802
NCT06881823,Prostate cancer,Gallium (68Ga) gozetotide
NCT06881823,Prostate cancer,Piflufolastat (18F)
NCT06881823,Prostate cancer,Flotufolastat F
NCT06881823,Prostate cancer,18F-PSMA-1007
NCT06977438,Obesity disorder,semaglutide
NCT06700538,Obesity disorder,ARO-INHBE
NCT06700538,Obesity disorder,tirzepatide
NCT07009808,Anxiety,Nalbuphine
NCT07009808,Anxiety,Nalbuphine
NCT07009808,Anxiety,Nalbuphine
NCT07009808,Depressive disorder,Nalbuphine
NCT07009808,Depressive disorder,Nalbuphine
NCT07009808,Depressive disorder,Nalbuphine
NCT06567808,Infectious disease,cefazolin
NCT06567808,Infectious disease,vancomycin
NCT06714708,Non-small cell lung carcinoma,Active comparator
NCT06751108,Non-small cell lung carcinoma,Corticosteroids (CS)
NCT06751108,Non-small cell lung carcinoma,Immune Checkpoint Inhibitors
NCT06642623,Diabetes mellitus,Enavogliflozin
NCT06642623,Diabetes mellitus,Dapagliflozin or Empagliflozin
NCT06594523,Metabolic dysfunction-associated steatohepatitis,Denifanstat
NCT06996223,Aortic valve stenosis,The Group A received PCSK9 inhibitor plus statin therapy
NCT06979323,Asthma,Depemokimab
NCT07012538,Malignant colon neoplasm,Renin-angiotensin system inhibitors (RASi)
NCT07012538,Malignant colon neoplasm,No renin-angiotensin system inhibitors (No RASi)
NCT06593938,Paroxysmal nocturnal hemoglobinuria,HRS-5965 capsule
NCT06593938,Paroxysmal nocturnal hemoglobinuria,eculizumab Injection
NCT06887738,Dermatomyositis,NM8074
NCT07125508,Anemia,Tranexamic Acid (TXA) treatment
NCT06735508,Non-small cell lung carcinoma,mRNA Neoantigen Vaccine
NCT06735508,Non-small cell lung carcinoma,Adebrelimab
NCT06844708,Inflammatory bowel disease,CMTS0929
NCT06771323,Cervical dystonia,valbenazine
NCT06820723,Anxiety,CYB003
NCT06820723,Depressive disorder,CYB003
NCT06820723,Endogenous depression,CYB003
NCT06762223,Metabolic dysfunction-associated steatotic liver disease,Henagliflozin
NCT06762223,Metabolic dysfunction-associated steatotic liver disease,Metformin
NCT06762223,Type 2 diabetes mellitus,Henagliflozin
NCT06762223,Type 2 diabetes mellitus,Metformin
NCT06688123,Type 2 diabetes mellitus,SHR-3167
NCT06688123,Type 2 diabetes mellitus,SHR-3167
NCT06688123,Type 2 diabetes mellitus,insulin glargine
NCT07078838,Endometrial cancer,tirzepatide
NCT07080138,Mixed anxiety and depressive disorder,All kinds of INSTI medications
NCT07080138,Mixed anxiety and depressive disorder,All kinds of conventional medications
NCT06753838,Hemostasis,Sampling of
NCT06859723,Pain,Low dose THC
NCT06859723,Pain,High dose THC
NCT06790823,Depressive disorder,The probiotic supplement (Moodamin capsuls)
NCT06980623,Heart failure,tirzepatide
NCT06980623,Heart failure,semaglutide
NCT06980623,Type 2 diabetes mellitus,tirzepatide
NCT06980623,Type 2 diabetes mellitus,semaglutide
NCT06846138,Maturity-onset diabetes of the young type 1,Metformin (Standard Treatment for Type
NCT06816108,Non-small cell lung carcinoma,ONO-7428
NCT07072208,Diffuse large B-cell lymphoma,Induction therapy-Pro regimen
NCT07072208,Diffuse large B-cell lymphoma,Consolidation therapy-Pro-pola regimen
NCT07025408,Burn,KJ101
NCT07025408,Burn,chymotrypsin
NCT06711523,Neutropenia,"PEG-G-CSF injection (Kexing Biopharmaceutical Co., Ltd.)"
NCT06711523,Neutropenia,PEG-G-CSF injection (Neulasta®，Amgen Europe B.V.)
NCT06989723,Fatty liver disease,pioglitazone
NCT06989723,Fatty liver disease,empagliflozin
NCT06989723,Fatty liver disease,Empagliflozin
NCT06989723,Type 2 diabetes mellitus,pioglitazone
NCT06989723,Type 2 diabetes mellitus,empagliflozin
NCT06989723,Type 2 diabetes mellitus,Empagliflozin
NCT06684938,Pain,sacroiliac injection
NCT06860438,Sepsis,Vasoconstrictor Agents
NCT06669208,Chikungunya,HydroVax-005 CHIKV
NCT07063823,Celiac disease,HB-2121
NCT06880523,Hepatocellular carcinoma,STRIDE (durvalumab + tremelimumab)
NCT06880523,Hepatocellular carcinoma,durvalumab
NCT06880523,Hepatocellular carcinoma,lenvatinib
NCT06745323,Small cell lung carcinoma,tarlatamab
NCT07123350,Inflammatory bowel disease,Patient switched from IV vedolizumab to subcutaneous vedolizumab as part of normal patient care
NCT07084350,Type 2 diabetes mellitus,lactulose
NCT07084350,Type 2 diabetes mellitus,PEG (solution given
NCT06741150,Cervical carcinoma,NWRD09 administered by intramuscular injection
NCT06698250,Hepatocellular carcinoma,Zanzalintinib
NCT06698250,Hepatocellular carcinoma,durvalumab
NCT06698250,Hepatocellular carcinoma,tremelimumab
NCT06856538,Pain,Bupivacain
NCT06950138,Obesity disorder,Triticum aestivum
NCT06950138,Obesity disorder,calcined magnesia
NCT07054138,Morbid obesity,dexmedetomidine
NCT06762808,Squamous cell carcinoma,atezolizumab
NCT06762808,Squamous cell carcinoma,talazoparib
NCT06792708,Narcolepsy,Lumryz
NCT07028008,Melanoma,tumor-infiltrating lymphocyte (TIL)
NCT07027423,Sarcoma,BOLD-100
NCT07027423,Sarcoma,Doxorubicin
NCT07027423,Sarcoma,BOLD-100
NCT07027423,Sarcoma,Doxorubicin
NCT06932523,Herpes zoster,Recombinant herpes zoster vaccine with low-dose adjuvant
NCT06932523,Herpes zoster,Recombinant herpes zoster vaccine with high-dose adjuvant
NCT06932523,Herpes zoster,Low-dose adjuvant
NCT06932523,Herpes zoster,High-dose adjuvant
NCT06932523,Herpes zoster,Shingrix (GSK)
NCT07120750,Hepatocellular carcinoma,Intervention for Group
NCT07120750,Hepatocellular carcinoma,Intervention for Group
NCT07067450,Esophageal squamous cell carcinoma,"Immune Checkpoint Inhibitors ( pembrolizumab, tislelizumab, sintilimab, camrelizumab, and toripalimab)"
NCT06738550,Constipation disorder,lactulose Oral Solution
NCT06934408,Obesity disorder,HRS-5817 Injection
NCT06902350,Adult glioblastoma,CS231295
NCT06902350,Small cell lung carcinoma,CS231295
NCT06800950,Influenza,QIV
NCT06800950,Influenza,QIV Control
NCT06903923,Obesity disorder,GLP-1 receptor agonist
NCT06705023,Coronary artery disorder,"Uncultured, autologous, adipose-derived regenerative cells (UA-ADRCs)"
NCT06705023,Heart failure,"Uncultured, autologous, adipose-derived regenerative cells (UA-ADRCs)"
NCT07079423,AL amyloidosis,Teclistamab (Tec)
NCT06901323,Phenylketonuria,levocarnitine
NCT06891950,Dengue disease,Dengue
NCT06654050,Mesothelioma,alrizomadlin
NCT06886750,Cervical dystonia,botulinum toxin type A Injection
NCT06921850,Hidradenitis suppurativa,bimekizumab
NCT06676410,HIV infectious disease,Dispensing Codivir®
NCT06676410,HIV infectious disease,Antiretrovirals
NCT06832410,Type 1 diabetes mellitus,Biological/Vaccine
NCT06994195,Fallopian tube carcinoma,BL-B01D1
NCT06994195,Fallopian tube carcinoma,"Liposomal doxorubicin, Paclitaxel or Topotecan"
NCT06994195,Ovarian carcinoma,BL-B01D1
NCT06994195,Ovarian carcinoma,"Liposomal doxorubicin, Paclitaxel or Topotecan"
NCT06994195,Primary peritoneal carcinoma,BL-B01D1
NCT06994195,Primary peritoneal carcinoma,"Liposomal doxorubicin, Paclitaxel or Topotecan"
NCT06946095,Heart failure,Chinese patent medicine
NCT06743581,Non-small cell lung carcinoma,cemiplimab
NCT06743581,Non-small cell lung carcinoma,dupilumab
NCT06690710,Osteoarthritis,allogeneic engineered Gingival Fibroblasts (aeGF)
NCT06737081,Anemia,SAL-0951 tablets
NCT06737081,Anemia,SAL-0951 tablets
NCT07079410,Oropharynx squamous cell carcinoma,Sintilimab+Cetuximab
NCT06617481,Prostate cancer,18F-rhPSMA-7.3 (Posluma)
NCT07071610,Atopic eczema,LNK01004 ointment
NCT07071610,Atopic eczema,LNK01004 ointment
NCT06967610,B-cell chronic lymphocytic leukemia,pirtobrutinib
NCT06967610,B-cell chronic lymphocytic leukemia,venetoclax
NCT06967610,B-cell chronic lymphocytic leukemia,obinutuzumab
NCT06660810,Soft tissue sarcoma,talimogene laherparepvec
NCT06846710,Psoriasis,HS-20118
NCT06793410,Childhood myelodysplastic syndrome,Early start post-transplant vaccination with Gardasil
NCT06793410,Childhood myelodysplastic syndrome,Late post-transplant vaccination with Gardasil
NCT06906081,Type 2 diabetes mellitus,"Kerendia (Finerenone, BAY94-8862)"
NCT06965881,Tuberous sclerosis 1,Radiprodil with Carbamazepine
NCT06965881,Tuberous sclerosis 1,Radiprodil with Itraconazole
NCT06612710,Ischemic stroke,extracellular vesicles derived from human induced neural stem cell for intravenous injection
NCT06701110,Tuberculosis,[U-14C] WX-081
NCT07036510,Glaucoma,TimoD implant
NCT07036510,Ocular hypertension,TimoD implant
NCT06712810,Mature T-cell and NK-cell non-Hodgkin lymphoma,Axl/Mer/CSF1R Inhibitor Q702
NCT06712810,Primary central nervous system lymphoma,Axl/Mer/CSF1R Inhibitor Q702
NCT06712810,Primary cutaneous T-cell non-Hodgkin lymphoma,Axl/Mer/CSF1R Inhibitor Q702
NCT07051512,Analgesic,dexmedetomidine
NCT07051512,Analgesic,dexmedetomidine
NCT07051512,Analgesic,dexmedetomidine
NCT06740812,Nausea and vomiting,fosaprepitant
NCT06740812,Nausea and vomiting,metoclopramide
NCT06740812,Vomiting,fosaprepitant
NCT06740812,Vomiting,metoclopramide
NCT06967012,Epilepsy,Oral Zonisamide Therapy
NCT06733610,Autoimmune hemolytic anemia,universal allogeneic anti-CD19/BCMA CAR T-cells
NCT07113210,Dry eye syndrome,pilocarpine HCL ophthalmic solution
NCT07113210,Presbyopia,pilocarpine HCL ophthalmic solution
NCT06851910,Trigeminal neuralgia,lacosamide
NCT06632912,Human papilloma virus infection,2 doses of vaccine Quadrivalent Recombinant Human Papillomavirus Vaccine (Hansenulapolymorpha)
NCT06632912,Human papilloma virus infection,3 doses of vaccine Quadrivalent Recombinant Human Papillomavirus Vaccine (Hansenulapolymorpha)
NCT06903312,Kidney neoplasm,Medical therapy
NCT06903312,Renal carcinoma,Medical therapy
NCT06903312,Renal cell adenocarcinoma,Medical therapy
NCT07013110,Rheumatoid arthritis,dnaJP1
NCT06590012,Atherosclerosis,Tertinat
NCT06740240,Neoplasm,68Ga-FAPI-Biotin
NCT06740240,Neoplasm,68Ga-FAPI/18F-FDG
NCT06660940,Diabetic kidney disease,Keluoxin Capsules
NCT06660940,Diabetic kidney disease,Keluoxin Capsule Simulants
NCT06660940,Diabetic kidney disease,irbesartan
NCT06660940,Diabetic retinopathy,Keluoxin Capsules
NCT06660940,Diabetic retinopathy,Keluoxin Capsule Simulants
NCT06660940,Diabetic retinopathy,irbesartan
NCT06576440,Endogenous depression,Ghrelin
NCT06689540,Hepatocellular carcinoma,MTS105
NCT06774040,Peripheral arterial disease,Etribnabdione
NCT06774040,Peripheral arterial disease,Etribnabdione
NCT06941467,Wound healing,Timolol Maleate Solution
NCT06572267,Coronary artery disorder,Mepolizumab low dose group
NCT06572267,Coronary artery disorder,Mepolizumab middle dose group
NCT06572267,Coronary artery disorder,Mepolizumab high dose group
NCT06783140,Malignant pancreatic neoplasm,Nab paclitaxel
NCT06783140,Malignant pancreatic neoplasm,gemcitabine
NCT06783140,Malignant pancreatic neoplasm,cisplatin
NCT06891040,Atopic eczema,VC005 groups
NCT07011667,Obesity disorder,CagriSema (Cagrilintide B and Semaglutide I)
NCT06799546,Paroxysmal nocturnal hemoglobinuria,HSK39297 tablets
NCT06799546,Paroxysmal nocturnal hemoglobinuria,eculizumab Injection
NCT06897046,Non-small cell lung carcinoma,QL1706
NCT06897046,Non-small cell lung carcinoma,QL1706+Carboplatin+Paclitaxel（Albumin-bound ）/ Pemetrexed
NCT06932146,Nephrolithiasis,LLX-424
NCT06926712,Respiratory system disorder,vitamin E
NCT06707246,Hidradenitis suppurativa,Secukinumab
NCT06621212,Myeloid neoplasm,mitoxantrone hydrochloride liposome
NCT06621212,Myeloid neoplasm,cytarabine
NCT06621212,Myeloid neoplasm,venetoclax
NCT06683612,Multiple sclerosis,PIPE-791
NCT06894212,Schizophrenia,SEP-363856
NCT06757712,Hypothyroidism,medical treatment
NCT06882746,Gastric carcinoma,BI
NCT06882746,Pancreatic ductal adenocarcinoma,BI
NCT06955546,Periodontal disorder,Toothpaste Product
NCT06955546,Periodontal disorder,Mouthwash Product
NCT07069140,Gingivitis,Lactoferrin-based Toothpaste and Mouthwash (Emoform Glic)
NCT07069140,Gingivitis,Lactoferrin-Based Toothpaste Only (Emoform Glic)
NCT07069140,Periodontal disorder,Lactoferrin-based Toothpaste and Mouthwash (Emoform Glic)
NCT07069140,Periodontal disorder,Lactoferrin-Based Toothpaste Only (Emoform Glic)
NCT06824467,Fallopian tube carcinoma,Sacituzumab tirumotecan
NCT06824467,Fallopian tube carcinoma,bevacizumab
NCT06824467,Fallopian tube carcinoma,H1 receptor antagonist
NCT06824467,Fallopian tube carcinoma,H2 receptor antagonist
NCT06824467,Fallopian tube carcinoma,Acetaminophen (or equivalent)
NCT06824467,Fallopian tube carcinoma,Dexamethasone (or equivalent)
NCT06824467,Fallopian tube carcinoma,Steroid mouthwash (dexamethasone or equivalent)
NCT06824467,Ovarian cancer,Sacituzumab tirumotecan
NCT06824467,Ovarian cancer,bevacizumab
NCT06824467,Ovarian cancer,H1 receptor antagonist
NCT06824467,Ovarian cancer,H2 receptor antagonist
NCT06824467,Ovarian cancer,Acetaminophen (or equivalent)
NCT06824467,Ovarian cancer,Dexamethasone (or equivalent)
NCT06824467,Ovarian cancer,Steroid mouthwash (dexamethasone or equivalent)
NCT06824467,Primary peritoneal carcinoma,Sacituzumab tirumotecan
NCT06824467,Primary peritoneal carcinoma,bevacizumab
NCT06824467,Primary peritoneal carcinoma,H1 receptor antagonist
NCT06824467,Primary peritoneal carcinoma,H2 receptor antagonist
NCT06824467,Primary peritoneal carcinoma,Acetaminophen (or equivalent)
NCT06824467,Primary peritoneal carcinoma,Dexamethasone (or equivalent)
NCT06824467,Primary peritoneal carcinoma,Steroid mouthwash (dexamethasone or equivalent)
NCT07059767,Asthma,ETH47
NCT06634667,Non-small cell lung carcinoma,third-generation EGFR-TKI combined with anlotinib
NCT06669429,Inherited lipid metabolism disorder,RS-C1001
NCT06669429,Inherited lipid metabolism disorder,RS-C1001
NCT06669429,Inherited lipid metabolism disorder,RS-C1001
NCT06937229,Agitation,KarXT
NCT06937229,Agitation,KarX-EC
NCT06595680,End stage renal failure,Medialipide
NCT06595680,End stage renal failure,NaCl
NCT06595680,End stage renal failure,Blood sample
NCT06790862,Vitiligo-associated multiple autoimmune disease susceptibility 1,SHR0302Base gel
NCT06820762,Small cell lung carcinoma,irinotecan liposome(II) plus Ivonescimab via intravenously (IV) Q3W for
NCT06773780,Aortic valve stenosis,local infiltration
NCT06773780,Aortic valve stenosis,PENG
NCT06773780,Aortic valve stenosis,FİB
NCT06764329,Androgenetic alopecia,Mesenchymal Stem Cells
NCT06613880,Aplastic anemia,standard IST combined with Romiplostim N01
NCT07066280,Radiodermatitis,Skin Repairing Cream
NCT07048080,Osteoarthritis,Prehabilitation Group Deuterated Water
NCT07048080,Osteoarthritis,Usual Care Group Deuterated Water
NCT06772480,Cirrhosis of liver,thalidomide
NCT06628362,Type 2 diabetes mellitus,CT-388
NCT06679062,Insomnia,suvorexant
NCT07053462,Kidney failure,Ex Vivo CRISPR-Cas9 Gene Editing of Donor Kidney
NCT07053462,Kidney neoplasm,Ex Vivo CRISPR-Cas9 Gene Editing of Donor Kidney
NCT06971380,AL amyloidosis,HBI0101 CART
NCT06838962,Autoimmune thrombocytopenic purpura,daratumumab Injection
NCT07005180,Parkinson disease,HBI-002
NCT06962280,Obesity disorder,tirzepatide
NCT06962280,Type 1 diabetes mellitus,tirzepatide
NCT07015762,Atopic eczema,IBI3002
NCT07098780,Obesity disorder,tranexamic acid
NCT06641180,Influenza,"High-Dose trivalent influenza vaccine (Split virion, Inactivated)"
NCT06641180,Influenza,"Standard-dose trivalent influenza vaccine (Split virion, Inactivated)"
NCT07084662,Diffuse large B-cell lymphoma,Xinlikang capsules
NCT07084662,Diffuse large B-cell lymphoma,mimic capsules
NCT06904729,Lupus nephritis,Low-dose CAR-T cells group
NCT06904729,Lupus nephritis,High-dose CAR-T cells group
NCT06603662,Osteoarthritis,prednisone
NCT06603662,Osteoarthritis,dexamethasone
NCT06999980,Cutaneous melanoma,Ipilimumab
NCT06999980,Cutaneous melanoma,Nivolumab
NCT06999980,Cutaneous melanoma,Nivolumab
NCT06612580,Prostate cancer,68Ga-AAZTA-NI-093
NCT06941129,Anti-neutrophil cytoplasmic antibody-associated vasculitis,UCAR T-cell
NCT06941129,Inclusion body myositis,UCAR T-cell
NCT06941129,Systemic lupus erythematosus,UCAR T-cell
NCT06941129,Systemic sclerosis,UCAR T-cell
NCT07055880,Rabies,"Rabies Vaccine (Serum-free Vero Cell), Freeze-dried"
NCT07055880,Rabies,Verorab®
NCT06702462,Asthma,HFA-152A propellant
NCT06702462,Asthma,HFA-134A propellant
NCT06851962,Maturity-onset diabetes of the young type 1,metformin
NCT06851962,Maturity-onset diabetes of the young type 1,dulaglutide
NCT06851962,Maturity-onset diabetes of the young type 1,Semaglutide
NCT06851962,Maturity-onset diabetes of the young type 1,Empagliflozin (BI
NCT06851962,Maturity-onset diabetes of the young type 1,canagliflozin
NCT06851962,Maturity-onset diabetes of the young type 1,dapagliflozin
NCT06851962,Maturity-onset diabetes of the young type 1,pioglitazone
NCT06851962,Maturity-onset diabetes of the young type 1,sitagliptin
NCT06851962,Maturity-onset diabetes of the young type 1,Vildagliptin (Galvus)
NCT06851962,Maturity-onset diabetes of the young type 1,linagliptin
NCT07080229,Cataract,Intranasal dexmedetomidine
NCT07080229,Hypertensive disorder,Intranasal dexmedetomidine
NCT07113262,Endocrine exophthalmos,IBI311
NCT07047040,Osteoarthritis,Ketorolac Tromethamine
NCT07047040,Osteoarthritis,gabapentin
NCT07047040,Osteoarthritis,Empty Medication Capsules
NCT07047040,Pain,Ketorolac Tromethamine
NCT07047040,Pain,gabapentin
NCT07047040,Pain,Empty Medication Capsules
NCT06698692,Esophageal squamous cell carcinoma,trilaciclib Injection [Cosela]
NCT06866444,Fibromyalgia,Observational
NCT07010744,Dyspepsia,Triple drug regimen
NCT07010744,Dyspepsia,Quadruple therapy
NCT07006792,Atopic eczema,lebrikizumab
NCT07015944,Endogenous depression,Standardised pharmacological treatment (antidepressants)
NCT06771544,Melanoma,pembrolizumab
NCT06771544,Melanoma,cyclophosphamide
NCT07121192,Influenza,Flu mRNA (Formulation A)
NCT07121192,Influenza,Flu mRNA (Formulation B)
NCT06792344,Systemic sclerosis,anti-CD19 CAR-T cells
NCT06644040,Osteoporosis,TeriQ Patch
NCT06644040,Osteoporosis,Teribone Inj.
NCT06644040,Osteoporosis,Forteo Inj.
NCT06843044,Anxiety,Ranquilon
NCT06843044,Anxiety,Afobazole
NCT06671392,Essential hypertension,DWC202405
NCT06671392,Essential hypertension,"DWC202405, DWC202314"
NCT06671392,Essential hypertension,"DWC202405, DWC202314P"
NCT06671392,Essential hypertension,"DWC202313, DWC202314"
NCT06671392,Essential hypertension,"DWC202313, DWC202314P"
NCT06593392,Pruritus,difelikefalin
NCT07100392,Hepatocellular carcinoma,tauroursodeoxycholic acid (TUDCA)
NCT07100392,Hepatocellular carcinoma,Camrelizumab
NCT07100392,Hepatocellular carcinoma,regorafenib
NCT06649344,Type 2 diabetes mellitus,HRS9531 Injection
NCT06649344,Type 2 diabetes mellitus,Semaglutide Injection
NCT06921044,Diffuse large B-cell lymphoma,R-miniMCOP:Rituximab / Mitoxantrone Liposome / Cyclophosphamide / Vincristine / Prednisone
NCT06659692,Infertility disorder,Gonadotropins Subcutaneous
NCT07010692,Skin cancer,Tirbanibulin ointment
NCT07010692,Squamous cell carcinoma,Tirbanibulin ointment
NCT07035392,Chemotherapy,Adebrelimab
NCT07035392,Chemotherapy,chemotherapy
NCT07035392,Non-small cell lung carcinoma,Adebrelimab
NCT07035392,Non-small cell lung carcinoma,chemotherapy
NCT06854640,Sepsis,BAY3389934
NCT06607744,Mal de Debarquement,Pharmacokinetic profiles of Selegiline TDS and EMSAM
NCT06611592,Obsessive-compulsive disorder,Pramipexole
NCT06611592,Obsessive-compulsive disorder,Pramipexole
NCT06611592,Obsessive-compulsive disorder,Pramipexole
NCT06797544,Cutaneous leishmaniasis,Levofloxacin
NCT07099144,Pulmonary hypertension,Inhaled nitric oxide (NO)
NCT06810544,Malignant glioma,TNG456
NCT06810544,Malignant glioma,abemaciclib
NCT06594744,Esophageal varices,carvedilol
NCT06594744,Hepatocellular carcinoma,carvedilol
NCT06642792,Classic Hodgkin lymphoma,AK129
NCT06642792,Classic Hodgkin lymphoma,AK117
NCT06974292,Atopic eczema,[14C]VC005
NCT07001592,Gastric adenocarcinoma,vvDD-hIL-2-RG-1
NCT07001592,Gastric carcinoma,vvDD-hIL-2-RG-1
NCT07001592,Peritoneum cancer,vvDD-hIL-2-RG-1
NCT06624644,Cutaneous melanoma,LNS8801
NCT06624644,Cutaneous melanoma,pembrolizumab
NCT06624644,Cutaneous melanoma,Chemotherapy (dacarbazine or temozolomide)
NCT06624644,Cutaneous melanoma,Immunotherapy (Pembrolizumab)
NCT06624644,Cutaneous melanoma,Immunotherapy (nivolumab and relatlimab)
NCT06624644,Cutaneous melanoma,Immunotherapy (ipilimumab and nivolumab)
NCT06624644,Melanoma,LNS8801
NCT06624644,Melanoma,pembrolizumab
NCT06624644,Melanoma,Chemotherapy (dacarbazine or temozolomide)
NCT06624644,Melanoma,Immunotherapy (Pembrolizumab)
NCT06624644,Melanoma,Immunotherapy (nivolumab and relatlimab)
NCT06624644,Melanoma,Immunotherapy (ipilimumab and nivolumab)
NCT07032792,Heart disorder,Feiba
NCT07032792,Heart disorder,FFP
NCT07113392,Influenza,Suraxavir Marboxil
NCT07113392,Influenza,oseltamivir
NCT06742892,Carcinoma,HLX43 DOSE
NCT06742892,Carcinoma,HLX43 DOSE
NCT06742892,Carcinoma,HLX43 DOSE
NCT07075289,Benign paroxysmal positional vertigo,DLBS1033
NCT07075289,Benign paroxysmal positional vertigo,Betahistine Mesylate tablet
NCT06707194,Ankylosing spondylitis,etanercept
NCT06707194,Ankylosing spondylitis,Benzathine Penicillin
NCT06707194,Spondyloarthropathy,etanercept
NCT06707194,Spondyloarthropathy,Benzathine Penicillin
NCT06977594,Cervical carcinoma,Paclitaxel and carboplatin
NCT06977594,Cervical carcinoma,Standard premedication (20 mg)
NCT06977594,Cervical carcinoma,Reduced premedication (10 mg)
NCT06977594,Cervical carcinoma,Reduced premedication (5 mg)
NCT06977594,Endometrial cancer,Paclitaxel and carboplatin
NCT06977594,Endometrial cancer,Standard premedication (20 mg)
NCT06977594,Endometrial cancer,Reduced premedication (10 mg)
NCT06977594,Endometrial cancer,Reduced premedication (5 mg)
NCT06977594,Ovarian cancer,Paclitaxel and carboplatin
NCT06977594,Ovarian cancer,Standard premedication (20 mg)
NCT06977594,Ovarian cancer,Reduced premedication (10 mg)
NCT06977594,Ovarian cancer,Reduced premedication (5 mg)
NCT06813729,Pain,Shotblocker
NCT06813729,Pain,Manuel Pressure
NCT06966362,Nicotine dependence,Motivation-Phase Varenicline
NCT06966362,Nicotine dependence,Motivation-Phase Nicotine Mini-Lozenge
NCT06966362,Nicotine dependence,Cessation-Phase Combination Nicotine Replacement Therapy (NRT)
NCT06966362,Nicotine dependence,Cessation-Phase Varenicline
NCT06773962,Parkinson disease,TB006
NCT06798376,Gastric adenocarcinoma,≤4 cycles of neoadjuvant PD-1 Inhibitors combined with chemotherapy
NCT06798376,Gastric adenocarcinoma,≥5 cycles of neoadjuvant PD-1 Inhibitors combined with chemotherapy
NCT07063576,Gastroesophageal reflux disease,Baclofen
NCT06760676,Cervical carcinoma,Alpaloritovorelli antibodies
NCT06891560,Adrenal cortex carcinoma,ENFORTUMAB VEDOTIN
NCT06930976,Glucose,13C6-Glucose
NCT06574360,Schizophrenia,S1RA plus NMDAE
NCT06945276,COVID-19,ALG-097558
NCT06945276,COVID-19,dabigatran
NCT06945276,COVID-19,itraconazole
NCT06667076,Carcinoma,amivantamab
NCT06667076,Carcinoma,lazertinib
NCT06667076,Carcinoma,Chemotherapy: Pemetrexed
NCT06667076,Carcinoma,Chemotherapy: Carboplatin
NCT06757894,Follicular lymphoma,Zuberitamab
NCT06757894,Follicular lymphoma,bendamustine
NCT06753994,Diabetes mellitus,SGLT-2 inhibitor
NCT06753994,Type 1 diabetes mellitus,SGLT-2 inhibitor
NCT07083960,Autoimmune hemolytic anemia,OM336
NCT07083960,Autoimmune thrombocytopenic purpura,OM336
NCT06577194,Rectal carcinoma,Sintilimab + IL-2 Combined with Capox
NCT06613360,Systemic lupus erythematosus,CLN-978
NCT06576960,Dental caries,Nano silver fluoride varnish and tri calcium phosphate varnish
NCT06609876,Hepatocellular carcinoma,Donafenib
NCT07093476,Dermatomyositis,metformin
NCT07093476,Dermatomyositis,alogliptin
NCT07093476,Dermatomyositis,empagliflozin
NCT07093476,Type 2 diabetes mellitus,metformin
NCT07093476,Type 2 diabetes mellitus,alogliptin
NCT07093476,Type 2 diabetes mellitus,empagliflozin
NCT06708260,Diabetic macular edema,"ENN0403, low dose"
NCT06708260,Diabetic macular edema,"ENN0403, high dose"
NCT06686576,Malignant colon neoplasm,QL1706
NCT06686576,Malignant colon neoplasm,CAPEOX
NCT06752694,Aplastic anemia,cyclosporine
NCT06752694,Aplastic anemia,fludarabine
NCT06752694,Aplastic anemia,Granulocyte Colony-Stimulating Factor
NCT06752694,Aplastic anemia,mycophenolate mofetil
NCT06752694,Aplastic anemia,ruxolitinib
NCT06752694,Aplastic anemia,sirolimus
NCT07101094,Schizophrenia,xanomeline and trospium chloride (X/T) therapy
NCT06796660,Kidney failure,Nephropathy Formula No.
NCT06796660,Kidney failure,integrated basic treatment for chronic kidney disease
NCT06706076,Non-small cell lung carcinoma,BH-30643
NCT06706076,Non-small cell lung carcinoma,BH-30643
NCT06750991,Diffuse large B-cell lymphoma,CDR-CHOP
NCT07125391,Ovarian cancer,Cohort A
NCT06631391,Neuroblastoma,umbilical cord blood NK cells
NCT06788691,Anemia,luspatercept
NCT06788691,Neutropenia,luspatercept
NCT06788691,Thrombocytopenia,luspatercept
NCT06883162,Nicotine dependence,varenicline
NCT07003191,Type 2 diabetes mellitus,Metformin Hydrochloride and Empagliflozin tables (Fixed-Dose Combination)
NCT06931691,Paroxysmal nocturnal hemoglobinuria,LNP023
NCT06698991,Wilson disease,Plasma Exchange
NCT07075562,Hepatocellular carcinoma,Bevacizumab Arterial Perfusion plus TACE
NCT06798662,Herpes zoster,Drug (famciclovir and gabapentin)
NCT07034391,Non-small cell lung carcinoma,denosumab combined anti-PD-1 inhibitor with chemotherapy
NCT07079462,Peritoneum cancer,Chemotherapy (control)
NCT06885762,Guillain-Barre syndrome,efgartigimod
NCT06882291,Polycystic ovary syndrome,Medical treatment
NCT06852391,Obesity disorder,semaglutide Pen Injector
NCT07053891,Lupus nephritis,Voclosporin (LUPKYNIS)
NCT06599762,Myelodysplastic syndrome,tranexamic acid
NCT06643962,Leukemia,venetoclax
NCT06643962,Leukemia,Idarubincin
NCT06643962,Leukemia,cytarabine
NCT06639191,Cervical carcinoma,[177Lu]Lu-AKIR001
NCT06639191,Vulvar carcinoma,[177Lu]Lu-AKIR001
NCT06940791,Primary central nervous system lymphoma,Tirabrutinib
NCT06828991,Diffuse large B-cell lymphoma,mosunetuzumab
NCT07123662,Leukemia,Gamma-Delta T cell injection
NCT06936462,Dry eye syndrome,topical cyclosporine eyedrops and hyaluronic eyedrops
NCT06861062,Diabetes mellitus,Vitamin D3
NCT06876662,B-cell chronic lymphocytic leukemia,pirtobrutinib
NCT06876662,Non-Hodgkin lymphoma,pirtobrutinib
NCT06792162,Gastric carcinoma,Carilizumab and Apatinib
NCT06964191,Glaucoma,Latanoprost
NCT06964191,Ocular hypertension,Latanoprost
NCT06645691,Heart failure,Hyperpolarized
NCT06678191,Asthma,"BDP/FF/G (Beclomethasone diprprionate, formoterol fumarate, glycopyrronium bromide)"
NCT07007962,Autoimmune thrombocytopenic purpura,rilzabrutinib
NCT06978062,Gastroesophageal cancer,Bemarituzumab
NCT06978062,Gastroesophageal cancer,FLOT
NCT07068191,Fatty liver disease,UDCA (Ursodeoxycholic acid)
NCT07068191,Fatty liver disease,S-adenosylmethionine
NCT07068191,Metabolic dysfunction-associated steatotic liver disease,UDCA (Ursodeoxycholic acid)
NCT07068191,Metabolic dysfunction-associated steatotic liver disease,S-adenosylmethionine
NCT06931080,Attention deficit-hyperactivity disorder,EB-1020 (Centanafadine)
NCT06931080,Attention deficit-hyperactivity disorder,EB-1020 (Centanafadine)
NCT06979362,Heart failure,CDR132L
NCT06632262,Non-small cell lung carcinoma,ABSK061 + ABSK043
NCT06632262,Non-small cell lung carcinoma,ABSK061+ABSK043 in combination with CAPOX
NCT06632262,Urothelial carcinoma,ABSK061 + ABSK043
NCT06632262,Urothelial carcinoma,ABSK061+ABSK043 in combination with CAPOX
NCT06659562,Parkinson disease,HER-096
NCT06659562,Parkinson disease,HER-096
NCT06961760,Lewy body dementia,zervimesine
NCT06992076,Hemophilia,marstacimab
NCT06641076,Arthritic joint disease,Sonelokimab
NCT06674460,Ischemic stroke,Edaravone Dexborneol Sublingual Tablets
NCT06701760,Traumatic brain injury,sodium lactate
NCT06955260,Congenital heart disease,empagliflozin
NCT06654960,Type 2 diabetes mellitus,HRS9531 injection
NCT06654960,Type 2 diabetes mellitus,Metformin Hydrochloride tablets
NCT06677060,Heart failure,Baxdrostat and dapagliflozin
NCT06927076,Endogenous depression,"N,N-Dimethyltryptamine"
NCT06618976,Thrombotic disease,sotagliflozin
NCT06618976,Thrombotic disease,empagliflozin
NCT06863376,Metabolic dysfunction-associated steatotic liver disease,Carbocysteine
NCT06897176,Cerebrovascular disorder,Cerebrolyisin
NCT07086976,Autoimmune hemolytic anemia,rilzabrutinib
NCT06673927,Insomnia,YZJ-1139
NCT06673927,Insomnia,YZJ-1139
NCT06743776,Amyotrophic lateral sclerosis,MN-166
NCT07002476,Cerebrovascular disorder,guideline-recommended SoC
NCT07002476,Cerebrovascular disorder,Recaticimab (intensive)
NCT06687876,Esophageal adenocarcinoma,metformin
NCT06839976,Lupus nephritis,CART19
NCT06839976,Systemic lupus erythematosus,CART19
NCT06629376,Gout,Pegylated Recombinant Candida Utilis Uricase for Injection
NCT06629376,Hyperuricemia,Pegylated Recombinant Candida Utilis Uricase for Injection
NCT06719960,Cognition,Dexmedetomidine group
NCT06719960,Cognition,Propofol group
NCT06690476,Esophageal squamous cell carcinoma,Dose escalation(IPM514 monotherapy)
NCT06690476,Esophageal squamous cell carcinoma,Dose expansion (IPM514 combined with tislelizumab)
NCT06690476,Esophageal squamous cell carcinoma,"Neoadjuvant therapy cohort(IPM514 combined with tislelizumab, cisplatin and paclitaxel)"
NCT06953076,Tumor of uterus,Relugolix/estradiol/norethisterone acetate
NCT06745076,Classic Hodgkin lymphoma,dacarbazine
NCT06745076,Classic Hodgkin lymphoma,doxorubicin
NCT06745076,Classic Hodgkin lymphoma,nivolumab
NCT06745076,Classic Hodgkin lymphoma,vinblastine
NCT06957327,Chordoma,ERAS-601
NCT06621576,Heart failure,HM2002 injection
NCT06621576,Myocardial ischemia,HM2002 injection
NCT06855576,Fever,Paracetamol ODT
NCT06855576,Fever,Alvedon film-coated tablet
NCT06855576,Fever,Panadol film-coated Tablet
NCT06855576,Pain,Paracetamol ODT
NCT06855576,Pain,Alvedon film-coated tablet
NCT06855576,Pain,Panadol film-coated Tablet
NCT06600776,Type 1 diabetes mellitus,Ultra Rapid Lispro (URLi)
NCT07027527,Atopic eczema,APG777
NCT07027527,Atopic eczema,APG990
NCT07027527,Atopic eczema,dupilumab
NCT06584227,Malignant pancreatic neoplasm,Adebrelimab and Chidamide Combined with Gemcitabine and S1
NCT06717360,Hypercholesterolemia,AG2304T
NCT06717360,Hypercholesterolemia,AG2304R
NCT06949176,Periapical periodontitis,Sodium Hypochlorite.
NCT06949176,Periapical periodontitis,Hydrogen peroxide.
NCT06949176,Periapical periodontitis,Sodium Sulfate.
NCT06819176,Human immunodeficiency virus,lenacapavir
NCT06979076,B-cell chronic lymphocytic leukemia,"MS-553, DS1"
NCT06979076,B-cell chronic lymphocytic leukemia,"MS-553, DS2"
NCT07085676,Rheumatoid arthritis,HBI0101 CART
NCT07085676,Systemic lupus erythematosus,HBI0101 CART
NCT07085676,Systemic sclerosis,HBI0101 CART
NCT06923176,Hepatocellular carcinoma,Biejia-Ruangan compound
NCT06857227,Rheumatoid arthritis,GNC-038
NCT06636162,Malignant glioma,DSP-0390
NCT06616194,Migraine disorder,rimegepant
NCT06659094,Obsessive-compulsive disorder,conventional medical treatment (TAU)
NCT07085091,Esophageal squamous cell carcinoma,ALX2004
NCT07085091,Esophageal squamous cell carcinoma,ALX2004
NCT07085091,Esophageal squamous cell carcinoma,ALX2004
NCT07085091,Non-small cell lung carcinoma,ALX2004
NCT07085091,Non-small cell lung carcinoma,ALX2004
NCT07085091,Non-small cell lung carcinoma,ALX2004
NCT06644794,Infertility disorder,Progesterone-modified natural cycle preparation for frozen embryo transfer
NCT06644794,Infertility disorder,Hormone replacement therapy cycle preparation for frozen embryo transfer
NCT06665594,Hyaluronic acid,Tranexamic Acid (TXA)
NCT06935162,AL amyloidosis,Teclistamab (Tec)
NCT06821191,Coronary artery disorder,clopidogrel
NCT06821191,Coronary artery disorder,prasugrel
NCT06583291,Parkinson disease,Allogeneic dopaminergic neural precursor cell(iDAP)
NCT07058194,Pain,bupivacaine
NCT06956391,Cancer,18F-FDG
NCT06726291,Endometrial cancer,NEPA (300mg netupitant/0.5mg palonosetron)
NCT07049094,Cerebrovascular disorder,scalp nerve block with
NCT07049094,Cerebrovascular disorder,scalp nerve block with
NCT06574594,Rheumatoid arthritis,methotrexate
NCT06574594,Rheumatoid arthritis,methotrexate
NCT06785662,Allergic rhinitis,The budesonide nasal irrigation
NCT06785662,Allergic rhinitis,The budesonide nasal spray
NCT07100691,Obesity disorder,metoclopramide
NCT06957691,Prostate adenocarcinoma,fezolinetant - reference formulation
NCT06957691,Prostate cancer,fezolinetant - reference formulation
NCT06957691,Prostate carcinoma,fezolinetant - reference formulation
NCT06957691,Prostate neoplasm,fezolinetant - reference formulation
NCT06916091,Obesity disorder,Eloralintide
NCT06691191,Coronary artery disorder,ticagrelor
NCT06691191,Coronary artery disorder,prasugrel
NCT06717191,Type 1 diabetes mellitus,biosimilar insulin glargine
NCT06697080,Androgenetic alopecia,Human umbilical cord mesenchymal stem cells
NCT07100080,Non-small cell lung carcinoma,Iza-bren
NCT07100080,Non-small cell lung carcinoma,carboplatin
NCT07100080,Non-small cell lung carcinoma,cisplatin
NCT07100080,Non-small cell lung carcinoma,pemetrexed
NCT07012980,Diffuse large B-cell lymphoma,glofitamab
NCT07012980,Diffuse large B-cell lymphoma,polatuzumab vedotin
NCT07012980,Diffuse large B-cell lymphoma,zanubrutinib
NCT06800092,Cancer,sildenafil
NCT07088380,Endogenous depression,ketamine hydrochloride
NCT06629480,HIV infectious disease,bictegravir
NCT06688292,"COPD, severe early onset",Taneasy
NCT06688292,"COPD, severe early onset",Actein effervescent
NCT06635889,Nephrolithiasis,bupivacaine
NCT06803589,Gastroparesis,Growth Hormone
NCT07033689,Malignant pancreatic neoplasm,Nal-IRI/FL
NCT07033689,Malignant pancreatic neoplasm,mFOLFIRINOX adjuvant chemotherapy
NCT07033689,Malignant pancreatic neoplasm,Gem/nab-PTX
NCT07089680,COVID-19,Nirmatrelvir/Ritonavir
NCT07129889,Myopia,gradual withdrawal of medication
NCT06817889,Lymphoma,remdesivir
NCT06817889,Respiratory syncytial virus infectious disease,remdesivir
NCT06926829,Attention deficit-hyperactivity disorder,EB-1020 (Centanafadine)
NCT06926829,Attention deficit-hyperactivity disorder,EB-1020 (Centanafadine)
NCT06737380,Systemic lupus erythematosus,single dose of UC-MSCs
NCT07039162,Esophageal squamous cell carcinoma,tislelizumab
NCT07039162,Esophageal squamous cell carcinoma,paclitaxel
NCT07039162,Esophageal squamous cell carcinoma,cisplatin
NCT07096362,Pancreatic ductal adenocarcinoma,5-Fluorouracil
NCT07096362,Pancreatic ductal adenocarcinoma,oxaliplatin
NCT07096362,Pancreatic ductal adenocarcinoma,leucovorin
NCT07096362,Pancreatic ductal adenocarcinoma,irinotecan
NCT07096362,Pancreatic ductal adenocarcinoma,gemcitabine
NCT07096362,Pancreatic ductal adenocarcinoma,Nab Paclitaxel
NCT06574880,Prostate cancer,Lu-PSMA-617
NCT06718062,Hyperuricemia,aliskiren
NCT06718062,Hyperuricemia,losartan
NCT06887062,Takayasu arteritis,bosentan
NCT06887062,Temporal arteritis,bosentan
NCT06744062,Essential hypertension,BR1015
NCT06744062,Essential hypertension,BR1015-1
NCT06744062,Essential hypertension,BR1015-2
NCT06780462,Behcet disease,Corticosteroids + Rivaroxaban
NCT06780462,Behcet disease,Corticosteroids alone
NCT06884891,Atopic eczema,QL2108 injection
NCT06884891,Atopic eczema,Dupixent®
NCT07037862,Duchenne muscular dystrophy,ENTR-601-44
NCT06705062,Graft versus host disease,reduced-dose PTCy
NCT06705062,Graft versus host disease,Standard dose PTCY
NCT07060391,Alzheimer disease,Donepezil drug treatment
NCT06795191,Prostate cancer,Triptorelin Mesylate
NCT06963580,Postpartum depression,MI078 capsule dose
NCT06963580,Postpartum depression,MI078 capsule dose
NCT06676891,Adult glioblastoma,RZ-001
NCT06660862,Prostate cancer,darolutamide
NCT06660862,Prostate cancer,Physician choice Androgen Deprivation (Hormone) Therapy
NCT06598462,Eosinophilic esophagitis,Solrikitug Low Dose
NCT06598462,Eosinophilic esophagitis,Solrikitug Mid Dose
NCT06598462,Eosinophilic esophagitis,Solrikitug High Dose
NCT06764680,Chemotherapy,Trifluorouracil tepidopyrimidine
NCT06764680,Chemotherapy,bevacizumab
NCT06764680,Chemotherapy,Sindilizumab
NCT06954662,Parkinson disease,Amino acid supplement
NCT06754462,Rheumatoid arthritis,IMVT-1402
NCT06827080,Cancer,30 mCi NYMO32
NCT06827080,Cancer,50 mCi NYMO32
NCT06827080,Cancer,80 mCi NYMO32
NCT06827080,Cancer,130 mCi NYMO32
NCT06827080,Cancer,200 mCi NYMO32
NCT06762080,Neoplastic meningitis,Cadonilimab (AK104)
NCT06762080,Neoplastic meningitis,Pemetrexed (Alimta)
NCT06732180,Parkinson disease,GT-02287
NCT06941480,Neuroendocrine carcinoma,177Lu-DTPA-SC16.56
NCT06795776,Sleep,Eschscholzia tablets
NCT07074327,Autosomal dominant polycystic kidney disease,VX-407
NCT07074327,Autosomal dominant polycystic kidney disease,LNG/EE
NCT07074327,Autosomal dominant polycystic kidney disease,NGM/EE
NCT07074327,Autosomal dominant polycystic kidney disease,NET/EE
NCT07074327,Autosomal dominant polycystic kidney disease,DRSP/EE
NCT07095127,Autoimmune thrombocytopenic purpura,NVG-2089
NCT07114627,Gastric carcinoma,Blood sampling for pharmacokinetics
NCT07023627,Ovarian cancer,INCB123667
NCT06761976,Cancer,Sevabertinib
NCT06880276,Atopic eczema,1.5% QLM3003 ointment
NCT06880276,Atopic eczema,2% QLM3003 ointment
NCT06995976,Cancer,68Ga-dPNE
NCT06995976,Cancer,18F-FDG
NCT06882876,Hepatocellular carcinoma,JS014 Combined With Toripalimab and TACE
NCT06790927,Hypertensive disorder,Usual Care
NCT06790927,Hypertensive disorder,Standard Medical Therapy
NCT06881927,Respiratory failure,Hydrocortisone Hemisuccinate
NCT06752876,Lupus erythematosus,CB-010
NCT06752876,Lupus nephritis,CB-010
NCT06752876,Systemic lupus erythematosus,CB-010
NCT07131527,Cholecystitis,gabapentin
NCT07131527,Cholecystitis,diclofenac sodium
NCT06783127,Prostate cancer,olaparib
NCT07021976,Hypertrophic cardiomyopathy,HRS-1893 Tablets
NCT06787976,Anxiety,Dolutegravir (DTG)
NCT06787976,Anxiety,Darunavir/Cobicistat (FDC)
NCT06787976,Insomnia,Dolutegravir (DTG)
NCT06787976,Insomnia,Darunavir/Cobicistat (FDC)
NCT06710327,Benign prostatic hyperplasia,Tranexamic Acid (IV)
NCT06606327,Obesity disorder,Diazoxide
NCT06646627,Ovarian cancer,B7-H3CART
NCT06937476,Endogenous depression,escitalopram
NCT06937476,Endogenous depression,Aripiprazole
NCT06937476,Rumination disorder,escitalopram
NCT06937476,Rumination disorder,Aripiprazole
NCT06670976,Soft tissue sarcoma,propranolol
NCT06784076,Systemic lupus erythematosus,anifrolumab
NCT06967194,ST-elevation myocardial infarction,Metoprolol (MET)
NCT06967194,ST-elevation myocardial infarction,Plcacebo
NCT06925360,Bronchopulmonary dysplasia,intravenous immunoglobulin
NCT06731894,Colon carcinoma,cannabidiol
NCT06731894,Colon carcinoma,dronabinol
NCT07046676,Epilepsy,sodium valproate
NCT06660394,Dravet syndrome,LP352
NCT07129460,Gastric intestinal metaplasia,Berberine hydrochloride
NCT06888960,Autoimmune hemolytic anemia,CC312
NCT06888960,Rheumatoid arthritis,CC312
NCT06888960,Systemic lupus erythematosus,CC312
NCT06888960,Systemic sclerosis,CC312
NCT07011576,Malignant colon neoplasm,fruquintinib
NCT07011576,Malignant colon neoplasm,FOLFIRI (Irinotecan
NCT07011576,Rectal carcinoma,fruquintinib
NCT07011576,Rectal carcinoma,FOLFIRI (Irinotecan
NCT07081360,Malignant pancreatic neoplasm,Neoadjuvant chemotherapy
NCT07081360,Pancreatic adenocarcinoma,Neoadjuvant chemotherapy
NCT06610760,Gastric intestinal metaplasia,Ursodeoxycholic Acid
NCT07128576,Thrombocytopenia,Romiplostim N01
NCT06855160,Chickenpox,Candidate varicella vaccine
NCT06855160,Chickenpox,Marketed varicella vaccine
NCT06855160,Chickenpox,MMR vaccine
NCT06855160,Chickenpox,Hepatitis A vaccine
NCT06855160,Chickenpox,PCV (pneumococcal conjugate vaccine)
NCT06855160,Chickenpox,PCV
NCT06855160,Chickenpox,Vaxneuvance
NCT06963060,Cholangiocarcinoma,Gemcitabine nab-PaclitaxelLenvatinibTislelizumab
NCT06703476,Childhood bladder carcinoma,alvimopan
NCT07030894,IgA glomerulonephritis,"""Nefecon®"",""Ambrisentan"""
NCT07030894,Proteinuria,"""Nefecon®"",""Ambrisentan"""
NCT06630260,Glioma susceptibility 1,avutometinib
NCT06630260,Glioma susceptibility 1,defactinib
NCT06630260,Glioma susceptibility 1,temozolomide
NCT06738160,Non-small cell lung carcinoma,Narlumosbart
NCT06908694,Prostate cancer,semaglutide Pen Injector
NCT06834594,Primary ovarian failure,Micronized progesterone
NCT06834594,Primary ovarian failure,Micronized Progesterone
NCT06834594,Turner syndrome,Micronized progesterone
NCT06834594,Turner syndrome,Micronized Progesterone
NCT06675994,Diabetes mellitus,"PCSK9 Antibody, PCSK9 Enzyme"
NCT06675994,Hypercholesterolemia,"PCSK9 Antibody, PCSK9 Enzyme"
NCT06675994,Hypertensive disorder,"PCSK9 Antibody, PCSK9 Enzyme"
NCT06675994,Prediabetes syndrome,"PCSK9 Antibody, PCSK9 Enzyme"
NCT06770894,Maturity-onset diabetes of the young type 1,SITagliptin
NCT06770894,Osteoporosis,SITagliptin
NCT06952465,Psoriasis,deucravacitinib
NCT06952465,Psoriasis,Any biologic treatment for psoriasis
NCT07027566,Dentin sensitivity,Potassium nitrate and sodium fluoride
NCT07027566,Dentin sensitivity,Cannabidiol (CBD) Gel
NCT07027566,Dentin sensitivity,Natrosol
NCT06732466,Gingivitis,Chlorhexidine toothpaste
NCT06724926,Malignant glioma,Azeliragon
NCT06724926,Neoplastic meningitis,Azeliragon
NCT06745726,Hypertensive disorder,Zestril
NCT07091357,Allergic rhinitis,SHR-1819 Injection
NCT07023965,Peripheral arterial disease,NL003
NCT06674265,Neuroblastoma,Allogenic NK cells infusion
NCT06604065,Parkinson disease,AMS2434 (amino acids)
NCT06619665,Narcolepsy,MK-6552
NCT06619665,Narcolepsy,modafinil
NCT06687265,Cirrhosis of liver,metformin
NCT06710665,Esophageal squamous cell carcinoma,Chemotherapy
NCT06815965,Lewy body dementia,neflamapimod
NCT06953726,Atrial fibrillation,apixaban
NCT06953726,Atrial fibrillation,rivaroxaban
NCT07042126,Dermatitis,611
NCT07096557,Systemic lupus erythematosus,Coenzyme Q10
NCT06941857,Malignant pancreatic neoplasm,oxaliplatin
NCT06941857,Malignant pancreatic neoplasm,irinotecan
NCT06941857,Malignant pancreatic neoplasm,Folinic Acid
NCT06941857,Malignant pancreatic neoplasm,5-Fluorouracil (5-FU)
NCT06941857,Malignant pancreatic neoplasm,NC410
NCT06941857,Malignant pancreatic neoplasm,nivolumab
NCT06941857,Malignant pancreatic neoplasm,ipilimumab
NCT06919848,Biliary tract cancer,TORIPALIMAB INJECTION(JS001 )
NCT06919848,Biliary tract cancer,lenvatinib
NCT06919848,Biliary tract cancer,H101
NCT06919848,Biliary tract cancer,FOLFOX
NCT06652048,Non-small cell lung carcinoma,Furmonertinib
NCT06652048,Non-small cell lung carcinoma,Furmonertinib
NCT06652048,Non-small cell lung carcinoma,Furmonertinib
NCT06739226,Melanoma,"Antigen-specific CAR T, CTL and DCvac to treat melanoma."
NCT06949826,Opiate dependence,buprenorphine Transdermal System
NCT06949826,Pain,buprenorphine Transdermal System
NCT06728657,Gastric adenocarcinoma,Anti-PD-1 monoclonal antibody
NCT06728657,Gastric adenocarcinoma,Chemotherapy
NCT07099157,Herpes zoster,Brivudine
NCT07099157,Herpes zoster,famciclovir
NCT06910657,Childhood bladder carcinoma,IDOV-Immune (oncolytic vaccinia virus)
NCT06910657,Gastric carcinoma,IDOV-Immune (oncolytic vaccinia virus)
NCT06910657,Hepatocellular carcinoma,IDOV-Immune (oncolytic vaccinia virus)
NCT06910657,Malignant pancreatic neoplasm,IDOV-Immune (oncolytic vaccinia virus)
NCT06910657,Melanoma,IDOV-Immune (oncolytic vaccinia virus)
NCT06910657,Nonpapillary renal cell carcinoma,IDOV-Immune (oncolytic vaccinia virus)
NCT06910657,Ovarian cancer,IDOV-Immune (oncolytic vaccinia virus)
NCT06910657,Prostate cancer,IDOV-Immune (oncolytic vaccinia virus)
NCT06910657,Sarcoma,IDOV-Immune (oncolytic vaccinia virus)
NCT07018557,Hypertensive disorder,eszopiclone
NCT07018557,Insomnia,eszopiclone
NCT06769126,Small cell lung carcinoma,Ceralasertib
NCT06769126,Small cell lung carcinoma,durvalumab
NCT06769126,Small cell lung carcinoma,etoposide
NCT06769126,Small cell lung carcinoma,Monalizumab
NCT06769126,Small cell lung carcinoma,Platinum Compound
NCT06769126,Small cell lung carcinoma,Saruparib
NCT06848426,Non-small cell lung carcinoma,Xingbaiji Formula
NCT07029126,Migraine disorder,fremanezumab
NCT06622057,Biliary tract cancer,D07001-Softgel Capsules
NCT06635057,Type 2 diabetes mellitus,tirzepatide
NCT06898957,Small cell lung carcinoma,YL201
NCT06898957,Small cell lung carcinoma,tarlatamab
NCT06898957,Small cell lung carcinoma,atezolizumab
NCT06898957,Small cell lung carcinoma,durvalumab
NCT06800157,Arthritic joint disease,Drug: LW402
NCT06901726,Diabetes mellitus,Human insulin enteric coated capsules in dose
NCT06901726,Diabetes mellitus,Human Insulin Injection in dose
NCT06986057,Cervical carcinoma,Iparomlimab and tuvonralimab (QL1706) combined with platinum-based chemotherapy
NCT07014826,IgA glomerulonephritis,HRS-5965
NCT07022457,Metastatic melanoma,Encorafenib + Binimetinib
NCT06956157,Obsessive-compulsive disorder,N-Acetylcysteine Tablets
NCT06832657,Age-related macular degeneration,JMKX003948 Ophthalmic Suspension
NCT06832657,Diabetic macular edema,JMKX003948 Ophthalmic Suspension
NCT06640257,Psoriatic arthritis,SHR-1314 injection
NCT07030426,Pelvic organ prolapse,Vaginal Estrogen - Twice Weekly
NCT07030426,Pelvic organ prolapse,Vaginal Estrogen - Daily
NCT06744426,Essential hypertension,BR1015
NCT06744426,Essential hypertension,BR1015-2
NCT06744426,Essential hypertension,BR1015-3
NCT06781957,Infertility disorder,Gonadotropins Subcutaneos
NCT06944457,Cancer,MPD-1
NCT07126873,Diabetes mellitus,E-islet
NCT06622031,Hepatocellular carcinoma,lenvatinib
NCT06622031,Hepatocellular carcinoma,PD-1 inhibitor
NCT06602531,Influenza,ARCT-2304
NCT06602531,Influenza,Control vaccine younger adults
NCT06602531,Influenza,Control vaccine older adults
NCT06638931,Adrenal cortex carcinoma,nivolumab
NCT06638931,Cholangiocarcinoma,nivolumab
NCT06638931,Mesothelioma,nivolumab
NCT06638931,Neuroblastoma,nivolumab
NCT06638931,Osteosarcoma,nivolumab
NCT06638931,Soft tissue sarcoma,nivolumab
NCT06638931,Thyroid tumor,nivolumab
NCT06734182,Non-small cell lung carcinoma,Envafolimab injections+intravenous Disitamab Vedotin+carboplatin
NCT07070882,Osteoarthritis,methylprednisolone
NCT06791031,Coronary artery disorder,inclisiran
NCT07084831,Cognitive impairment,Xanomeline/trospium
NCT06701331,Atopic eczema,upadacitinib
NCT06760182,Allergic rhinitis,TQH2722 injection
NCT07116473,Amyloidosis,Acoramidis (AG10)
NCT07116473,Cardiomyopathy,Acoramidis (AG10)
NCT07116473,Heart disorder,Acoramidis (AG10)
NCT06952231,Diabetes mellitus,Sitagliptin + Metformin
NCT06952231,Diabetes mellitus,Empagliflozin + Metformin
NCT06752473,Nasopharyngeal carcinoma,KSD-101
NCT07088731,Suppressor of tumorigenicity 3,Sintilimab
NCT06962631,Autoimmune thrombocytopenic purpura,5% (5g/100 ml) intravenous immunoglobin
NCT06908031,Rectum adenocarcinoma,PD-1 monoclonal antibody
NCT06908031,Rectum adenocarcinoma,mFOLFOX6 regimen
NCT06908031,Rectum adenocarcinoma,cetuximab
NCT06908031,Rectum adenocarcinoma,bevacizumab
NCT06735131,Triple-negative breast carcinoma,toripalimab
NCT06735131,Triple-negative breast carcinoma,chemotherapy regimen selected by the investigator
NCT06986031,Infertility disorder,Vaginal Product
NCT06762431,B-cell chronic lymphocytic leukemia,lenalidomide
NCT06762431,B-cell chronic lymphocytic leukemia,lenalidomide
NCT06990282,Gingivitis,Ozonated olive oil
NCT06732882,Asthma,AZD4604
NCT07046273,Type 2 diabetes mellitus,F027
NCT07046273,Type 2 diabetes mellitus,Ozempic®
NCT06653231,Periodontitis,local delivery of Curcumin gel
NCT06678282,Precursor B-cell acute lymphoblastic leukemia,JY231 Injection
NCT06848582,Soft tissue sarcoma,umbilical cord blood NK cells
NCT06649682,Nonpapillary renal cell carcinoma,68Ga-NYM096 PET/CT and
NCT06701682,"Familial acute respiratory distress syndrome, ANLN-related, dog",Cohort A: vilobelimab
NCT07080931,Androgenetic alopecia,5% minoxidil foam
NCT06992531,Fibromyalgia,Blood Product
NCT06992531,Postural orthostatic tachycardia syndrome,Blood Product
NCT07015931,Acne,retinoic acid cream
NCT07015931,Acne,adapalene cream
NCT06588231,Coronary artery disorder,"optimal medical therapy ：aspirin, clopidogrel, statins."
NCT06732531,Childhood bladder carcinoma,BH011
NCT06863831,Esophageal squamous cell carcinoma,Yishen Qutong Granules
NCT06863831,Esophageal squamous cell carcinoma,Yishen Qutong Simulant Granules
NCT06639282,Cognitive impairment,siponimod
NCT06926582,Psoriasis,HS-10374
NCT06614231,Non-small cell lung carcinoma,Tislelizumab Combined With Chemotherapy
NCT06688331,Diabetes mellitus,ex vivo expanded CD4+CD25+CD127- regulatory T cells (Tregs)
NCT06688331,Diabetes mellitus,Anti-CD20 (rituximab)
NCT06904482,Myelodysplastic syndrome,Haplo-Identical / Cord Blood Transplant
NCT06610266,Gastric intestinal metaplasia,Weifuchun
NCT06610266,Gastric intestinal metaplasia,folic acid
NCT06819826,IgA glomerulonephritis,SC0062 strength
NCT06945926,Lumbar spinal stenosis,oxytocin nasal spray
NCT06945926,Spinal stenosis,oxytocin nasal spray
NCT06616974,Pulmonary hypertension,TX000045- Dose A
NCT06616974,Pulmonary hypertension,TX000045- Dose B
NCT06756074,Malignant pancreatic neoplasm,Reinforced pancreaticojejunostomy with tissue adhesive glue modified cyanoacrylate (glubran
NCT06756074,Pancreatic ductal adenocarcinoma,Reinforced pancreaticojejunostomy with tissue adhesive glue modified cyanoacrylate (glubran
NCT06583265,Paroxysmal familial ventricular fibrillation,Observational
NCT06589765,Type 2 diabetes mellitus,HRS-7535 tablet
NCT06589765,Type 2 diabetes mellitus,dapagliflozin tablet
NCT06778265,Parkinson disease,UX-DA001
NCT06665165,Amyotrophic lateral sclerosis,AMX0114
NCT06856265,Hypertrophic cardiomyopathy,mavacamten
NCT06931626,Small cell lung carcinoma,NMS-03305293
NCT06931626,Small cell lung carcinoma,temozolomide
NCT07020026,Parkinson disease,[18F]PI-2620
NCT07104266,Triple-negative breast carcinoma,Celecoxib (Celebrex)
NCT06899126,Non-small cell lung carcinoma,trastuzumab deruxtecan
NCT06899126,Non-small cell lung carcinoma,pembrolizumab
NCT06899126,Non-small cell lung carcinoma,pemetrexed
NCT06899126,Non-small cell lung carcinoma,Chemotherapy
NCT06806826,Allergic rhinitis,omalizumab
NCT06756126,Atopic eczema,AK120
NCT07086326,Non-small cell lung carcinoma,Ivonescimab+Chemo
NCT07086326,Non-small cell lung carcinoma,Penpulimab+Chemo
NCT06717126,Uveal melanoma,roginolisib
NCT06717126,Uveal melanoma,Investigator choice of standard therapy
NCT07109726,Cervical carcinoma,TER-2013
NCT07109726,Cervical carcinoma,Fulvestrant injection
NCT07109726,Endometrial cancer,TER-2013
NCT07109726,Endometrial cancer,Fulvestrant injection
NCT07109726,Esophageal squamous cell carcinoma,TER-2013
NCT07109726,Esophageal squamous cell carcinoma,Fulvestrant injection
NCT07109726,Ovarian cancer,TER-2013
NCT07109726,Ovarian cancer,Fulvestrant injection
NCT06927726,Hypertensive disorder,4% Articaine HCL With
NCT06927726,Hypertensive disorder,3% plain mepivacaine HCL
NCT07040566,Nicotine dependence,Varenicline
NCT07023666,Sickle cell disease,deferoxamine
NCT07023666,Sickle cell disease,deferasirox
NCT07023666,Sickle cell disease,deferiprone
NCT06842966,Cholecystitis,4-MUST
NCT06818266,Sickle cell disease,Tocilizumab (RoActemra®
NCT06692426,Duchenne muscular dystrophy,MyoPAXon
NCT06692426,Duchenne muscular dystrophy,tacrolimus
NCT06841666,Attention deficit-hyperactivity disorder,atomoxetine
NCT06889766,Sarcoma,NY-ESO-1 TCR redirected autologous T cell product
NCT06889766,Sarcoma,Non-myeloablative lymphodepleting chemotherapy
NCT06839066,Nasopharyngeal carcinoma,HLX43 DOSE
NCT06839066,Nasopharyngeal carcinoma,HLX43 DOSE
NCT06839066,Nasopharyngeal carcinoma,HLX43 DOSE
NCT06775366,Circadian rhythm,remimazolam
NCT06775366,Circadian rhythm,propofol
NCT07038226,Constipation disorder,Oral capsule-delivered FMT
NCT07038226,Parkinson disease,Oral capsule-delivered FMT
NCT06831526,Adult glioblastoma,Azeliragon
NCT06831526,Adult glioblastoma,temozolomide
NCT06692166,Cervical carcinoma,9MW2821
NCT06692166,Cervical carcinoma,Chemotherapy
NCT06961266,Narcolepsy,JZP441
NCT06567366,Large B-cell lymphoma,CAR T-cell therapy
NCT06567366,Large B-cell lymphoma,glofitamab
NCT06567366,Large B-cell lymphoma,obinutuzumab
NCT06735326,Fallopian tube carcinoma,Fluzoparib
NCT06735326,Fallopian tube carcinoma,bevacizumab
NCT06735326,Fallopian tube carcinoma,paclitaxel
NCT06735326,Fallopian tube carcinoma,carboplatin
NCT06735326,Ovarian cancer,Fluzoparib
NCT06735326,Ovarian cancer,bevacizumab
NCT06735326,Ovarian cancer,paclitaxel
NCT06735326,Ovarian cancer,carboplatin
NCT06735326,Peritoneum cancer,Fluzoparib
NCT06735326,Peritoneum cancer,bevacizumab
NCT06735326,Peritoneum cancer,paclitaxel
NCT06735326,Peritoneum cancer,carboplatin
NCT06864026,Psoriatic arthritis,tirzepatide
NCT06745882,Non-small cell lung carcinoma,cisplatin
NCT06745882,Non-small cell lung carcinoma,carboplatin
NCT06745882,Non-small cell lung carcinoma,pemetrexed
NCT06745882,Non-small cell lung carcinoma,pembrolizumab
NCT06745882,Non-small cell lung carcinoma,Abraxane
NCT06745882,Non-small cell lung carcinoma,paclitaxel
NCT06635720,Nephrotic syndrome,prednisone
NCT06769620,Amyotrophic lateral sclerosis,ORT247
NCT06590831,Iron deficiency anemia,Lactoferrin
NCT07100782,Endometriosis,Relugolix CT
NCT06790082,Cancer,[68Ga]Ga-FAPI-46 PET/CT
NCT07115082,Primary ovarian failure,Climen
NCT07115082,Primary ovarian failure,hA-MSCs
NCT06636682,Prostate cancer,FK-PC101
NCT06636682,Prostate cancer,Standard of Care (SOC)
NCT06884982,Hepatocellular carcinoma,QL1706 Plus Lenvatinib
NCT06576882,Gastritis,vonoprazan
NCT06576882,Gastritis,amoxicillin
NCT06576882,Gastritis,clarithromycin
NCT07035782,Primary interstitial lung disease specific to childhood,sevoflurane
NCT06955520,Gastroesophageal reflux disease,vonoprazan
NCT06955520,Gastroesophageal reflux disease,Esomeprazole
NCT07132320,Decubitus ulcer,Pressure Ulcer Nursing AI Application Training
NCT07132320,Decubitus ulcer,Traditional Pressure Ulcer Nursing Education
NCT07038382,Lupus nephritis,HLX79
NCT07038382,Lupus nephritis,HLX79
NCT07038382,Lupus nephritis,HLX79
NCT06597682,Long COVID-19,prednisone
NCT06597682,Long COVID-19,Budesonide/Formoterol
NCT06597682,Long COVID-19,Vitamin C combined with Coenzyme Q10 oral treatment
NCT06597682,Long COVID-19,Montelukast tablets oral treatment
NCT07083882,Type 1 diabetes mellitus,freezedried autologous encapsulated fecal microbiota transplantation
NCT07073820,Pulmonary hypertension,PF-07868489
NCT06938282,Malignant pancreatic neoplasm,HRS-4642
NCT06696482,Apathy,Escitalopram
NCT07076082,Peripheral arterial disease,Clopidogrel (Plavix) Pharmacogenetic Test Reagents
NCT06616220,Scoliosis,dexamethasone
NCT06616220,Scoliosis,0.9%NaCl
NCT06873282,Tuberculosis,TB/Flu-05E
NCT07019220,Childhood bladder carcinoma,gemcitabine
NCT07096882,Non-small cell lung carcinoma,SDT-M001 injection
NCT06710782,Hyaluronic acid,hyaluronic acid
NCT07104682,Alveolar soft part sarcoma,GCAR1
NCT07104682,Sarcoma,GCAR1
NCT06935474,Lupus nephritis,C-CAR168
NCT06710574,Movement disorder,PD-RBD
NCT06710574,Movement disorder,iRBD
NCT06710574,Parkinson disease,PD-RBD
NCT06710574,Parkinson disease,iRBD
NCT06710574,REM sleep behavior disorder,PD-RBD
NCT06710574,REM sleep behavior disorder,iRBD
NCT06594874,Non-small cell lung carcinoma,HS-10370
NCT06594874,Non-small cell lung carcinoma,Adebrelimab
NCT06594874,Non-small cell lung carcinoma,cisplatin
NCT06594874,Non-small cell lung carcinoma,carboplatin
NCT06594874,Non-small cell lung carcinoma,pemetrexed
NCT06753474,Influenza,Influenza Virus influenza A H3N2 strain
NCT06891365,Hepatic steatosis,NNC0581-0001
NCT06591520,Biliary tract cancer,"AK112, Gemcitabine, Cisplatin"
NCT06591520,Biliary tract cancer,"Durvalumab, Gemcitabine, Cisplatin"
NCT06994520,Atopic eczema,Triamcinolone (TAC)
NCT06634420,Hereditary angioedema,NTLA-2002
NCT06977074,Non-small cell lung carcinoma,PD-1 inhibitor
NCT06977074,Non-small cell lung carcinoma,Platinum Doublet
NCT06799065,Ovarian cancer,ATX-295
NCT06844474,Non-small cell lung carcinoma,SHR-1826；Adebrelimab；SHR-8068；Bevacizumab
NCT06709274,Non-small cell lung carcinoma,osimertinib
NCT06709274,Non-small cell lung carcinoma,alectinib
NCT06709274,Non-small cell lung carcinoma,TORIPALIMAB INJECTION (JS001 ) combine with chemotherapy
NCT07031765,Glioma susceptibility 1,exHSC
NCT07031765,Glioma susceptibility 1,nivolumab
NCT06652165,Diffuse large B-cell lymphoma,zanubrutinib combined with BEAM
NCT06652165,Diffuse large B-cell lymphoma,BEAM
NCT06581120,Diabetes mellitus,Glucagon-Like Peptide-1 receptor agonists
NCT06581120,Morbid obesity,Glucagon-Like Peptide-1 receptor agonists
NCT06799520,Systemic lupus erythematosus,VIS171
NCT06678074,ST-elevation myocardial infarction,Atibuclimab (IC14)
NCT06593665,Testicular cancer,Inrathecal Morphine
NCT06593665,Testicular cancer,Intravenous Methadone
NCT06853665,Attention deficit-hyperactivity disorder,Adderall XR (mixed salts amphetamine)
NCT06853665,Autism,Adderall XR (mixed salts amphetamine)
NCT06913374,Thrombocytopenia,dexamethasone
NCT06913374,Thrombocytopenia,dexamethasone
NCT07053774,Pain,Intravenous oxytocin
NCT07053774,Pain,Intranasal oxytocin
NCT07114874,Schizophrenia,NBI-1117568
NCT06728865,Non-small cell lung carcinoma,The treatment regimen is Furmonertinib combined with Bevacizumab.
NCT06865365,Obesity disorder,"Liraglutide daily (0.6-3.0mg, highest tolerable dose) additional to dietological measures and lifestyle optimization suggestions"
NCT06995274,Autism,Umbilical Cord Blood Infusion (Autologous and Allogeneic)
NCT06841874,Carcinoma,taletrectinib
NCT06771674,Oropharynx squamous cell carcinoma,pembrolizumab
NCT06771674,Oropharynx squamous cell carcinoma,nivolumab
NCT06771674,Oropharynx squamous cell carcinoma,nivolumab
NCT06771674,Oropharynx squamous cell carcinoma,pembrolizumab
NCT06771674,Oropharynx squamous cell carcinoma,pembrolizumab
NCT06747520,Kidney failure,ET-26HCl
NCT06641674,Cancer,18F-LF13
NCT06592274,Psoriasis,HB0017
NCT06592274,Psoriasis,HB0017
NCT06592274,Psoriasis,HB0017
NCT06615674,ST-elevation myocardial infarction,Forxiga®
NCT06615557,Social phobia,Fasedienol Nasal Spray
NCT06991257,Heart failure,Low Dose PF-07328948
NCT06991257,Heart failure,Medium Dose PF-07328948
NCT06991257,Heart failure,High Dose PF-07328948
NCT06571448,Trigeminal neuralgia,SR750 tablet
NCT06571448,Trigeminal neuralgia,SR750 tablet
NCT06784648,Cutaneous melanoma,pembrolizumab (KEYTRUDA®)
NCT06784648,Cutaneous melanoma,BI-1607
NCT06784648,Cutaneous melanoma,Ipilimumab (YervoyTM
NCT06784648,Melanoma,pembrolizumab (KEYTRUDA®)
NCT06784648,Melanoma,BI-1607
NCT06784648,Melanoma,Ipilimumab (YervoyTM
NCT06784648,Uveal melanoma,pembrolizumab (KEYTRUDA®)
NCT06784648,Uveal melanoma,BI-1607
NCT06784648,Uveal melanoma,Ipilimumab (YervoyTM
NCT06782048,Gastric neoplasm,Pyrvinium
NCT06826326,Autism,Escitalopram
NCT06743126,Melanoma,IMA203
NCT06743126,Melanoma,nivolumab plus relatlimab
NCT06743126,Melanoma,lifileucel
NCT06743126,Melanoma,nivolumab
NCT06743126,Melanoma,pembrolizumab
NCT06743126,Melanoma,ipilimumab
NCT06743126,Melanoma,dacarbazine
NCT06743126,Melanoma,temozolomide
NCT06743126,Melanoma,paclitaxel
NCT06743126,Melanoma,paclitaxel plus carboplatin
NCT06743126,Melanoma,Albumin-Bound Paclitaxel
NCT06967857,Depressive disorder,DEX IR tablets
NCT06967857,Depressive disorder,DEX XL
NCT06620757,Atrial fibrillation,Single antiplatelet therapy (SAPT)
NCT06586957,Gastric carcinoma,NKT3964
NCT06586957,Ovarian cancer,NKT3964
NCT06586957,Ovarian carcinoma,NKT3964
NCT06586957,Small cell lung carcinoma,NKT3964
NCT06975748,Neurotrophic keratopathy,STSP-0902 ophthalmic solution
NCT06975748,Neurotrophic keratopathy,STSP-0902 ophthalmic solution
NCT06861348,Leukemia,Inotuzumab Ozogamicin±Donor Lymphocyte Infusion
NCT06763926,Infertility disorder,Subcutaneous Triptorelin
NCT06763926,Infertility disorder,Intranasal nafarelin
NCT06592326,Urothelial carcinoma,9MW2821
NCT06592326,Urothelial carcinoma,toripalimab
NCT06592326,Urothelial carcinoma,gemcitabine
NCT06592326,Urothelial carcinoma,Cisplatin/Carboplatin
NCT06631326,Hepatocellular carcinoma,Lenvatinib + PD-1 monoclonal antibody
NCT06934057,Renal carcinoma,nivolumab
NCT06934057,Renal carcinoma,cabozantinib
NCT06934057,Renal cell adenocarcinoma,nivolumab
NCT06934057,Renal cell adenocarcinoma,cabozantinib
NCT07107126,Childhood myelodysplastic syndrome,RPT1G
NCT07101926,Hemophilia,blood sampling
NCT06702657,Cerebrovascular disorder,medication
NCT06602557,Pneumonia,amikacin
NCT06602557,Pneumonia,Standard of care
NCT07122648,Dermatomyositis,PN-101
NCT07122648,Dermatomyositis,PN-101
NCT06701526,Migraine disorder,eptinezumab
NCT06887426,Multiple sclerosis,cladribine
NCT06887426,Secondary progressive multiple sclerosis,cladribine
NCT06633757,Primary ciliary dyskinesia,RCT1100
NCT06575257,Prostate cancer,darolutamide
NCT06575257,Prostate cancer,goserelin
NCT06848231,Multiple system atrophy,YA-101
NCT07119931,Hepatocellular carcinoma,lparomlimab and Tuvonralimab Injection in Combination with HAIC and bevacizumab
NCT06566482,Obstructive sleep apnea syndrome,Dexmedetomidine-esketamine combination
NCT06971731,Phenylketonuria,JNT-517 Tablet
NCT06971731,Phenylketonuria,JNT-517 Tablet
NCT06860282,COVID-19,remdesivir
NCT06860282,COVID-19,CX2101A
NCT07085182,Chemotherapy,SBRT combined with Tislelizumab followed by Tislelizumab
NCT07085182,Non-small cell lung carcinoma,SBRT combined with Tislelizumab followed by Tislelizumab
NCT06697431,Mucocutaneous lymph node syndrome,anakinra
NCT06697431,Mucocutaneous lymph node syndrome,"Intravenous Immunoglobulins, Human"
NCT07007182,Gastric adenocarcinoma,FLOT regimen
NCT07007182,Gastric adenocarcinoma,PD-1 Inhibitors
NCT07007182,Gastric adenocarcinoma,capecitabine
NCT07007182,Gastric adenocarcinoma,CAPEOX regimen
NCT07007182,Gastric adenocarcinoma,SOX regimen
NCT06640582,Adult glioblastoma,Tumor Infiltrating Lymphocytes (TIL)
NCT06640582,Adult glioblastoma,cyclophosphamide
NCT06640582,Adult glioblastoma,fludarabine
NCT06640582,Adult glioblastoma,Interleukin-2
NCT06640582,Adult glioblastoma,pembrolizumab
NCT06640582,Malignant glioma,Tumor Infiltrating Lymphocytes (TIL)
NCT06640582,Malignant glioma,cyclophosphamide
NCT06640582,Malignant glioma,fludarabine
NCT06640582,Malignant glioma,Interleukin-2
NCT06640582,Malignant glioma,pembrolizumab
NCT06640582,Meningioma,Tumor Infiltrating Lymphocytes (TIL)
NCT06640582,Meningioma,cyclophosphamide
NCT06640582,Meningioma,fludarabine
NCT06640582,Meningioma,Interleukin-2
NCT06640582,Meningioma,pembrolizumab
NCT06762782,Hepatocellular carcinoma,Postoperative adjuvant lenvatinib
NCT06835582,Pain,methadone
NCT06586320,Parkinson disease,150% of their routine home dopaminergic medications dose right in the clinic
NCT06918431,Precursor B-cell acute lymphoblastic leukemia,ASPARAGINASE ERWINIA CHRYSANTHEMI
NCT06918431,Precursor B-cell acute lymphoblastic leukemia,cyclophosphamide
NCT06918431,Precursor B-cell acute lymphoblastic leukemia,cytarabine
NCT06918431,Precursor B-cell acute lymphoblastic leukemia,cytarabine
NCT06918431,Precursor B-cell acute lymphoblastic leukemia,daunorubicin hydrochloride
NCT06918431,Precursor B-cell acute lymphoblastic leukemia,dexamethasone
NCT06918431,Precursor B-cell acute lymphoblastic leukemia,mercaptopurine
NCT06918431,Precursor B-cell acute lymphoblastic leukemia,methotrexate
NCT06918431,Precursor B-cell acute lymphoblastic leukemia,rituximab
NCT06918431,Precursor B-cell acute lymphoblastic leukemia,vincristine sulfate
NCT06864182,COVID-19,CX2101A tablet
NCT06864182,COVID-19,CX2101A enteric-coated tablet
NCT06710431,Anxiety,AFA-281
NCT06818331,Malignant glioma,paclitaxel
NCT06943482,Granulomatous mastitis,prednisolone
NCT06943482,Granulomatous mastitis,methotrexate
NCT06943482,Granulomatous mastitis,folic acid
NCT06943482,Granulomatous mastitis,omeprazole
NCT07099482,Type 2 diabetes mellitus,Propolis gel (10%)
NCT06852820,Hepatocellular carcinoma,Lu-PSMA-617
NCT07086820,Tuberculosis,Tuberculosis window prophylaxis with weekly rifapentine and isoniazid for
NCT07086820,Tuberculosis,Standard of care tuberculosis prophylaxis with weekly rifapentine and isoniazid for
NCT06661720,Nonpapillary renal cell carcinoma,pembrolizumab
NCT06661720,Nonpapillary renal cell carcinoma,tivozanib
NCT06703073,"Familial acute respiratory distress syndrome, ANLN-related, dog",Cohort A: vilobelimab
NCT06703073,"Familial acute respiratory distress syndrome, ANLN-related, dog",Cohort B: paridiprubart
NCT06703073,"Familial acute respiratory distress syndrome, ANLN-related, dog",Cohort C: bevacizumab
NCT06818682,Prostate carcinoma,ADT for
NCT06818682,Prostate carcinoma,ADT for
NCT06942520,Diabetic macular edema,Aflibercept (2.0 mg)
NCT06687174,IgA glomerulonephritis,MY008211A tablets
NCT06604520,Frontotemporal dementia,vortioxetine
NCT06679374,Parkinson disease,varenicline
NCT06975774,Tuberculosis,Purified Protein Derivative of BCG（BCG-PPD）
NCT06767774,Diabetes mellitus,Combination therapy
NCT06767774,Diabetes mellitus,High intensity statin monotherapy
NCT07127874,Malignant colon neoplasm,PHN-012
NCT07127874,Malignant pancreatic neoplasm,PHN-012
NCT06692465,Alopecia,GT20029 Tincture
NCT06851065,Myelodysplastic syndrome,luspatercept
NCT06851065,Myelodysplastic syndrome,Erythropoiesis-stimulating agents
NCT06973720,Obesity disorder,MET097
NCT06693674,Tetralogy of fallot,Entresto Pill
NCT06618820,Pain,tranexamic acid
NCT06752720,Cerebrovascular disorder,Stem cell Transplantation
NCT06625320,Malignant pancreatic neoplasm,RMC-6236
NCT06625320,Malignant pancreatic neoplasm,gemcitabine
NCT06625320,Malignant pancreatic neoplasm,nab-paclitaxel
NCT06625320,Malignant pancreatic neoplasm,irinotecan
NCT06625320,Malignant pancreatic neoplasm,Liposomal irinotecan
NCT06625320,Malignant pancreatic neoplasm,5-fluorouracil
NCT06625320,Malignant pancreatic neoplasm,leucovorin
NCT06625320,Malignant pancreatic neoplasm,oxaliplatin
NCT06772974,Hyperemesis gravidarum,Doxylamine Succinate USP
NCT07061574,Type 1 diabetes mellitus,Anti-thymocyte globulin (ATG)
NCT07061574,Type 1 diabetes mellitus,verapamil extended-release capsule
NCT07061574,Type 1 diabetes mellitus,adalimumab
NCT06966674,ST-elevation myocardial infarction,Intracoronary tirofiban
NCT06856174,HIV infectious disease,Transdermal estradiol gel
NCT06856174,HIV infectious disease,Micronized Progesterone
NCT06856174,Menopause,Transdermal estradiol gel
NCT06856174,Menopause,Micronized Progesterone
NCT06736574,Heart failure,Omecamtiv Mecarbil (OM)
NCT06853574,Sepsis,Fluid therapy
NCT06853574,Sepsis,Noradrenaline infusion
NCT06700720,Coronary artery disorder,Dose
NCT06700720,Coronary artery disorder,Dose
NCT06700720,Coronary artery disorder,evolocumab
NCT06699420,Coronary microvascular disorder,Qishenyiqi dripping pills
NCT06866574,Anal carcinoma,Recombinant Human Papillomavirus
NCT06866574,Anal carcinoma,Aluminum Adjuvant
NCT06866574,Anogenital human papillomavirus infection,Recombinant Human Papillomavirus
NCT06866574,Anogenital human papillomavirus infection,Aluminum Adjuvant
NCT07101120,Endogenous depression,KH607 tablets
NCT07101120,Endogenous depression,KH607 tablets
NCT07101120,Endogenous depression,KH607 tablets
NCT06970574,Cholecystitis,Levobupivacaine
NCT06902974,Post-traumatic stress disorder,Psilocybin
NCT06870565,Cervical carcinoma,paclitaxel and platinum
NCT06870565,Cervical carcinoma,platinum
NCT07085520,Osteoarthritis,Microneedle with
NCT07085520,Osteoarthritis,Microneedle with
NCT07085520,Osteoarthritis,Microneedle with
NCT07085520,Osteoporosis,Microneedle with
NCT07085520,Osteoporosis,Microneedle with
NCT07085520,Osteoporosis,Microneedle with
NCT07090174,Anal carcinoma,PDS0101
NCT07090174,Cervical carcinoma,PDS0101
NCT06951074,Type 1 diabetes mellitus,Insulin producing stem cells infusion
NCT06872320,Congenital heart disease,Lactobacillus Rhamnosus
NCT06872320,Nutritional deficiency disease,Lactobacillus Rhamnosus
NCT07075120,Hepatocellular carcinoma,Ipilimumab and Nivolumab
NCT06912074,Esophageal squamous cell carcinoma,Induction chemoimmunotherapy
NCT06912074,Esophageal squamous cell carcinoma,Concurrent Chemotherapy
NCT06649474,Adenocarcinoma,assess the serum HMGB1 concentrations before and after an oxaliplatin-based chemotherapy
NCT06649474,Malignant pancreatic neoplasm,assess the serum HMGB1 concentrations before and after an oxaliplatin-based chemotherapy
NCT06932874,Type 2 diabetes mellitus,Glucophage (Metformin Hydrochloride Tablets)
NCT06932874,Type 2 diabetes mellitus,New sustained-release metformin tablets (Ⅲ)
NCT06585527,Glioma susceptibility 1,TS-2021
NCT06585527,Malignant glioma,TS-2021
NCT06727773,Cognitive impairment,memantine
NCT06774131,Urothelial carcinoma,UGN-104
NCT07055282,Nephrolithiasis,Empagliflozin (Jardiance®)
NCT06856031,Inflammatory bowel disease,Optimized Treatment (OPT)
NCT06850831,ST-elevation myocardial infarction,Antipac
NCT06830031,Diffuse large B-cell lymphoma,C402-CD19-CAR
NCT06830031,High grade B-cell lymphoma,C402-CD19-CAR
NCT06830031,Primary mediastinal large B-cell lymphoma,C402-CD19-CAR
NCT07013682,Periodontitis,PRF as adjunct to non-surgical mechanical debridement
NCT07013682,Periodontitis,"Control, non-surgical mechanical debridement alone"
NCT06660173,Type 2 diabetes mellitus,Maridebart Cafraglutide
NCT06997731,Periodontitis,Application of minocycline and hyaluronic acid gel.
NCT06827431,Endogenous depression,Ammoxetine
NCT06827431,Endogenous depression,Ammoxetine
NCT06827431,Endogenous depression,sertraline
NCT06833931,Duchenne muscular dystrophy,IV infusion
NCT07129473,Hyperemesis gravidarum,metformin Extended Release Oral Tablet
NCT06828731,Prediabetes syndrome,Empagliflozin
NCT07095231,COVID-19,STX-S
NCT06680531,Insomnia,YZJ-1139 tablets
NCT06680531,Insomnia,Escitalopram oxalate tablets
NCT06680531,Insomnia,YZJ-1139 simulated tablets
NCT06687473,Helicobacter pylori,Bismuth-based susceptibility-guided treatment
NCT06862531,COVID-19,blood sample
NCT07066982,Sarcoma,CD146/HER2 CAR-T cells
NCT06960382,Allergic asthma,ALUTARD SQ® Felis domesticus
NCT06960382,Allergic rhinitis,ALUTARD SQ® Felis domesticus
NCT06696131,Intracerebral hemorrhage,TNK
NCT06890182,Non-small cell lung carcinoma,Firmonertinib combined with Carboplatin/Cisplatin and Pemetrexed
NCT06765876,Leukemia,Autologous CAR123 T lymphocytes
NCT06765876,Myelodysplastic syndrome,Autologous CAR123 T lymphocytes
NCT06820476,Obesity disorder,NNC0487-0111
NCT06725927,Heart failure,Influenza vaccination
NCT06634927,Type 2 diabetes mellitus,Ozempic®
NCT06634927,Type 2 diabetes mellitus,HDG1901
NCT06887127,Rheumatoid arthritis,TLL-018
NCT06570473,Pulmonary hypertension,empagliflozin
NCT06570473,Pulmonary hypertension,ranolazine
NCT07081373,Anal fistula,"A single dose of liposomal bupivacaine is administered at the conclusion of surgery without adjunctive analgesics, followed by a supplemental dose"
NCT07097831,Hyperlipidemia,HRS-1301 Tablets
NCT07097831,Hyperlipidemia,Rosuvastatin Calcium Tablets
NCT06895031,Non-small cell lung carcinoma,JYP0015
NCT06895031,Pancreatic ductal adenocarcinoma,JYP0015
NCT06994273,Analgesic,fentanyl
NCT06994273,Analgesic,dexmedetomidine
NCT06568731,Obesity disorder,Danuglipron
NCT06965231,Cutaneous melanoma,Toripalimab combined with Endostar
NCT07107373,Hypertrophic cardiomyopathy,mavacamten
NCT06702631,Pain,nitrous oxide
NCT06637631,Crohn disease,SAR441566
NCT06774274,Pain,Ketamine infusion
NCT06774274,Pain,PCA Ketamine
NCT07025174,Biliary tract cancer,PD-1/CTLA-4 Dual Functional Antibody
NCT07025174,Biliary tract cancer,"Gemcitabine, Cisplatin"
NCT07025174,Biliary tract cancer,Anlotinib
NCT07025174,Biliary tract cancer,Oxaliplatin +
NCT07025174,Cholangiocarcinoma,PD-1/CTLA-4 Dual Functional Antibody
NCT07025174,Cholangiocarcinoma,"Gemcitabine, Cisplatin"
NCT07025174,Cholangiocarcinoma,Anlotinib
NCT07025174,Cholangiocarcinoma,Oxaliplatin +
NCT06890065,Precursor B-cell acute lymphoblastic leukemia,JY231 Injection
NCT06810765,Post-traumatic stress disorder,ibogaine with magnesium treatment
NCT06810765,Post-traumatic stress disorder,5-MeO-DMT
NCT07057765,Diffuse large B-cell lymphoma,Observational Assessment of Standard R-CHOP Treatment
NCT06601465,Cognitive impairment,vericiguat
NCT06601465,Heart failure,vericiguat
NCT06766565,Non-small cell lung carcinoma,QYJD Compound Preparation
NCT06752174,Poliomyelitis,sIPV+bOPV
NCT06752174,Poliomyelitis,wIPV+bOPV
NCT06580574,Gastric carcinoma,"PD1/PDL1 antibody monotherapy, up to"
NCT06580574,Malignant colon neoplasm,"PD1/PDL1 antibody monotherapy, up to"
NCT06975865,Sickle cell disease,Rilzabrutinib
NCT06852365,Polycystic ovary syndrome,"Oral Contraceptives, Low-Dose"
NCT06841965,Cerebrovascular disorder,Intravenous thrombolysis
NCT07109765,Hidradenitis suppurativa,secukinumab
NCT07007065,Wet macular degeneration,Surabgene Lomparvovec (ABBV-RGX-314)
NCT07007065,Wet macular degeneration,Ranibizumab Control
NCT06584474,Bronchopulmonary dysplasia,Azithromycin neubilization
NCT06584474,Premature,Azithromycin neubilization
NCT06989827,Cataract,Preservative free artificial tear
NCT06887673,Endometrial cancer,MONTELUKAST SODIUM
NCT06887673,Ovarian cancer,MONTELUKAST SODIUM
NCT06887673,Sarcoma,MONTELUKAST SODIUM
NCT06767527,Triple-negative breast carcinoma,AK112
NCT06767527,Triple-negative breast carcinoma,Nab-paclitaxel
NCT06625073,Cardiovascular disorder,empagliflozin
NCT06625073,Kidney disorder,empagliflozin
NCT06581627,Sickle cell disease,Etavopivat
NCT06581627,Thalassemia,Etavopivat
NCT06666673,Cerebrovascular disorder,tizanidine
NCT06709573,Sepsis,vasopressin - early initiation
NCT06709573,Sepsis,vasopressin - standard initiation
NCT07085624,Sepsis,ceftazidime
NCT07085624,Sepsis,plasma ceftazidime dosage
NCT06955416,Diabetic ketoacidosis,Reamberin
NCT06807424,Arthritic joint disease,Icotrokinra
NCT06699524,Hepatocellular carcinoma,in vitro （chemotherapy）
NCT06811324,Weight loss,tirzepatide
NCT06719024,Vitiligo-associated multiple autoimmune disease susceptibility 1,Ruxolitinib Cream
NCT06719024,Vitiligo-associated multiple autoimmune disease susceptibility 1,Aqueous cream
NCT06629324,Autism,Autologous Bone Marrow Mononuclear Cell Transfusion
NCT06929624,Diffuse large B-cell lymphoma,SHR-A1912 Injection
NCT06929624,Diffuse large B-cell lymphoma,rituximab Injection
NCT06929624,Diffuse large B-cell lymphoma,Gemcitabine Hydrochloride for Injection
NCT06929624,Diffuse large B-cell lymphoma,oxaliplatin Injection
NCT06990516,Ovarian cancer,SHR-A1811
NCT06990516,Ovarian cancer,carboplatin
NCT06990516,Ovarian cancer,oxaliplatin
NCT06990516,Ovarian cancer,bevacizumab
NCT06942416,Cervical carcinoma,Paclitaxel and Cisplatin/ Carboplatin
NCT06942416,Cervical carcinoma,Iparomlimab and Tuvonralimab
NCT06716424,Type 2 diabetes mellitus,iGlarLixi (insulin glargine/lixisenatide)
NCT06976216,Alzheimer disease,KarXT
NCT06976216,Alzheimer disease,KarX-EC
NCT06712316,Non-small cell lung carcinoma,BNT327
NCT06712316,Non-small cell lung carcinoma,pembrolizumab
NCT06712316,Non-small cell lung carcinoma,carboplatin
NCT06712316,Non-small cell lung carcinoma,pemetrexed
NCT06712316,Non-small cell lung carcinoma,paclitaxel
NCT06789016,Scoliosis,dexmedetomidine
NCT06789016,Scoliosis,0.9%NaCl
NCT06939816,Metabolic dysfunction-associated steatohepatitis,Vonafexor low dose
NCT06939816,Metabolic dysfunction-associated steatohepatitis,Vonafexor high dose
NCT07077616,Malignant glioma,"Biological: personalized vaccine Based on genetic and transcriptional sequencing information, personalized peptide vaccines would be designed and produced"
NCT06765616,Rectal carcinoma,Adebrelimab Injection combined with radiotherapy and chemotherapy
NCT07080216,Cervical carcinoma,ZG005
NCT07080216,Cervical carcinoma,Gecacitinib
NCT07080216,Cervical carcinoma,bevacizumab
NCT06659263,Lactation,RE104 for Injection
NCT06886516,Thrombocytopenia,apixaban
NCT06633016,Endogenous depression,ABX-002
NCT06809816,Osteoporosis,Sodium pentaborate pentahydrate
NCT06900816,Asthma,CHF
NCT06900816,Asthma,CHF
NCT07095816,Analgesic,acetaminophen
NCT07095816,Analgesic,Sterilized water
NCT07095816,Neoplasm,acetaminophen
NCT07095816,Neoplasm,Sterilized water
NCT06829563,Diabetes mellitus,RZ-629
NCT06660563,Lymphoma,JNJ-80948543
NCT06660563,Lymphoma,JNJ-75348780
NCT06845163,Diabetic macular edema,dapagliflozin
NCT06845163,Diabetic macular edema,Anti-VEGF drug
NCT07097363,B-cell non-Hodgkin lymphoma,cyclophosphamide
NCT07097363,B-cell non-Hodgkin lymphoma,doxorubicin
NCT07097363,B-cell non-Hodgkin lymphoma,epcoritamab
NCT07097363,B-cell non-Hodgkin lymphoma,etoposide
NCT07097363,B-cell non-Hodgkin lymphoma,prednisone
NCT07097363,B-cell non-Hodgkin lymphoma,rituximab
NCT07097363,Burkitt lymphoma,cyclophosphamide
NCT07097363,Burkitt lymphoma,doxorubicin
NCT07097363,Burkitt lymphoma,epcoritamab
NCT07097363,Burkitt lymphoma,etoposide
NCT07097363,Burkitt lymphoma,prednisone
NCT07097363,Burkitt lymphoma,rituximab
NCT07097363,Diffuse large B-cell lymphoma,cyclophosphamide
NCT07097363,Diffuse large B-cell lymphoma,doxorubicin
NCT07097363,Diffuse large B-cell lymphoma,epcoritamab
NCT07097363,Diffuse large B-cell lymphoma,etoposide
NCT07097363,Diffuse large B-cell lymphoma,prednisone
NCT07097363,Diffuse large B-cell lymphoma,rituximab
NCT07097363,High grade B-cell lymphoma,cyclophosphamide
NCT07097363,High grade B-cell lymphoma,doxorubicin
NCT07097363,High grade B-cell lymphoma,epcoritamab
NCT07097363,High grade B-cell lymphoma,etoposide
NCT07097363,High grade B-cell lymphoma,prednisone
NCT07097363,High grade B-cell lymphoma,rituximab
NCT07097363,Primary mediastinal large B-cell lymphoma,cyclophosphamide
NCT07097363,Primary mediastinal large B-cell lymphoma,doxorubicin
NCT07097363,Primary mediastinal large B-cell lymphoma,epcoritamab
NCT07097363,Primary mediastinal large B-cell lymphoma,etoposide
NCT07097363,Primary mediastinal large B-cell lymphoma,prednisone
NCT07097363,Primary mediastinal large B-cell lymphoma,rituximab
NCT06821763,Periapical periodontitis,Calcium Hydroxide Intracanal medication
NCT06821763,Periapical periodontitis,triple antibiotic paste (TAP)
NCT06759363,Metabolic dysfunction-associated steatotic liver disease,Sodium-Butyrate
NCT06759363,Metabolic dysfunction-associated steatotic liver disease,Calcium Butyrate
NCT06577363,Cytomegalovirus,maribavir
NCT06967363,Fibromyalgia,Medication
NCT06997263,Anxiety,Melatonin
NCT06997263,Anxiety,Melatonin
NCT06903065,Metabolic dysfunction-associated steatohepatitis,RO7790121
NCT06899165,Anxiety,Psilocybin
NCT06899165,Depressive disorder,Psilocybin
NCT06753565,Rheumatoid arthritis,carnitine
NCT06753565,Rheumatoid arthritis,Disease-modifying anti-rheumatic drugs
NCT06947473,Systemic sclerosis,umbilical cord blood CD19-BCMA CAR-T cells infusion
NCT06849973,Rett syndrome,Drug: Bionetide
NCT06970665,Age-related macular degeneration,avacincaptad pegol
NCT06723665,Prostate cancer,18F-PSMA-1007
NCT06723665,Prostate cancer,18F-FDG
NCT07074665,Malaria,5µg R21/50µg Matrix-M
NCT07074665,Malaria,10µg R21/50µg Matrix-M
NCT06996730,Alzheimer disease,donanemab
NCT06996730,Alzheimer disease,RG6289
NCT06753630,Epicondylitis,Polydeoxyribonucleotide Injection
NCT06741930,Epilepsy,ketamine
NCT06741930,Epilepsy,midazolam
NCT06741930,Epilepsy,propofol
NCT06741930,Seizure,ketamine
NCT06741930,Seizure,midazolam
NCT06741930,Seizure,propofol
NCT06901830,Pain,YZJ-4729
NCT06901830,Pain,Active Comparator: Morphine
NCT07061925,Bronchitis,ALC-2203-1
NCT07061925,Bronchitis,ALC-2203-2
NCT07061925,Bronchitis,ALC-2203-AC
NCT07061925,Bronchitis,Placabo
NCT06993025,Biliary tract cancer,Ivonescimab+chemotherapy
NCT06955325,Non-small cell lung carcinoma,Icotinib
NCT06955325,Non-small cell lung carcinoma,Rezivertinib
NCT06955325,Non-small cell lung carcinoma,ensartinib
NCT06955325,Non-small cell lung carcinoma,Benmelstobart
NCT07100925,Skin squamous cell carcinoma,tolododekin alfa
NCT06739265,Mature T-cell and NK-cell non-Hodgkin lymphoma,Golidocitinib plus CHOP
NCT07035665,IgA glomerulonephritis,HRS-5965 Capsules
NCT07035665,Paroxysmal nocturnal hemoglobinuria,HRS-5965 Capsules
NCT06916065,Obesity disorder,Eloralintide and Tirzepatide
NCT06916065,Obesity disorder,Eloralintide
NCT06671665,Osteopenia,calcium supplementation
NCT07104565,Autoimmune thrombocytopenic purpura,INCA000585
NCT07021365,Coccygodynia,Phenol Injection
NCT06758024,Inflammatory bowel disease,infliximab
NCT06758024,Inflammatory bowel disease,infliximab
NCT06622824,Androgenetic alopecia,KX-826
NCT06622824,Androgenetic alopecia,KX-826
NCT06686524,Dermatomyositis,Anti-CD19 UCAR-T cells
NCT06657924,Thromboembolism,tranexamic acid
NCT07086924,Psoriasis,methotrexate
NCT07086924,Psoriatic arthritis,methotrexate
NCT07011524,Asthma,CM512 injection
NCT06798324,Nicotine dependence,Varenicline
NCT07106125,Urinary tract infection,Trimethoprim-Sulfamethoxazole (TMP-SMX)
NCT06959225,Hidradenitis suppurativa,Ruxolitinib Cream
NCT06897930,Lupus erythematosus,AZD0120
NCT06897930,Lupus erythematosus,cyclophosphamide
NCT06897930,Lupus erythematosus,fludarabine
NCT06701825,Kidney disorder,tacrolimus
NCT06701825,Kidney disorder,tacrolimus
NCT06649825,Classic familial adenomatous polyposis,Vitamin B1
NCT07098663,Obesity disorder,MKP10241
NCT07098663,Type 2 diabetes mellitus,MKP10241
NCT07016763,Allergic rhinitis,Mometasone Furoate Nasal Spray (MFNS)
NCT06807463,Celiac disease,TEV-53408
NCT07024563,"IgA nephropathy, susceptibility to, 1",ravulizumab
NCT07068763,Rectal carcinoma,capecitabine
NCT07068763,Rectal carcinoma,PD-1/CTLA-4 inhibitor (Aiparolitoworixureli injection)
NCT06982963,Celiac disease,FB102
NCT07083765,Hypertensive disorder,"Dehydrated Alcohol Injection, USP"
NCT07087106,Multiple sclerosis,[F-18]FDG
NCT06909006,Weight loss,Semaglutide
NCT07029906,Heart failure,Bisoprolol
NCT06784206,Small cell lung carcinoma,Adebrelimab Maintenance Therapy After Concurrent Chemoradiotherapy with Hyperfractionated Radiotherapy
NCT06672549,Obesity disorder,Orforglipron
NCT06876649,B-cell chronic lymphocytic leukemia,pirtobrutinib
NCT06876649,Non-Hodgkin lymphoma,pirtobrutinib
NCT06998706,Interstitial lung disease,REGEND001 Autologous Basal Layer Stem Cell Suspension
NCT07031206,Anxiety,Paracervical block- Lidocaine without epinephrine
NCT07031206,Anxiety,Benzocaine Gel applied to the cervix
NCT07031206,Anxiety,hydroxyzine hydrochloride
NCT07031206,Pain,Paracervical block- Lidocaine without epinephrine
NCT07031206,Pain,Benzocaine Gel applied to the cervix
NCT07031206,Pain,hydroxyzine hydrochloride
NCT06872606,Rectum adenocarcinoma,Pucotenlimab
NCT06872606,Rectum adenocarcinoma,bevacizumab
NCT06872606,Rectum adenocarcinoma,oxaliplatin
NCT06872606,Rectum adenocarcinoma,Trifluridine/Tipiracil Hydrochloride
NCT07114406,Digestive system disorder,PBK_M2502
NCT07114406,Digestive system disorder,PBK_M2502
NCT07124299,Nephrolithiasis,Experimental: Alpha-blocker group
NCT07124299,Nephrolithiasis,No intervention (observational study)
NCT07071636,Metabolic dysfunction-associated steatotic liver disease,Peg-IFN α-2b combined with NAs
NCT06984536,Childhood myelodysplastic syndrome,Reduced ATG plus mini PTCy
NCT06785636,Prostate cancer,Pocenbrodib
NCT06785636,Prostate cancer,Cohort
NCT06920849,Periodontal disorder,SRP+iPRF
NCT06920849,Periodontitis,SRP+iPRF
NCT07057349,Metastatic malignant neoplasm,[18F]CSB-321
NCT07014449,Hematopoietic and lymphoid cell neoplasm,WBC100 QD
NCT07097506,Metabolic dysfunction-associated steatotic liver disease,"bis-octanoyl (R)-1,3-butanediol (C8 ketone di-ester)"
NCT07097506,Obesity disorder,"bis-octanoyl (R)-1,3-butanediol (C8 ketone di-ester)"
NCT06600906,Pancreatic ductal adenocarcinoma,Hyperpolarized
NCT06709313,Diabetes mellitus,Chromium
NCT06731036,Fanconi anemia,CD34+ cell enriched stem cell graft
NCT06731036,Sickle cell disease,CD34+ cell enriched stem cell graft
NCT06712836,Obesity disorder,MET097
NCT07049549,Periodontitis,Injectable PRF
NCT06867549,Depressive disorder,propofol
NCT07062549,Nonpapillary renal cell carcinoma,111In-XYIMSR-01
NCT07123506,Atrial fibrillation,Beta-blocker treatment group
NCT07123506,Atrial fibrillation,Non-treatment group
NCT07123506,Tachycardia,Beta-blocker treatment group
NCT07123506,Tachycardia,Non-treatment group
NCT07066306,Vomiting,ketamine
NCT07066306,Vomiting,Articaine Hydrochloride + Epinephrine
NCT07053306,Type 2 diabetes mellitus,empagliflozin
NCT06723106,Antiphospholipid syndrome,RAY121
NCT06723106,Autoimmune thrombocytopenic purpura,RAY121
NCT06723106,Behcet disease,RAY121
NCT06723106,Dermatomyositis,RAY121
NCT06877299,Non-small cell lung carcinoma,Low-Dose Radiation(LDRT) + Stereotactic body radiotherapy (SBRT)
NCT07048249,Ewing sarcoma,Romiplostim (AMG-531)
NCT07044349,Fallopian tube carcinoma,Utidelone capsule
NCT07044349,Fallopian tube carcinoma,Utidelone capsule
NCT07044349,Fallopian tube carcinoma,Utidelone capsule
NCT07044349,Fallopian tube carcinoma,Utidelone capsule
NCT07044349,Ovarian cancer,Utidelone capsule
NCT07044349,Ovarian cancer,Utidelone capsule
NCT07044349,Ovarian cancer,Utidelone capsule
NCT07044349,Ovarian cancer,Utidelone capsule
NCT07044349,Primary peritoneal carcinoma,Utidelone capsule
NCT07044349,Primary peritoneal carcinoma,Utidelone capsule
NCT07044349,Primary peritoneal carcinoma,Utidelone capsule
NCT07044349,Primary peritoneal carcinoma,Utidelone capsule
NCT07006506,Graft versus host disease,belumosudil
NCT07006506,Hematopoietic and lymphoid cell neoplasm,belumosudil
NCT06962306,Pain,methadone hydrochloride
NCT06962306,Pain,Fentanyl/Hydromorphone
NCT07011706,Atopic eczema,ATI-045
NCT07011706,Dermatitis,ATI-045
NCT06945406,Diabetes mellitus,LY4057996 SC
NCT06945406,Diabetes mellitus,LY4057996 IV
NCT06945406,Diabetes mellitus,Degludec SC
NCT06945406,Diabetes mellitus,Lispro SC
NCT06945406,Diabetes mellitus,Degludec IV
NCT06945406,Diabetes mellitus,Pre-study basal insulin SC
NCT06863506,Non-small cell lung carcinoma,befotertinib
NCT06598059,Hearing loss disorder,dexamethasone
NCT06593600,Postural orthostatic tachycardia syndrome,REGN7544
NCT06934200,Food allergy,omalizumab
NCT07053800,Lupus nephritis,obecabtagene autoleucel
NCT06704100,Gastroesophageal reflux disease,Fosamprenavir Calcium & Sodium Alginate
NCT06675500,Atrial fibrillation,Magnesium sulphate
NCT06639152,Infertility disorder,oil-based contrast medium
NCT06639152,Infertility disorder,water-based contrast medium
NCT06908252,HIV infectious disease,Pre-Exposure Prophylaxis (PrEP)
NCT06650800,Depressive disorder,Psilocybin
NCT06938152,Osteoporosis,Romosozumab followed by Denosumab
NCT06938152,Osteoporosis,Romosozumab and Denosumab Cycle Therapy
NCT06982352,Atopic eczema,LPX-TI641
NCT06982352,Psoriasis,LPX-TI641
NCT06613100,Prostate cancer,Xaluritamig
NCT06999252,Malignant colon neoplasm,rimegepant
NCT06999252,Malignant colon neoplasm,PD-1
NCT06766500,Maturity-onset diabetes of the young type 1,Empagliflozin + Metformin hydrochloride
NCT06766500,Maturity-onset diabetes of the young type 1,Synjardy®
NCT07082452,Leukemia,venetoclax
NCT07082452,Leukemia,azacitidine
NCT06635252,Alzheimer disease,STA
NCT06727552,Atopic eczema,Barzolvolimab
NCT06809400,Parkinson disease,LY4006896
NCT06864052,Atrial fibrillation,Administration of Apixaban
NCT06864052,Atrial fibrillation,Administration of Edoxaban
NCT06864052,Cerebrovascular disorder,Administration of Apixaban
NCT06864052,Cerebrovascular disorder,Administration of Edoxaban
NCT07070700,Intrahepatic cholangiocarcinoma,QL1706 (bispecific antibody targeting PD-1 and CLTA-4)
NCT07070700,Intrahepatic cholangiocarcinoma,lenvatinib
NCT07120152,Inflammatory bowel disease,Subcutaneous infliximab CT-P13 Remsima®SC
NCT07120152,Rheumatoid arthritis,Subcutaneous infliximab CT-P13 Remsima®SC
NCT07109700,Type 2 diabetes mellitus,HDM1005
NCT07109700,Type 2 diabetes mellitus,HDM1005
NCT07109700,Type 2 diabetes mellitus,HDM1005
NCT07109700,Type 2 diabetes mellitus,HDM1005
NCT07109700,Type 2 diabetes mellitus,Dulaglutide
NCT06680752,Myelodysplastic syndrome,ARD103
NCT06680752,Myelodysplastic syndrome,cyclophosphamide
NCT06680752,Myelodysplastic syndrome,fludarabine
NCT07118319,Amyotrophic lateral sclerosis,Human Allogeneic Induced Pluripotent Stem Cells (iPSCs) -Derived Motor Neuron Progenitor Cells (XS228CN)
NCT07118319,Amyotrophic lateral sclerosis,Human Allogeneic Induced Pluripotent Stem Cells (iPSCs) -Derived Motor Neuron Progenitor Cells (XS228CN)
NCT06974487,Type 2 diabetes mellitus,GZR102 injection
NCT06974487,Type 2 diabetes mellitus,GZR4 injection
NCT06974487,Type 2 diabetes mellitus,GZR18 injection
NCT06801587,Pain,Triamcinolone acetonide plus ropivacaine
NCT06801587,Pain,Ropivacaine alone
NCT06780787,Rectum adenocarcinoma,Balstilimab
NCT06780787,Rectum adenocarcinoma,Botensilimab
NCT06780787,Rectum adenocarcinoma,capecitabine
NCT06780787,Rectum adenocarcinoma,fluorouracil
NCT06780787,Rectum adenocarcinoma,leucovorin calcium
NCT06780787,Rectum adenocarcinoma,oxaliplatin
NCT07008287,Non-small cell lung carcinoma,taletrectinib
NCT06808087,Appendicitis,tramadol
NCT06914687,Gastric adenocarcinoma,tislelizumab
NCT06914687,Gastric adenocarcinoma,S-1
NCT06914687,Gastric adenocarcinoma,oxaliplatin
NCT06914687,Gastric adenocarcinoma,docetaxel
NCT06914687,Gastric adenocarcinoma,paclitaxel
NCT06644833,Endogenous depression,Antidepressant
NCT06570187,Sepsis,dexmedetomidine
NCT06570187,Sepsis,propofol
NCT06827587,Myasthenia gravis,Efgartigimod + Telitacicept (1-week interval) group
NCT06827587,Myasthenia gravis,Efgartigimod + Telitacicept (2-week interval) group
NCT06827587,Myasthenia gravis,Telitacicept-only group
NCT06799533,Melanoma,PF-08046031
NCT06799533,Metastatic melanoma,PF-08046031
NCT06870487,Classic Hodgkin lymphoma,PF-08046032
NCT06870487,Classic Hodgkin lymphoma,Sasanlimab
NCT06870487,Diffuse large B-cell lymphoma,PF-08046032
NCT06870487,Diffuse large B-cell lymphoma,Sasanlimab
NCT06870487,Melanoma,PF-08046032
NCT06870487,Melanoma,Sasanlimab
NCT06870487,Non-small cell lung carcinoma,PF-08046032
NCT06870487,Non-small cell lung carcinoma,Sasanlimab
NCT06828887,Mal de Debarquement,LV232
NCT06828887,Mal de Debarquement,LV232
NCT06828887,Mal de Debarquement,escitalopram
NCT06912087,Carcinoma,Zanzalintinib
NCT06912087,Carcinoma,cetuximab
NCT06912087,Carcinoma,pembrolizumab
NCT07093333,Autoimmune encephalitis,ART5803
NCT06904287,Migraine disorder,magnesium
NCT06873087,Rosacea,İsotretinoin
NCT06962787,Renal carcinoma,BL-B01D1
NCT06962787,Renal carcinoma,axitinib
NCT06962787,Renal carcinoma,pembrolizumab
NCT06997549,Depressive disorder,Patients treated with Esketamine
NCT06997549,Mixed anxiety and depressive disorder,Patients treated with Esketamine
NCT06997549,Osteochondritis dissecans,Patients treated with Esketamine
NCT06759649,Cancer,COM503
NCT06759649,Cancer,Zimberelimab
NCT06827249,Bronchiolitis,Peginterferon α-2b injection
NCT06827249,Bronchiolitis,Recombinant Human Interferon α2b
NCT07052006,Childhood myelodysplastic syndrome,HT-6184
NCT06714006,Autosomal dominant polycystic kidney disease,PYC-003
NCT06826859,Preeclampsia,Daily aspirin (ASA)
NCT06826859,Preeclampsia,Split dose aspirin (ASA)
NCT06578000,Epicondylitis,magnesium sulfate
NCT06711900,Non-small cell lung carcinoma,SKB264
NCT06711900,Non-small cell lung carcinoma,pembrolizumab
NCT06711900,Non-small cell lung carcinoma,pemetrexed
NCT06711900,Non-small cell lung carcinoma,carboplatin or cisplatin
NCT07088159,Amyotrophic lateral sclerosis,SPG302
NCT06903559,Kidney failure,Roxadustat
NCT06903559,Kidney failure,Conventional Anemia Management
NCT06617000,Hepatocellular carcinoma,SCG101
NCT06821659,Sjogren syndrome,anti-CD19 CAR-T cells
NCT06821659,Systemic sclerosis,anti-CD19 CAR-T cells
NCT06932159,Type 2 diabetes mellitus,Empagliflozin + Linagliptin film-coated tablets
NCT06932159,Type 2 diabetes mellitus,Glyxambi film-coated tablets
NCT06972459,Obesity disorder,Orforglipron
NCT07091500,Obesity disorder,semaglutide
NCT06619600,Diabetes mellitus,dapagliflozin
NCT06619600,Heart failure,dapagliflozin
NCT06891300,Endogenous depression,ketamine hydrochloride
NCT06851559,Eosinophilic esophagitis,vonoprazan
NCT06607900,Amyotrophic lateral sclerosis,hUC-MSC-sEV-001 nasal drops
NCT06607900,Lewy body dementia,hUC-MSC-sEV-001 nasal drops
NCT06607900,Multiple system atrophy,hUC-MSC-sEV-001 nasal drops
NCT06607900,Parkinson disease,hUC-MSC-sEV-001 nasal drops
NCT06870500,Psoriatic arthritis,methotrexate
NCT06969300,Rosacea,Gold micro-needles combined with salicylic acid
NCT06997900,Infertility disorder,Combination therapy : Follitropin delta and HP-hMG
NCT06997900,Paroxysmal familial ventricular fibrillation,Combination therapy : Follitropin delta and HP-hMG
NCT06817200,Parkinson disease,Amantadine (100mg) as add on therapy.
NCT06799559,Schizophrenia,3-6mg QLM1016
NCT06799559,Schizophrenia,10-20 mg Aripiprazole oral solution film
NCT06624059,Non-small cell lung carcinoma,alectinib
NCT06624059,Non-small cell lung carcinoma,cisplatin
NCT06624059,Non-small cell lung carcinoma,carboplatin
NCT06624059,Non-small cell lung carcinoma,pemetrexed
NCT06731959,"COPD, severe early onset",Flexlamose
NCT06673459,Chemotherapy,TBICy
NCT06673459,Chemotherapy,BuCy
NCT06643000,Neoplastic meningitis,furmonertinib
NCT06643000,Non-small cell lung carcinoma,furmonertinib
NCT06866600,Heart failure,low dose CABG+iPSC-CMs
NCT06866600,Heart failure,High dose CABG/LVAD+iPSC-CMs
NCT06654700,Herpes zoster,Recombinant Zoster Vaccine (CHO Cell)
NCT06860659,Dry eye syndrome,"0.28% Sodium Hyaluronate , preservative free eye drops"
NCT06860659,Dry eye syndrome,"0.18% Sodium Hyaluronate , preservative free eye drops"
NCT06860659,Hyaluronic acid,"0.28% Sodium Hyaluronate , preservative free eye drops"
NCT06860659,Hyaluronic acid,"0.18% Sodium Hyaluronate , preservative free eye drops"
NCT06807359,Prostate cancer,verteporfin Injection
NCT07043400,Gastroesophageal junction adenocarcinoma,Subcutaneous Tislelizumab
NCT07043400,Gastroesophageal junction adenocarcinoma,Intravenous Tislelizumab
NCT07043400,Gastroesophageal junction adenocarcinoma,cisplatin
NCT07043400,Gastroesophageal junction adenocarcinoma,leucovorin
NCT07043400,Gastroesophageal junction adenocarcinoma,5-fluorouracil (5-FU)
NCT07043400,Gastroesophageal junction adenocarcinoma,oxaliplatin
NCT07043400,Gastroesophageal junction adenocarcinoma,capecitabine
NCT06669000,Gout,DNA sample
NCT06669000,Gout,Serum collection
NCT07036159,Malaria,"RTS,S/AS01E vaccine"
NCT06615700,Type 2 diabetes mellitus,NA-931
NCT07100418,Hyperlipidemia,HRS-7249 Injection
NCT07100418,Hyperlipidemia,sodium chloride Injection
NCT07104318,Helicobacter pylori,Bismuth quadruple therapy with optimized PPI
NCT07104318,Helicobacter pylori,Bismuth quadruple therapy with standard PPI
NCT07104318,Helicobacter pylori,Clarithromycin triple therapy with optimized PPI
NCT07104318,Helicobacter pylori,Clarithromycin triple therapy with standard PPI
NCT07104318,Helicobacter pylori,Standard bismuth quadruple therapy
NCT07018518,Hepatocellular carcinoma,PIN +anti-PD1
NCT06948318,Autoimmune thrombocytopenic purpura,Mezagitamab
NCT06888518,Bacterial vaginosis,antibiotic
NCT06632236,Glioma susceptibility 1,amivantamab
NCT06968936,Anemia,Sucrose Iron，subcutaneous recombinant human erythropoietin，intravenous vitamin C
NCT06735118,Metabolic dysfunction-associated steatotic liver disease,Neoadjuvant chemotherapy
NCT06731218,Diabetes mellitus,RGB-5088
NCT06965413,Obesity disorder,RO7204239
NCT06965413,Obesity disorder,tirzepatide
NCT06564818,Endogenous depression,CYB003
NCT06721013,Autoimmune thrombocytopenic purpura,pirtobrutinib
NCT06960213,Hereditary angioedema,ADX-324
NCT07054736,Atopic eczema,XKH001 Injection
NCT06866236,Kidney failure,QRX-3
NCT07075718,Glaucoma,Gen
NCT07075718,Glaucoma,Timolol eye drops
NCT06869018,Type 2 diabetes mellitus,LY3549492
NCT06572813,Malignant pancreatic neoplasm,bortezomib Injection
NCT06572813,Malignant pancreatic neoplasm,Sintilimab
NCT06572813,Malignant pancreatic neoplasm,mFOLFIRINOX
NCT06921213,Syphilis,Linezolid (LZD)
NCT06921213,Syphilis,amoxicillin
NCT06921213,Syphilis,Benzathine Penicillin G
NCT06971913,Systemic lupus erythematosus,Interleukin-2 (IL-2)
NCT06971913,Systemic lupus erythematosus,Ganciclovir (GCV)
NCT06975813,Myofascial pain syndrome,masseter muscle
NCT06975813,Myofascial pain syndrome,masseter and sternocleidomastoid muscle
NCT07022418,Diabetic kidney disease,Formoterol furmarate (20 μg)
NCT06685718,Non-small cell lung carcinoma,BG-60366
NCT06659718,Diabetes mellitus,Oral semaglutide
NCT06659718,Diabetes mellitus,sitagliptin
NCT06586515,Non-small cell lung carcinoma,LY3962673
NCT06586515,Non-small cell lung carcinoma,cetuximab
NCT06586515,Non-small cell lung carcinoma,gemcitabine
NCT06586515,Non-small cell lung carcinoma,nab-paclitaxel
NCT06586515,Non-small cell lung carcinoma,oxaliplatin
NCT06586515,Non-small cell lung carcinoma,leucovorin
NCT06586515,Non-small cell lung carcinoma,irinotecan
NCT06586515,Non-small cell lung carcinoma,5-fluorouracil
NCT06586515,Pancreatic ductal adenocarcinoma,LY3962673
NCT06586515,Pancreatic ductal adenocarcinoma,cetuximab
NCT06586515,Pancreatic ductal adenocarcinoma,gemcitabine
NCT06586515,Pancreatic ductal adenocarcinoma,nab-paclitaxel
NCT06586515,Pancreatic ductal adenocarcinoma,oxaliplatin
NCT06586515,Pancreatic ductal adenocarcinoma,leucovorin
NCT06586515,Pancreatic ductal adenocarcinoma,irinotecan
NCT06586515,Pancreatic ductal adenocarcinoma,5-fluorouracil
NCT06812715,B-cell chronic lymphocytic leukemia,pirtobrutinib
NCT06742515,Precursor B-cell acute lymphoblastic leukemia,Blinatumomab plus Reduced-dose Chemotherapy
NCT06747832,Small cell lung carcinoma,iNK cells
NCT07074652,Anxiety,escitalopram
NCT07083232,Myocardial infarction,low dose Streptozotocin
NCT07083232,Myocardial infarction,"Sitagliptin (Novartis, USA)"
NCT07083232,Myocardial infarction,"Pioglitazone hydrochloride (Unipharma., Egypt)"
NCT07083232,Myocardial infarction,"Dapagliflozine hemihydrate (Janssen, USA)"
NCT06780332,Phenylketonuria,RDD to Palynziq
NCT06863532,Type 2 diabetes mellitus,Cofrogliptin+SGLT2i+Metformin
NCT06863532,Type 2 diabetes mellitus,Metformin dose escalation
NCT06834932,Inherited lipid metabolism disorder,Rosuvastatin Dose
NCT06834932,Inherited lipid metabolism disorder,Rosuvastatin dose
NCT06834932,Inherited lipid metabolism disorder,AZD0780
NCT07010432,Obesity disorder,Cagrilintide
NCT07010432,Obesity disorder,semaglutide
NCT06643832,Pain,Lidocaine (drug)
NCT06785337,"COPD, severe early onset",Inhaled nitroglycerin
NCT06972537,Pneumonia,Increase the frequency and extended infusion time of Piperacillin Sodium and Tazobactam Sodium for Injection (Bonda)
NCT06972537,Pneumonia,Extended Infusion Time of Piperacillin Sodium and Tazobactam Sodium for Injection (Bonda)
NCT06626737,Graft versus host disease,Dapagliflozin (DAPA)
NCT07120815,Polycystic ovary syndrome,Metformin
NCT07120815,Polycystic ovary syndrome,Metformin
NCT06619015,Obesity disorder,pramlintide acetate
NCT06619015,Obesity disorder,semaglutide Pen Injector
NCT06619015,Obesity disorder,Sodium Chloride
NCT06619015,Prediabetes syndrome,pramlintide acetate
NCT06619015,Prediabetes syndrome,semaglutide Pen Injector
NCT06619015,Prediabetes syndrome,Sodium Chloride
NCT07127315,Chemotherapy,Gonadotropin-releasing hormone agonist
NCT07127315,Chemotherapy,Chemotherapy
NCT07053215,Non-small cell lung carcinoma,Camrelizumab
NCT07053215,Non-small cell lung carcinoma,Platinum-based doublet chemotherapy
NCT06943937,Autoimmune thrombocytopenic purpura,YTS109 cell injection
NCT06943937,Lupus nephritis,YTS109 cell injection
NCT07003815,Biliary tract cancer,Envafolimab + Gemcitabine + Cisplatin + Simvastatin
NCT07024615,Pancreatic ductal adenocarcinoma,ASP2138
NCT07024615,Pancreatic ductal adenocarcinoma,oxaliplatin
NCT07024615,Pancreatic ductal adenocarcinoma,leucovorin
NCT07024615,Pancreatic ductal adenocarcinoma,5-FU
NCT07024615,Pancreatic ductal adenocarcinoma,irinotecan
NCT07024615,Pancreatic ductal adenocarcinoma,gemcitabine
NCT07024615,Pancreatic ductal adenocarcinoma,Nab-paclitaxel
NCT07024615,Pancreatic ductal adenocarcinoma,capecitabine
NCT07020715,Multiple sclerosis,Tolerogenic dendritic cells (tolDC)
NCT07116915,"COPD, severe early onset",HRS-9821 Powder for Inhalation.
NCT07116915,"COPD, severe early onset",Moxifloxacin Hydrochloride Tablets
NCT07087015,Post-traumatic stress disorder,ropivacaine
NCT06712615,Type 2 diabetes mellitus,PG-102
NCT06846515,Arthritic joint disease,AR882
NCT06846515,Arthritic joint disease,AR882
NCT06846515,Gout,AR882
NCT06846515,Gout,AR882
NCT06846515,Hyperuricemia,AR882
NCT06846515,Hyperuricemia,AR882
NCT06723015,Cognitive impairment,18F-AV-1451
NCT06723015,Dementia,18F-AV-1451
NCT06906315,Dental pulp necrosis,dexamethasone
NCT06906315,Dental pulp necrosis,Ibuprofen group
NCT06812585,Multiple sclerosis,Metformin (Cidophage®)
NCT06578585,Migraine disorder,ubrogepant
NCT06578585,Migraine disorder,Lu AG09222
NCT06624085,Lymphoma,glofitamab
NCT06624085,Lymphoma,tocilizumab
NCT06624085,Lymphoma,obinutuzumab
NCT06624085,Lymphoma,gemcitabine
NCT06624085,Lymphoma,oxaliplatin
NCT06678685,Atrial septal defect,.spironolactone
NCT07060885,Allergic rhinitis,HDM SLIT-tablet (12 SQ-HDM)
NCT06587737,Cerebrovascular disorder,colchicine
NCT07019415,Maturity-onset diabetes of the young type 1,Vitamin D
NCT06672237,Amyloidosis,nexiguran ziclumeran
NCT06672237,Hereditary disease,nexiguran ziclumeran
NCT06672237,Neurodegenerative disease,nexiguran ziclumeran
NCT06672237,Neuromuscular disease,nexiguran ziclumeran
NCT06709885,Colon adenocarcinoma,Chidamide + Tislelizumab + chemotherapy (CapeOX )
NCT06709885,Colon adenocarcinoma,CapeOX
NCT06748937,Tuberculosis,Alpibectir
NCT06748937,Tuberculosis,Alpibectir
NCT06748937,Tuberculosis,"Isoniazid, rifampicin, pyrazinamide and ethambutol fixed dose combination, weight based"
NCT06748937,Tuberculosis,Alpibectir
NCT06899815,Pulmonary hypertension,F230 tablets
NCT06921785,Hepatocellular carcinoma,tremelimumab
NCT06921785,Hepatocellular carcinoma,Rilvegostomig
NCT06921785,Hepatocellular carcinoma,bevacizumab
NCT06921785,Hepatocellular carcinoma,atezolizumab
NCT06937385,Migraine disorder,0.5% Bupivacaine HCl
NCT06937385,Migraine disorder,standard IV treatment for headache
NCT06637137,Anemia,iron
NCT06637137,Iron deficiency anemia,iron
NCT06594315,Malignant glioma,Deuterated Glucose
NCT06934915,Autism,prednisone
NCT06681337,Lupus nephritis,BCMA CART + CD19 CART
NCT06717815,Lupus nephritis,IPG11406
NCT06888115,Primary biliary cholangitis,CS0159
NCT06686537,Infertility disorder,Estradiol Patches
NCT06686537,Obesity disorder,Estradiol Patches
NCT06945237,Gastroesophageal reflux disease,Flupentixol-Melitracen + Lansoprazole
NCT06801015,Obesity disorder,semaglutide
NCT06801015,Obesity disorder,tirzepatide
NCT06918015,Follicular lymphoma,ZGCVP
NCT07092215,Pain,Synthetic interstitial fluid (SIF) / SIF neutral pH
NCT07092215,Pain,Synthetic interstitial fluid (SIF) / SIF acidic pH
NCT07092215,Pain,Synthetic interstitial fluid (SIF) / SIF acidic pH + BCTC
NCT07092215,Pain,LPS
NCT07092215,Pain,LPS
NCT07092215,Pain,LPS
NCT07092215,Pain,LPS
NCT07092215,Pain,LPS
NCT07092215,Pain,LPS
NCT07092215,Pain,LPS
NCT06625515,Endometrial cancer,ATX-559
NCT06625515,Malignant colon neoplasm,ATX-559
NCT06625515,Rectum adenocarcinoma,ATX-559
NCT07044115,Lupus nephritis,Recombinant Humanized Monoclonal Antibody MIL62 Injection
NCT07016737,Esophageal squamous cell carcinoma,Sintilimab Combined With Docetaxel Monotherapy
NCT07132515,Cirrhosis of liver,"Enoxaparin, warfarrin, or apixaban"
NCT07132515,Hepatocellular carcinoma,"Enoxaparin, warfarrin, or apixaban"
NCT06661915,Acquired polycythemia vera,Decitabine and Cedazuridine
NCT06661915,Acquired polycythemia vera,Iadademstat
NCT06661915,Essential thrombocythemia,Decitabine and Cedazuridine
NCT06661915,Essential thrombocythemia,Iadademstat
NCT06661915,Myeloproliferative neoplasm,Decitabine and Cedazuridine
NCT06661915,Myeloproliferative neoplasm,Iadademstat
NCT06855615,Type 2 diabetes mellitus,Mixtard®
NCT06855615,Type 2 diabetes mellitus,Insulatard® once daily and thrice daily prandial Actrapid®
NCT06764615,Crohn disease,Zasocitinib
NCT06665256,Acquired idiopathic inflammatory myopathy,Rapcabtagene autoleucel
NCT06907056,HIV infectious disease,dual therapy
NCT06907056,HIV infectious disease,Standard Medical Therapy
NCT06640309,Rheumatoid arthritis,Nicotinamide Tablet
NCT06640309,Rheumatoid arthritis,conventional synthetic antirheumatic drugs
NCT06836609,Metabolic dysfunction-associated steatohepatitis,ALN-CIDEB
NCT06836609,Metabolic dysfunction-associated steatotic liver disease,ALN-CIDEB
NCT06762509,Wilson disease,botulinum toxin type A
NCT06676709,COVID-19,IMMUNEPOTENT-CRP (I-CRP)
NCT06973109,Osteoporosis,romosozumab
NCT06973109,Osteoporosis,Alendronate (Fosamax)
NCT06671509,Insomnia,YZJ-1139
NCT07034807,Diabetic kidney disease,the traditional Chinese medicine prescription ' Shenzhuo Decoction '
NCT07057856,Crohn disease,Ustekinumab (UST)
NCT06760156,Large B-cell lymphoma,tafasitamab
NCT06760156,Large B-cell lymphoma,lenalidomide
NCT06823856,Maturity-onset diabetes of the young type 1,Empagliflozin + Metformin hydrochloride
NCT06823856,Maturity-onset diabetes of the young type 1,Synjardy
NCT07014709,Pancreatic intraductal papillary-mucinous neoplasm,GLP1 receptor agonist
NCT06798909,Cytomegalovirus,Valganciclovir (Pre-emptive CMV Therapy)
NCT06798909,Cytomegalovirus,Valganciclovir CMV Prophylaxis
NCT06598007,Pancreatic ductal adenocarcinoma,CT3001
NCT07111507,Metastatic prostate carcinoma,tarlatamab
NCT06611007,Osteoarthritis,embolization therapy
NCT07051707,"COPD, severe early onset",Standard medical care
NCT06972056,Migraine disorder,atogepant
NCT06972056,Migraine disorder,Propranolol
NCT06972056,Migraine disorder,topiramate
NCT06735209,Malaria,PfSPZ Vaccine
NCT06735209,Malaria,PfSPZ (7G8) Challenge
NCT06670209,Type 2 diabetes mellitus,GZR18 and metformin
NCT06684509,Classic Hodgkin lymphoma,Atrovastain
NCT06684509,Leukemia,Atrovastain
NCT07084909,Nonpapillary renal cell carcinoma,piflufolastat F
NCT06657209,Diabetes mellitus,tirzepatide
NCT06657209,Diabetes mellitus,pioglitazone
NCT06880107,Cerebrovascular disorder,blood withdrawal
NCT06922656,Type 1 diabetes mellitus,Dapagliflozin (DAPA)
NCT06922656,Type 1 diabetes mellitus,pioglitazone
NCT06962956,Gingivitis,0.76% Sodium Monofluorophosphate Dentifrice
NCT06962956,Gingivitis,0.454% Stannous Fluoride Dentifrice
NCT06962956,Gingivitis,0.454% Stannous Fluoride Dentifrice
NCT06849609,Amyotrophic lateral sclerosis,VGN-R13
NCT07064109,Acrocephalosyndactyly,Colchicine
NCT06736509,Agitation,AXS-05 (dextromethorphan-bupropion)
NCT07054307,Penile carcinoma,MRG003
NCT07054307,Penile carcinoma,HX008
NCT06968507,Sudden sensorineural hearing loss,Methylprednisolone (drug)
NCT06968507,Sudden sensorineural hearing loss,dexamethasone
NCT06599307,Secondary progressive multiple sclerosis,rituximab
NCT06848088,Melanoma,Fianlimab+cemiplimab
NCT07089888,Gout,allopurinol
NCT07089888,Gout,Dotinurad
NCT06939088,Schizophrenia,tirzepatide
NCT07014488,Prostate cancer,HRS-5041 Tablets
NCT07014488,Prostate cancer,Rifampicin Capsule
NCT06637007,Sarcoma,Chidamide Tablets combined with AK112
NCT06929507,Diabetic macular edema,Intravitreal injection of Faricimab or Aflibercept
NCT06647888,Diabetes mellitus,Envlo Tablet
NCT06647888,Diabetes mellitus,Envlomet SR Tablet
NCT06871488,Attention deficit-hyperactivity disorder,CNS Stimulant
NCT06941688,Mature T-cell and NK-cell non-Hodgkin lymphoma,Decitabine with GemOx
NCT06941688,Mature T-cell and NK-cell non-Hodgkin lymphoma,GemOx
NCT06923488,Myelodysplastic syndrome,Leflunomide
NCT06923488,Myelodysplastic syndrome,Leflunomide
NCT06923488,Myelodysplastic syndrome,decitabine
NCT07088588,Ovarian cancer,SYN608
NCT07069309,COVID-19,BNT162b2 (Omi LP.8.1)
NCT06693609,Social phobia,EMP-01
NCT07110207,Frontotemporal dementia,Blood test
NCT06703788,Diabetes mellitus,A fiixed combination of Chinese herbal medicine
NCT06703788,Obesity disorder,A fiixed combination of Chinese herbal medicine
NCT06625307,Heart failure,NNC0537-1482
NCT06937307,Cirrhosis of liver,Droxidopa capsules
NCT07072988,Myasthenia gravis,Efgartigimod
NCT06807788,Takayasu arteritis,clopidogrel
NCT07032688,Type 2 diabetes mellitus,SHR-3167 Injection
NCT07032688,Type 2 diabetes mellitus,Insulin Degludec Injection
NCT07105488,Atopic eczema,BFB759
NCT06738407,Sexually transmitted disease,Doxycycline hyclate delayed released
NCT06738407,Sexually transmitted disease,Doxycycline hyclate delayed released
NCT06738407,Syphilis,Doxycycline hyclate delayed released
NCT06738407,Syphilis,Doxycycline hyclate delayed released
NCT06867107,Duchenne muscular dystrophy,SAT-3247
NCT07030907,Ovarian cancer,OPB-101
NCT06652607,Metastatic malignant neoplasm,enzalutamide
NCT06652607,Metastatic malignant neoplasm,Apalutamide (Erleada™)
NCT06652607,Metastatic malignant neoplasm,Darolutamide (Nubeqa®)
NCT06652607,Metastatic malignant neoplasm,Taxotere (docetaxel)
NCT06652607,Metastatic malignant neoplasm,Abiraterone acetate + Prednisone or Prednisolone
NCT06652607,Prostate cancer,enzalutamide
NCT06652607,Prostate cancer,Apalutamide (Erleada™)
NCT06652607,Prostate cancer,Darolutamide (Nubeqa®)
NCT06652607,Prostate cancer,Taxotere (docetaxel)
NCT06652607,Prostate cancer,Abiraterone acetate + Prednisone or Prednisolone
NCT06663007,Prostate cancer,RC48
NCT06663007,Prostate cancer,Envafolimab
NCT06881888,Diabetic macular edema,Octreotide (drug)
NCT06688188,Childhood malignant neoplasm,68Ga-JH12
NCT07080437,Esophageal squamous cell carcinoma,Immunotherapy Therapy
NCT06608537,Rectal carcinoma,neoadjuvant SCRT followed by Sintilimab plus CAPOX
NCT06989437,Cachexia,ponsegromab
NCT06806137,Chickenpox,Investigational varicella vaccine
NCT06806137,Chickenpox,Marketed varicella vaccine
NCT06806137,Chickenpox,MMR vaccine
NCT06806137,Chickenpox,Hepatitis A vaccine
NCT06806137,Chickenpox,PCV (pneumococcal conjugate vaccine)
NCT06806137,Chickenpox,PCV
NCT06806137,Chickenpox,Vaxneuvance
NCT07014137,Sarcoma,ABSK043 single agent
NCT06902532,Dental caries,Fluoride Mouthwash
NCT06786637,Anxiety,Nociceptin Receptor Antagonist (LY-2940094)
NCT06786637,Depressive disorder,Nociceptin Receptor Antagonist (LY-2940094)
NCT06665737,Non-Hodgkin lymphoma,Early receiving G-CSF group
NCT06665737,Non-Hodgkin lymphoma,Late receiving G-CSF group
NCT06879132,Type 2 diabetes mellitus,BR3409
NCT06879132,Type 2 diabetes mellitus,BR3409-1
NCT06879132,Type 2 diabetes mellitus,BR3409-2
NCT06924632,Androgenetic alopecia,minoxidil
NCT06793332,Triple-negative breast carcinoma,Ivonescimab Combined With TROP2 ADC
NCT06687837,Parkinson disease,autologous dopaminergic cell implantation
NCT06608732,Precursor B-cell acute lymphoblastic leukemia,Inaticabtagene autoleucel
NCT07110532,Influenza,A/Arkansas/08/2020 (pH1N1)
NCT07067632,Hypertensive disorder,Antihypertensive treatment
NCT06568237,Multiple system atrophy,TEV-56286
NCT07075237,Schizophrenia,Paliperidone Palmitate Injection (PP1M)
NCT07007637,Hidradenitis suppurativa,Sonelokimab
NCT06691152,Systemic lupus erythematosus,CD19 Universal CAR-T cells
NCT06780137,Small cell lung carcinoma,Gocatamig
NCT06780137,Small cell lung carcinoma,Ifinatamab Deruxtecan (I-DXd)
NCT06780137,Small cell lung carcinoma,durvalumab
NCT07065552,Endometrial cancer,tirzepatide
NCT07065552,Obesity disorder,tirzepatide
NCT07013552,Infective endocarditis,Administration of a single or repeated dose of a long half-life antibiotic - oritavancin
NCT07013552,Infective endocarditis,Administration of a repeated dose of a short half-life antibiotic - vancomycin
NCT07013552,Nosocomial infection,Administration of a single or repeated dose of a long half-life antibiotic - oritavancin
NCT07013552,Nosocomial infection,Administration of a repeated dose of a short half-life antibiotic - vancomycin
NCT06704932,Osteoarthritis,SAR446959
NCT06974032,Pain,Xylocaine jelly
NCT06974032,Pain,Surgilube
NCT06925737,Prostate cancer,Ifinatamab deruxtecan
NCT06925737,Prostate cancer,docetaxel
NCT06925737,Prostate cancer,prednisone
NCT06601452,Polycystic ovary syndrome,a compound prescription of Chinese medicine
NCT06598332,Graft versus host disease,5-Azacytidine
NCT06667037,Myopia,0.01% Atropine
NCT06724237,Mature T-cell and NK-cell non-Hodgkin lymphoma,High Dose Chemotherapy
NCT06724237,Mature T-cell and NK-cell non-Hodgkin lymphoma,Stem Cell Mobilization Therapy
NCT06814132,Kidney failure,MK-5684
NCT06814132,Kidney failure,prednisone
NCT06814132,Kidney failure,fludrocortisone acetate
NCT06613009,Small cell lung carcinoma,IBI3009
NCT06820307,Pain,suzetrigine
NCT06820307,Pain,DRSP/EE
NCT06820307,Pain,NGM/EE
NCT06999707,Hepatocellular carcinoma,tremelimumab
NCT06999707,Hepatocellular carcinoma,durvalumab
NCT07065409,Moyamoya disease,iPSC-EVs
NCT07114107,Allergic asthma,"basic medications (antihistamines, mometasone furoate nasal spray, ICS-LABA"
NCT07114107,Allergic rhinitis,"basic medications (antihistamines, mometasone furoate nasal spray, ICS-LABA"
NCT06852807,Neuroblastoma,18F-MFBG
NCT06946407,Primary central nervous system lymphoma,"Rituximab, Methotrexate, and Thiotepa (R-MT) Induction Followed by Etoposide and Cytarabine (EA) Consolidation"
NCT06578507,Sickle cell disease,Hydroxycarbamid
NCT06847607,Autoimmune hemolytic anemia,iptacopan
NCT06871007,Primary mediastinal large B-cell lymphoma,nivolumab
NCT07068607,Gastritis,vonoprazan
NCT07068607,Gastritis,Tetracycline
NCT07068607,Gastritis,minocycline
NCT07068607,Gastritis,bismuth
NCT07068607,Gastritis,clarithromycin
NCT07068607,Gastritis,amoxicillin
NCT07096609,Gastrointestinal stromal tumor,Lenvatinib Capsules
NCT07081607,Mature T-cell and NK-cell non-Hodgkin lymphoma,golidocitinib with azacytidine and chidamide
NCT06819007,Ovarian cancer,trastuzumab deruxtecan
NCT06819007,Ovarian cancer,bevacizumab
NCT06718309,Non-small cell lung carcinoma,Chemotherapy
NCT06718309,Non-small cell lung carcinoma,Immunotherapy
NCT06913907,Rheumatoid arthritis,Methotrexate (MTX)
NCT07012109,Acquired polycythemia vera,BEBT-507 Injection
NCT06650007,Diabetes mellitus,HRS9531 Injection
NCT06846307,Traumatic brain injury,mannitol
NCT07047209,Amyotrophic lateral sclerosis,digoxin
NCT06789107,Systemic lupus erythematosus,Blinatumomab
NCT06900907,Hyaluronic acid,methylprednisolone
NCT06969807,Diabetic kidney disease,Amimestrocel
NCT06809088,Cirrhosis of liver,Albumin
NCT07083388,Diabetes mellitus,Dapagliflozin
NCT07083388,Diabetes mellitus,dapagliflozin
NCT07083388,Diabetes mellitus,pioglitazone
NCT07083388,Diabetes mellitus,Metformin HCl
NCT06964009,Ovarian cancer,DT2216
NCT06964009,Ovarian cancer,paclitaxel
NCT06964009,Ovarian carcinoma,DT2216
NCT06964009,Ovarian carcinoma,paclitaxel
NCT06731907,Non-small cell lung carcinoma,pembrolizumab
NCT06731907,Non-small cell lung carcinoma,carboplatin
NCT06731907,Non-small cell lung carcinoma,paclitaxel
NCT06731907,Non-small cell lung carcinoma,Nab-paclitaxel
NCT06731907,Non-small cell lung carcinoma,pemetrexed
NCT06731907,Non-small cell lung carcinoma,HER3-DXd
NCT06600009,Psoriatic arthritis,secukinumab
NCT06600009,Psoriatic arthritis,adalimumab
NCT07092007,Cervical carcinoma,NWRD09 administered by intramuscular injection
NCT06768307,Chemotherapy,First-line Immunotherapy Combined with Chemoradiotherapy for ES-SCLC
NCT06768307,Small cell lung carcinoma,First-line Immunotherapy Combined with Chemoradiotherapy for ES-SCLC
NCT07055607,Obesity disorder,semaglutide
NCT06738732,Dravet syndrome,CBD: GT4 Transdermal Delivery System
NCT06799637,Exocrine pancreatic carcinoma,XNW28012
NCT06799637,Ovarian cancer,XNW28012
NCT06941415,Cirrhosis of liver,bumetanide
NCT06941415,Cirrhosis of liver,furosemide
NCT06669585,Memory,Cannabis (smoked flower)
NCT06924385,Preeclampsia,Telpegfilgrastim Injection
NCT06924385,Preeclampsia,Telpegfilgrastim Injection
NCT06924385,Preeclampsia,Telpegfilgrastim Injection
NCT06924385,Preeclampsia,Telpegfilgrastim Injection
NCT06924385,Preeclampsia,Telpegfilgrastim Injection
NCT06999785,Cancer,Blood test
NCT06751485,Ovarian cancer,JSKN003
NCT06751485,Ovarian cancer,doxorubicin
NCT06751485,Ovarian cancer,paclitaxel
NCT06751485,Ovarian cancer,topotecan
NCT06780085,Carcinoma,Raludotatug Deruxtecan
NCT06780085,Carcinoma,Ifinatamab Deruxtecan
NCT06780085,Carcinoma,Docetetaxel
NCT06581315,Hepatocellular carcinoma,Donafenib
NCT06891885,Retinitis pigmentosa,DSP-3077 Retinal Sheet Cohort
NCT06891885,Retinitis pigmentosa,DSP-3077 Retinal Sheet Cohort
NCT06891885,Retinitis pigmentosa,DSP-3077 Retinal Sheet Cohort
NCT07036185,Cholangiocarcinoma,KJ015 Injection (Subcutaneous Injection)
NCT07036185,Non-small cell lung carcinoma,KJ015 Injection (Subcutaneous Injection)
NCT06882785,Schizophrenia,KarXT
NCT06633185,Wound healing,phenytoin cream
NCT06633185,Wound healing,no phenytoin cream
NCT06849115,Amyotrophic lateral sclerosis,L-Carnitine Injection，1000mg once daily
NCT06884085,Essential hypertension,Co-administration of AD-227A and AD-227B
NCT06884085,Essential hypertension,Administration of AD-227
NCT06841185,Hepatocellular carcinoma,HLX13
NCT06841185,Hepatocellular carcinoma,US-sourced YERVOY®
NCT06841185,Hepatocellular carcinoma,EU-sourced YERVOY®
NCT06846385,Allergic rhinitis,MG-K10 Humanized Monoclonal Antibody Injection
NCT07040085,Cerebrovascular disorder,Y-6
NCT07032285,Soft tissue sarcoma,Cirtuvivint
NCT06926985,IgA glomerulonephritis,anti-CD19/BCMA CAR NK cells
NCT06733285,Dentin sensitivity,Sensodyne Rapid Relief
NCT06733285,Dentin sensitivity,Colgate Cavity Protection
NCT07098585,Attention deficit-hyperactivity disorder,Lisdexamfetamine capsule
NCT07098585,Attention deficit-hyperactivity disorder,"Elvanse® (Lisdexamfetamine dimesylate capsules, hard)"
NCT06902285,Sleep,Magnesium Threonate
NCT06754085,Prostate cancer,Florastamin[18F] Injection
NCT06721156,Dementia,MK-1167
NCT06695585,Overactive bladder,Lidocaine
NCT07093385,Age-related macular degeneration,faricimab Injection
NCT07047885,Primary cutaneous T-cell non-Hodgkin lymphoma,ropeginterferon alfa-2b
NCT06977685,Cirrhosis of liver,Non-selective beta-blockers
NCT06904300,Gastric carcinoma,AK112 + paclitaxel
NCT06904300,Gastric carcinoma,Paclitaxel ± ramucirumab
NCT06831500,Orthostatic hypotension,Administration of Carbidopa/levodopa
NCT06831500,Parkinson disease,Administration of Carbidopa/levodopa
NCT06931652,Primary central nervous system lymphoma,epcoritamab
NCT06823752,Insomnia,lemborexant
NCT06717152,Dry eye syndrome,SJP-0132
NCT06754852,Von Willebrand disease (hereditary or acquired),HMB-002 (Part A)
NCT06754852,Von Willebrand disease (hereditary or acquired),HMB-002 (Part B)
NCT06684600,Esophageal squamous cell carcinoma,Dalpiciclib + Pyrotinib
NCT07104500,Weight loss,VK2735
NCT06567600,Intrahepatic cholangiocarcinoma,Low-dose Gemcitabine and Cisplatin Chemotherapy plus PD-1/PD-L1Antibody
NCT06578052,Malignant pancreatic neoplasm,Irinotecan liposome Capecitabine
NCT06970600,Malaria,Artemether-lumefantrine (Coartem)
NCT06670352,IgA glomerulonephritis,HSK39297
NCT06670352,IgA glomerulonephritis,HSK39297
NCT06670352,IgA glomerulonephritis,HSK39297
NCT06756152,Childhood myelodysplastic syndrome,Conditioning regimen: Treosulfan
NCT06756152,Lymphoma,Conditioning regimen: Treosulfan
NCT06948552,Renal pelvis/ureter urothelial carcinoma,5-Aminolevulinic acid Hydrochloride (Gliolan®)
NCT06996652,REM sleep behavior disorder,adalimumab
NCT07030400,B-cell chronic lymphocytic leukemia,Bruton's tyrosine kinase inhibitor
NCT07030400,B-cell chronic lymphocytic leukemia,B-Cell Lymphoma
NCT06940700,Asthma,SHR4597
NCT06940700,Asthma,Budesonide inhalant
NCT06626152,Endogenous depression,Apo-levocarb
NCT06993233,Hidradenitis suppurativa,CIT-013 high dose
NCT06993233,Hidradenitis suppurativa,CIT-013 medium dose
NCT06762587,Influenza,baloxavir marboxil
NCT06762587,Influenza,oseltamivir
NCT06762587,Nosocomial infection,baloxavir marboxil
NCT06762587,Nosocomial infection,oseltamivir
NCT06788587,Substance abuse,LDX-01 plus TAU
NCT07004387,Kidney failure,Amino acid solution
NCT07004387,Kidney failure,Amino Acid infusion
NCT06863987,Essential hypertension,valsartan Oral Solution
NCT06983054,Type 2 diabetes mellitus,ertugliflozine
NCT06893887,Hepatocellular carcinoma,FOLFOX4
NCT06893887,Hepatocellular carcinoma,Adebrelimab
NCT06893887,Hepatocellular carcinoma,Apatinib
NCT06893887,Hepatocellular carcinoma,Icaritin
NCT06893887,Hepatocellular carcinoma,SHR-1701
NCT06893887,Hepatocellular carcinoma,QL1706
NCT06893887,Hepatocellular carcinoma,bevacizumab
NCT06893887,Hepatocellular carcinoma,The original treatment regimen
NCT07108387,Temporal arteritis,tocilizumab
NCT07108387,Temporal arteritis,Discontinue Tocilizumab
NCT07081633,Hepatocellular carcinoma,durvalumab
NCT07081633,Hepatocellular carcinoma,tremelimumab
NCT06837233,Allergic rhinitis,Pumecitinib Nasal Spray
NCT06837233,Allergic rhinitis,Pumecitinib Nasal Spray
NCT06837233,Allergic rhinitis,Pumecitinib nasal spray
NCT06757387,Mature T-cell and NK-cell non-Hodgkin lymphoma,chidamide and golidocitinib
NCT06810687,Urinary tract infection,Methenamine Hippurate
NCT06818487,Dry eye syndrome,Ganyan1
NCT06818487,Dry eye syndrome,sodium hyaluronate
NCT06818487,Dry eye syndrome,1/2Ganyan1
NCT06973187,B-cell chronic lymphocytic leukemia,BGB-16673
NCT06973187,B-cell chronic lymphocytic leukemia,pirtobrutinib
NCT06852287,Intrahepatic cholangiocarcinoma,chemotherapy with gemcitabine and oxaliplatin
NCT06871787,Ovarian cancer,indocyanine green
NCT06871787,Vulvar carcinoma,indocyanine green
NCT06778187,Myelodysplastic syndrome,Oral arsenic trioxide
NCT06890533,Pain,Experimental: YZJ-4729
NCT06890533,Pain,Active Comparator: Morphine
NCT06906887,Gastroesophageal cancer,Induction Chemotherapy (modified FLOT or modified FOLFOX-6)
NCT06906887,Gastroesophageal cancer,Chemotherapy
NCT07110987,Hyperbilirubinemia,ursodeoxycholic acid (UDCA)
NCT06868849,Malignant pancreatic neoplasm,JMT203 Injection
NCT07018349,Androgenetic alopecia,2.5% Oral minoxidil
NCT07018349,Androgenetic alopecia,1% Oral Minoxidil
NCT06961006,Melanoma,V940
NCT06961006,Melanoma,pembrolizumab
NCT06621849,Pain,morphine
NCT06906549,Rheumatoid arthritis,Rituximab
NCT06906549,Rheumatoid arthritis,Rituximab
NCT06624436,Sepsis,dexamethasone
NCT06624436,Sepsis,tocilizumab
NCT06624436,Sepsis,anakinra
NCT06624436,Sepsis,LPS
NCT06784349,Inherited lipid metabolism disorder,ALN-APOC3
NCT06585449,Huntington disease,ALN-HTT02
NCT06607549,Primary central nervous system lymphoma,Loncastuximab tesirine and rituximab (Lonca-R)
NCT06723236,Cholangiocarcinoma,MGC028
NCT06723236,Exocrine pancreatic carcinoma,MGC028
NCT06780449,Obesity disorder,Cagrilintide
NCT06780449,Obesity disorder,semaglutide
NCT06820749,Bronchiectasis,HSK31858
NCT06578949,Paroxysmal nocturnal hemoglobinuria,ravulizumab
NCT06939036,Cutaneous neuroendocrine carcinoma,225Ac-SSO110 + SoC
NCT06939036,Cutaneous neuroendocrine carcinoma,atezolizumab
NCT06939036,Cutaneous neuroendocrine carcinoma,durvalumab
NCT06939036,Cutaneous neuroendocrine carcinoma,avelumab
NCT06939036,Cutaneous neuroendocrine carcinoma,pembrolizumab
NCT06939036,Cutaneous neuroendocrine carcinoma,retifanlimab
NCT06708936,Nonpapillary renal cell carcinoma,KSD-201
NCT07015736,Infectious otitis media,Amoxicillin-Clavulanic acid
NCT06807736,HIV infectious disease,Cabotegravir long-acting
NCT06807736,HIV infectious disease,Tenofovir emtricitabine
NCT06807736,HIV infectious disease,Dapivirine containing vaginal ring
NCT06978049,Wound healing,Topical Lactic Acid Gel (BAYER)
NCT06571149,Ischemic stroke,Tenecteplase or Alteplase
NCT06831136,Pancreatic ductal adenocarcinoma,Neoadjuvant Chemotherapy (NAC)
NCT06831136,Pancreatic ductal adenocarcinoma,Immunotherapy (pembrolizumab)
NCT07027436,Hepatocellular carcinoma,Chemotherapy/Radiation
NCT06907849,Lumbar spinal stenosis,124I-evuzamitide
NCT06788249,Endogenous depression,Ketamine only
NCT07011849,Nonpapillary renal cell carcinoma,pembrolizumab
NCT07011849,Nonpapillary renal cell carcinoma,lenvatinib
NCT06795906,Asthma,AZD8630
NCT07075406,Myelodysplastic syndrome,luspatercept
NCT06904170,Hepatocellular carcinoma,Durvalumab Plus Tremelimumab
NCT06904170,Hepatocellular carcinoma,HAIC (GEMOX)
NCT06989359,"IgA nephropathy, susceptibility to, 1",ADX-038
NCT06897475,Type 2 diabetes mellitus,LY3457263
NCT07001475,Attention deficit-hyperactivity disorder,BI
NCT07001475,Borderline personality disorder,BI
NCT06690775,Fallopian tube carcinoma,TORL-1-23
NCT06690775,Fallopian tube carcinoma,TORL-1-23
NCT06690775,Fallopian tube carcinoma,TORL-1-23
NCT06690775,Fallopian tube carcinoma,Pegfilgrastim (drug)
NCT06690775,Ovarian carcinoma,TORL-1-23
NCT06690775,Ovarian carcinoma,TORL-1-23
NCT06690775,Ovarian carcinoma,TORL-1-23
NCT06690775,Ovarian carcinoma,Pegfilgrastim (drug)
NCT06827470,Pertussis,Biological: Bordetella pertussis J820
NCT06979375,Heart failure,CDR132L
NCT07109375,Fabry disease,pegunigalsidase alfa
NCT06913075,Adenomyosis,GnRH agonist downregulation
NCT06913075,Adenomyosis,GnRH agonist and Letrozole
NCT07085559,AL amyloidosis,Metabolically Armed BCMA CAR-T cells.
NCT07118475,Diabetes mellitus,Autologous islet transplantation
NCT06672575,Adult glioblastoma,Ivonescimab
NCT06935175,Pediatric hepatocellular carcinoma,SHR-1826
NCT06935175,Pediatric hepatocellular carcinoma,SHR-1826 and immunotherapy combination therapy
NCT07124559,Tuberculosis,rifapentine
NCT07124559,Tuberculosis,isoniazid
NCT07124559,Tuberculosis,dolutegravir
NCT07063875,Uveal melanoma,aldesleukin
NCT06988475,Cancer,capmatinib
NCT06988475,Childhood malignant neoplasm,capmatinib
NCT06988475,Gastric carcinoma,capmatinib
NCT06988475,Malignant glioma,capmatinib
NCT06988475,Neuroblastoma,capmatinib
NCT06988475,Soft tissue sarcoma,capmatinib
NCT07107659,Lupus nephritis,ONT01 is a small molecule CD11b modulator.
NCT07107659,Systemic lupus erythematosus,ONT01 is a small molecule CD11b modulator.
NCT06709859,Carcinoma,Afatinib plus chemotherapy as conversion treatment
NCT07111559,Cerebrovascular disorder,rt-PA
NCT07111559,Cerebrovascular disorder,DAPT
NCT07111559,Ischemic stroke,rt-PA
NCT07111559,Ischemic stroke,DAPT
NCT06866275,Autism,KZ101
NCT06751875,Endogenous depression,lithium
NCT07075575,Nicotine dependence,Nicotine Polacrilex Gum (2 mg)
NCT07130175,Heart failure,Guideline-Directed Medical Therapy (GDMT)
NCT06863259,Precursor B-cell acute lymphoblastic leukemia,"Inotuzumab Ozogamicin, Venetoclax, and Dexamethasone"
NCT07037875,Gastroesophageal reflux disease,Linaprazan glurate
NCT07037875,Gastroesophageal reflux disease,Linaprazan Glurate
NCT07037875,Gastroesophageal reflux disease,Lansoprazole
NCT06636175,B-cell chronic lymphocytic leukemia,64Cu-LLP2A
NCT06636175,Follicular lymphoma,64Cu-LLP2A
NCT06636175,Marginal zone lymphoma,64Cu-LLP2A
NCT06582875,Obesity disorder,tirzepatide
NCT06655259,Metastatic prostate carcinoma,Standard Medical Therapy
NCT06977659,Injury,norepinephrine
NCT06588699,Fatty liver disease,digoxin
NCT06588699,Metabolic dysfunction-associated steatohepatitis,digoxin
NCT06588699,Metabolic dysfunction-associated steatotic liver disease,digoxin
NCT06953999,Malignant pancreatic neoplasm,"Ivonescimab, AK117, Albumin-bound Paclitaxel, Gemcitabine"
NCT06604442,Prostate cancer,Flotufolastat (18F)
NCT06604442,Prostate cancer,piflufolastat (18F)
NCT06625970,Prostate cancer,darolutamide
NCT06625970,Prostate cancer,ADT (Standard of Care)
NCT07085975,Asthma,Adenosine
NCT06581575,Herpes zoster,JCXH-105
NCT06581575,Herpes zoster,Shingrix
NCT07069270,Small cell lung carcinoma,Vunakizumab (IL-17A inhibitor)
NCT07069270,Small cell lung carcinoma,Adebrelimab
NCT07069270,Small cell lung carcinoma,Chemotherapy
NCT06666270,Ovarian cancer,SYN818
NCT06666270,Prostate cancer,SYN818
NCT07091370,Autoimmune hemolytic anemia,Inaticabtagene Autoleucel Injection
NCT06740370,Hepatocellular carcinoma,lenvatinib
NCT06740370,Hepatocellular carcinoma,PD-1 Inhibitors
NCT06754475,Heart failure,Standart medical treatment
NCT07079475,Non-small cell lung carcinoma,DZD6008
NCT07079475,Non-small cell lung carcinoma,sunvozertinib
NCT07079475,Non-small cell lung carcinoma,osimertinib
NCT06651970,B-cell chronic lymphocytic leukemia,acalabrutinib
NCT06651970,Heart failure,acalabrutinib
NCT06712875,Low grade glioma,Trametinib and Nivolumab
NCT06712875,Low grade glioma,"Dabrafenib, trametinib, nivolumab"
NCT06712875,Malignant glioma,Trametinib and Nivolumab
NCT06712875,Malignant glioma,"Dabrafenib, trametinib, nivolumab"
NCT06829459,Non-small cell lung carcinoma,Glumetinib
NCT06829459,Non-small cell lung carcinoma,Osimertinib mesylate
NCT06829459,Non-small cell lung carcinoma,pemetrexed
NCT06829459,Non-small cell lung carcinoma,Cisplatin or carboplatin
NCT06901570,Coronary microvascular disorder,Kuangxiong Aerosol
NCT06900075,Type 2 diabetes mellitus,Efsubaglutide Alfa
NCT06900075,Type 2 diabetes mellitus,Efsubaglutide Alfa
NCT06624475,Basal cell carcinoma,nivolumab
NCT06624475,Basal cell carcinoma,Opdualag
NCT06736275,Cachexia,SXRN
NCT06782659,Erectile dysfunction,ASP-001
NCT06782659,Erectile dysfunction,Viagra
NCT07014059,Graft versus host disease,Autologous Serum
NCT07097259,Hypogonadism,Reference: Follitropin alfa
NCT07097259,Hypogonadism,Zoladex
NCT06770270,Rectal carcinoma,Pucotenlimab
NCT07074470,Primary central nervous system lymphoma,"Induction therapy-2 cycles of VPX (Teniposide, PD-1 monoclonal antibody plus Selinixor)"
NCT07074470,Primary central nervous system lymphoma,"Consolidation therapy-4 cycles of VPX (Teniposide, PD-1 monoclonal antibody plus Selinixor)"
NCT07074470,Primary central nervous system lymphoma,Maintenance treatment-PD-1 monoclonal antibody
NCT07108075,Cirrhosis of liver,carvedilol
NCT07108075,Cirrhosis of liver,metformin
NCT07058675,Polycystic ovary syndrome,metformin hydrochloride
NCT07058675,Polycystic ovary syndrome,Myoinositol
NCT07053670,B-cell non-Hodgkin lymphoma,CAR T cells
NCT06731075,Type 2 diabetes mellitus,ORMD-0801
NCT06731075,Type 2 diabetes mellitus,ORMD-0801
NCT07089875,Gout,allopurinol
NCT07089875,Gout,Dotinurad
NCT07053475,Heart failure,ferric carboxymaltose
NCT07053475,Heart failure,ferrous sulfate
NCT07053475,Iron deficiency anemia,ferric carboxymaltose
NCT07053475,Iron deficiency anemia,ferrous sulfate
NCT06933459,Inherited lipid metabolism disorder,Test Drug
NCT06933459,Inherited lipid metabolism disorder,Reference Drug
NCT06776770,Gastric carcinoma,Adebrelimab
NCT06915870,Diabetes mellitus,Dapagliflozin
NCT06915870,Diabetes mellitus,Empagliflozin
NCT06915870,Heart failure,Dapagliflozin
NCT06915870,Heart failure,Empagliflozin
NCT06669299,Ventricular tachycardia,"Antiarrhythmic Drug Therapy (amiodarone, sotalol, or mexiletine)"
NCT06700499,Atopic eczema,AK120
NCT06909799,Tuberculosis,N-Acetyl Cysteine (NAC)
NCT06909799,Tuberculosis,Standard TB treatment
NCT06847542,Wet macular degeneration,ranibizumab
NCT07076342,Endogenous depression,PET Scan with [11C]ABP688
NCT06911606,Small cell lung carcinoma,4 cycles of Serplulimab combined with etoposide and carboplatin or cisplatin
NCT06944106,Malignant pancreatic neoplasm,AK112
NCT06846099,Cervical carcinoma,RP903
NCT06846099,Endometrial cancer,RP903
NCT06846099,Ovarian cancer,RP903
NCT06839599,Diarrheal disease,CMTS4520 (dietary fiber probiotics)
NCT06951399,Non-small cell lung carcinoma,Pembrolizumab (KEYTRUDA®)
NCT07089199,Non-small cell lung carcinoma,neoadjuvant therapy
NCT07089199,Non-small cell lung carcinoma,Adjuvant therapy
NCT07067099,Hidradenitis suppurativa,Plasma with neutralizing autoantibodies to Type I Interferons
NCT06721442,Diabetes mellitus,Dapagliflozin (DAPA)
NCT06937749,Metabolic dysfunction-associated steatohepatitis,IBI362
NCT07029399,Endometrial cancer,NKT5097 CDK2/CDK4 dual degrader
NCT07029399,Ovarian cancer,NKT5097 CDK2/CDK4 dual degrader
NCT06751199,Diabetes mellitus,human umbilical cord mesenchymal stem cells
NCT06751199,Diabetes mellitus,allogeneic islet
NCT07092306,Ewing sarcoma,Irinotecan Hydrochloride Liposome Injection Combined with Temozolomide and Vincristine (NALIRI-VT)
NCT07092306,Ewing sarcoma,Irinotecan Combined with Temozolomide and Vincristine (VIT)
NCT07098806,Neoplastic meningitis,186RNL
NCT06683742,Wet macular degeneration,EYP-1901
NCT06683742,Wet macular degeneration,Aflibercept (2.0 mg)
NCT07089706,COVID-19,mRNA-1283 Variant-containing Formulation
NCT06870942,Hepatocellular carcinoma,Maintenance first-line treatment plus radiation therapy
NCT06598449,Dravet syndrome,fenfluramine
NCT06823999,Cerebrovascular disorder,Ascorbic acid (Vitamin C)
NCT07046299,Ischemic stroke,Best Medical Treatment Alone
NCT06605599,Bipolar I disorder,ABBV-932
NCT06605599,Bipolar II disorder,ABBV-932
NCT06831149,Squamous cell carcinoma,ICG (Indocyanine Green)
NCT07093606,Autoimmune thrombocytopenic purpura,eltrombopag
NCT06780306,Dry eye syndrome,TTAX03
NCT07104799,Myelofibrosis,momelotinib
NCT06947499,Diphtheria,LBVD
NCT06947499,Diphtheria,Pentavalent vaccine and Inactivated Polio vaccine
NCT06947499,Pertussis,LBVD
NCT06947499,Pertussis,Pentavalent vaccine and Inactivated Polio vaccine
NCT06947499,Poliomyelitis,LBVD
NCT06947499,Poliomyelitis,Pentavalent vaccine and Inactivated Polio vaccine
NCT06947499,Tetanus,LBVD
NCT06947499,Tetanus,Pentavalent vaccine and Inactivated Polio vaccine
NCT06906341,Fallopian tube carcinoma,Relacorilant
NCT06906341,Fallopian tube carcinoma,Nab-paclitaxel
NCT06906341,Fallopian tube carcinoma,Bevacizumab
NCT06906341,Ovarian cancer,Relacorilant
NCT06906341,Ovarian cancer,Nab-paclitaxel
NCT06906341,Ovarian cancer,Bevacizumab
NCT06972641,Myelodysplastic syndrome,decitabine
NCT06972641,Myelodysplastic syndrome,Sorafenib (BAY-43-9006)，giritinib
NCT06972641,Myelodysplastic syndrome,Avastinib
NCT06972641,Myelodysplastic syndrome,Venetoclax
NCT06951841,Small cell lung carcinoma,Liposome Irinotecan
NCT06951841,Small cell lung carcinoma,Platinum
NCT06951841,Small cell lung carcinoma,tislelizumab
NCT06951841,Small cell lung carcinoma,Anlotinib
NCT06901817,Neoplastic meningitis,Intraventricular Pemetrexed
NCT06901817,Neoplastic meningitis,Intraventricular Nivolumab
NCT06901817,Neoplastic meningitis,Intraventricular Dexamethasone
NCT06709417,Esophageal squamous cell carcinoma,Sintilimab
NCT06709417,Esophageal squamous cell carcinoma,Chemotherapy
NCT07014917,B-cell chronic lymphocytic leukemia,venetoclax
NCT07014917,B-cell chronic lymphocytic leukemia,acalabrutinib
NCT07014917,B-cell chronic lymphocytic leukemia,venetoclax
NCT07014917,B-cell chronic lymphocytic leukemia,acalabrutinib
NCT06673017,Pancreatic ductal adenocarcinoma,PTM-101
NCT06772441,Prostate cancer,Androgen deprivation therapy (ADT)
NCT06580041,Depressive disorder,pramipexole
NCT06580041,Depressive disorder,methylphenidate
NCT06580041,Depressive disorder,phenelzine
NCT06580041,Endogenous depression,pramipexole
NCT06580041,Endogenous depression,methylphenidate
NCT06580041,Endogenous depression,phenelzine
NCT06927817,Cholecystitis,"hyoscine-n-butylbromide, ondansetron"
NCT06927817,Cholecystitis,• hyoscine-n-butylbromide • ondansetron
NCT06927817,Pain,"hyoscine-n-butylbromide, ondansetron"
NCT06927817,Pain,• hyoscine-n-butylbromide • ondansetron
NCT06665217,Diffuse large B-cell lymphoma,"Glofitamab, Polatuzumab Vedotin, Zanubrutinib, Lenalidomide and Prednisone as Induction Therapy"
NCT06686641,Macular retinal edema,Local and systemical treatment
NCT07076641,Digestive system disorder,Lidocaine IV
NCT07076641,Digestive system disorder,morphine
NCT07115641,Rheumatoid arthritis,Huoluo Pills
NCT07115641,Rheumatoid arthritis,Iguratimod Tablets
NCT06756334,Prostate cancer,[18F]AlF-PSMA-N5
NCT06756334,Prostate cancer,[18F]F-DCFPyL
NCT06873334,Huntington disease,SKY-0515
NCT06887517,Lupus erythematosus,Antimalarial with or without oral glucocorticosteroid
NCT06943534,Food allergy,5mg/kg omalizumab injection
NCT06943534,Food allergy,15mg/kg omalizumab injection
NCT06671041,Dry eye syndrome,Preservative Free eye drop
NCT06685341,Insomnia,YZJ-1139
NCT06685341,Insomnia,zolpidem
NCT06564441,Obesity disorder,Survodutide
NCT06564441,Obesity disorder,bupropion
NCT06564441,Obesity disorder,caffeine
NCT06564441,Obesity disorder,midazolam
NCT07115017,Multiple sclerosis,[18F] FZTA
NCT06714617,Fallopian tube carcinoma,BL-M17D1
NCT06714617,Gastric carcinoma,BL-M17D1
NCT06714617,Ovarian cancer,BL-M17D1
NCT06714617,Peritoneum cancer,BL-M17D1
NCT06567041,Diabetes mellitus,NNC0519-0130
NCT06567041,Obesity disorder,NNC0519-0130
NCT07085117,Endocrine exophthalmos,teprotumumab
NCT06832917,Rectal carcinoma,AK104 plus
NCT06832917,Rectal carcinoma,Chemo only
NCT06796517,Burkitt lymphoma,CAR-T Therapy
NCT06796517,Burkitt lymphoma,Bispecific antibody
NCT06796517,Burkitt lymphoma,Antibody-Drug Conjugate
NCT06796517,Burkitt lymphoma,Monoclonal antibody
NCT06796517,Burkitt lymphoma,Proteasome Inhibitor
NCT06796517,Burkitt lymphoma,IMiD treatment
NCT06796517,High grade B-cell lymphoma,CAR-T Therapy
NCT06796517,High grade B-cell lymphoma,Bispecific antibody
NCT06796517,High grade B-cell lymphoma,Antibody-Drug Conjugate
NCT06796517,High grade B-cell lymphoma,Monoclonal antibody
NCT06796517,High grade B-cell lymphoma,Proteasome Inhibitor
NCT06796517,High grade B-cell lymphoma,IMiD treatment
NCT06796517,Primary mediastinal large B-cell lymphoma,CAR-T Therapy
NCT06796517,Primary mediastinal large B-cell lymphoma,Bispecific antibody
NCT06796517,Primary mediastinal large B-cell lymphoma,Antibody-Drug Conjugate
NCT06796517,Primary mediastinal large B-cell lymphoma,Monoclonal antibody
NCT06796517,Primary mediastinal large B-cell lymphoma,Proteasome Inhibitor
NCT06796517,Primary mediastinal large B-cell lymphoma,IMiD treatment
NCT06725641,Asthma,Test preparation：Methylcholine chloroacetate for inhalation
NCT06725641,Asthma,Reference preparation：Methylcholine chloroacetate for inhalation（Provocholine）
NCT06712641,Sepsis,Gentamicin + narrow spectrum betalactam
NCT06712641,Sepsis,cefotaxime
NCT06712641,Sepsis,Piperacillin-tazobactam
NCT06651541,Female sexual dysfunction,BZ371A
NCT06979141,Cough,dexmedetomidine
NCT06979141,Cough,magnesium sulfate
NCT06979141,Cough,lidocaine
NCT07068906,B-cell non-Hodgkin lymphoma,CAR-T cells chimenric antigen receptor T cells
NCT07076199,Diabetes mellitus,Insulin icodec
NCT07076199,Diabetes mellitus,insulin glargine
NCT07076199,Diabetes mellitus,"insulin aspart, human"
NCT06811142,Cerebrovascular disorder,Botulinum Toxin Type A (BoNT-A)
NCT06811142,Spasticity,Botulinum Toxin Type A (BoNT-A)
NCT06895499,Hidradenitis suppurativa,HB0043
NCT06895499,Hidradenitis suppurativa,HB0043
NCT06895499,Hidradenitis suppurativa,HB0043
NCT07052799,Myocardial infarction,Aspirin
NCT06738342,Wound healing,CHX
NCT07099742,Obesity disorder,tirzepatide
NCT06987942,Chickenpox,Varicella vaccine+TIV
NCT06987942,Chickenpox,Varicella vaccine
NCT06987942,Chickenpox,TIV
NCT06656299,Cholecystitis,bupivacaine Injection
NCT06656299,Cholecystitis,"paracetamol, tramadol, and ondansetron"
NCT07080242,Cutaneous neuroendocrine carcinoma,BL-M14D1
NCT07080242,Neuroendocrine carcinoma,BL-M14D1
NCT07080242,Prostate cancer,BL-M14D1
NCT06890299,Type 2 diabetes mellitus,BR3006
NCT06890299,Type 2 diabetes mellitus,BR3006A
NCT06890299,Type 2 diabetes mellitus,BR3006B
NCT06890299,Type 2 diabetes mellitus,BR3006C
NCT07115342,Allergic rhinitis,Standard Allergic Rhinitis Treatment
NCT06959199,Cerebrovascular disorder,Best Medical Treatment
NCT06959199,Ischemic stroke,Best Medical Treatment
NCT06712199,Morbid obesity,oxalidine
NCT07071506,Migraine disorder,Active drug for chronic migraine treatment.
NCT07024706,B-cell chronic lymphocytic leukemia,acalabrutinib
NCT07024706,B-cell chronic lymphocytic leukemia,venetoclax
NCT07063199,Autoimmune thrombocytopenic purpura,daratumumab Injection
NCT06755099,Female sexual dysfunction,Botox
NCT06632106,Hepatocellular carcinoma,Tyrosine kinase inhibitor (TKIs)
NCT06632106,Hepatocellular carcinoma,Immune Checkpoint Inhibitors
NCT06687499,Helicobacter pylori,Bismuth-based susceptibility-guided treatment
NCT06994299,Hepatocellular carcinoma,tremelimumab
NCT06994299,Hepatocellular carcinoma,durvalumab
NCT06901999,Primary central nervous system lymphoma,Orelabrutinib
NCT06901999,Primary central nervous system lymphoma,RCHOP+MTX or Thiotepa
NCT06854406,Irritable bowel syndrome,varenicline
NCT06795399,Heart failure,OPC-131461
NCT07059299,Esophageal adenocarcinoma,tislelizumab
NCT07059299,Esophageal adenocarcinoma,FLOT Chemotherapy
NCT07059299,Gastric adenocarcinoma,tislelizumab
NCT07059299,Gastric adenocarcinoma,FLOT Chemotherapy
NCT07059299,Gastroesophageal junction adenocarcinoma,tislelizumab
NCT07059299,Gastroesophageal junction adenocarcinoma,FLOT Chemotherapy
NCT07054606,Dry eye syndrome,perfluorohexyloctane Ophthalmic Solution
NCT06823375,Hepatocellular carcinoma,Atezolizumab plus Bevacizumab
NCT06857175,Urothelial carcinoma,BL-B01D1
NCT06857175,Urothelial carcinoma,Docetaxel or Paclitaxel
NCT06688175,Chemotherapy,IMRT combined with lobaplatin-based concurrent chemotherapy
NCT07049575,Hidradenitis suppurativa,Ruxolitinib Cream
NCT06675175,Atherosclerotic cardiovascular disease,AZD4144
NCT07034859,Pituitary gland adenoma,cabergoline
NCT07058259,"COPD, severe early onset",Standard COPD Pharmacological Therapy (LAMA + LABA or LAMA + LABA + ICS)
NCT06799000,Hidradenitis suppurativa,Remibrutinib Dose A
NCT06799000,Hidradenitis suppurativa,Remibrutinib Dose B
NCT06987500,Neoplasm,XNW29016
NCT06987500,Neoplasm,XNW29016
NCT07078500,Diffuse large B-cell lymphoma,orelabrutinib combined with the Pola-R-CHP regimen
NCT06576375,Polycystic ovary syndrome,dapagliflozin
NCT06576375,Polycystic ovary syndrome,metformin
NCT06625359,Primary central nervous system lymphoma,Thiotepa in conditioning before transplantation
NCT06873659,Gastric carcinoma,SON-DP
NCT07084259,Coronary artery disorder,PCSK9 inhibitor
NCT07084259,Coronary artery disorder,Standard Lipid-Lowering Therapy
NCT06881459,Type 1 diabetes mellitus,oxytocin
NCT06575075,Obsessive-compulsive disorder,RR-HNK/Hydroxynorketamine
NCT07037459,Obesity disorder,Maridebart cafraglutide
NCT07124000,Adenocarcinoma,trastuzumab deruxtecan
NCT07124000,Anal carcinoma,trastuzumab deruxtecan
NCT07124000,Cervical carcinoma,trastuzumab deruxtecan
NCT07124000,Childhood bladder carcinoma,trastuzumab deruxtecan
NCT07124000,Endometrial cancer,trastuzumab deruxtecan
NCT07124000,Malignant pancreatic neoplasm,trastuzumab deruxtecan
NCT07124000,Melanoma,trastuzumab deruxtecan
NCT07124000,Nonpapillary renal cell carcinoma,trastuzumab deruxtecan
NCT07124000,Ovarian cancer,trastuzumab deruxtecan
NCT07124000,Prostate cancer,trastuzumab deruxtecan
NCT07124000,Sarcoma,trastuzumab deruxtecan
NCT07124000,Small cell lung carcinoma,trastuzumab deruxtecan
NCT07124000,Testicular cancer,trastuzumab deruxtecan
NCT07124000,Vaginal carcinoma,trastuzumab deruxtecan
NCT07124000,Vulvar carcinoma,trastuzumab deruxtecan
NCT06682000,Essential hypertension,"DWC202404, DWC202314"
NCT06682000,Essential hypertension,"DWC202404, DWC202314P"
NCT06682000,Hypertensive disorder,"DWC202404, DWC202314"
NCT06682000,Hypertensive disorder,"DWC202404, DWC202314P"
NCT06769659,Epilepsy,NPT
NCT06774859,Influenza,baloxavir marboxil
NCT06774859,Influenza,oseltamivir
NCT06752759,Ketamine,nebulized ketamine
NCT06939959,Dry eye syndrome,Artificial tear
NCT06939959,Dry eye syndrome,"insulin, regular, human"
NCT07040059,Gastroesophageal junction adenocarcinoma,AUR103 Calcium
NCT07040059,Gastroesophageal junction adenocarcinoma,Trastuzumab + CAPOX (Capecitabine + Oxaliplatin)
NCT07046559,Cancer,LY4066708
NCT07046559,Cancer,LY4066708
NCT06982859,Diabetes mellitus,Retatrutide
NCT06982859,Diabetes mellitus,semaglutide
NCT06627270,Lip and oral cavity carcinoma,metronidazole
NCT06940570,Aplastic anemia,PCA plus methadone (Experimental)
NCT06940570,Aplastic anemia,PCA Alone (SOC)
NCT06940570,Leukemia,PCA plus methadone (Experimental)
NCT06940570,Leukemia,PCA Alone (SOC)
NCT06878170,COVID-19,RBM-001
NCT06671470,Insomnia,YZJ-1139 tablets
NCT06671470,Insomnia,Ticagrelor Tablets
NCT06861075,Cirrhosis of liver,carvedilol
NCT06810336,Pain,remifentanil
NCT06810336,Pain,methadone
NCT06841913,Influenza,LAIV nasal vaccine is chosen as a model viral infection
NCT06663436,Diarrheal disease,altSonflex1-2-3 Dose A
NCT06663436,Diarrheal disease,altSonflex1-2-3 Dose B
NCT06663436,Diarrheal disease,altSonflex1-2-3 Dose C
NCT06663436,Diarrheal disease,TYPHIBEV
NCT06663436,Diarrheal disease,MR-VAC
NCT06801236,Prostate cancer,ACE-232 tablets
NCT06864936,Multiple sclerosis,ublituximab
NCT06645249,Atrial fibrillation,Amiodarone (Antiarrhythmic drug)
NCT06681636,Anogenital human papillomavirus infection,Human papillomavirus
NCT06681636,Cervical carcinoma,Human papillomavirus
NCT07044336,Endometrial cancer,Puxitatug Samrotecan
NCT07044336,Endometrial cancer,doxorubicin
NCT07044336,Endometrial cancer,paclitaxel
NCT06883136,Non-small cell lung carcinoma,Sintilimab+Cis-platinum/Carboplatin with Pemetrexed or Gemcitabine
NCT06731413,Non-small cell lung carcinoma,Reduced Dose of Chemotherapy and Immunotherapy
NCT06833749,Obesity disorder,KBP-336
NCT07066436,Diffuse large B-cell lymphoma,MRI contrast-enhancing agents
NCT06764836,Hepatocellular carcinoma,IMM27M
NCT06764836,Hepatocellular carcinoma,IMM2510
NCT07031713,Systemic lupus erythematosus,CAR-T Therapy
NCT06623136,Non-small cell lung carcinoma,ES102
NCT06623136,Non-small cell lung carcinoma,toripalimab
NCT06958536,Crohn disease,SAR442970
NCT07118449,Coronary artery disorder,XC001
NCT07037836,"COPD, severe early onset",Inhaled Treprostinil (Tyvaso Nebulizer)
NCT07037836,Hypoxemia,Inhaled Treprostinil (Tyvaso Nebulizer)
NCT06693336,Carcinoma,SMS001
NCT06671236,Alzheimer disease,Autologous Human Polyclonal Regulatory T Cells Injection (NP001 Cell Injection)
NCT06671236,Amyotrophic lateral sclerosis,Autologous Human Polyclonal Regulatory T Cells Injection (NP001 Cell Injection)
NCT06671236,Multiple system atrophy,Autologous Human Polyclonal Regulatory T Cells Injection (NP001 Cell Injection)
NCT06920836,Cough,QR052107B
NCT06920836,Cough,QR052107B
NCT06616636,Childhood myelodysplastic syndrome,azacitidine
NCT06616636,Childhood myelodysplastic syndrome,Rezatapopt
NCT07042113,Atopic eczema,new formulations of
NCT07042113,Atopic eczema,existing formulations of
NCT06706713,Non-small cell lung carcinoma,BEBT-109 Capsule
NCT06786936,Depressive disorder,secukinumab
NCT06786936,Depressive disorder,bimekizumab
NCT06786936,Depressive disorder,ixekizumab
NCT06786936,Psoriatic arthritis,secukinumab
NCT06786936,Psoriatic arthritis,bimekizumab
NCT06786936,Psoriatic arthritis,ixekizumab
NCT07128199,Non-small cell lung carcinoma,cisplatin
NCT07128199,Non-small cell lung carcinoma,carboplatin
NCT07128199,Non-small cell lung carcinoma,pemetrexed
NCT07128199,Non-small cell lung carcinoma,TAS6417
NCT06847399,Binge eating disorder,tirzepatide
NCT06847399,Binge eating disorder,Lisdexamfetamine Dimesylate
NCT06929936,Non-small cell lung carcinoma,Trilaciclib combined with Docetaxel
NCT06980649,Graves disease,BHV-1300
NCT06915506,Sepsis,Shenfu Injection
NCT07028749,Hypertriglyceridemia,MAR001
NCT07063849,Influenza,A/Texas
NCT06667349,ST-elevation myocardial infarction,ticagrelor
NCT06684106,Hyperlipidemia,Ursodeoxycholic acid (UDCA)
NCT07046806,Hereditary angioedema,Deucrictibant XR tablet
NCT07046806,Hereditary angioedema,Deucrictibant
NCT06914206,Herpes zoster,esketamine group
NCT06914206,Herpes zoster,PRF group
NCT06916806,Acquired idiopathic inflammatory myopathy,AZD5492
NCT06916806,Systemic lupus erythematosus,AZD5492
NCT07016399,Triple-negative breast carcinoma,carboplatin
NCT07016399,Triple-negative breast carcinoma,cyclophosphamide
NCT07016399,Triple-negative breast carcinoma,darolutamide
NCT07016399,Triple-negative breast carcinoma,doxorubicin
NCT07016399,Triple-negative breast carcinoma,epirubicin
NCT07016399,Triple-negative breast carcinoma,paclitaxel
NCT07016399,Triple-negative breast carcinoma,pembrolizumab
NCT06840899,Spinal cord injury,CBD
NCT06937099,Crohn disease,mirikizumab
NCT06937099,Crohn disease,mirikizumab
NCT06937099,Crohn disease,tirzepatide
NCT07017699,Psoriasis,deucravacitinib
NCT07017699,Psoriasis,Other systemic treatments for PsO
NCT07020949,Maturity-onset diabetes of the young type 1,THDBH120 injection
NCT07015749,Asthma,IBI3002
NCT06737549,Dysphagia,Nerver growth factor (NGF) injection
NCT06737549,Ischemic stroke,Nerver growth factor (NGF) injection
NCT07098949,Gastric carcinoma,Chemotherapy
NCT07076706,Androgenetic alopecia,minoxidil + finasteride
NCT07076706,Androgenetic alopecia,minoxidil + finasteride
NCT06628206,Psoriatic arthritis,LPX-TI641
NCT06628206,Rheumatoid arthritis,LPX-TI641
NCT07081906,Overactive bladder,Oral Oxybutynin
NCT07081906,Overactive bladder,transdermal oxybutinin
NCT06586606,Alzheimer disease,MK-1708
NCT06586606,Alzheimer disease,itraconazole
NCT07069699,Burkitt lymphoma,Pidnarulex
NCT06856499,Fallopian tube carcinoma,Cirtuvivint
NCT06856499,Fallopian tube carcinoma,olaparib
NCT06856499,Primary peritoneal carcinoma,Cirtuvivint
NCT06856499,Primary peritoneal carcinoma,olaparib
NCT06946849,Intrahepatic cholangiocarcinoma,FOLFIRI or FOLFOX or Regorafenib
NCT06901349,Obesity disorder,Bimagrumab
NCT06901349,Obesity disorder,tirzepatide
NCT06981949,Pain,dexmedetomidine
NCT06981949,Pain,ropivacaine
NCT06606106,Obesity disorder,LY3537031
NCT06900049,Duchenne muscular dystrophy,LE051
NCT06663306,Neoplastic meningitis,pemetrexed
NCT06663306,Neoplastic meningitis,bevacizumab
NCT07046949,Tumor of uterus,Parenteral administration of analgesics
NCT06801249,Cushing syndrome,Metarapone
NCT06801249,Cushing syndrome,Standardized antihypertensive therapy
NCT06708949,Nonpapillary renal cell carcinoma,Drugs Nivolumab
NCT06708949,Nonpapillary renal cell carcinoma,ipilimumab
NCT06708949,Nonpapillary renal cell carcinoma,BMS-986213 (Relatlimab-Nivolumab FDC)
NCT06716970,Essential hypertension,QR12000
NCT06716970,Essential hypertension,QR12000
NCT06716970,Essential hypertension,QR12000
NCT06716970,Essential hypertension,QR12000
NCT06716970,Essential hypertension,Sacubitril/valsartan
NCT06716970,Essential hypertension,Sacubitril/valsartan
NCT06841770,Spinal cord injury,OPC1
NCT07006675,Pain,600 mg Ibuprofen
NCT07017270,Diabetes mellitus,Semaglutide Pen
NCT07017270,End stage renal failure,Semaglutide Pen
NCT07017270,Kidney disorder,Semaglutide Pen
NCT06664970,Myelodysplastic syndrome,Azacitidine or Ruxolitinib combined with Selinexor
NCT07113275,Rectal carcinoma,capecitabine
NCT07113275,Rectal carcinoma,oxaliplatin
NCT07113275,Rectal carcinoma,Camrelizumab
NCT06764875,Gastroesophageal junction adenocarcinoma,Rilvegostomig
NCT06764875,Gastroesophageal junction adenocarcinoma,trastuzumab deruxtecan
NCT06764875,Gastroesophageal junction adenocarcinoma,trastuzumab
NCT06764875,Gastroesophageal junction adenocarcinoma,pembrolizumab
NCT06764875,Gastroesophageal junction adenocarcinoma,5-fluorouracil
NCT06764875,Gastroesophageal junction adenocarcinoma,capecitabine
NCT06764875,Gastroesophageal junction adenocarcinoma,cisplatin
NCT06764875,Gastroesophageal junction adenocarcinoma,oxaliplatin
NCT06757075,Pain,ibuprofen
NCT06757075,Pain,Acetominophen
NCT07009470,Hepatocellular carcinoma,Finotonlimab (an anti-PD-1 monoclonal antibody) and Anbeizhu (a bevacizumab biosimilar)
NCT06715670,Cirrhosis of liver,Zibotentan
NCT07098975,Fetal growth restriction,Pravastatin
NCT07098975,Preeclampsia,Pravastatin
NCT06619275,Gastrointestinal stromal tumor,ripretinib
NCT07043270,Pancreatic adenocarcinoma,Nab-paclitaxel + Gemcitabine
NCT07043270,Pancreatic adenocarcinoma,modified FOLFIRINOX (mFOLFIRINOX)
NCT06961370,Age-related macular degeneration,RO7669330
NCT06961370,Age-related macular degeneration,Syfovre™
NCT06961370,Age-related macular degeneration,Izervay™
NCT06684470,Diarrheal disease,mirtazapine
NCT06684470,Superficial epidermolytic ichthyosis,mirtazapine
NCT07079670,COVID-19,"SARS-CoV-2 (COVID-19) vaccine, protein NVX-CoV2705"
NCT06746870,Non-small cell lung carcinoma,IMM2510
NCT06746870,Non-small cell lung carcinoma,Chemotherapy (pemetrexed + cisplatin/carboplatin)
NCT06746870,Non-small cell lung carcinoma,Chemotherapy (paclitaxel + cisplatin/carboplatin)
NCT06746870,Non-small cell lung carcinoma,Chemotherapy(Nab-paclitaxel)
NCT07052370,Hematopoietic and lymphoid cell neoplasm,Thymoglobulin
NCT07052370,Hematopoietic and lymphoid cell neoplasm,cyclophosphamide
NCT07052370,Hematopoietic and lymphoid cell neoplasm,fludarabine
NCT07052370,Hematopoietic and lymphoid cell neoplasm,thiotepa
NCT07052370,Hematopoietic and lymphoid cell neoplasm,melphalan
NCT07052370,Hematopoietic and lymphoid cell neoplasm,mesna
NCT07052370,Hematopoietic and lymphoid cell neoplasm,filgrastim
NCT07052370,Hematopoietic and lymphoid cell neoplasm,blinatumomab
NCT07080775,Parkinson disease,human allogeneic induced pluripotent stem cell (iPSC)-derived dopaminergic neural progenitor cell injection
NCT06609070,Squamous cell carcinoma,CHG0521 Oral Coating
NCT07118670,Proliferative diabetic retinopathy,Aflibercept
NCT06632470,Dementia,Secretome injection
NCT06632470,Dementia,Vitamin B12 Injection
NCT06623370,Muscle weakness,methylprednisolone
NCT07004075,Low grade glioma,Luvometinib
NCT07004075,Low grade glioma,"Chemotherapeutic Agent COG-V/C Carboplatin + Vindesine, Carboplatin, Temozolomide"
NCT06857370,Diphtheria,"Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed (DTcP Lot"
NCT06857370,Diphtheria,"Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed (DTcP Lot"
NCT06857370,Diphtheria,"Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed (DTcP Lot"
NCT06831175,Adrenal cortex carcinoma,Camrelizumab
NCT06831175,Adrenal cortex carcinoma,Apatinib
NCT06831175,Adrenal cortex carcinoma,mitotane
NCT06907641,Prostate cancer,64Cu-SAR-bisPSMA
NCT06947941,Psychotic disorder,KarXT
NCT06947941,Psychotic disorder,KarX-EC
NCT06888817,Malignant glioma,bevacizumab
NCT06888817,Malignant glioma,dexamethasone
NCT06642441,Chemotherapy,Chemotherapy + vitamin D2
NCT06642441,Chemotherapy,Chemotherapy
NCT06642441,Vitamin D,Chemotherapy + vitamin D2
NCT06642441,Vitamin D,Chemotherapy
NCT06687941,Carcinoma,AST-201
NCT06931119,Pruritus,EMEND® (EE mend) (aprepitant) capsules (80mg +125mg) Marketing Authorization Holder and Importer: Merck Sharp & Dohme (Israel-1996) Company Ltd.
NCT06860841,Type 2 diabetes mellitus,D-Chiro-Inositol Combined with Metformin
NCT06914141,Diabetes mellitus,tirzepatide
NCT06914141,Diabetes mellitus,semaglutide
NCT06801041,Anxiety,Psilocybin
NCT06801041,Cancer,Psilocybin
NCT06801041,Depressive disorder,Psilocybin
NCT07023341,Hypertrophic cardiomyopathy,BAY3723113
NCT06608017,Allergic rhinitis,Chinese Herbal Medicine granules
NCT06915441,Bronchopulmonary dysplasia,SOLE
NCT06915441,Bronchopulmonary dysplasia,MOLE
NCT06577441,Childhood myelodysplastic syndrome,Decitabine and Cedazuridine
NCT06577441,Childhood myelodysplastic syndrome,enasidenib
NCT06634641,Psychotic disorder,blood test
NCT07132541,Malignant pancreatic neoplasm,Pancreatic parenchymal injection of N-butyl-2-cyanoacrylate(Histoacryl®)
NCT07014319,Cytomegalovirus,maribavir
NCT06773117,Cough,Susu Xiao'er Zhike Granules
NCT06773117,Cough,Extremely-low dose Susu Xiao'er Zhike Granules
NCT07038941,Androgenetic alopecia,CG2001
NCT06785519,Lupus nephritis,CD19/BCMA Lupus Nephritis Targeted CAR T-cells injection
NCT07126119,Renal pelvis/ureter urothelial carcinoma,Nab-Paclitaxel
NCT07126119,Renal pelvis/ureter urothelial carcinoma,tislelizumab
NCT06676917,Non-small cell lung carcinoma,datopotamab deruxtecan
NCT06755541,Primary biliary cholangitis,Fenofibrate in Combination With Ursodeoxycholic Acid
NCT06736717,Malignant pancreatic neoplasm,Onvansertib
NCT06736717,Malignant pancreatic neoplasm,NALIRIFOX
NCT06931041,Dry eye syndrome,insulin lispro
NCT06931041,Sjogren syndrome,insulin lispro
NCT06768619,Thrombocytopenia,Group
NCT06768619,Thrombocytopenia,Group
NCT07035613,Inflammatory bowel disease,BXD treatment
NCT06654336,Prostate adenocarcinoma,ELIGARD
NCT06825013,"COPD, severe early onset",Bronchodilators inhalation
NCT06649136,Rheumatoid arthritis,methotrexate
NCT06996236,Myopia,Treatment with brimonidine eye drops
NCT06708013,Endogenous depression,Transcranial Magnetic Stimulation
NCT07016113,Vitiligo-associated multiple autoimmune disease susceptibility 1,0.005% latanoprost gel
NCT07016113,Vitiligo-associated multiple autoimmune disease susceptibility 1,0.1% mometasone furoate cream
NCT06823713,Cirrhosis of liver,RTX001
NCT06758713,B-cell non-Hodgkin lymphoma,CAR-T
NCT06866613,Ankle injury,Esflurbiprofen Topical System (EFTS)
NCT06867536,Lymphoma,Glofitamab + Obinutuzumab
NCT07001436,Kidney failure,Azvudine tablets
NCT06623513,Pancreatitis,Parecoxib Sodium
NCT06623513,Pancreatitis,Indomethacin suppository
NCT06800313,Prostate cancer,HLD-0915
NCT06858813,Pediatric hepatocellular carcinoma,lenvatinib
NCT06858813,Pediatric hepatocellular carcinoma,ABBV-324
NCT06737536,Obesity disorder,NNC0662-0419
NCT06779318,Malignant pancreatic neoplasm,S-1
NCT06797518,Glomerulonephritis,iptacopan
NCT06714513,Tuberculosis,QTP101
NCT07040813,Migraine disorder,CGRP mAbs and onabotulinumtoxin A
NCT06632418,Anal fistula,RhPDGF-BB
NCT06618118,Endogenous depression,Fosigotifator
NCT06728618,Oropharynx squamous cell carcinoma,"Drug: Tislelizumab, Cetuximab, Cisplatin and Nab-paclitaxel"
NCT06749418,Preeclampsia,eplerenone
NCT06661018,ST-elevation myocardial infarction,Coenzyme Q
NCT06761313,Glaucoma,Triple combination formula
NCT06761313,Glaucoma,Bimatoprost .03% sterile ophthalmic solution
NCT07001618,Non-small cell lung carcinoma,MaaT033 capsule
NCT07001618,Non-small cell lung carcinoma,cemiplimab
NCT07001618,Non-small cell lung carcinoma,cisplatin
NCT07001618,Non-small cell lung carcinoma,Carboplatine
NCT07001618,Non-small cell lung carcinoma,Pemetrexed (Alimta)
NCT07001618,Non-small cell lung carcinoma,bevacizumab
NCT07001618,Non-small cell lung carcinoma,paclitaxel
NCT07001618,Non-small cell lung carcinoma,gemcitabine
NCT07001618,Non-small cell lung carcinoma,docetaxel
NCT07001618,Non-small cell lung carcinoma,Vinorelbine i.v.
NCT07001618,Non-small cell lung carcinoma,Vinorelbine oral
NCT06570213,Post-traumatic stress disorder,Stellate Ganglion Block
NCT06802913,Insomnia,Inhaled Melatonin (100 μg)
NCT06802913,Insomnia,Oral Melatonin (4 mg)
NCT06640413,Classic familial adenomatous polyposis,[177Lu]Lu-OncoFAP-23
NCT06640413,Classic familial adenomatous polyposis,L19IL2
NCT07047118,Prostate cancer,JSB462
NCT07047118,Prostate cancer,AAA617
NCT06701513,Psoriasis,deucravacitinib
NCT06954818,Herpes zoster,A zoster mRNA vaccine SYS6017
NCT06839313,Stomatitis,"Kenacort A Orabase® pomad , Bristol-Myers Squibb İlaçları Inc. İstanbul , Türkiye"
NCT07064018,Cervical carcinoma,Spedox-6
NCT07064018,Cervical carcinoma,pegfilgrastim
NCT07064018,Cervical carcinoma,filgrastim
NCT07064018,Non-small cell lung carcinoma,Spedox-6
NCT07064018,Non-small cell lung carcinoma,pegfilgrastim
NCT07064018,Non-small cell lung carcinoma,filgrastim
NCT07064018,Ovarian cancer,Spedox-6
NCT07064018,Ovarian cancer,pegfilgrastim
NCT07064018,Ovarian cancer,filgrastim
NCT06843018,Pharyngitis,Grammidin with anesthetic
NCT06843018,Pharyngitis,Septolete Total
NCT06626113,Obesity disorder,ascorbic acid
NCT06849713,B-cell chronic lymphocytic leukemia,zanubrutinib
NCT06849713,B-cell chronic lymphocytic leukemia,Sonrotoclax
NCT06849713,B-cell chronic lymphocytic leukemia,obinutuzumab
NCT07043218,Precursor B-cell acute lymphoblastic leukemia,Chimeric Antigen Receptor T Cells (CAR-T)
NCT06629818,AL amyloidosis,Daratumumab
NCT06629818,AL amyloidosis,venetoclax
NCT06629818,AL amyloidosis,dexamethasone
NCT06923618,Non-small cell lung carcinoma,Blood samples
NCT06966518,Ketamine,Ketamine and Magnesium Sulfate
NCT06826118,Follicular lymphoma,axicabtagene ciloleucel
NCT06826118,Lymphoma,axicabtagene ciloleucel
NCT06762041,Autism,Metformin treatment
NCT06613841,Adult glioblastoma,Fluciclovine F18
NCT06875141,Preeclampsia,DM199
NCT06607419,Precursor B-cell acute lymphoblastic leukemia,blinatumomab
NCT07042919,Cirrhosis of liver,Zanzalintinib
NCT06751017,COVID-19,S-892216
NCT06751017,COVID-19,carbamazepine
NCT07053917,Cerebrovascular disorder,Psilocybin (Usona Institute)
NCT07053917,Ischemic stroke,Psilocybin (Usona Institute)
NCT06946641,Atopic eczema,QLS12010
NCT06946641,Hidradenitis suppurativa,QLS12010
NCT06946641,Rheumatoid arthritis,QLS12010
NCT06868017,HER2 positive breast carcinoma,Cohort A will receive an initial load dose of
NCT06868017,HER2 positive breast carcinoma,Cohort B will receive an initial load dose of
NCT07071441,Pancreatitis,indomethacin
NCT07071441,Pancreatitis,Diclofenac
NCT07067541,Atopic eczema,Control lidocaine cream
NCT07067541,Atopic eczema,Experimental lidocaine cream + moisturizer cream
NCT06608641,Bipolar I disorder,Endoxifen enteric-coated tablet (8 mg)
NCT06970119,Prostate cancer,INR102 injection
NCT06676319,Asthma,Lunsekimig
NCT06676319,Asthma,Short-Acting Beta Agonists (SABA)
NCT06676319,Asthma,Fluticasone/salmeterol
NCT06676319,Asthma,Budesonide/formoterol
NCT07020819,Guillain-Barre syndrome,Tanruprubart
NCT06824519,Influenza,"Influenza Vaccine (Split Virion), Inactivated, Quadrivalent, ZFA02 Adjuvant (low dose)"
NCT06824519,Influenza,"Influenza Vaccine (Split Virion), Inactivated, Quadrivalent, ZFA02 Adjuvant (high dose)"
NCT06824519,Influenza,"Influenza Vaccine (Split Virion), Inactivated, Quadrivalent"
NCT06999941,Atopic eczema,Deucravacitinib
NCT06999941,Psoriasis,Deucravacitinib
NCT07033819,Ovarian cancer,Neoadjuvant therapy with fluazoparib in combination with apatinib
NCT07033819,Ovarian cancer,Chemotherapy
NCT07033819,Ovarian cancer,Maintenance treatment
NCT07123519,Anti-neutrophil cytoplasmic antibody-associated vasculitis,YTS109 cell
NCT07123519,Antiphospholipid syndrome,YTS109 cell
NCT07123519,Inclusion body myositis,YTS109 cell
NCT07123519,Lupus nephritis,YTS109 cell
NCT07123519,Systemic lupus erythematosus,YTS109 cell
NCT06673641,Acne,"Clindamycin Phosphate, Adapalene, and Benzoyl Peroxide Topical Gel"
NCT06673641,Acne,3.1%
NCT06673641,Acne,1.2%
NCT06766019,Malignant pancreatic neoplasm,"Adebrelimab combined with irinotecan liposomal (II), oxaliplatin, and"
NCT06903819,Depressive disorder,ketamine
NCT06903819,Depressive disorder,standard general anesthesia
NCT06903819,Post-traumatic stress disorder,ketamine
NCT06903819,Post-traumatic stress disorder,standard general anesthesia
NCT06984341,Systemic lupus erythematosus,P-CD19CD20-ALLO1 Cells
NCT06984341,Systemic lupus erythematosus,cyclophosphamide
NCT06984341,Systemic lupus erythematosus,fludarabine
NCT06984341,Systemic lupus erythematosus,Rimiducid
NCT06727019,Myopia,Atropine (0.01%)
NCT06976619,Type 1 diabetes mellitus,liraglutide Pen Injector
NCT06976619,Type 2 diabetes mellitus,liraglutide Pen Injector
NCT06974019,Pain,Buffered Lidocaine
NCT06974019,Pain,Lidocaine
NCT06619886,Malignant pancreatic neoplasm,"Autologous, engineered T Cells targeting TP53 R248Q"
NCT06670963,Anemia,iron
NCT06670963,Anemia,EPO
NCT06670963,Anemia,0.9 % NaCl
NCT06670963,Sepsis,iron
NCT06670963,Sepsis,EPO
NCT06670963,Sepsis,0.9 % NaCl
NCT06603363,Coronary artery disorder,Rosuvastatin
NCT06910839,Obesity disorder,PF-07976016
NCT06910839,Obesity disorder,PF-06882961
NCT07101939,Obesity disorder,(S)-pindolol benzoate
NCT07101939,Obesity disorder,semaglutide
NCT06897839,Bronchopulmonary dysplasia,Zelpultide alfa
NCT06708286,Diphtheria,"Tetanus, Reduced Diphtheria and Acellular Pertussis (Five Components) Combined Vaccine, Adsorbed (Tdcp))"
NCT06708286,Diphtheria,23-valent Pneumococcal Polysaccharide Vaccine (PPV23)
NCT06708286,Diphtheria,Tdcp
NCT06708286,Diphtheria,PPV23
NCT06708286,Diphtheria,Tdcp
NCT06708286,Diphtheria,PPV23
NCT06708286,Diphtheria,Tdcp
NCT06708286,Diphtheria,PPV23
NCT06708286,Diphtheria,Tdcp
NCT06708286,Diphtheria,Diphtheria-tetanus-acellular pertussis vaccine (DTaP)
NCT06708286,Pertussis,"Tetanus, Reduced Diphtheria and Acellular Pertussis (Five Components) Combined Vaccine, Adsorbed (Tdcp))"
NCT06708286,Pertussis,23-valent Pneumococcal Polysaccharide Vaccine (PPV23)
NCT06708286,Pertussis,Tdcp
NCT06708286,Pertussis,PPV23
NCT06708286,Pertussis,Tdcp
NCT06708286,Pertussis,PPV23
NCT06708286,Pertussis,Tdcp
NCT06708286,Pertussis,PPV23
NCT06708286,Pertussis,Tdcp
NCT06708286,Pertussis,Diphtheria-tetanus-acellular pertussis vaccine (DTaP)
NCT06708286,Tetanus,"Tetanus, Reduced Diphtheria and Acellular Pertussis (Five Components) Combined Vaccine, Adsorbed (Tdcp))"
NCT06708286,Tetanus,23-valent Pneumococcal Polysaccharide Vaccine (PPV23)
NCT06708286,Tetanus,Tdcp
NCT06708286,Tetanus,PPV23
NCT06708286,Tetanus,Tdcp
NCT06708286,Tetanus,PPV23
NCT06708286,Tetanus,Tdcp
NCT06708286,Tetanus,PPV23
NCT06708286,Tetanus,Tdcp
NCT06708286,Tetanus,Diphtheria-tetanus-acellular pertussis vaccine (DTaP)
NCT07116863,Essential hypertension,KDF1901-R0
NCT07116863,Essential hypertension,KDF1901-L
NCT07116863,Essential hypertension,KDF1901
NCT07116863,Essential hypertension,KDF1901-R1
NCT07023939,Dental caries,"ART: Atraumatic restorative treatment, SMART: Silver-Modified Atraumatic Restorative Treatment"
NCT06922539,Small cell lung carcinoma,Fenretinide
NCT06922539,Small cell lung carcinoma,Fenretinide
NCT07102186,Acne,use of adapalene gel
NCT07102186,Acne,use of adapalene gel
NCT07043686,Ischemic stroke,Cerebrolysin treatment
NCT06724263,Hepatocellular carcinoma,B1962
NCT06724263,Small cell lung carcinoma,B1962
NCT06900686,Malignant colon neoplasm,PD1 Inhibitor
NCT06900686,Rectal carcinoma,PD1 Inhibitor
NCT06740786,Atrial fibrillation,Dapagliflozin Treatment Group
NCT06969586,Cataract,Netarsudil
NCT06969586,Cataract,artificial tear substitute
NCT06969586,Fuchs' endothelial dystrophy,Netarsudil
NCT06969586,Fuchs' endothelial dystrophy,artificial tear substitute
NCT06969586,Glaucoma,Netarsudil
NCT06969586,Glaucoma,artificial tear substitute
NCT07018063,Gastric adenocarcinoma,nab-paclitaxel
NCT07018063,Gastric adenocarcinoma,oxaliplatin
NCT07018063,Gastric adenocarcinoma,S-1
NCT07018063,Gastric adenocarcinoma,sintilimab
NCT07018063,Gastric carcinoma,nab-paclitaxel
NCT07018063,Gastric carcinoma,oxaliplatin
NCT07018063,Gastric carcinoma,S-1
NCT07018063,Gastric carcinoma,sintilimab
NCT06689163,Prostate cancer,HRS-1167 tablets
NCT06689163,Prostate cancer,Abiraterone Acetate tablets（II）
NCT06689163,Prostate cancer,Prednisone Acetate tablets
NCT06721286,Intrahepatic cholangiocarcinoma,Teripalimab
NCT06721286,Intrahepatic cholangiocarcinoma,Gemcitabine + Cisplatin
NCT06766786,Diabetes mellitus,Magnesium Sulfate high dose
NCT06766786,Exocrine pancreatic insufficiency,Magnesium Sulfate high dose
NCT07047586,Hepatocellular carcinoma,tislelizumab
NCT07047586,Hepatocellular carcinoma,lenvatinib
NCT07064486,Type 2 diabetes mellitus,BGM0504
NCT07064486,Type 2 diabetes mellitus,BGM0504
NCT07064486,Type 2 diabetes mellitus,semaglutide
NCT06621563,Non-small cell lung carcinoma,HS-20117 combined HS-20093
NCT06621563,Non-small cell lung carcinoma,HS-20117 combined Platinum-containing chemotherapy
NCT06621563,Non-small cell lung carcinoma,HS-20117 combined HS-20093 and
NCT06621563,Non-small cell lung carcinoma,HS-20117+CAPEOX
NCT06621563,Non-small cell lung carcinoma,HS-20117+FOLFIRI
NCT06621563,Non-small cell lung carcinoma,HS-20117+mFOLFOX6
NCT06574763,Ovarian cancer,RC48/Carboplatin
NCT06860763,Attention deficit-hyperactivity disorder,Chinese herbal medicine
NCT06778863,Childhood bladder carcinoma,CLSP-1025
NCT06778863,Ovarian cancer,CLSP-1025
NCT06778863,Pancreatic adenocarcinoma,CLSP-1025
NCT06778863,Prostate cancer,CLSP-1025
NCT06780163,Menopause,17β-estradiol
NCT06780163,Overactive bladder,17β-estradiol
NCT06745063,Obesity disorder,empagliflozin
NCT06836063,Endogenous depression,Ropanicant
NCT07110363,Non-small cell lung carcinoma,BT02
NCT07110363,Small cell lung carcinoma,BT02
NCT07112963,Dental caries,Fluoride Varnish
NCT07007286,Hepatocellular carcinoma,"ETV,TDF,TAF,TMF combination with PEG IFNα-2b"
NCT07007286,Hepatocellular carcinoma,"ETV,TDF,TAF or TMF"
NCT06985186,Adenomyosis,Ultra-Long GnRH Agonists + Letrozole
NCT06985186,Adenomyosis,Ultra-Long GnRH Agonists
NCT06592586,Meningitis,GBS-NN/NN2 vaccine
NCT06592586,Neonatal sepsis,GBS-NN/NN2 vaccine
NCT06592586,Pneumonia,GBS-NN/NN2 vaccine
NCT06582186,Hematopoietic and lymphoid cell neoplasm,Individualization of first voriconazole maintenance doses
NCT06633835,COVID-19,protein subunit: Novavax COVID-19 vaccine
NCT06633835,COVID-19,Pfizer mRNA COVID-19 vaccine
NCT07126158,Exocrine pancreatic carcinoma,defactinib
NCT07126158,Exocrine pancreatic carcinoma,avutometinib
NCT07126158,Malignant pancreatic neoplasm,defactinib
NCT07126158,Malignant pancreatic neoplasm,avutometinib
NCT07126158,Pancreatic adenocarcinoma,defactinib
NCT07126158,Pancreatic adenocarcinoma,avutometinib
NCT06840535,Prostate cancer,[68Ga]Ga-OncoACP3
NCT06688435,Myasthenia gravis,SYS6020 injection
NCT06674135,Type 1 diabetes mellitus,biosimilar insulin glargine
NCT06976658,Diabetes mellitus,Dorzagliatin
NCT06733935,Acquired idiopathic inflammatory myopathy,NKX019
NCT06733935,Acquired idiopathic inflammatory myopathy,fludarabine
NCT06733935,Acquired idiopathic inflammatory myopathy,cyclophosphamide
NCT06733935,Anti-neutrophil cytoplasmic antibody-associated vasculitis,NKX019
NCT06733935,Anti-neutrophil cytoplasmic antibody-associated vasculitis,fludarabine
NCT06733935,Anti-neutrophil cytoplasmic antibody-associated vasculitis,cyclophosphamide
NCT06733935,Systemic sclerosis,NKX019
NCT06733935,Systemic sclerosis,fludarabine
NCT06733935,Systemic sclerosis,cyclophosphamide
NCT06666335,Familial Mediterranean fever,anakinra
NCT06760858,Gastric carcinoma,tislelizumab
NCT06760858,Gastric carcinoma,SOX
NCT06956235,Hidradenitis suppurativa,Tulisokibart
NCT06948435,Hypertensive disorder,Orforglipron
NCT07113158,Sudden sensorineural hearing loss,Aspirin + Acid folic
NCT06572735,Ovarian cancer,Blood sampling
NCT06639958,Childhood acute lymphoblastic leukemia,mercaptopurine
NCT06834035,Epidermolysis bullosa,immunoglobulin G
NCT07078435,Endometriosis,Blood test
NCT07078435,Endometriosis,Stool samples
NCT07078435,Endometriosis,Stool samples
NCT07023835,Amyotrophic lateral sclerosis,50 mg Usnoflast
NCT07023835,Amyotrophic lateral sclerosis,75 mg Usnoflast
NCT06925386,Acne,Standard therapy
NCT06925386,Acne,Secretome
NCT06860386,Nonpapillary renal cell carcinoma,pembrolizumab
NCT06860386,Nonpapillary renal cell carcinoma,axitinib
NCT06932263,Asthma,Tozorakimab
NCT06917963,Inflammatory bowel disease,Intensified intravenous omeprazole therapy (loading dose
NCT06917963,Inflammatory bowel disease,Standard intravenous omeprazole therapy (40 mg IV once daily at
NCT06917963,Malignant colon neoplasm,Intensified intravenous omeprazole therapy (loading dose
NCT06917963,Malignant colon neoplasm,Standard intravenous omeprazole therapy (40 mg IV once daily at
NCT07119463,Gastric carcinoma,Human Serum Albumin Infusion for LAT Group
NCT07119463,Gastric carcinoma,Human Serum Albumin Infusion for HAT Group
NCT06782724,Amyotrophic lateral sclerosis,Psilocybin therapy
NCT06782724,"COPD, severe early onset",Psilocybin therapy
NCT06782724,Endogenous depression,Psilocybin therapy
NCT06660134,Atrial fibrillation,Glucagon-like peptide-1 receptor agonists (GLP
NCT06660134,Type 2 diabetes mellitus,Glucagon-like peptide-1 receptor agonists (GLP
NCT07109817,Peripheral neuropathy,Desloratodine
NCT06949124,Endometriosis,SHR7280 Tablets
NCT07073417,Obesity disorder,XW003 injection
NCT07073417,Obesity disorder,semaglutide injection
NCT07035834,Lupus nephritis,Gliflozin
NCT06734234,Kidney disorder,GSK4771261
NCT06981234,Type 1 diabetes mellitus,acetazolamide
NCT06977724,Dry eye syndrome,ABBV-319
NCT06977724,Systemic lupus erythematosus,ABBV-319
NCT06817434,Moyamoya disease,Revascularization/Conservative management
NCT06810934,COVID-19,CoTend-BXBB (SARS2-30404)
NCT06810934,COVID-19,CoTend-s3BXBB (SARS2-17032)
NCT06653634,Juvenile idiopathic arthritis,methotrexate
NCT06653634,Juvenile idiopathic arthritis,TNF Inhibitor
NCT06854224,Endogenous depression,Suvorexant (dual orexin receptor antagonist)
NCT06613334,Schizophrenia,Blood test: measurement of plasma antipsychotic concentration
NCT06969534,Carcinoma,Pucotenlimab combined with GP regimen
NCT06693934,Diabetes mellitus,Medication
NCT06693934,Hypertensive disorder,Medication
NCT06693934,Inherited lipid metabolism disorder,Medication
NCT06693934,Obesity disorder,Medication
NCT07122024,Helicobacter pylori,Keverprazan
NCT07122024,Helicobacter pylori,Keverprazan
NCT07122024,Helicobacter pylori,rabeprazole
NCT06966024,Nonpapillary renal cell carcinoma,DCC-2812
NCT06966024,Urothelial carcinoma,DCC-2812
NCT06890624,Malignant colon neoplasm,cmFOLFOXIRI plus PD-1 inhibitor
NCT06890624,Malignant colon neoplasm,mFOLFOX6
NCT06771934,Allergic asthma,Allergen-specific immunotherapy(AIT)
NCT06771934,Allergic asthma,omalizumab
NCT07050134,Hypertriglyceridemia,DR10624 Injection；
NCT06786234,Essential thrombocythemia,STP938
NCT07094516,Alzheimer disease,VHB937
NCT07094516,Alzheimer disease,VHB937
NCT06893016,Obesity disorder,RAY1225
NCT07099534,Borderline personality disorder,IV Ketamine (0.5 mg/kg) Infusion - Two Doses Administered
NCT06964217,Hypertensive disorder,Monotherapy
NCT06964217,Hypertensive disorder,Combination therapy
NCT06805617,Adrenal cortex carcinoma,Ivonescimab
NCT06813417,Alveolar soft part sarcoma,GCAR1
NCT06813417,Sarcoma,GCAR1
NCT06585241,COVID-19,mRNA-1273 Variant-containing Formulation
NCT06570317,Non-small cell lung carcinoma,nintedanib
NCT07128641,Follicular lymphoma,Odronextamab
NCT07128641,Lymphoma,Odronextamab
NCT06764017,Diffuse large B-cell lymphoma,CHiR-DEL
NCT06804434,Pain,Lidocaine Intravenous Infusion
NCT06719934,Adenomyosis,Dienogest
NCT06931717,Non-small cell lung carcinoma,cemiplimab
NCT07097441,Hypertensive disorder,neostigmine (reversal agent)
NCT07097441,Tachycardia,neostigmine (reversal agent)
NCT06751134,Neuroblastoma,Chimeric Natural Killer Receptor Universal T-cells (CNK-UT)
NCT06689917,Precursor B-cell acute lymphoblastic leukemia,JY231 Injection
NCT06963034,Schizophrenia,NBI-1117568
NCT06960317,Pain,Buffered Lidocaine
NCT06960317,Pain,Unbuffered lidocaine
NCT06960317,Pain,Xylocaine jelly
NCT06960317,Pain,Surgilube
NCT06969417,Herpes zoster,pregabalin
NCT06969417,Herpes zoster,lacosamide
NCT06905834,Graft versus host disease,Subconjuntival injection of expanded allogenic adult adipose tissue-derived mesenchymal stem cells (ASC
NCT06892834,Gingivitis,Stannous Fluoride Dentifrice
NCT06892834,Gingivitis,Sodium Fluoride Dentifrice
NCT06892834,Gingivitis,Sodium monofluorophosphate dentifrice
NCT06648434,Exocrine pancreatic carcinoma,Zunsemetinib
NCT06648434,Exocrine pancreatic carcinoma,mFOLFIRINOX
NCT06648434,Malignant pancreatic neoplasm,Zunsemetinib
NCT06648434,Malignant pancreatic neoplasm,mFOLFIRINOX
NCT06604117,Atherosclerosis,Statin
NCT06604117,Atherosclerosis,Probucol
NCT06604117,Ischemic stroke,Statin
NCT06604117,Ischemic stroke,Probucol
NCT06793917,Gastric carcinoma,tislelizumab
NCT06793917,Gastric carcinoma,oxaliplatin Injection
NCT06793917,Gastric carcinoma,Levo-Leucovorin
NCT06793917,Gastric carcinoma,5-fluorouracil
NCT06793917,Gastric carcinoma,paclitaxel
NCT06786624,Endogenous depression,NBI-1065845
NCT06772324,Autism,NORSPAN Buprenorphine Transdermal Patchs for Very-low dose group
NCT06772324,Autism,NORSPAN Buprenorphine Transdermal Patchs for Lower dose group
NCT06772324,Autism,NORSPAN Buprenorphine Transdermal Patchs for higher dose group
NCT06632834,Dilated cardiomyopathy,simvastatin therapy
NCT06792734,Lymphoma,BTM-3566
NCT06911034,Iron deficiency anemia,Iron Carboxymaltose
NCT06911034,Iron deficiency anemia,iron sucrose Injection
NCT06974734,Carcinoma,PF-08046037
NCT06974734,Carcinoma,sasanlimab
NCT06974734,Melanoma,PF-08046037
NCT06974734,Melanoma,sasanlimab
NCT07038824,Duchenne muscular dystrophy,ENTR-601-45
NCT06751524,Hepatocellular carcinoma,Botensilimab
NCT06751524,Hepatocellular carcinoma,Balstililmab
NCT06751524,Malignant pancreatic neoplasm,Botensilimab
NCT06751524,Malignant pancreatic neoplasm,Balstililmab
NCT06751524,Melanoma,Botensilimab
NCT06751524,Melanoma,Balstililmab
NCT06751524,Non-small cell lung carcinoma,Botensilimab
NCT06751524,Non-small cell lung carcinoma,Balstililmab
NCT06751524,Ovarian cancer,Botensilimab
NCT06751524,Ovarian cancer,Balstililmab
NCT06751524,Prostate cancer,Botensilimab
NCT06751524,Prostate cancer,Balstililmab
NCT06751524,Sarcoma,Botensilimab
NCT06751524,Sarcoma,Balstililmab
NCT07027124,Prostate cancer,darolutamide
NCT07027124,Prostate cancer,pembrolizumab
NCT07027124,Prostate cancer,Lupron
NCT06842524,Polycystic ovary syndrome,Dihydroartemisinin
NCT06982534,Systemic sclerosis,UTAA91 injection
NCT06998524,Von Willebrand disease (hereditary or acquired),emicizumab
NCT06998524,Von Willebrand disease (hereditary or acquired),von Willebrand Factor (VWF) Concentrates
NCT06998524,Von Willebrand disease (hereditary or acquired),Factor VIII (FVIII) Concentrates
NCT06998524,Von Willebrand disease (hereditary or acquired),von Willebrand Factor (VWF) and Factor VIII (FVIII) Concentrates
NCT06998524,Von Willebrand disease (hereditary or acquired),Bypassing Agents
NCT07032324,B-cell non-Hodgkin lymphoma,CAR T cells
NCT06836024,Constipation disorder,PEG
NCT06671834,Acne,PF-07905428
NCT07074834,Coronary artery disorder,Metoprolol Succinate Sustained-Release Tablets
NCT07074834,Coronary artery disorder,Trimetazidine
NCT07074834,Coronary artery disorder,Routine Drug Therapy
NCT07090824,Diabetes mellitus,Diluted Humalog U-200 Insulin
NCT07090824,Diabetes mellitus,Diluted U-500 Humulin Insulin
NCT07090824,Diabetes mellitus,Lyumjev U-100 Insulin
NCT06775834,Hypertrophic cardiomyopathy,HRS-1893
NCT06906224,Schizophrenia,"Low-dose group (buspirone tablets, clozapine)"
NCT06906224,Schizophrenia,"High-dose group (buspirone tablets, clozapine)"
NCT06999434,Alzheimer disease,[
NCT06999434,Alzheimer disease,[18F]MK6240
NCT06999434,Alzheimer disease,[11C]PIB
NCT06864624,Non-small cell lung carcinoma,sunvozertinib
NCT06631534,Atrial septal defect,dexmedetomidine
NCT06631534,Delirium,dexmedetomidine
NCT06902818,Gastric ulcer,"AD-115A, AD-1151"
NCT06628713,Hereditary angioedema,sebetralstat
NCT07008118,Myeloproliferative neoplasm,INCA035784
NCT06861413,Cystic fibrosis,VX-828
NCT06861413,Cystic fibrosis,VX-828
NCT06849219,Trigeminal neuralgia,oxcarbazepine
NCT06849219,Trigeminal neuralgia,carbamazepine
NCT06700941,Anogenital human papillomavirus infection,HPV vaccine
NCT06700941,Cervical intraepithelial neoplasia,HPV vaccine
NCT06996119,Childhood myelodysplastic syndrome,busulfan
NCT06996119,Childhood myelodysplastic syndrome,cyclophosphamide
NCT06996119,Childhood myelodysplastic syndrome,emapalumab
NCT06996119,Childhood myelodysplastic syndrome,fludarabine
NCT06996119,Childhood myelodysplastic syndrome,melphalan
NCT06996119,Childhood myelodysplastic syndrome,mycophenolate mofetil
NCT06996119,Childhood myelodysplastic syndrome,tacrolimus
NCT06996119,Graft versus host disease,busulfan
NCT06996119,Graft versus host disease,cyclophosphamide
NCT06996119,Graft versus host disease,emapalumab
NCT06996119,Graft versus host disease,fludarabine
NCT06996119,Graft versus host disease,melphalan
NCT06996119,Graft versus host disease,mycophenolate mofetil
NCT06996119,Graft versus host disease,tacrolimus
NCT06689241,Morbid obesity,enoxaparin
NCT06689241,Morbid obesity,rivaroxaban
NCT07044141,Vitiligo-associated multiple autoimmune disease susceptibility 1,azathioprine
NCT07044141,Vitiligo-associated multiple autoimmune disease susceptibility 1,tofacitinib
NCT06613919,Tuberculosis,Anti-Tuberculosis Treatment
NCT06613919,Tuberculosis,Anti-Tuberculosis Treatment
NCT06613919,Uveitis,Anti-Tuberculosis Treatment
NCT06613919,Uveitis,Anti-Tuberculosis Treatment
NCT06662318,Pain,fentanyl citrate
NCT06662318,Pain,dexmedetomidine
NCT06662318,Pain,lidocaine hydrochloride
NCT06572618,Mantle cell lymphoma,Nemtabrutinib
NCT06572618,Mantle cell lymphoma,rituximab
NCT07039318,Diabetic kidney disease,Mesenchymal stem cells
NCT06913218,Malignant pancreatic neoplasm,AK154
NCT06913218,Malignant pancreatic neoplasm,Cadonilimab
NCT06913218,Malignant pancreatic neoplasm,Ivonescimab (SMT112 or AK112) Injection
NCT06913218,Malignant pancreatic neoplasm,mFOLFORINOX
NCT06832618,Atopic eczema,ruxolitinib
NCT07129018,Biliary tract cancer,Trastuzumab-rezetecan + Pertuzumab + Iparomlimab and Tuvonralimab for HER2 Overexpression BTC
NCT07129018,Biliary tract cancer,Trastuzumab-rezetecan + Pertuzumab + Iparomlimab and Tuvonralimab for HER2 Moderate/Low BTC
NCT06900218,Nasopharyngeal carcinoma,Sintilimab
NCT06900218,Nasopharyngeal carcinoma,capecitabine
NCT06601218,Cancer,Oral cannabis low THC
NCT06601218,Cancer,Oral cannabis high THC
NCT06601218,Cancer,Oral cannabis THC/CBD
NCT06986018,Acquired idiopathic inflammatory myopathy,RD06-04 Cell Injection Infusion
NCT06986018,Anti-neutrophil cytoplasmic antibody-associated vasculitis,RD06-04 Cell Injection Infusion
NCT07036952,Polycystic ovary syndrome,Omega
NCT07036952,Polycystic ovary syndrome,Omega -3 fatty acids
NCT06788652,Mantle cell lymphoma,lisocabtagene maraleucel
NCT06683352,COVID-19,Investigational Influenza Vaccine
NCT06683352,COVID-19,COVID-19 Vaccine
NCT06683352,COVID-19,Licensed Influenza Vaccine
NCT06683352,COVID-19,Licensed Influenza Vaccine
NCT06596252,Eosinophilic esophagitis,budesonide
NCT06825819,COVID-19,Subjects with and without Long COVID
NCT07100119,Amyotrophic lateral sclerosis,LY4256984
NCT06858319,Glomerulonephritis,zigakibart
NCT06980519,Cancer,MNPR-101-PCTA-177Lu
NCT06962319,Malaria,dihydroartemisinin-piperaquine (DP)
NCT06962319,Malaria,Pyronaridine-artesunate (PA)
NCT06962319,Malaria,Artemether-lumefantrine
NCT06650319,Wilson disease,intravenous LY-M003
NCT06599619,Melanoma,"Single agent, adjuvant anti-PD1 therapy"
NCT06626919,Muscle weakness,anito-cel
NCT06626919,Muscle weakness,Standard Lymphodepletion regimen
NCT06626919,Myasthenia gravis,anito-cel
NCT06626919,Myasthenia gravis,Standard Lymphodepletion regimen
NCT06948019,Hereditary spastic paraplegia,BFB-101 (AAV9-CBh-AP4B1)
NCT06948019,Movement disorder,BFB-101 (AAV9-CBh-AP4B1)
NCT07053319,Type 2 diabetes mellitus,Empagliflozin
NCT07053319,Type 2 diabetes mellitus,Pioglitazone
NCT07053319,Type 2 diabetes mellitus,Empagliflozin
NCT06830642,Cervical dystonia,MTR-601
NCT06935370,Heart failure,Vicadrostat
NCT06935370,Heart failure,empagliflozin
NCT06603142,Hyperuricemia,Febuxostat
NCT06603142,Hyperuricemia,Febuxostat
NCT06603142,Hyperuricemia,AR882
NCT06603142,Hyperuricemia,AR882
NCT06603142,Hyperuricemia,AR882
NCT06603142,Hyperuricemia,AR882
NCT06603142,Hyperuricemia,Febuxostat
NCT06603142,Hyperuricemia,Febuxostat
NCT06615570,Pain,VX-973
NCT06788470,Bronchopulmonary dysplasia,MSC
NCT07105852,Cholangiocarcinoma,Sacituzumab tirumotecan (iv)+Putolizumab injection (iv)
NCT06724952,Rheumatoid arthritis,MTX S.C or IM and Silymarin
NCT06724952,Rheumatoid arthritis,MTX S.C or IM
NCT07083752,Hemiplegia,Botulinum toxin application
NCT07083752,Spasticity,Botulinum toxin application
NCT06745219,Cervical carcinoma,herombopag
NCT06750419,Nonpapillary renal cell carcinoma,89Zr-TLX250 PET/CT
NCT06801119,Systemic lupus erythematosus,HN2301 injection
NCT06576973,Esophageal squamous cell carcinoma,"Adbelimumab, Albumin paclitaxel, Carboplatin, Apatinib"
NCT06944873,Inflammatory bowel disease,Blood test
NCT06838273,Non-small cell lung carcinoma,BL-B01D1
NCT06838273,Non-small cell lung carcinoma,osimertinib
NCT06838273,Non-small cell lung carcinoma,osimertinib
NCT06875973,Atherosclerotic cardiovascular disease,Pelacarsen (TQJ230)
NCT06866873,Lymphoma,CAR-T
NCT06710132,Gastric carcinoma,M9140
NCT06710132,Malignant pancreatic neoplasm,M9140
NCT06710132,Non-small cell lung carcinoma,M9140
NCT06710132,Pancreatic ductal adenocarcinoma,M9140
NCT06746532,Perinatal asphyxia,Intranasal breast milk
NCT06758037,Diffuse large B-cell lymphoma,Drug therapy
NCT06765356,Paroxysmal atrial fibrillation,Low-dose Colchicine
NCT06765356,Persistent atrial fibrillation,Low-dose Colchicine
NCT06755515,Cervical carcinoma,Rulonilimab
NCT06755515,Cervical carcinoma,cisplatin/carboplatin + paclitaxel ± bevacizumab
NCT07114315,Malignant pancreatic neoplasm,AK112
NCT07114315,Malignant pancreatic neoplasm,AK130
NCT06898385,Malignant pancreatic neoplasm,IX001 TCR-T injection
NCT06898385,Malignant pancreatic neoplasm,fludarabine
NCT06898385,Malignant pancreatic neoplasm,cyclophosphamide
NCT06679985,Hepatocellular carcinoma,Casdozokitug
NCT06679985,Hepatocellular carcinoma,toripalimab
NCT06679985,Hepatocellular carcinoma,bevacizumab
NCT06793215,Non-small cell lung carcinoma,Divarasib
NCT06793215,Non-small cell lung carcinoma,pembrolizumab
NCT06793215,Non-small cell lung carcinoma,pemetrexed
NCT06793215,Non-small cell lung carcinoma,carboplatin
NCT06793215,Non-small cell lung carcinoma,cisplatin
NCT06653985,Osteoarthritis,Hyaluronic and corticosteroid injection
NCT06851832,Herpes zoster,Recombinant zoster vaccine(CHO cell)(low adjuvant)
NCT06851832,Herpes zoster,Recombinant Zoster Vaccine (CHO cell)
NCT06851832,Herpes zoster,"Zoster Vaccine, Live"
NCT06851832,Herpes zoster,Recombinant Zoster Vaccine (CHO cell)
NCT06851832,Herpes zoster,Recombinant Zoster Vaccine (CHO cell) (Adjuvant control)
NCT06624137,Endogenous depression,Serotonergic Psychedelic
NCT06624137,Migraine disorder,Serotonergic Psychedelic
NCT06624137,Nicotine dependence,Serotonergic Psychedelic
NCT06624137,Obsessive-compulsive disorder,Serotonergic Psychedelic
NCT06624137,Osteochondritis dissecans,Serotonergic Psychedelic
NCT06624137,Post-traumatic stress disorder,Serotonergic Psychedelic
NCT06596915,Melanoma,BA1302
NCT06596915,Non-small cell lung carcinoma,BA1302
NCT06596915,Pancreatic adenocarcinoma,BA1302
NCT07011485,Alopecia,Minoxidil
NCT07011485,Alopecia,PDFE-2304 Topical Solution
NCT07011485,Androgenetic alopecia,Minoxidil
NCT07011485,Androgenetic alopecia,PDFE-2304 Topical Solution
NCT06959485,Diabetic kidney disease,Oxygen Therapy
NCT06888232,Thalassemia,thalidomide
NCT07107932,Tetanus,Siltartoxatug Injection (Brand name: Sintetol®)
NCT06858332,Atherosclerotic cardiovascular disease,atorvastatin
NCT06858332,Atherosclerotic cardiovascular disease,simvastatin
NCT06858332,Atherosclerotic cardiovascular disease,Rozuvastatin
NCT06858332,Atherosclerotic cardiovascular disease,ezetimibe
NCT06858332,Atherosclerotic cardiovascular disease,niacin
NCT06858332,Atherosclerotic cardiovascular disease,Ciprofibrate
NCT06858332,Atherosclerotic cardiovascular disease,fenofibrate
NCT06858332,Atherosclerotic cardiovascular disease,bezafibrate
NCT06858332,Atherosclerotic cardiovascular disease,evolocumab
NCT06858332,Atherosclerotic cardiovascular disease,alirocumab
NCT06858332,Atherosclerotic cardiovascular disease,inclisiran
NCT06734637,Acquired polycythemia vera,Peginterferon α-2b injection
NCT06734637,Essential thrombocythemia,Peginterferon α-2b injection
NCT07027137,Periodontitis,SRP+ANB+SURG
NCT06985537,Granulomatous mastitis,Ultrasound guided intralesional Steroids injection (Triamicinolone)
NCT06754332,Primary ovarian failure,human chorionic gonadotropin
NCT06808932,Opiate dependence,VK4-116
NCT06708637,Age-related macular degeneration,FYB203
NCT06708637,Diabetic macular edema,FYB203
NCT06708637,Diabetic retinopathy,FYB203
NCT07057037,Frozen shoulder,NEMO-103 Injection
NCT07057037,Rotator cuff syndrome,NEMO-103 Injection
NCT06807437,Exocrine pancreatic carcinoma,lanreotide
NCT06807437,Pancreatic neoplasm,lanreotide
NCT07113015,Parkinson disease,propranolol
NCT07113015,Parkinson disease,amantadine
NCT07113015,Tremor,propranolol
NCT07113015,Tremor,amantadine
NCT06681415,Hypoalbuminemia,Adding
NCT06802315,Myelodysplastic syndrome,Cyclophosphamide (CTX)
NCT06802315,Myelodysplastic syndrome,Fludarabine (Fludara)
NCT06802315,Myelodysplastic syndrome,Busulfan (conditioning for ALLO Transplant)
NCT06583837,Lymphoma,Orelabrutinib
NCT06867315,Benign prostatic hyperplasia,tamsulosin hydrochloride
NCT07108985,Diabetes mellitus,SITagliptin
NCT07108985,Diabetes mellitus,Sitagliptin
NCT07108985,Diabetes mellitus,Sitagliptin
NCT07108985,Diabetes mellitus,Sitagliptin
NCT07108985,Hyperglycemia,SITagliptin
NCT07108985,Hyperglycemia,Sitagliptin
NCT07108985,Hyperglycemia,Sitagliptin
NCT07108985,Hyperglycemia,Sitagliptin
NCT06630585,Type 1 diabetes mellitus,tirzepatide
NCT06607185,Non-small cell lung carcinoma,LY4066434.
NCT06607185,Non-small cell lung carcinoma,cetuximab
NCT06607185,Non-small cell lung carcinoma,Nab paclitaxel
NCT06607185,Non-small cell lung carcinoma,gemcitabine
NCT06607185,Non-small cell lung carcinoma,oxaliplatin
NCT06607185,Non-small cell lung carcinoma,leucovorin
NCT06607185,Non-small cell lung carcinoma,irinotecan
NCT06607185,Non-small cell lung carcinoma,5Fluorouracil
NCT06607185,Non-small cell lung carcinoma,carboplatin
NCT06607185,Non-small cell lung carcinoma,cisplatin
NCT06607185,Non-small cell lung carcinoma,pemetrexed
NCT06607185,Non-small cell lung carcinoma,pembrolizumab
NCT06607185,Pancreatic ductal adenocarcinoma,LY4066434.
NCT06607185,Pancreatic ductal adenocarcinoma,cetuximab
NCT06607185,Pancreatic ductal adenocarcinoma,Nab paclitaxel
NCT06607185,Pancreatic ductal adenocarcinoma,gemcitabine
NCT06607185,Pancreatic ductal adenocarcinoma,oxaliplatin
NCT06607185,Pancreatic ductal adenocarcinoma,leucovorin
NCT06607185,Pancreatic ductal adenocarcinoma,irinotecan
NCT06607185,Pancreatic ductal adenocarcinoma,5Fluorouracil
NCT06607185,Pancreatic ductal adenocarcinoma,carboplatin
NCT06607185,Pancreatic ductal adenocarcinoma,cisplatin
NCT06607185,Pancreatic ductal adenocarcinoma,pemetrexed
NCT06607185,Pancreatic ductal adenocarcinoma,pembrolizumab
NCT06703437,Prostate cancer,ethanol
NCT06703437,Prostate cancer,Lidocaine IV
NCT06923137,COVID-19,BNT162b2
NCT06888037,Gastric adenocarcinoma,Initial treatment: PD-1+ Oxaliplatin-based chemotherapy (CAPOX/SOX/FOLFOX）
NCT06888037,Gastric adenocarcinoma,Maintenance treatment (after
NCT06949137,Osteoporosis,Human Umbilical Cord-derived Mesenchymal stem cell
NCT06644937,Hepatocellular carcinoma,TACE combined with Acoradine
NCT06771115,Obesity disorder,VTX3232 Dose A
NCT06771115,Obesity disorder,VTX3232 Dose A in combination with semaglutide
NCT07014215,Non-small cell lung carcinoma,Sintilimab combined with Bevacizumab and tafolecimab
NCT06680115,Nasopharyngeal carcinoma,Sintilimab
NCT06971185,Myelodysplastic syndrome,luspatercept
NCT06971185,Myelodysplastic syndrome,Erythropoiesis-stimulating agent (ESA)
NCT06797115,Type 2 diabetes mellitus,SGLT-2 inhibitor
NCT06798415,Cutaneous leishmaniasis,metronidazole
NCT06620185,Influenza,FLUENZ
NCT06620185,Influenza,Influenza challenge virus
NCT06734871,B-cell non-Hodgkin lymphoma,CAR T cells
NCT06816771,Rhabdomyosarcoma,pazopanib
NCT06816771,Rhabdomyosarcoma,TGI chemotherapy
NCT06816771,Rhabdomyosarcoma,CIV chemotherapy
NCT06958393,Delirium,dexmedetomidine
NCT06958393,Delirium,esketamine
NCT06958393,Delirium,esmolol
NCT06958393,Delirium,sufentanil
NCT06958393,Delirium,remifentanil
NCT06639711,Cataract,taurine
NCT06799611,Autoimmune thrombocytopenic purpura,CM336 Injection
NCT06719011,Obesity disorder,NNC0174-1213 A
NCT06719011,Obesity disorder,Cagrilintide B
NCT06882811,Sepsis,CD83-positive MSC
NCT06882811,Sepsis,regulatory MSC
NCT07128693,Esophageal squamous cell carcinoma,Sacituzumab Tirumotecan in combination with tislelizumab
NCT07128693,Esophageal squamous cell carcinoma,Sacituzumab Tirumotecan in combination with anlotinib
NCT06825793,Obesity disorder,Semaglutide Subcutaneous Injection
NCT06842511,Periodontitis,open flap debridement and Hyaluronic Acid-Based Gel application
NCT06895811,Metastatic prostate carcinoma,PSMA-UCAR T (BRL-302)
NCT06949111,Malignant colon neoplasm,CAPOX
NCT06949111,Malignant colon neoplasm,capecitabine
NCT06949111,Malignant colon neoplasm,Iparomlimab and Tuvonralimab Injection
NCT06613893,Type 2 diabetes mellitus,TIVA
NCT06613893,Type 2 diabetes mellitus,Inhalational anesthesia
NCT06795893,Systemic lupus erythematosus,anifrolumab
NCT06893211,Obesity disorder,tirzepatide
NCT06728371,Pain,methadone
NCT06728371,Pain,morphine
NCT07010393,Thyroid tumor,dabrafenib
NCT07010393,Thyroid tumor,trametinib
NCT07010393,Thyroid tumor,selpercatinib
NCT07010393,Thyroid tumor,pralsetinib
NCT07010393,Thyroid tumor,lenvatinib
NCT07010393,Thyroid tumor,larotrectinib
NCT07010393,Thyroid tumor,Anlotinib
NCT07010393,Thyroid tumor,pembrolizumab
NCT07010393,Thyroid tumor,Sintilimab
NCT07010393,Thyroid tumor,cabozantinib
NCT07010393,Thyroid tumor,Bemosuzumab
NCT07024693,Fuchs' endothelial dystrophy,DT-168
NCT06620393,Traumatic brain injury,dexmedetomidine
NCT06780111,Esophageal squamous cell carcinoma,pembrolizumab
NCT06780111,Esophageal squamous cell carcinoma,I-DXd
NCT06780111,Esophageal squamous cell carcinoma,leucovorin
NCT06780111,Esophageal squamous cell carcinoma,levoleucovorin
NCT06780111,Esophageal squamous cell carcinoma,5-Fluorouracil (5-FU)
NCT06780111,Esophageal squamous cell carcinoma,oxaliplatin
NCT06976671,Frozen shoulder,bevacizumab
NCT06768671,Hidradenitis suppurativa,Sonelokimab
NCT06803693,Diffuse large B-cell lymphoma,polatuzumab vedotin
NCT06803693,Diffuse large B-cell lymphoma,rituximab
NCT06803693,Diffuse large B-cell lymphoma,cyclophosphamide
NCT06803693,Diffuse large B-cell lymphoma,doxorubicin
NCT06803693,Diffuse large B-cell lymphoma,prednisone
NCT06803693,Diffuse large B-cell lymphoma,zanubrutinib
NCT06803693,Diffuse large B-cell lymphoma,lenalidomide
NCT06803693,Diffuse large B-cell lymphoma,decitabine
NCT06612593,Parkinson disease,cilostazol
NCT06612593,Parkinson disease,Standard treatment
NCT06660693,Colitis,upadacitinib Oral Product
NCT06604611,Heart failure,Colchicine
NCT06864793,Infertility disorder,QL1012D
NCT06864793,Infertility disorder,Gonal-F®
NCT06889493,Neuroendocrine carcinoma,Seneca Valley Virus-001 (SVV-001)
NCT06889493,Neuroendocrine carcinoma,nivolumab
NCT06889493,Neuroendocrine carcinoma,ipilimumab
NCT06912711,Nasopharyngeal carcinoma,toripalimab
NCT06912711,Nasopharyngeal carcinoma,Nimotuzumab
NCT07072793,COVID-19,nirmatrelvir-ritonavir
NCT06903611,Dry eye syndrome,CAM-101
NCT06717711,Prostate carcinoma,PDE5 inhibitor (tadalafil)
NCT07105111,Bipolar disorder,valbenazine
NCT07105111,Endogenous depression,valbenazine
NCT07105111,Schizophrenia,valbenazine
NCT06807593,Cancer,ustekinumab
NCT06977711,Diffuse large B-cell lymphoma,Loncastuximab
NCT06977711,Diffuse large B-cell lymphoma,roflumilast
NCT06977711,Diffuse large B-cell lymphoma,rituximab
NCT06977711,Diffuse large B-cell lymphoma,cyclophosphamide
NCT06977711,Diffuse large B-cell lymphoma,vincristine
NCT06977711,Diffuse large B-cell lymphoma,doxorubicin
NCT06977711,Diffuse large B-cell lymphoma,prednisone
NCT06873711,Colitis,vedolizumab
NCT07129642,Graves disease,Allogeneic CAR-T
NCT06828042,Antiphospholipid syndrome,anti-CD19 CAR T cell therapy
NCT06828042,Sjogren syndrome,anti-CD19 CAR T cell therapy
NCT06828042,Systemic sclerosis,anti-CD19 CAR T cell therapy
NCT06925542,Inclusion body myositis,CTX112
NCT06925542,Juvenile dermatomyositis,CTX112
NCT06925542,Lupus erythematosus,CTX112
NCT06925542,Lupus nephritis,CTX112
NCT06925542,Systemic lupus erythematosus,CTX112
NCT06925542,Systemic sclerosis,CTX112
NCT06730542,Primary central nervous system lymphoma,zanubrutinib
NCT06730542,Primary central nervous system lymphoma,methotrexate
NCT06730542,Primary central nervous system lymphoma,polatuzumab vedotin
NCT06730542,Primary central nervous system lymphoma,rituximab
NCT06730542,Primary central nervous system lymphoma,cyclophosphamide
NCT06730542,Primary central nervous system lymphoma,doxorubicin
NCT06730542,Primary central nervous system lymphoma,prednisone
NCT07090499,Carcinoma,PF-08046876
NCT07090499,Childhood bladder carcinoma,PF-08046876
NCT07090499,Esophageal adenocarcinoma,PF-08046876
NCT07090499,Esophageal squamous cell carcinoma,PF-08046876
NCT07090499,Gastroesophageal junction adenocarcinoma,PF-08046876
NCT07090499,Malignant pancreatic neoplasm,PF-08046876
NCT07090499,Pancreatic adenocarcinoma,PF-08046876
NCT07090499,Urothelial carcinoma,PF-08046876
NCT06857942,Psoriasis,tirzepatide
NCT07065942,Constipation disorder,lactulose Oral Solution
NCT07065942,Constipation disorder,Live Combined B. Subtilis and E. Faecium Enteric-coated Capsules
NCT07065942,Diabetes mellitus,lactulose Oral Solution
NCT07065942,Diabetes mellitus,Live Combined B. Subtilis and E. Faecium Enteric-coated Capsules
NCT07025642,Overactive bladder,Urodynamic evaluation before and after solifenacin treatment.
NCT07025642,Overactive bladder,Urodynamic evaluation before and after mirabegron treatment.
NCT07025642,Overactive bladder,Urodynamic evaluation before and after combined treatment with solifenacin and mirabegron.
NCT07025642,Overactive bladder,Urodynamic evaluation before and after Botulinum toxin (Botox) injection.
NCT06698042,Non-small cell lung carcinoma,Pembrolizumab (+) Berahyaluronidase alfa
NCT06698042,Non-small cell lung carcinoma,pembrolizumab
NCT06616142,Primary aldosteronism,[18F]CETO tracer
NCT06616142,Primary aldosteronism,Dexamethasone oral
NCT07015242,Lymphoma,rituximab
NCT07015242,Lymphoma,methotrexate
NCT07015242,Lymphoma,procarbazine
NCT07015242,Lymphoma,temozolomide
NCT07015242,Lymphoma,Liso-cel
NCT07015242,Lymphoma,fludarabine
NCT07015242,Lymphoma,cyclophosphamide
NCT07015242,Lymphoma,Calcium folinate
NCT06926842,Obesity disorder,Petrelintide
NCT06926842,Type 2 diabetes mellitus,Petrelintide
NCT06934642,Metabolic dysfunction-associated steatotic liver disease,tirzepatide
NCT06934642,Obesity disorder,tirzepatide
NCT07097142,Childhood bladder carcinoma,cisplatin
NCT07097142,Childhood bladder carcinoma,gemcitabine
NCT07097142,Childhood bladder carcinoma,mitomycin
NCT07097142,Childhood bladder carcinoma,fluorouracil
NCT06864533,Chemotherapy,docetaxel
NCT06864533,Prostate cancer,docetaxel
NCT06575933,Non-small cell lung carcinoma,MK-1084
NCT06575933,Non-small cell lung carcinoma,midazolam
NCT06575933,Non-small cell lung carcinoma,digoxin
NCT06923787,Malignant colon neoplasm,lidocaine
NCT06923787,Malignant colon neoplasm,dexamethasone
NCT06631287,COVID-19,baricitinib
NCT06639087,Heart failure,AZD5462
NCT06639087,Heart failure,dapagliflozin
NCT06964087,Type 1 diabetes mellitus,OPT101
NCT06592833,Endogenous depression,Psilocybin
NCT06592833,Endogenous depression,pimavanserin
NCT06667687,Non-Hodgkin lymphoma,ABBV-291
NCT06780033,Hypertensive disorder,ART-101 - SAD
NCT06760533,Superficial epidermolytic ichthyosis,Psilocybin
NCT06760533,Superficial epidermolytic ichthyosis,niacin
NCT06711887,Lupus nephritis,Ianalumab
NCT06770933,Diabetic retinopathy,VX-01
NCT06909253,Myasthenia gravis,ravulizumab
NCT07001254,Aplastic anemia,romiplostim
NCT07001254,Aplastic anemia,Immunosuppressive therapy (IST)
NCT07016854,Cerebrovascular disorder,The best medical treatment
NCT06859333,Influenza,"Combined preparation of imidazolylethylamide of pentanedioic acid and N,N'-bis-[2-(1,3-diazocyclopenta-2,4-dien-4-yl)ethyl] diamide of malonic acid"
NCT06859333,Influenza,"Combined preparation of imidazolylethylamide of pentanedioic acid and N,N'-bis-[2-(1,3-diazocyclopenta-2,4-dien-4-yl)ethyl] diamide of malonic acid"
NCT06859333,Influenza,"Combined preparation of imidazolylethylamide of pentanedioic acid and N,N'-bis-[2-(1,3-diazocyclopenta-2,4-dien-4-yl)ethyl] diamide of malonic acid"
NCT06668987,Meningioma,B10 L-BPA Injection
NCT06744751,Anorexia nervosa,Fecal Microbiota Transplantation
NCT06613854,Type 2 diabetes mellitus,Oral semaglutide
NCT06613854,Type 2 diabetes mellitus,empagliflozin
NCT06608433,Adrenocortical insufficiency,semaglutide
NCT07110051,Childhood malignant neoplasm,nalbuphine
NCT07110051,Childhood malignant neoplasm,tramadol
NCT06590454,Gastric intestinal metaplasia,Pyrvinium
NCT06685354,Hepatocellular carcinoma,hepatic arterial infusion of recombinant human type
NCT06990854,Postherpetic neuralgia,"Pharmacotherapy：① Pregabalin ( Lyrica™ ，Pfizer Inc. America) ② Methylcobalamin ( Mecobalamin tablets， Weicai (China) Pharmaceutical Co., Ltd， China）"
NCT06858254,Parkinson disease,Autologous mesenchymal stem cells
NCT07132333,Inflammatory bowel disease,Biologic Agent
NCT07132333,Psoriasis,Biologic Agent
NCT07088133,Hepatocellular carcinoma,NA(s)+HT-102+FD-001
NCT06919354,Type 1 diabetes mellitus,GNTI-122
NCT07024654,Osteoarthritis,doxycycline Injection
NCT06711354,Multiple sclerosis,Anti-CD20 Monoclonal Antibody
NCT06847854,Diabetic macular edema,RO7497372
NCT06666933,Polycystic ovary syndrome,metformin
NCT06911333,Neoplasm,AD1208
NCT06806033,Diffuse large B-cell lymphoma,obinutuzumab
NCT06806033,Diffuse large B-cell lymphoma,glofitamab
NCT06806033,Diffuse large B-cell lymphoma,gemcitabine
NCT06806033,Diffuse large B-cell lymphoma,oxaliplatin
NCT06920433,Systemic lupus erythematosus,UCAR T-cell group
NCT07123454,B-cell non-Hodgkin lymphoma,AZD4512
NCT06772454,"COPD, severe early onset",Antitumor therapy
NCT06772454,"COPD, severe early onset",Inhaled preparation for COPD
NCT06785454,Hypertensive disorder,Lorundrostat
NCT06785454,Obstructive sleep apnea syndrome,Lorundrostat
NCT06669754,Hereditary angioedema,Deucrictibant
NCT06892054,Pancreatic adenocarcinoma,Sotorasib
NCT07020533,B-cell chronic lymphocytic leukemia,letermovir
NCT07020533,B-cell chronic lymphocytic leukemia,Multi-peptide CMV-Modified Vaccinia Ankara Vaccine
NCT07020533,B-cell chronic lymphocytic leukemia,Recombinant Granulocyte Colony-Stimulating Factor
NCT07020533,Childhood myelodysplastic syndrome,letermovir
NCT07020533,Childhood myelodysplastic syndrome,Multi-peptide CMV-Modified Vaccinia Ankara Vaccine
NCT07020533,Childhood myelodysplastic syndrome,Recombinant Granulocyte Colony-Stimulating Factor
NCT07020533,Hodgkins lymphoma,letermovir
NCT07020533,Hodgkins lymphoma,Multi-peptide CMV-Modified Vaccinia Ankara Vaccine
NCT07020533,Hodgkins lymphoma,Recombinant Granulocyte Colony-Stimulating Factor
NCT07020533,Myelofibrosis,letermovir
NCT07020533,Myelofibrosis,Multi-peptide CMV-Modified Vaccinia Ankara Vaccine
NCT07020533,Myelofibrosis,Recombinant Granulocyte Colony-Stimulating Factor
NCT07020533,Myeloproliferative neoplasm,letermovir
NCT07020533,Myeloproliferative neoplasm,Multi-peptide CMV-Modified Vaccinia Ankara Vaccine
NCT07020533,Myeloproliferative neoplasm,Recombinant Granulocyte Colony-Stimulating Factor
NCT07020533,Non-Hodgkin lymphoma,letermovir
NCT07020533,Non-Hodgkin lymphoma,Multi-peptide CMV-Modified Vaccinia Ankara Vaccine
NCT07020533,Non-Hodgkin lymphoma,Recombinant Granulocyte Colony-Stimulating Factor
NCT06912633,Retinitis pigmentosa,human retinal progenitor cells
NCT06949033,Gastric carcinoma,Neoadjuvant cadonilimab combined with perioperative SOX
NCT06872333,Sickle cell disease,alemtuzumab
NCT06872333,Sickle cell disease,Cell Infusion
NCT06872333,Sickle cell disease,Thymoglobulin
NCT06872333,Sickle cell disease,fludarabine
NCT06872333,Sickle cell disease,busulfan
NCT06872333,Sickle cell disease,thiotepa
NCT06872333,Sickle cell disease,cyclophosphamide
NCT06872333,Sickle cell disease,sirolimus
NCT06872333,Sickle cell disease,tacrolimus
NCT06872333,Sickle cell disease,mycophenolate mofetil
NCT06908733,Non-small cell lung carcinoma,"3-4 cycles of Tislelizumab combined with platinum-based chemotherapy, evaluated by MDT and assigned to treatment strategies based on eligibility and patient preference."
NCT07124533,Dental caries,Toothpaste Tablet
NCT07124533,Dental caries,Conventional Toothpaste
NCT07080333,Childhood bladder carcinoma,biopsy
NCT06720233,Anemia,SAL-0951 tablets
NCT06674577,IgA glomerulonephritis,Atacicept
NCT06674577,"IgA nephropathy, susceptibility to, 1",Atacicept
NCT06610747,Diabetic macular edema,Aflibercept
NCT06730347,Endometrial cancer,Lorigerlimab
NCT06643247,Herpes zoster,Drug
NCT06591377,Ischemic stroke,ticagrelor
NCT06591377,Ischemic stroke,cilostazol
NCT06591377,Ischemic stroke,Aspirin
NCT06591377,Ischemic stroke,Aspirin
NCT06628947,Retinitis pigmentosa,100 μg KIO-301
NCT06628947,Retinitis pigmentosa,50 μg KIO-301
NCT06710977,Cataract,Safety of intracameral levofloxacin in cataract surgery
NCT06710977,Cataract,Use of intracameral cefazolin in cataract surgery
NCT07104877,Gastric carcinoma,SYS6010
NCT07104877,Gastric carcinoma,SYH2051
NCT06726577,Amyotrophic lateral sclerosis,TP04HN106
NCT06957977,Gastric carcinoma,PD1 Inhibitor
NCT06692647,Pain,MK-4318
NCT06692647,Pain,diltiazem
NCT07117877,Ovarian cancer,Etoposide Capsules
NCT07117877,Ovarian cancer,bevacizumab
NCT07117877,Ovarian cancer,Iparomlimab and Tuvonralimab (QL1706)
NCT06974877,Amyloidosis,124I AT-01
NCT06631677,Food allergy,dupilumab
NCT07064577,Radiodermatitis,ROS-scavenging Nanoenzymes
NCT07055477,Mature T-cell and NK-cell non-Hodgkin lymphoma,cyclophosphamide
NCT07055477,Mature T-cell and NK-cell non-Hodgkin lymphoma,fludarabine
NCT07055477,Mature T-cell and NK-cell non-Hodgkin lymphoma,Autologous CCR4 CAR T cells
NCT07055477,Mycosis fungoides,cyclophosphamide
NCT07055477,Mycosis fungoides,fludarabine
NCT07055477,Mycosis fungoides,Autologous CCR4 CAR T cells
NCT07055477,Primary cutaneous T-cell non-Hodgkin lymphoma,cyclophosphamide
NCT07055477,Primary cutaneous T-cell non-Hodgkin lymphoma,fludarabine
NCT07055477,Primary cutaneous T-cell non-Hodgkin lymphoma,Autologous CCR4 CAR T cells
NCT07039747,Irritable bowel syndrome,treatment with DIELEN® Protect
NCT06851247,Nasopharyngeal carcinoma,toripalimab
NCT06851247,Nasopharyngeal carcinoma,Anlotinib
NCT06851247,Nasopharyngeal carcinoma,gemcitabine
NCT06851247,Nasopharyngeal carcinoma,cisplatin
NCT06826677,Small cell lung carcinoma,durvalumab
NCT06808477,Atopic eczema,BBT001
NCT07094477,Lymphoma,CD22/CD19 CAR-T cell immunotherapy
NCT07013747,Acne,Acne mRNA vaccine
NCT06824077,Delirium,dexmedetomidine
NCT06824077,Sleep,dexmedetomidine
NCT06942377,Endometrial cancer,amlodipine
NCT06625177,Vitiligo-associated multiple autoimmune disease susceptibility 1,TEV-53408
NCT06641453,Hepatocellular carcinoma,GPC3-CART cells
NCT06641453,Hepatocellular carcinoma,Fludarabine Phosphate for Injection
NCT06641453,Hepatocellular carcinoma,Cyclophosphamide for Injection
NCT06928753,Chikungunya,Ixchiq
NCT06742853,Inherited lipid metabolism disorder,AZD0780
NCT06742853,Inherited lipid metabolism disorder,ezetimibe
NCT06742853,Inherited lipid metabolism disorder,rosuvastatin
NCT06742853,Inherited lipid metabolism disorder,bempedoic acid
NCT06854653,Primary cutaneous T-cell non-Hodgkin lymphoma,PTX-100
NCT06881251,Dermatitis,dupilumab
NCT06881251,Dermatitis,JNJ-95475939
NCT07067177,Patent ductus arteriosus,Paracetamol (drug)
NCT06953453,Cancer,Inhaled Fentanyl Aerosol
NCT06953453,Cancer,Fentanyl Citrate Injection
NCT06977451,Amyotrophic lateral sclerosis,nL-CHCHD-001
NCT06995651,Exocrine pancreatic insufficiency,Dorzagliatin
NCT06604351,Non-small cell lung carcinoma,"Sintilimab, Nab-Paclitaxel, and Carboplatin"
NCT06895577,Rectal carcinoma,neoadjuvant SCRT followed by Sintilimab plus CAPOX
NCT06775353,Exudative vitreoretinopathy 1,Dexamethasone eyedrop
NCT06991153,Interstitial lung disease,Medical Treatment
NCT07128953,Anal fistula,Solution of Zuoqing San for fumigation and washing of the postoperative wound of anal fistula
NCT06757153,Adult glioblastoma,NRG-103
NCT06750653,Dermatitis,Vaseline
NCT07028853,Prostate cancer,Mevrometostat
NCT07028853,Prostate cancer,enzalutamide
NCT07028853,Prostate carcinoma,Mevrometostat
NCT07028853,Prostate carcinoma,enzalutamide
NCT06879353,Ovarian cancer,Tranexamic Acid (TXA)
NCT06658977,Amyotrophic lateral sclerosis,Abacavir
NCT06809777,Anogenital human papillomavirus infection,Topical
NCT06603077,Hidradenitis suppurativa,AVTX-009 Regimen
NCT06603077,Hidradenitis suppurativa,AVTX-009 Regimen
NCT06910553,Inflammatory bowel disease,Exposed to IBD pharmacotherapy during pregnancy
NCT06653153,Alzheimer disease,Remternetug
NCT06855277,Prostate cancer,AAA817
NCT06855277,Prostate cancer,ARPI
NCT06855277,Prostate cancer,Standard of Care
NCT06724653,Heart failure,RAS blocker tapering group
NCT06724653,Heart failure,Beta blocker tapering out
NCT07067853,Migraine disorder,propranolol
NCT06999577,Cough,omeprazole
NCT06989177,Obesity disorder,semaglutide
NCT06989177,Weight loss,semaglutide
NCT06866977,Malignant pancreatic neoplasm,Oncolytic virus VRT106
NCT06866977,Malignant pancreatic neoplasm,Chemotherapy
NCT06819553,Urolithiasis,Oral Potassium Citrate
NCT06683053,Congestive heart failure,empagliflozin
NCT06904105,Obesity disorder,HRS-7535 Tablets
NCT06785298,Parkinson disease,Levodopa/carbidopa
NCT06785298,Parkinson disease,fexofenadine
NCT07076498,Malignant glioma,M032
NCT06571045,Diabetic macular edema,ranibizumab
NCT06571045,Diabetic macular edema,EYE103
NCT06901245,Prader-Willi syndrome,tirzepatide
NCT06717347,Diffuse large B-cell lymphoma,Zilovertamab vedotin
NCT06717347,Diffuse large B-cell lymphoma,rituximab
NCT06717347,Diffuse large B-cell lymphoma,cyclophosphamide
NCT06717347,Diffuse large B-cell lymphoma,doxorubicin
NCT06717347,Diffuse large B-cell lymphoma,Rituximab Biosimilar
NCT06717347,Diffuse large B-cell lymphoma,prednisone
NCT06717347,Diffuse large B-cell lymphoma,prednisolone
NCT06717347,Diffuse large B-cell lymphoma,vincristine
NCT06717347,Diffuse large B-cell lymphoma,Rescue medication
NCT06671483,Psoriatic arthritis,Zasocitinib
NCT06671483,Psoriatic arthritis,Active Comparator
NCT06986083,Prostate cancer,Local anesthesia
NCT06906497,Atopic eczema,lebrikizumab
NCT07011797,Obesity disorder,CX11
NCT06797297,Melanoma,IBI363
NCT06797297,Melanoma,pembrolizumab
NCT06855498,Hidradenitis suppurativa,povorcitinib
NCT06580145,Major depressive disorder,leucine
NCT06580145,Major depressive disorder,lysine
NCT06767345,Coronary artery disorder,"statins, ezetimibe"
NCT06767345,Coronary artery disorder,Combination therapy
NCT06767345,Coronary atherosclerosis,"statins, ezetimibe"
NCT06767345,Coronary atherosclerosis,Combination therapy
NCT07044297,Human immunodeficiency virus,MK-8527
NCT07044297,Human immunodeficiency virus,FTC/TDF
NCT06836505,Neuroblastoma,CART therapy
NCT06610305,Endogenous depression,Transdermal estradiol
NCT06610305,Endogenous depression,progesterone
NCT07006805,Multiple sclerosis,CABA-201
NCT06577298,Poliomyelitis,Recombinant Trivalent Poliomyelitis Vaccine (Sf-RVN Cell) (VLP-Polio) low adjuvant dose
NCT06577298,Poliomyelitis,VLP-Polio medium dose
NCT06577298,Poliomyelitis,VLP-Polio high dose
NCT06577298,Poliomyelitis,Vaccine Poliomyelitis Inactivated (IPV)
NCT06922045,Hemophilia,STSP-0601 for Injection
NCT06975345,Pain,Medical treatment.
NCT06884345,Ovarian cancer,METR-NK cells combined with Solvatinib
NCT06753747,Esophageal cancer,palbociclib
NCT06753747,Esophageal cancer,Afatinib(30mg)
NCT06753747,Esophageal cancer,Afatinib(40mg)
NCT06753747,Esophageal cancer,Afatinib(RP2D)
NCT06584045,Autoimmune encephalitis,Calculus bovis sativus (CBS)
NCT06855147,Type 2 diabetes mellitus,[14C]HRS9531
NCT06855147,Weight loss,[14C]HRS9531
NCT06759298,Borderline personality disorder,methylphenidate
NCT06794645,Chordoma,pembrolizumab
NCT06794645,Chordoma,Pemetrexed Phase
NCT06647498,Alzheimer disease,Remternetug
NCT06647498,Dementia,Remternetug
NCT06789445,Retinitis pigmentosa,OpCT-001
NCT06855745,Atopic eczema,zabalafin
NCT07042945,HIV infectious disease,MK-4646
NCT07038447,Lupus nephritis,KITE-363
NCT07038447,Lupus nephritis,fludarabine
NCT07038447,Lupus nephritis,cyclophosphamide
NCT07038447,Systemic lupus erythematosus,KITE-363
NCT07038447,Systemic lupus erythematosus,fludarabine
NCT07038447,Systemic lupus erythematosus,cyclophosphamide
NCT07038447,Systemic sclerosis,KITE-363
NCT07038447,Systemic sclerosis,fludarabine
NCT07038447,Systemic sclerosis,cyclophosphamide
NCT06868277,Carcinoma,Rilvegostomig
NCT06868277,Carcinoma,pembrolizumab
NCT06827353,Ovarian carcinoma,maintenance therapy with bevacizumab
NCT06827353,Ovarian carcinoma,maintenance therapy with niraparib
NCT06729853,Gout,SAP-001
NCT06729853,Hyperuricemia,SAP-001
NCT06582277,Influenza,OVX836 shot
NCT06900777,Primary interstitial lung disease specific to childhood,tacrolimus
NCT06900777,Primary interstitial lung disease specific to childhood,dexamethasone
NCT06900777,Vitiligo-associated multiple autoimmune disease susceptibility 1,tacrolimus
NCT06900777,Vitiligo-associated multiple autoimmune disease susceptibility 1,dexamethasone
NCT07073053,Type 2 diabetes mellitus,Semaglutide
NCT07073053,Type 2 diabetes mellitus,Semaglutide
NCT07099677,Hypertensive disorder,Beta Blocker
NCT07099677,Hypertensive disorder,ACE inhibitor
NCT07099677,Hypertensive disorder,Calcium channel blocker
NCT06817577,Injury,NG004
NCT07020377,Diabetes mellitus,Dapagliflozin (DAPA)
NCT06685653,Non-small cell lung carcinoma,Adebrelimab+RGL-270
NCT06685653,Non-small cell lung carcinoma,Adebrelimab+RGL-270/single RGL-270
NCT07088653,Gingivitis,MicroRepair ABX mouthwash
NCT07088653,Gingivitis,Chlorhexidine
NCT07011953,Schizophrenia,Antipsychotics plus Levothyroxine Sodium
NCT06868953,Migraine disorder,combination of sumatriptan
NCT06710847,Endometrial cancer,GSK4418959
NCT06710847,Endometrial cancer,PD-1 inhibitor
NCT06710847,Malignant colon neoplasm,GSK4418959
NCT06710847,Malignant colon neoplasm,PD-1 inhibitor
NCT06710847,Rectal carcinoma,GSK4418959
NCT06710847,Rectal carcinoma,PD-1 inhibitor
NCT06662877,Biliary tract cancer,Albumin-bound Paclitaxel + Tegafur Gimeracil Oteracil (S-1) + Anlotinib
NCT06662877,Biliary tract cancer,Oxaliplatin + Leucovorin + Fluorouracil (FOLFOX regimen)
NCT06662877,Chemotherapy,Albumin-bound Paclitaxel + Tegafur Gimeracil Oteracil (S-1) + Anlotinib
NCT06662877,Chemotherapy,Oxaliplatin + Leucovorin + Fluorouracil (FOLFOX regimen)
NCT06973577,Anxiety,Centanafadine
NCT06973577,Attention deficit-hyperactivity disorder,Centanafadine
NCT06973577,Social phobia,Centanafadine
NCT07018453,Type 2 diabetes mellitus,SHR-3167
NCT07018453,Type 2 diabetes mellitus,insulin degludec
NCT07108153,Cystic fibrosis,SION-719
NCT06791577,Pain,Carboxytherapy
NCT06776198,Osteosarcoma,Chemotherapy
NCT07088445,Wet macular degeneration,faricimab
NCT06625047,Adult glioblastoma,temozolomide
NCT06625047,Glioma susceptibility 1,temozolomide
NCT06625047,Malignant glioma,temozolomide
NCT07059377,Diabetes mellitus,semaglutide
NCT07059377,Diabetes mellitus,Nicotine replacement
NCT07059377,Nicotine dependence,semaglutide
NCT07059377,Nicotine dependence,Nicotine replacement
NCT07120477,Ketamine,Intravenous Esketamine
NCT06985147,Acquired polycythemia vera,DISC-3405
NCT06654947,Biliary tract cancer,Surufatinib+Toripalimab+GEMOX
NCT06636877,Essential hypertension,BR1019
NCT06636877,Essential hypertension,BR1019-2
NCT06636877,Essential hypertension,BR1019-3
NCT06636877,Type 2 diabetes mellitus,BR1019
NCT06636877,Type 2 diabetes mellitus,BR1019-2
NCT06636877,Type 2 diabetes mellitus,BR1019-3
NCT06939777,Tetanus,SNA02-48
NCT06939777,Tetanus,HTIG
NCT06939777,Tetanus,Tetanus Toxoid
NCT06860477,Intrahepatic cholangiocarcinoma,tislelizumab
NCT06860477,Intrahepatic cholangiocarcinoma,lenvatinib
NCT06860477,Intrahepatic cholangiocarcinoma,"FOLFOX (5-fluorouracil, Leucovorin, Oxaliplatin)"
NCT06913647,End stage renal failure,canagliflozin
NCT06898047,Migraine disorder,Rimegepant for acute migraine treatment
NCT06939647,Pulmonary hypertension,Treprostinil Palmitil
NCT07115277,Prostate cancer,Flotufolastat F-18 Injection
NCT06671977,Depressive disorder,DMT-Medium Dose
NCT06671977,Depressive disorder,DMT-Low Dose
NCT06671977,Depressive disorder,THC-Medium Dose
NCT06671977,Depressive disorder,THC-Low Dose
NCT06903377,Non-small cell lung carcinoma,ZG005 for Injection
NCT06903377,Non-small cell lung carcinoma,Gecacitinib Hydrochloride Tablets
NCT07061847,Migraine disorder,Lidocaine (drug)
NCT06896747,Female infertility,Mechanically Engineered Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes
NCT06896747,Female infertility,Umbilical cord mesenchymal stem cell-derived exosomes
NCT06896747,Female infertility,platelet-rich plasma
NCT06690047,Hereditary angioedema,Ruconest
NCT07047547,Heart failure,vericiguat
NCT06982547,Rheumatoid arthritis,UTAA91 injection
NCT06649045,Obstructive sleep apnea syndrome,Orforglipron
NCT06821945,Schizophrenia,BR5402A
NCT06821945,Schizophrenia,BR5402A-1
NCT06821945,Schizophrenia,BR5402B
NCT06821945,Schizophrenia,BR5402B-1
NCT06821945,Schizophrenia,BR5402C
NCT06821945,Schizophrenia,BR5402C-1
NCT06821945,Schizophrenia,BR5402D
NCT06821945,Schizophrenia,BR5402D-1
NCT06606847,Non-small cell lung carcinoma,Oleclumab
NCT06606847,Non-small cell lung carcinoma,durvalumab
NCT06934447,Systemic lupus erythematosus,anti-BCMA/CD70-CAR-T cells
NCT06899477,Colon carcinoma,mFOLFOXIRI
NCT06899477,Colon carcinoma,mFOLFOX-6
NCT06899477,Colon carcinoma,CAPOX
NCT06899477,Malignant colon neoplasm,mFOLFOXIRI
NCT06899477,Malignant colon neoplasm,mFOLFOX-6
NCT06899477,Malignant colon neoplasm,CAPOX
NCT06591598,Diabetic macular edema,"Aflibercept (BAY86-5321, Eylea)"
NCT06591598,Wet macular degeneration,"Aflibercept (BAY86-5321, Eylea)"
NCT06646445,Malignant colon neoplasm,pembrolizumab Injection [Keytruda]
NCT06646445,Malignant colon neoplasm,Adjuvant chemotherapy
NCT06600698,Prostate cancer,INM176
NCT06790498,Diabetic kidney disease,Renal Autologous Cell Therapy (REACT)
NCT06570798,Systemic lupus erythematosus,inebilizumab
NCT06570798,Systemic lupus erythematosus,blinatumomab
NCT06647745,Hypertensive disorder,THP-00101
NCT06647745,Hypertensive disorder,THP-00102
NCT06647745,Hypertensive disorder,THP-00103
NCT06647745,Hypertensive disorder,THP-00104
NCT06647745,Hypertensive disorder,THP-00105
NCT06647745,Hypertensive disorder,THP-00106
NCT06647745,Type 2 diabetes mellitus,THP-00101
NCT06647745,Type 2 diabetes mellitus,THP-00102
NCT06647745,Type 2 diabetes mellitus,THP-00103
NCT06647745,Type 2 diabetes mellitus,THP-00104
NCT06647745,Type 2 diabetes mellitus,THP-00105
NCT06647745,Type 2 diabetes mellitus,THP-00106
NCT07095205,Endogenous depression,Nicotine transdermal patch
NCT07095205,Endogenous depression,PET Scan with [18F] VAT
NCT06732505,Neuroendocrine neoplasm,[225Ac]Ac-DOTATATE
NCT06975605,Tuberous sclerosis 1,Radiprodil + co-administered drugs
NCT06926205,Richter syndrome,Mosunetuzumab (IV)
NCT06805305,Adult glioblastoma,DOC1021
NCT06805305,Adult glioblastoma,Temodar (Temozolomide)
NCT06991361,Graft versus host disease,EVE-Treg
NCT06662383,Obesity disorder,Retatrutide
NCT06662383,Obesity disorder,tirzepatide
NCT07015983,Lupus erythematosus,CC-97540
NCT07015983,Lupus erythematosus,fludarabine
NCT07015983,Lupus erythematosus,cyclophosphamide
NCT07015983,Lupus nephritis,CC-97540
NCT07015983,Lupus nephritis,fludarabine
NCT07015983,Lupus nephritis,cyclophosphamide
NCT07052383,Osteosarcoma,DIT309 cell injection
NCT07052383,Soft tissue sarcoma,DIT309 cell injection
NCT06763783,Juvenile idiopathic arthritis,Shingrix
NCT06763783,Juvenile idiopathic arthritis,vaccination with
NCT06763783,Polymyalgia rheumatica,Shingrix
NCT06763783,Polymyalgia rheumatica,vaccination with
NCT06763783,Psoriatic arthritis,Shingrix
NCT06763783,Psoriatic arthritis,vaccination with
NCT06763783,Scleroderma,Shingrix
NCT06763783,Scleroderma,vaccination with
NCT06763783,Systemic lupus erythematosus,Shingrix
NCT06763783,Systemic lupus erythematosus,vaccination with
NCT06763783,Temporal arteritis,Shingrix
NCT06763783,Temporal arteritis,vaccination with
NCT06937905,Neuroendocrine carcinoma,Standard of Care Chemotherapy
NCT06937905,Neuroendocrine carcinoma,tarlatamab
NCT06659705,Pancreatic ductal adenocarcinoma,68Ga-FAPI-46 for PET / CT scan and
NCT07117305,T-cell non-Hodgkin lymphoma,CD7 CAR-T combined with autologous hematopoietic stem cell transplantation
NCT06616597,Metastatic prostate carcinoma,ABIRATERONE ACETATE
NCT06616597,Metastatic prostate carcinoma,dexamethasone
NCT06616597,Metastatic prostate carcinoma,metronidazole
NCT06616597,Prostate cancer,ABIRATERONE ACETATE
NCT06616597,Prostate cancer,dexamethasone
NCT06616597,Prostate cancer,metronidazole
NCT06818097,Chemotherapy,TKI
NCT06818097,Chemotherapy,anti PD-1
NCT06818097,Chemotherapy,XELOX chemotherapy
NCT06704698,Vomiting,Liposomal bupivacaine
NCT06704698,Vomiting,bupivacaine hydrochloride
NCT06625398,Endocrine exophthalmos,VRDN-003
NCT06970405,Obesity disorder,Garetosmab
NCT06728345,Migraine disorder,rimegepant
NCT07053345,Depressive disorder,Esketamine
NCT07053345,Depressive disorder,Esketamine
NCT06756945,ST-elevation myocardial infarction,aspirin
NCT06756945,ST-elevation myocardial infarction,aspirin
NCT07058545,Type 2 diabetes mellitus,CJC-1134-PC Injection
NCT06846398,Hereditary angioedema,BW-20805
NCT06846398,Hereditary angioedema,BW-20805
NCT06846398,Hereditary angioedema,BW-20805
NCT06589245,Bronchopulmonary dysplasia,Alvesco Inhalant Product
NCT06868745,Circadian rhythm,Experimental: melatonin treatment group
NCT06868745,Glaucoma,Experimental: melatonin treatment group
NCT06670105,B-cell non-Hodgkin lymphoma,glofitamab
NCT07054398,Acne,isotretinoin
NCT06951945,Obesity disorder,THDBH120 injection
NCT06839105,Non-small cell lung carcinoma,Taxol
NCT06839105,Non-small cell lung carcinoma,Cisplatin or Carboplatin
NCT06839105,Non-small cell lung carcinoma,pemetrexed
NCT06839105,Non-small cell lung carcinoma,oxaliplatin
NCT06839105,Non-small cell lung carcinoma,capecitabine
NCT06839105,Non-small cell lung carcinoma,bevacizumab
NCT06839105,Non-small cell lung carcinoma,Renvastinib
NCT06839105,Non-small cell lung carcinoma,AWT020
NCT07101705,Non-Hodgkin lymphoma,OriV508 Injection
NCT07059845,Ovarian cancer,mirvetuximab soravtansine
NCT07059845,Ovarian cancer,bevacizumab
NCT07059845,Ovarian cancer,carboplatin
NCT07109245,Cognition,haloperidol
NCT07109245,Cognition,insulin lispro
NCT06780683,Crohn disease,upadacitinib
NCT06780683,Inflammatory bowel disease,upadacitinib
NCT06714383,Osteosarcoma,trilaciclib
NCT06714383,Osteosarcoma,Pirarubicin
NCT06714383,Osteosarcoma,Lobaplatin
NCT06885697,Mesothelioma,TNhYP217 CAR T Cells
NCT06885697,Mesothelioma,fludarabine
NCT06885697,Mesothelioma,cyclophosphamide
NCT07096583,Ovarian cancer,METR-NK cell（metabolic remodeling nature killer cells）
NCT06750783,Prediabetes syndrome,Xuezhikang
NCT06750783,Prediabetes syndrome,atorvastatin
NCT07063797,Osteoporosis,Denosumab treatment in type
NCT07063797,Osteoporosis,Eldecalcitol treatment in type
NCT07063797,Type 2 diabetes mellitus,Denosumab treatment in type
NCT07063797,Type 2 diabetes mellitus,Eldecalcitol treatment in type
NCT06642961,Asthma,GR1802 injection
NCT06642961,Asthma,GR1802 injection
NCT06956261,Neoplasm,NW-301V
NCT06956261,Neoplasm,Drug: NW-301D
NCT06692361,Depressive disorder,FMT capsule
NCT06692361,Depressive disorder,Escitalopram (Lexapro)
NCT06692361,Depressive disorder,Corn Starch capsules
NCT06692361,Endogenous depression,FMT capsule
NCT06692361,Endogenous depression,Escitalopram (Lexapro)
NCT06692361,Endogenous depression,Corn Starch capsules
NCT07035561,Interstitial lung disease,Rituximab (Mabthera)
NCT06828861,Prader-Willi syndrome,ARD-101
NCT06894771,Childhood malignant neoplasm,MK-4700
NCT06894771,Childhood malignant neoplasm,pembrolizumab
NCT07005583,Triple-negative breast carcinoma,QL1706 Plus Olaparib
NCT07041983,Obesity disorder,anti obesity medication
NCT07074028,Sepsis,blood sampling
NCT07003997,Endogenous depression,baricitinib
NCT06700083,Heart failure,SHR-6934 injection
NCT07098897,IgA glomerulonephritis,Telitacicept
NCT07098897,IgA glomerulonephritis,Corticosteroid
NCT07098897,IgA glomerulonephritis,ACE Inhibitor or Angiotensin receptor antagonist
NCT06766461,Sepsis,Double dosing of beta-lactam antibiotic
NCT06720597,Erectile dysfunction,Daily low-dose PDE5 inhibitor therapy
NCT06720597,Erectile dysfunction,Testosterone therapy as per clinical guidelines.
NCT06720597,Hypogonadism,Daily low-dose PDE5 inhibitor therapy
NCT06720597,Hypogonadism,Testosterone therapy as per clinical guidelines.
NCT06941883,Spasticity,Botulinum toxin injection under anatomical landmark
NCT06941883,Spasticity,Ultrasound-guided botulinum toxin injection
NCT06939283,Non-Hodgkin lymphoma,WTX-330
NCT06700798,Marginal zone lymphoma,Orelabrutinib
NCT06700798,Marginal zone lymphoma,rituximab
NCT06700798,Marginal zone lymphoma,cyclophosphamide
NCT06700798,Marginal zone lymphoma,vincristine
NCT06700798,Marginal zone lymphoma,Prednisone tablet
NCT07066098,Malignant pancreatic neoplasm,IBI343
NCT06718998,Obesity disorder,NNC0519-0130
NCT06780345,Sepsis,Vitamin C
NCT06593145,Large B-cell lymphoma,FCTX-CL19-1 (Tarcidomgen Kimleucel)
NCT06593145,Mantle cell lymphoma,FCTX-CL19-1 (Tarcidomgen Kimleucel)
NCT06944145,Benign prostatic hyperplasia,raloxifene
NCT06944145,Benign prostatic hyperplasia,finasteride
NCT06820645,Autosomal dominant hypocalcemia,calcium gluconate
NCT06820645,Injury,calcium gluconate
NCT06708845,Lupus nephritis,zamtocabtagene autoleucel
NCT06708845,Lupus nephritis,cyclophosphamide
NCT06708845,Lupus nephritis,fludarabine
NCT06708845,Systemic lupus erythematosus,zamtocabtagene autoleucel
NCT06708845,Systemic lupus erythematosus,cyclophosphamide
NCT06708845,Systemic lupus erythematosus,fludarabine
NCT06708845,Systemic sclerosis,zamtocabtagene autoleucel
NCT06708845,Systemic sclerosis,cyclophosphamide
NCT06708845,Systemic sclerosis,fludarabine
NCT06776445,Rosacea,minocycline combined with hydroxychloroquine
NCT06776445,Rosacea,gabapentin
NCT06776445,Rosacea,gabapentin
NCT06590298,Psychotic disorder,Adjunctive Aripiprazole for improving Weight and Metabolic Outcomes in Females
NCT07018245,Depressive disorder,TJ0113
NCT06579105,Diabetes mellitus,AZD5004
NCT06579105,Diabetes mellitus,semaglutide
NCT06954805,Lymphoma,rituximab
NCT06954805,Lymphoma,etoposide
NCT06954805,Lymphoma,prednisone
NCT06954805,Lymphoma,vincristine
NCT06954805,Lymphoma,cyclophosphamide
NCT06954805,Lymphoma,doxorubicin
NCT06962098,Diabetic kidney disease,Isuzinaxib
NCT06681298,Gastroesophageal junction adenocarcinoma,The experimental group received Nivolumab
NCT06814145,Hypertensive disorder,sotatercept
NCT06576245,Dry eye syndrome,Tear Substitute Treatment (Supportive Therapy)
NCT06681805,Vomiting,Mirtazapine + Bupivacaine + Morphine
NCT06681805,Vomiting,Mirtazapine + Bupivacaine + Morphine
NCT07035405,Cerebrovascular disorder,colchicine
NCT07078305,Hepatocellular carcinoma,Regorafenib and tislelizumab
NCT07078305,Hepatocellular carcinoma,regorafenib
NCT06909305,Pain,Ozone
NCT06909305,Pain,Dextrose prolotherapy
NCT06909305,Pain,dexmedetomidine
NCT06679205,Back pain,Usual Care
NCT07105098,Schizophrenia,NBI-1117568
NCT06723405,Atopic eczema,EVO301
NCT06687083,Newborn respiratory distress syndrome,nasal continuous positive pressure ventilation mode
NCT06644183,B-cell chronic lymphocytic leukemia,Roginolisib
NCT06644183,B-cell chronic lymphocytic leukemia,venetoclax
NCT06644183,B-cell chronic lymphocytic leukemia,rituximab
NCT06644183,Leukemia,Roginolisib
NCT06644183,Leukemia,venetoclax
NCT06644183,Leukemia,rituximab
NCT07125183,Sarcoma,doxorubicin
NCT06865105,Psoriatic arthritis,Lutikizumab
NCT06865105,Psoriatic arthritis,risankizumab
NCT07100405,Hepatocellular carcinoma,PD-1 inhibitor
NCT07052305,Large B-cell lymphoma,NT-I7
NCT07052305,Large B-cell lymphoma,CAR T-cell therapy
NCT06826105,Nutritional deficiency disease,Zenpep
NCT06818305,Nonpapillary renal cell carcinoma,Finerenone (BAY
NCT06818305,Nonpapillary renal cell carcinoma,empagliflozin
NCT06795698,Thrombotic disease,enoxaparin
NCT06987305,Cerebrovascular disorder,Intravenous rhTNK-tPA
NCT06688305,Childhood malignant neoplasm,68Ga-NI-FAPI
NCT07012798,Hepatocellular carcinoma,durvalumab
NCT07012798,Hepatocellular carcinoma,bevacizumab
NCT07012798,Hepatocellular carcinoma,HAIC of FOLFOX
NCT07059611,Esophageal adenocarcinoma,RP2
NCT07059611,Esophageal adenocarcinoma,pegfilgrastim
NCT07059611,Esophageal adenocarcinoma,filgrastim
NCT07059611,Gastric adenocarcinoma,RP2
NCT07059611,Gastric adenocarcinoma,pegfilgrastim
NCT07059611,Gastric adenocarcinoma,filgrastim
NCT07059611,Gastroesophageal junction adenocarcinoma,RP2
NCT07059611,Gastroesophageal junction adenocarcinoma,pegfilgrastim
NCT07059611,Gastroesophageal junction adenocarcinoma,filgrastim
NCT06628128,Phenylketonuria,JNT-517 Tablet
NCT06832228,Diffuse large B-cell lymphoma,Pomalidomide Combination With Rituximab and Anti-PD-1 Antibody （PPR）
NCT06624228,Psoriatic arthritis,bimekizumab
NCT06624228,Psoriatic arthritis,risankizumab
NCT07116811,Bell's palsy,Steroids therapy
NCT06871111,Cirrhosis of liver,Commensal Bacteria Strains
NCT06765928,Myelodysplastic syndrome,selinexor in combination with venetoclax
NCT06789328,Osteoarthritis,perineural Dexamethasone
NCT06789328,Osteoarthritis,intravenous Dexamethsone
NCT06767761,Diabetes mellitus,GZR4
NCT06767761,Diabetes mellitus,Insulin Glargine U100 group
NCT06923228,Atopic eczema,CGB-500 Ointment with
NCT06923228,Atopic eczema,Ruxolitinib
NCT07072728,Cancer,Psilocybin therapy
NCT07072728,Endometrial cancer,Psilocybin therapy
NCT07072728,Gastric carcinoma,Psilocybin therapy
NCT07072728,Prostate carcinoma,Psilocybin therapy
NCT07076693,Non-small cell lung carcinoma,Standard Medical Therapy
NCT06828328,Malignant pancreatic neoplasm,GC203 TIL
NCT06984328,Cutaneous melanoma,Acasunlimab
NCT06984328,Cutaneous melanoma,pembrolizumab
NCT06633328,Aplastic anemia,CD7 CAR-T cells injection
NCT06641128,Rheumatoid arthritis,MTX SC or IM
NCT06641128,Rheumatoid arthritis,Empagliflozin
NCT06745128,Obesity disorder,tirzepatide
NCT06960928,Long COVID-19,Low-dose sirolimus
NCT06761911,Hodgkins lymphoma,Brentuximab Vedotin (Bv)
NCT06761911,Hodgkins lymphoma,Sintilimab
NCT06761911,Hodgkins lymphoma,tislelizumab
NCT06761911,Hodgkins lymphoma,bendamustine
NCT07098728,Seizure,Levetiracetam IV
NCT07098728,Seizure,phenobarbital
NCT06958328,Malignant pancreatic neoplasm,fluorouracil
NCT06958328,Malignant pancreatic neoplasm,irinotecan hydrochloride
NCT06958328,Malignant pancreatic neoplasm,leucovorin calcium
NCT06958328,Malignant pancreatic neoplasm,oxaliplatin
NCT06958328,Malignant pancreatic neoplasm,Irinotecan Sucrosofate
NCT06958328,Malignant pancreatic neoplasm,gemcitabine
NCT06958328,Malignant pancreatic neoplasm,Nab paclitaxel
NCT06958328,Malignant pancreatic neoplasm,capecitabine
NCT06977061,Gastric neoplasm,Fruquintinib Combined with Sintilimab and Stereotactic Body Radiation Therapy
NCT07011511,Malaria,MMV055 Dose
NCT07011511,Malaria,MMV055 Dose
NCT07011511,Malaria,MMV055 Dose
NCT07011511,Malaria,MMV055 Dose
NCT07011511,Malaria,MMV055 Dose
NCT07011511,Malaria,MMV055 Dose
NCT06813911,Atherosclerotic cardiovascular disease,Pelacarsen
NCT06813911,Atherosclerotic cardiovascular disease,inclisiran
NCT06655311,Hypercholesterolemia,Enlicitide Chloride
NCT06708611,Heart failure,torsemide
NCT06684028,Cancer,68Ga-FAPI-JNU
NCT07045311,Triple-negative breast carcinoma,JS207 in combination with
NCT07045311,Triple-negative breast carcinoma,JS207 in combination with Albumin paclitaxel
NCT06972628,Metastatic prostate carcinoma,Administering Lutetium-177-PSMA-617 (PLUVICTO)
NCT06972628,Prostate cancer,Administering Lutetium-177-PSMA-617 (PLUVICTO)
NCT06599528,Female infertility,T-R (Test-Reference drug)
NCT06599528,Female infertility,R-T (Reference-Test drug)
NCT06931028,Obesity disorder,IBI362
NCT06629428,Multiple sclerosis,ublituximab
NCT06934811,"Familial acute respiratory distress syndrome, ANLN-related, dog",Ciprofol
NCT06934811,"Familial acute respiratory distress syndrome, ANLN-related, dog",midazolam
NCT06581328,Crohn disease,Vedolizumab IV
NCT06581328,Crohn disease,Vedolizumab SC
NCT06742528,Iron deficiency anemia,ferrous sulfate
NCT06742528,Iron deficiency anemia,Iron Polymaltose Complex
NCT07037511,Asthma,Salbutamol
NCT06977828,Non-small cell lung carcinoma,tislelizumab in combination with anlotinib and platinum-based doublet chemotherapy
NCT06580288,IgA glomerulonephritis,finerenone
NCT07029178,Radiodermatitis,Taurine granule
NCT06869278,Multiple sclerosis,LCAR-AIO T cells
NCT06869278,Myasthenia gravis,LCAR-AIO T cells
NCT07008378,Multiple sclerosis,P-CD19CD20-ALLO1 Cells
NCT07008378,Multiple sclerosis,cyclophosphamide
NCT07008378,Multiple sclerosis,fludarabine
NCT07128888,Obesity disorder,"GZR18 injection,digoxin tablets, rosuvastatin calcium tablets and warfarin sodium tablets"
NCT06978088,B-cell chronic lymphocytic leukemia,LP-168
NCT06978088,B-cell chronic lymphocytic leukemia,obinutuzumab
NCT07001878,Psychotic disorder,metformin
NCT06614907,Atopic eczema,QL2108 injection
NCT06614907,Atopic eczema,Dupixent®
NCT07056088,Hypoglycemia,Insulin Drip Therapy
NCT07056088,Hypoglycemia,Insulin boluses
NCT07041788,Cancer,Iparomlimab and Tuvonralimab Injection
NCT06600178,Coronary microvascular disorder,Dapagliflozin
NCT07046078,Childhood myelodysplastic syndrome,cytarabine
NCT07046078,Childhood myelodysplastic syndrome,fludarabine
NCT07046078,Childhood myelodysplastic syndrome,idarubicin
NCT07046078,Childhood myelodysplastic syndrome,Peripheral Blood Stem Cell
NCT07046078,Childhood myelodysplastic syndrome,Recombinant Granulocyte Colony-Stimulating Factor
NCT06900088,Childhood myelodysplastic syndrome,selinexor
NCT06578078,Heart failure,sodium zirconium cyclosilicate
NCT06578078,Heart failure,Standard of care treatment (RAASi therapy)
NCT06567678,Coronary artery disorder,Colchicine
NCT06915688,"COPD, severe early onset",doxycycline
NCT06915688,"COPD, severe early onset",levofloxacin
NCT06819488,Type 2 diabetes mellitus,[14C]HRS-7535
NCT06819488,Weight loss,[14C]HRS-7535
NCT06822478,Leishmaniasis,Arnica Tincture
NCT06822478,Leishmaniasis,Meglumine antimoniate.
NCT06836778,Hepatocellular carcinoma,Carvedilol Tablets
NCT07007078,Acne,dihydroartemisinin
NCT06828588,Metastatic malignant neoplasm,ABY-025 Loading Dose
NCT06828588,Metastatic malignant neoplasm,[68Ga]Ga-ABY-025
NCT06760078,Hypertensive disorder,intravenous tranexamic acid (TXA) infusion
NCT06858878,Type 2 diabetes mellitus,Maridebart cafraglutide
NCT07120607,Leukemia,CD7 CAR-γδT cell（QH106）
NCT07120607,Leukemia,Fludarabine (FLU)
NCT07120607,Leukemia,Cyclophosphamide (CTX)
NCT06770088,Spondyloarthropathy,vnacicizumab
NCT07053488,Cirrhosis of liver,Ex Vivo CRISPR-Cas9 Gene Editing of Donor Liver
NCT06937788,Atopic eczema,upadacitinib
NCT06937788,Atopic eczema,dupilumab
NCT07133178,Chikungunya,VLA1553
NCT07133178,Chikungunya,Control
NCT06619288,HIV infectious disease,B/F/TAF
NCT06619288,HIV infectious disease,TDF+3TC+EFV
NCT06619288,HIV infectious disease,DTG/3TC
NCT06818578,Dental pulp necrosis,Different Antibiotic Combinations
NCT06818578,Pulpitis,Different Antibiotic Combinations
NCT06847178,Diabetes mellitus,Low-dose LC-Z300-01 twice daily in blinding
NCT06847178,Diabetes mellitus,High-dose LC-Z300-01 twice daily in blinding
NCT06847178,Diabetes mellitus,High-dose LCZ300-1 twice daily in open-label
NCT06847178,Type 2 diabetes mellitus,Low-dose LC-Z300-01 twice daily in blinding
NCT06847178,Type 2 diabetes mellitus,High-dose LC-Z300-01 twice daily in blinding
NCT06847178,Type 2 diabetes mellitus,High-dose LCZ300-1 twice daily in open-label
NCT06790888,Autoimmune thrombocytopenic purpura,eltrombopag
NCT06895278,Juvenile idiopathic arthritis,methotrexate
NCT06895278,Juvenile idiopathic arthritis,Biological Drug
NCT06652971,Type 2 diabetes mellitus,CKD-379
NCT06942988,Erectile dysfunction,intracavernous platelet rich plasma therapy
NCT06717178,Cancer,Chemotherapy
NCT06855771,Carcinoma,BMS-986504
NCT06841978,Cerebrovascular disorder,Intravenous Thrombolysis
NCT06893978,Preeclampsia,Placenta organoids treatment
NCT06982378,Diabetes mellitus,GLP-1 receptor agonist
NCT06982378,Metabolic dysfunction-associated steatotic liver disease,GLP-1 receptor agonist
NCT06982378,Obesity disorder,GLP-1 receptor agonist
NCT06723171,Psoriasis,IRX4204
NCT07014878,Non-small cell lung carcinoma,TCR-T cells
NCT06603571,Obesity disorder,LY3841136
NCT06603571,Obesity disorder,tirzepatide
NCT07077278,Postural orthostatic tachycardia syndrome,Low sodium oxybate (LXB)
NCT06731478,Gastric carcinoma,trastuzumab deruxtecan
NCT06731478,Gastric carcinoma,pembrolizumab
NCT06731478,Gastric carcinoma,trastuzumab
NCT06731478,Gastric carcinoma,Chemotherapy
NCT06994078,Urothelial carcinoma,68Ga-NOTA-Nectin-4 antibody fragment
NCT06798571,Menopause,elagolix Oral Tablet
NCT06798571,Menopause,Estradiol patch
NCT06756178,Delirium,Propofol Group
NCT06756178,Delirium,Remimazolam Intervention
NCT06756178,Delirium,Dexmedetomidine Intervention
NCT06833788,Postpartum depression,Ferric carboxymaltose IV
NCT06833788,Postpartum depression,TIMOFÉROL®
NCT06789588,Atrial fibrillation,pharmacogenetic algorithm
NCT06789588,Atrial fibrillation,Clinical treatment
NCT06731088,Sepsis,midazolam
NCT06731088,Sepsis,Remazolam besylate
NCT06705478,Endogenous depression,Pramipexole ER
NCT06705478,Endogenous depression,escitalopram
NCT07076407,Endogenous depression,Azetukalner
NCT06898788,Depressive disorder,Visbiome
NCT07121088,Diabetes mellitus,(Intensive treatment) Chuanzhi Tongluo Capsules
NCT07121088,Diabetes mellitus,(Sequential treatment) Chuanzhi Tongluo Capsules
NCT07121088,Diabetes mellitus,TCM Syndrome Differentiation Decoction
NCT06712888,Nasopharyngeal carcinoma,TORIPALIMAB INJECTION (JS001 ) combine with GP chemotherapy
NCT06639607,Glioma susceptibility 1,PEP-CMV vaccine
NCT06639607,Glioma susceptibility 1,Tetanus booster
NCT06639607,Glioma susceptibility 1,nivolumab
NCT06639607,Glioma susceptibility 1,temozolomide
NCT06639607,Medulloblastoma,PEP-CMV vaccine
NCT06639607,Medulloblastoma,Tetanus booster
NCT06639607,Medulloblastoma,nivolumab
NCT06639607,Medulloblastoma,temozolomide
NCT06732388,Barrett esophagus,itraconazole
NCT06732388,Esophageal adenocarcinoma,itraconazole
NCT06876688,Primary central nervous system lymphoma,Relma-cel Followed by Tislelizumab
NCT06681688,Cataract,"Omidria, {0.3%-1% Intraocular Solution}, VIGAMOX {0.5% moxifloxacin hydrochloride}, Kenalog {0.4 ml"
NCT06681688,Cataract,"Ketorolac (0.5%) {Toradol}, moxifloxacin (0.5%) {VIGAMOX}, prednisolone acetate (1%) {Pred Forte}"
NCT06677788,Metabolic dysfunction-associated steatohepatitis,roflumilast
NCT06677788,Metabolic dysfunction-associated steatohepatitis,Vitamin E capsule
NCT07061288,Schizophrenia,KarXT
NCT06629688,Maturity-onset diabetes of the young type 1,semaglutide
NCT06702488,Mental disorder,dexmedetomidine
NCT07103278,Benign prostatic hyperplasia,AD-116
NCT07103278,Benign prostatic hyperplasia,AD-1161
NCT06991907,Hepatocellular carcinoma,PD-1 Inhibitors
NCT07127107,Migraine disorder,Non-steroidal anti-inflammatory drugs (NSAIDs)
NCT06626607,Aortic aneurysm,CCB use
NCT06626607,Aortic aneurysm,non-CCB use
NCT06896188,Pancreatic adenocarcinoma,retifanlimab
NCT06896188,Pancreatic adenocarcinoma,Chemotherapy
NCT06896188,Pancreatic adenocarcinoma,9-ING-41
NCT07111988,Obsessive-compulsive disorder,valbenazine
NCT06709807,Type 2 diabetes mellitus,CKD-378
NCT07081178,Obesity disorder,semaglutide
NCT07085507,Multiple sclerosis,VT7208
NCT06712407,IgA glomerulonephritis,TARPEYO®
NCT06716307,Obesity disorder,CagriSema (cagrilintide B and semaglutide I)
NCT06716307,Obesity disorder,CagriSema A
NCT06582888,Nicotine dependence,Varenicline Tartrate
NCT06905288,Ankylosing spondylitis,secukinumab
NCT07120971,Bronchopulmonary dysplasia,Metformin (open-label)
NCT07120971,Bronchopulmonary dysplasia,Metformin (open-label)
NCT07120971,Bronchopulmonary dysplasia,Metformin (open-label)
NCT07120971,Bronchopulmonary dysplasia,Metformin (open-label)
NCT07120971,Bronchopulmonary dysplasia,Metformin (open-label)
NCT07120971,Bronchopulmonary dysplasia,Metformin (open-label)
NCT07120971,Bronchopulmonary dysplasia,Metformin (open-label)
NCT07120971,Bronchopulmonary dysplasia,Metformin (open-label)
NCT07120971,Bronchopulmonary dysplasia,Metformin (open-label)
NCT07055893,Rabies,Rabies vaccine
NCT07055893,Rabies,Verorab®
NCT06854211,Obstructive sleep apnea syndrome,Morphine p.o.
NCT06664411,Diffuse large B-cell lymphoma,"Polatuzumab Vedotin, Zanubrutinib, Rituximab, Lenalidomide and Prednisone as Induction Therapy"
NCT06797193,Portal hypertension,Perflutren Lipid Microspheres
NCT07035093,Obesity disorder,Retatrutide
NCT06646211,Primary central nervous system lymphoma,"Zanubrutinib , Thiotepa"
NCT06646211,Primary central nervous system lymphoma,"Methotrexate , Thiotepa and Zanubrutinib"
NCT06646211,Primary central nervous system lymphoma,ASCT±Zanubrutinib
NCT06961071,Hypoparathyroidism,Parathyroid Allotransplant
NCT07053293,Type 2 diabetes mellitus,empagliflozin
NCT07129993,Childhood bladder carcinoma,Dato-DXd
NCT07129993,Childhood bladder carcinoma,carboplatin
NCT07129993,Childhood bladder carcinoma,cisplatin
NCT07129993,Childhood bladder carcinoma,gemcitabine
NCT06775093,Infertility disorder,GLP-1 receptor agonist
NCT06775093,Infertility disorder,metformin
NCT06775093,Obesity disorder,GLP-1 receptor agonist
NCT06775093,Obesity disorder,metformin
NCT06775093,Polycystic ovary syndrome,GLP-1 receptor agonist
NCT06775093,Polycystic ovary syndrome,metformin
NCT06742411,Gastric carcinoma,XELOX+Sintilimab+HBOT
NCT06958211,Hidradenitis suppurativa,Ruxolitinib Cream
NCT07077811,Atrial fibrillation,antiarrhythmic drug
NCT07077811,Heart failure,antiarrhythmic drug
NCT06698211,Graft versus host disease,Posaconazole tablet
NCT07011693,Endogenous depression,sertraline
NCT07011693,Endogenous depression,Agomelatine
NCT07011693,Endogenous depression,aripiprazole
NCT06975111,Menopause,metformin
NCT06975111,Menopause,semaglutide
NCT06975111,Menopause,Anti-hypertensives
NCT06975111,Menopause,Lipid Lowering Medication
NCT06975111,Menopause,fezolinetant
NCT06975111,Menopause,Hormonal therapy
NCT06589271,Lumbar disk degenerative disorder,human umbilical cord mesenchymal stem cell suspension
NCT06914193,Postherpetic neuralgia,esketamine+PRF treatment group
NCT06914193,Postherpetic neuralgia,PRF treatment group
NCT06863493,Psoriasis,SFA002
NCT06863493,Psoriasis,Otezla
NCT06863961,Atopic eczema,Afimkibart
NCT07023861,Gastric carcinoma,18F-FDG
NCT07023861,Gastric carcinoma,89Zr-LNCab190
NCT07023861,Gastric carcinoma,89Zr-LNCab002
NCT07023861,Gastric carcinoma,89Zr-LNCab072
NCT07023861,Urothelial carcinoma,18F-FDG
NCT07023861,Urothelial carcinoma,89Zr-LNCab190
NCT07023861,Urothelial carcinoma,89Zr-LNCab002
NCT07023861,Urothelial carcinoma,89Zr-LNCab072
NCT06964711,Endogenous depression,GW117 ODT
NCT07079228,Malignant pancreatic neoplasm,QLS31905
NCT07079228,Malignant pancreatic neoplasm,Nab-paclitaxel.
NCT07079228,Malignant pancreatic neoplasm,gemcitabine
NCT07079228,Malignant pancreatic neoplasm,Nab-paclitaxel.
NCT07079228,Malignant pancreatic neoplasm,gemcitabine
NCT07124728,Hypertensive disorder,Antihypertensive Medication Management
NCT07124728,Hypertensive disorder,Statin Medication Management
NCT07124728,Hypertensive disorder,Antiplatelet or Anticoagulant Therapy
NCT07088328,Perinatal asphyxia,pentoxifylline
NCT06988228,Cerebrovascular disorder,15% Dextrose Injection
NCT06719661,Type 2 diabetes mellitus,Dapagliflozin
NCT07018661,Gastric carcinoma,[18F]-FAPI-74
NCT07018661,Gastric neoplasm,[18F]-FAPI-74
NCT06927128,Renal pelvis/ureter urothelial carcinoma,"Gemcitabine, Cisplatin"
NCT06946628,Diabetes mellitus,Group A (triple combination therapy group)
NCT06946628,Diabetes mellitus,Group B (standard therapy group)
NCT07090161,Hypertensive disorder,iloperidone
NCT06881628,Cirrhosis of liver,Tranexamic Acid and vitamin K
NCT06720428,Dry eye syndrome,Artificial tear
NCT06821061,COVID-19,Investigational Influenza Vaccine
NCT06821061,COVID-19,Investigational COVID-19 Vaccine
NCT06821061,COVID-19,Licensed Influenza Vaccine
NCT06821061,COVID-19,Licensed Influenza Vaccine
NCT06821061,COVID-19,Licensed Influenza Vaccine
NCT06821061,COVID-19,Licensed COVID-19 Vaccine
NCT06821061,Influenza,Investigational Influenza Vaccine
NCT06821061,Influenza,Investigational COVID-19 Vaccine
NCT06821061,Influenza,Licensed Influenza Vaccine
NCT06821061,Influenza,Licensed Influenza Vaccine
NCT06821061,Influenza,Licensed Influenza Vaccine
NCT06821061,Influenza,Licensed COVID-19 Vaccine
NCT06763328,Invasive breast carcinoma,Extended Release Metformin Hydrochloride
NCT07116928,Type 2 diabetes mellitus,ganagliflozin
NCT06592261,Obesity disorder,Insulin regular
NCT06592261,Obesity disorder,Insulin regular
NCT06592261,Obesity disorder,Octreotide Acetate
NCT06592261,Obesity disorder,Dextrose
NCT06592261,Obesity disorder,Glucagon
NCT06884111,Heart failure,EE001，70-105ml per day by IV
NCT06983028,"IgA nephropathy, susceptibility to, 1",Atacicept
NCT06983028,Nephrotic syndrome,Atacicept
NCT07120828,Type 2 diabetes mellitus,Empagliflozin (oral)
NCT07120828,Type 2 diabetes mellitus,Dapagliflozin (DAPA)
NCT07120828,Type 2 diabetes mellitus,Metfomin
NCT06642428,Chemotherapy,Neoadjuvant therapy + vitamin D2
NCT06642428,Chemotherapy,Neoadjuvant therapy
NCT06642428,Vitamin D,Neoadjuvant therapy + vitamin D2
NCT06642428,Vitamin D,Neoadjuvant therapy
NCT06921928,Biliary tract cancer,AZD4360
NCT06921928,Gastric carcinoma,AZD4360
NCT06921928,Pancreatic ductal adenocarcinoma,AZD4360
NCT06789861,Pain,TT5
NCT06582628,Metastatic prostate carcinoma,Enzalutamide capsule
NCT06582628,Metastatic prostate carcinoma,Enzalutamide capsule and Talazoparib capsule
NCT06623461,Melanoma,Standard of Care Immune Checkpoint Blockade
NCT06623461,Melanoma,LND101
NCT06616961,Obesity disorder,Semaglutide Pen
NCT06616961,Type 2 diabetes mellitus,Semaglutide Pen
NCT06765109,Non-small cell lung carcinoma,Neladalkib (NVL-655)
NCT06765109,Non-small cell lung carcinoma,alectinib
NCT06795009,Endometrial cancer,Zanzalintinib
NCT06795009,Endometrial cancer,paclitaxel
NCT06795009,Uterine cancer,Zanzalintinib
NCT06795009,Uterine cancer,paclitaxel
NCT07071909,Cancer,Commercial CAR-T
NCT07071909,Cancer,Investigational CAR-T
NCT07071909,Leukemia,Commercial CAR-T
NCT07071909,Leukemia,Investigational CAR-T
NCT07071909,Lymphoma,Commercial CAR-T
NCT07071909,Lymphoma,Investigational CAR-T
NCT06574009,Opiate dependence,Medication optimization
NCT06701656,"Familial acute respiratory distress syndrome, ANLN-related, dog",Cohort C: bevacizumab
NCT07085156,Myelodysplastic syndrome,Fludarabine
NCT06889909,Type 2 diabetes mellitus,Trelagliptin
NCT06889909,Type 2 diabetes mellitus,Vildagliptin
NCT06577909,Autoimmune thrombocytopenic purpura,prednisone
NCT06577909,Autoimmune thrombocytopenic purpura,IVIg
NCT06601309,Esophageal squamous cell carcinoma,Serplulimab
NCT06601309,Esophageal squamous cell carcinoma,Paclitaxel+Cisplatin (Neoadjuvant Chemotherapy)
NCT06601309,Esophageal squamous cell carcinoma,Paclitaxel+Cisplatin(Concurrent Chemoradiotherapy)
NCT06883656,Type 2 diabetes mellitus,SAL067
NCT06634056,Non-small cell lung carcinoma,pentoxifylline
NCT07053007,Non-small cell lung carcinoma,NK-102
NCT07053007,Non-small cell lung carcinoma,atezolizumab
NCT06783309,Type 1 diabetes mellitus,CNP-103
NCT06801509,Herpes zoster,Recombinant Herpes Zoster Vaccine (SCTV04C) Low-Dose
NCT06801509,Herpes zoster,Recombinant Herpes Zoster Vaccine (SCTV04C) High-Dose
NCT06801509,Herpes zoster,Shingrix®
NCT06801509,Herpes zoster,Ganwei®
NCT07086456,Non-small cell lung carcinoma,Surufatinib
NCT07086456,Non-small cell lung carcinoma,tislelizumab
NCT07086456,Non-small cell lung carcinoma,Concurrent Chemotherapy
NCT06589609,Oropharynx squamous cell carcinoma,FluBHPVE6E7
NCT07076056,Type 2 diabetes mellitus,DW1026C1
NCT07076056,Type 2 diabetes mellitus,DW1026C2
NCT07076056,Type 2 diabetes mellitus,DW1026S
NCT06983509,Kidney failure,Regiocit
NCT06983509,Kidney failure,Biphozyl
NCT06983509,Kidney failure,Prismasol
NCT06935409,Osteosarcoma,HS-20093
NCT06935409,Osteosarcoma,Gemcitabine combined with docetaxel
NCT06625411,Endocrine exophthalmos,VRDN-003
NCT06846411,Diabetes mellitus,empagliflozin
NCT06846411,Diabetes mellitus,metformin
NCT06609811,Influenza,Intranasal Influenza Live Attenuated Vaccine
NCT06609811,Influenza,Intranasal Influenza Live Attenuated Vaccine
NCT06825728,"COPD, severe early onset",Different doses of Metoprolol.
NCT06863311,Nonpapillary renal cell carcinoma,XL092
NCT06863311,Nonpapillary renal cell carcinoma,nivolumab
NCT06833411,Temporal arteritis,prednisone
NCT06833411,Temporal arteritis,prednisone
NCT06626711,Cancer,propofol
NCT06626711,Cancer,sevoflurane
NCT06923111,Sickle cell disease,Xromi
NCT06880328,Schizophrenia,Ralmitaront
NCT06643728,Obesity disorder,Bimagrumab
NCT06643728,Obesity disorder,tirzepatide
NCT06946511,Dementia,Peptide PMS-001 Intravenous Injection
NCT06998628,Rheumatoid arthritis,methotrexate
NCT06998628,Rheumatoid arthritis,pentoxifylline
NCT06837311,Cerebrovascular disorder,Biological assessment
NCT06836128,Polycystic ovary syndrome,N-acetyl cysteine
NCT06836128,Polycystic ovary syndrome,Metfomin
NCT07042828,Urticaria,Bilastine oral dispersible tablets
NCT07042828,Urticaria,Bilaxten oral dispersible tablets
NCT06850311,Atopic eczema,herbal ointment
NCT06949228,Ischemic stroke,tenecteplase
NCT07048028,Dental pulp necrosis,Chitosan Low Molecular Weight (20-200 Mpa.S)
NCT07048028,Dental pulp necrosis,Sodium Hypochlorite
NCT07048028,Dental pulp necrosis,EDTA chelating agents
NCT07048028,Periapical periodontitis,Chitosan Low Molecular Weight (20-200 Mpa.S)
NCT07048028,Periapical periodontitis,Sodium Hypochlorite
NCT07048028,Periapical periodontitis,EDTA chelating agents
NCT06888128,Post-traumatic stress disorder,Psilocybin
NCT06888128,Post-traumatic stress disorder,Psilocybin
NCT06871228,Atrial fibrillation,Continuous DOAC therapy
NCT06572228,Asthma,dupilumab
NCT06572228,Asthma,ICS/LABA
NCT06920693,Atopic eczema,GB-7624
NCT06806228,Glioma susceptibility 1,S-Gboxin
NCT06640361,Gastrointestinal stromal tumor,Olverembatinib
NCT06646783,Gastric adenocarcinoma,[68Ga]Ga-NODAGA-SNA014
NCT06909383,Cancer,Nanocrystalline megestrol acetate
NCT06584383,Parkinson disease,Best Medical Treatment
NCT06957561,Childhood bladder carcinoma,Disitamab Vedotin Injection
NCT06957561,Childhood bladder carcinoma,Ivonescimab（AK112，a PD-1/VEGF bispecific antibody）
NCT06905483,"COPD, severe early onset",Budesonide/Glycopyrronium/Formoterol (BGF)
NCT06905483,"COPD, severe early onset",Fluticasone Furoate/Umeclidinium/Vilanterol (FUV)
NCT06844383,Prostate cancer,Talazoparib with enzalutamide
NCT06844383,Prostate cancer,talazoparib
NCT06588283,Obesity disorder,ixekizumab
NCT06588283,Obesity disorder,tirzepatide
NCT06588283,Psoriasis,ixekizumab
NCT06588283,Psoriasis,tirzepatide
NCT07022483,Endometrial cancer,trastuzumab deruxtecan
NCT07022483,Endometrial cancer,Chemotherapy
NCT07125261,Epilepsy,BHV-700
NCT06989983,Heart failure,AZD5462 film-coated tablet
NCT06989983,Heart failure,[14C]AZD5462 Solution for Infusion
NCT06989983,Heart failure,[14C]AZD5462 Oral Solution
NCT06568861,COVID-19,ALG-097558
NCT06666283,Diabetic kidney disease,AP303
NCT06666283,Diabetic kidney disease,AP303
NCT06756061,Graft versus host disease,Prednisone + Jakavi(ruxolitinib)
NCT06756061,Graft versus host disease,prednisone
NCT06601283,Malignant pancreatic neoplasm,Vitmain C plus herbal medicine
NCT06987383,Obesity disorder,vibegron
NCT07065383,Maturity-onset diabetes of the young type 1,Semaglutide administration plus dietary counselling and physical activity encouragement
NCT07065383,Maturity-onset diabetes of the young type 1,Semaglutide plus a personalised and supervised program of resistance and endurance training
NCT07030283,Pancreatic ductal adenocarcinoma,paclitaxel
NCT07030283,Pancreatic ductal adenocarcinoma,NALIRIFOX
NCT06732583,Tuberculosis,Tuberculosis (TB) vaccine (Ad5-105K)
NCT06732583,Tuberculosis,Ad5-105K
NCT07131683,Autoimmune encephalitis,Human umbilical cord mesenchymal stem cell derived exosomes
NCT06571383,Obesity disorder,semaglutide
NCT06571461,Malignant pancreatic neoplasm,Liposomal Irinotecan
NCT06571461,Malignant pancreatic neoplasm,oxaliplatin
NCT06571461,Malignant pancreatic neoplasm,S-1
NCT06571461,Malignant pancreatic neoplasm,gemcitabine
NCT06571461,Malignant pancreatic neoplasm,capecitabine
NCT07106528,Small cell lung carcinoma,Organoid Drug Sensitivity Testing-Guided Therapy
NCT07106528,Small cell lung carcinoma,topotecan
NCT06682728,Urothelial carcinoma,Sacituzumab Govitecan (SG)
NCT06682728,Urothelial carcinoma,nivolumab
NCT07095361,Pleural effusion,Fibrinolytic once daily
NCT07095361,Pleural effusion,Fibrinolytic twice daily
NCT07095361,Pleural effusion,DNA degradation once daily
NCT07095361,Pleural effusion,DNA degradation twice daily
NCT06868628,Multiple system atrophy,Foralumab Nasal
NCT06680661,Hodgkins lymphoma,cyclophosphamide
NCT06680661,Hodgkins lymphoma,fludarabine
NCT06680661,Hodgkins lymphoma,thiotepa
NCT06680661,Hodgkins lymphoma,Double Umbilical Cord Transplant
NCT06680661,Hodgkins lymphoma,tacrolimus
NCT06680661,Hodgkins lymphoma,mycophenolate mofetil
NCT06680661,Hodgkins lymphoma,abatacept
NCT06680661,Lymphoma,cyclophosphamide
NCT06680661,Lymphoma,fludarabine
NCT06680661,Lymphoma,thiotepa
NCT06680661,Lymphoma,Double Umbilical Cord Transplant
NCT06680661,Lymphoma,tacrolimus
NCT06680661,Lymphoma,mycophenolate mofetil
NCT06680661,Lymphoma,abatacept
NCT06680661,Myelodysplastic syndrome,cyclophosphamide
NCT06680661,Myelodysplastic syndrome,fludarabine
NCT06680661,Myelodysplastic syndrome,thiotepa
NCT06680661,Myelodysplastic syndrome,Double Umbilical Cord Transplant
NCT06680661,Myelodysplastic syndrome,tacrolimus
NCT06680661,Myelodysplastic syndrome,mycophenolate mofetil
NCT06680661,Myelodysplastic syndrome,abatacept
NCT07101328,B-cell non-Hodgkin lymphoma,LY4152199 - IV
NCT07101328,B-cell non-Hodgkin lymphoma,LY4152199 - SC
NCT07101328,Burkitt lymphoma,LY4152199 - IV
NCT07101328,Burkitt lymphoma,LY4152199 - SC
NCT07101328,Leukemia,LY4152199 - IV
NCT07101328,Leukemia,LY4152199 - SC
NCT07101328,Lymphoma,LY4152199 - IV
NCT07101328,Lymphoma,LY4152199 - SC
NCT06723561,Spinal cord injury,4.5mg daily dose of naltrexone
NCT07043361,Metabolic disease,semaglutide
NCT06750861,Pancreatic adenocarcinoma,QL1706
NCT06812728,Rectal cancer,mFOLFIRINOX
NCT06812728,Rectal cancer,mFolfox6
NCT06904261,Fabry disease,Migalastat HCl
NCT06699628,Apathy,IRL757
NCT06793228,Small cell lung carcinoma,Nanocrystalline Megestrol Acetate
NCT06793228,Small cell lung carcinoma,tislelizumab
NCT06793228,Small cell lung carcinoma,PTOC
NCT07129161,Carcinoma,4 cycles(Iparomlimab and Tuvonralimab
NCT07129161,Carcinoma,4 cycles(Iparomlimab and Tuvonralimab
NCT06587061,Malignant pancreatic neoplasm,HRS-4642+AG
NCT06587061,Malignant pancreatic neoplasm,HRS-4642+AG +Adebrelimab
NCT06676293,Nasopharyngeal carcinoma,Anti-PD1
NCT06676293,Nasopharyngeal carcinoma,asparaginase
NCT06594393,Epidermolysis bullosa,TCP-25 gel
NCT06624371,Malignant glioma,atovaquone
NCT06624371,Medulloblastoma,atovaquone
NCT06610071,Skin squamous cell carcinoma,ICG administration
NCT06610071,Skin squamous cell carcinoma,ICG administration
NCT06610071,Skin squamous cell carcinoma,ICG administration
NCT06610071,Skin squamous cell carcinoma,ICG administration
NCT06888193,Hidradenitis suppurativa,bimekizumab
NCT06888193,Psoriatic arthritis,bimekizumab
NCT06894693,B-cell non-Hodgkin lymphoma,RS001 injection
NCT06704893,Osteoarthritis,ASA injection
NCT06704893,Osteoarthritis,ASA injection
NCT06704893,Osteoarthritis,HA injection group
NCT06863571,Ischemic stroke,PPA Intervention
NCT06932393,Alopecia,exosomes
NCT06682793,Cancer,A2B395
NCT06682793,Malignant colon neoplasm,A2B395
NCT06682793,Non-small cell lung carcinoma,A2B395
NCT06682793,Nonpapillary renal cell carcinoma,A2B395
NCT06682793,Rectal carcinoma,A2B395
NCT06682793,Renal carcinoma,A2B395
NCT06836271,Prostate cancer,isopropyl alcohol
NCT06836271,Prostate cancer,Povidine-iodine
NCT06808971,Gastric adenocarcinoma,"Adebrelimab, Nab-paclitaxel, Oxaliplatin, Tegafur Gimeracil Oteracil Potassium Capsule"
NCT06602193,Parkinson disease,BIIB122
NCT06878599,Sudden sensorineural hearing loss,dexamethasone
NCT06978699,Paroxysmal nocturnal hemoglobinuria,XH-S003 Capsule
NCT07041099,Sjogren syndrome,CLN-978
NCT06699199,Dental caries,Silver diamine Fluoride
NCT06699199,Dental caries,Silver diamine fluoride- potassium iodide
NCT06854042,Malaria,E1018
NCT06907342,Neoplasm,FOLFOX or FOLFIRI
NCT07024199,Pain,Drug administration according to protocol (paracetamol + ibuprofen OR paracetamol + metamizol)
NCT07024199,Pancreatitis,Drug administration according to protocol (paracetamol + ibuprofen OR paracetamol + metamizol)
NCT06591299,Ischemic stroke,cilostazol
NCT06591299,Ischemic stroke,Clopidogrel
NCT07011342,Prostate cancer,18F-rhPSMA-7.3
NCT07054099,Chickenpox,MG1111 (Barycela inj.)
NCT07054099,Chickenpox,VARIVAX™
NCT06914999,Hypopharynx squamous cell carcinoma,SODIUM FLUORIDE F-18
NCT06914999,Laryngeal squamous cell carcinoma,SODIUM FLUORIDE F-18
NCT06914999,Oropharynx squamous cell carcinoma,SODIUM FLUORIDE F-18
NCT06749899,Nasopharyngeal carcinoma,QL1706
NCT06749899,Nasopharyngeal carcinoma,gemcitabine
NCT06749899,Nasopharyngeal carcinoma,cisplatin
NCT07030699,Lymphoma,epcoritamab
NCT07030699,Lymphoma,lenalidomide
NCT07030699,Lymphoma,tafasitamab
NCT06946199,Rheumatoid arthritis,cizutamig
NCT06592599,Nasopharyngeal carcinoma,toripalimab
NCT07032142,Cancer,I-01/23
NCT06880042,Vitiligo-associated multiple autoimmune disease susceptibility 1,tacrolimus
NCT06880042,Vitiligo-associated multiple autoimmune disease susceptibility 1,Calcipotriol
NCT06731699,Non-Hodgkin lymphoma,FD-001
NCT07102342,Parkinson disease,Human Dopaminergic Progenitor Cells
NCT06566742,Myelodysplastic syndrome,olutasidenib
NCT07003542,Adult glioblastoma,sitagliptin
NCT06926075,Glioma susceptibility 1,A novel hGIIA-Vimentin Inhibitor
NCT06926075,Glioma susceptibility 1,Dose expansion
NCT06926075,Malignant pancreatic neoplasm,A novel hGIIA-Vimentin Inhibitor
NCT06926075,Malignant pancreatic neoplasm,Dose expansion
NCT06926075,Ovarian cancer,A novel hGIIA-Vimentin Inhibitor
NCT06926075,Ovarian cancer,Dose expansion
NCT06926075,Skin cancer,A novel hGIIA-Vimentin Inhibitor
NCT06926075,Skin cancer,Dose expansion
NCT07018570,Gastroesophageal junction adenocarcinoma,pembrolizumab
NCT07018570,Gastroesophageal junction adenocarcinoma,docetaxel
NCT07018570,Gastroesophageal junction adenocarcinoma,oxaliplatin
NCT07018570,Gastroesophageal junction adenocarcinoma,Levofolinate
NCT07018570,Gastroesophageal junction adenocarcinoma,Fluorouracil (5-FU)
NCT06988670,Hypoparathyroidism,EXT608
NCT06944470,Non-small cell lung carcinoma,Paclitaxel + Carboplatin/cisplatin for squamous cell carcinoma and pemetrexed + carboplatin/cisplatin for non-squamous cell carcinoma
NCT06944470,Non-small cell lung carcinoma,JS207
NCT07073170,Type 2 diabetes mellitus,LY3549492
NCT06631170,Atopic eczema,Roflumilast Cream
NCT06831370,Hodgkins lymphoma,brentuximab vedotin
NCT06831370,Hodgkins lymphoma,doxorubicin
NCT06831370,Hodgkins lymphoma,vinblastine
NCT06831370,Hodgkins lymphoma,dacarbazine
NCT06692270,Esophageal cancer,tislelizumab
NCT06614270,Antiphospholipid syndrome,anti-CD19 CAR-NK cells
NCT06614270,Systemic sclerosis,anti-CD19 CAR-NK cells
NCT06780670,Prostate cancer,Investigators choice of SoC
NCT06780670,Prostate cancer,AAA817
NCT06780670,Prostate cancer,AAA817
NCT06780670,Prostate cancer,AAA817
NCT06876675,Hyperlipidemia,lorlatinib
NCT06876675,Non-small cell lung carcinoma,lorlatinib
NCT06924970,Sickle cell disease,Tebapivat
NCT06638970,Epilepsy,Secretome
NCT06927375,Endocrine exophthalmos,Tocilizumab(400mg) combined with Flupentixol Melitracen(0.5mg:10mg)
NCT06927375,Endocrine exophthalmos,Tocilizumab(400mg)
NCT06793670,Heart failure,landiolol
NCT06681870,Endometrial cancer,ASP1893
NCT06681870,Non-small cell lung carcinoma,ASP1893
NCT06681870,Ovarian cancer,ASP1893
NCT06681870,Testicular cancer,ASP1893
NCT06710470,Psoriasis,deucravacitinib
NCT06710470,Psoriasis,Systemic psoriasis medications
NCT07092670,Fertility,Dabrafenib + Trametinib
NCT07092670,Fertility,pembrolizumab
NCT07092670,Fertility,nivolumab
NCT07092670,Melanoma,Dabrafenib + Trametinib
NCT07092670,Melanoma,pembrolizumab
NCT07092670,Melanoma,nivolumab
NCT06592170,Lymphoma,Linperlisib combination with obinutuzumab
NCT07010575,Wilson disease,New TETA
NCT07010575,Wilson disease,Standard of Care
NCT06952842,Retinitis pigmentosa,ZVS203e
NCT07012642,Lymphedema,GLP-1 Receptor Agonists
NCT06891742,Hepatocellular carcinoma,OriC902
NCT06914037,Mature T-cell and NK-cell non-Hodgkin lymphoma,CHT101
NCT06914037,Non-Hodgkin lymphoma,CHT101
NCT06914037,Primary cutaneous T-cell non-Hodgkin lymphoma,CHT101
NCT06663332,Arthritic joint disease,guselkumab
NCT06663332,Colitis,guselkumab
NCT06793137,Rectal carcinoma,metronidazole
NCT06959732,Follicular lymphoma,"zanubrutinib, obinutuzumab,combined with CVP"
NCT07051252,Narcolepsy,HBS-201
NCT06616532,Small cell lung carcinoma,PM8002
NCT06616532,Small cell lung carcinoma,paclitaxel
NCT06616532,Small cell lung carcinoma,topotecan
NCT06582732,Glaucoma,Travoprost Intracameral Implant exchanged at Month
NCT06582732,Glaucoma,Travoprost Intracameral Implant exchanged at Month
NCT06582732,Glaucoma,Travoprost Intracameral Implant exchanged at Month
NCT06582732,Glaucoma,Travoprost Intracameral Implant exchanged at Month
NCT06582732,Glaucoma,Travoprost intracameral implant exchanged at Month
NCT06582732,Glaucoma,Travoprost intracameral implant exchanged at Month
NCT06582732,Glaucoma,Travoprost intracameral implant exchanged at Month
NCT06582732,Ocular hypertension,Travoprost Intracameral Implant exchanged at Month
NCT06582732,Ocular hypertension,Travoprost Intracameral Implant exchanged at Month
NCT06582732,Ocular hypertension,Travoprost Intracameral Implant exchanged at Month
NCT06582732,Ocular hypertension,Travoprost Intracameral Implant exchanged at Month
NCT06582732,Ocular hypertension,Travoprost intracameral implant exchanged at Month
NCT06582732,Ocular hypertension,Travoprost intracameral implant exchanged at Month
NCT06582732,Ocular hypertension,Travoprost intracameral implant exchanged at Month
NCT06768632,Thrombocytopenia,Group
NCT06768632,Thrombocytopenia,Group
NCT07065032,Type 2 diabetes mellitus,ZT002 Injection
NCT07065032,Type 2 diabetes mellitus,ZT002 Injection
NCT06707532,Kidney failure,propofol
NCT06707532,Kidney failure,rocuronium
NCT06789432,Hyperlipidemia,Atorvastatin
NCT06789432,Hyperlipidemia,atorvastatin
NCT07059832,Cancer,68Ga-NODAGA-SNA006
NCT07052032,Rheumatoid arthritis,CND261
NCT07020832,End stage renal failure,pegcetacoplan
NCT06775652,Esophageal squamous cell carcinoma,Neoadjuvant Chemoradiotherapy
NCT06782932,Malignant pancreatic neoplasm,AGEN2373
NCT06782932,Malignant pancreatic neoplasm,Balstilimab
NCT06782932,Malignant pancreatic neoplasm,cyclophosphamide
NCT06782932,Malignant pancreatic neoplasm,GVAX
NCT06782932,Malignant pancreatic neoplasm,AGEN2373 (RP2D)
NCT06782932,Malignant pancreatic neoplasm,Balstilimab
NCT06782932,Malignant pancreatic neoplasm,mKRASvax
NCT06579352,Duchenne muscular dystrophy,Human Umbilical Cord Mesenchymal Stem Cells (UC-MSC)
NCT06589778,Non-small cell lung carcinoma,SHR-A2102
NCT06589778,Non-small cell lung carcinoma,Adebelimab (SHR-1316)
NCT06589778,Non-small cell lung carcinoma,SHR-8068
NCT07112378,Eosinophilic esophagitis,dupilumab
NCT06837571,Pain,Measurement of Methadone in the Interstitial Fluid before and after prescribed dose taken in vivo
NCT07017478,Depressive disorder,LSD
NCT07017478,Endogenous depression,LSD
NCT06624878,Ovarian cancer,esketamine
NCT06831071,Melanoma,Pimonidazole
NCT07061171,Obstructive sleep apnea syndrome,Herbal Decoction
NCT06588478,B-cell chronic lymphocytic leukemia,pirtobrutinib
NCT06932471,Paroxysmal nocturnal hemoglobinuria,MY008211A tablets
NCT07057778,Autoimmune thrombocytopenic purpura,Iguratimod
NCT07057778,Autoimmune thrombocytopenic purpura,low-dose rituximab
NCT07009171,Obesity disorder,KDS2010
NCT06795178,Prostate cancer,FP-014
NCT06846671,B-cell chronic lymphocytic leukemia,BGB-16673
NCT06846671,B-cell chronic lymphocytic leukemia,bendamustine
NCT06846671,B-cell chronic lymphocytic leukemia,idelalisib
NCT06846671,B-cell chronic lymphocytic leukemia,rituximab
NCT06846671,B-cell chronic lymphocytic leukemia,venetoclax
NCT06953271,Overactive bladder,METHENAMINE HIPPURATE
NCT06953271,Overactive bladder,Typically prescribed oral antibiotic prophylaxis
NCT06953271,Urinary tract infection,METHENAMINE HIPPURATE
NCT06953271,Urinary tract infection,Typically prescribed oral antibiotic prophylaxis
NCT06785571,Respiratory insufficiency,nalbuphine hydrochloride Injection
NCT06785571,Respiratory insufficiency,hydromorphone hydrochloride Injection
NCT07126678,Follicular lymphoma,"zanubrutinib, bendamustine, and obinutuzumab"
NCT07010263,Small cell lung carcinoma,AK112
NCT06635135,Depressive disorder,Aticaprant
NCT06767735,Diabetes mellitus,GZR4
NCT06767735,Diabetes mellitus,Insulin Glargine U100
NCT06900335,Prader-Willi syndrome,GH treatment (Somatropin)
NCT06752135,Suppressor of tumorigenicity 3,neoadjuvant chemotherapy (cisplatin or carboplatin plus paclitaxel)
NCT07010835,Systemic lupus erythematosus,YK012
NCT06779435,Diffuse large B-cell lymphoma,Low intensity treatment options
NCT06779435,Diffuse large B-cell lymphoma,Conventional immunochemotherapy regimen
NCT06684535,Pain,dexmedetomidine
NCT06588335,Esophageal squamous cell carcinoma,BTLA inhibitor (JS004)
NCT06588335,Esophageal squamous cell carcinoma,toripalimab
NCT06588335,Esophageal squamous cell carcinoma,"Paclitaxel, Cisplatin"
NCT06856135,Crohn disease,Vedolizumab IV
NCT06783335,Heart failure,Standard of Care Pharmacologic Therapy
NCT06919835,Cerebrovascular disorder,cilostazol
NCT06694935,Metabolic dysfunction-associated steatotic liver disease,QX1206
NCT06694935,Type 2 diabetes mellitus,QX1206
NCT06595186,Glioma susceptibility 1,JK-1201I
NCT06595186,Glioma susceptibility 1,Temozolomide (TMZ)
NCT07093086,B-cell non-Hodgkin lymphoma,Triple-targeted CAR-T Therapy
NCT07096986,Glomerulonephritis,Forxiga
NCT06851663,Cervical carcinoma,[68Ga]Ga-NOTA-T4
NCT06851663,Cervical carcinoma,[68Ga]Ga-NOTA-RT4
NCT06851663,Cervical carcinoma,[18F]F-RESCA-T4
NCT06851663,Cervical carcinoma,[18F]F-RESCA-RT4
NCT06851663,Childhood bladder carcinoma,[68Ga]Ga-NOTA-T4
NCT06851663,Childhood bladder carcinoma,[68Ga]Ga-NOTA-RT4
NCT06851663,Childhood bladder carcinoma,[18F]F-RESCA-T4
NCT06851663,Childhood bladder carcinoma,[18F]F-RESCA-RT4
NCT06851663,Cholangiocarcinoma,[68Ga]Ga-NOTA-T4
NCT06851663,Cholangiocarcinoma,[68Ga]Ga-NOTA-RT4
NCT06851663,Cholangiocarcinoma,[18F]F-RESCA-T4
NCT06851663,Cholangiocarcinoma,[18F]F-RESCA-RT4
NCT06851663,Endometrial cancer,[68Ga]Ga-NOTA-T4
NCT06851663,Endometrial cancer,[68Ga]Ga-NOTA-RT4
NCT06851663,Endometrial cancer,[18F]F-RESCA-T4
NCT06851663,Endometrial cancer,[18F]F-RESCA-RT4
NCT06851663,Nasopharyngeal carcinoma,[68Ga]Ga-NOTA-T4
NCT06851663,Nasopharyngeal carcinoma,[68Ga]Ga-NOTA-RT4
NCT06851663,Nasopharyngeal carcinoma,[18F]F-RESCA-T4
NCT06851663,Nasopharyngeal carcinoma,[18F]F-RESCA-RT4
NCT06851663,Ovarian cancer,[68Ga]Ga-NOTA-T4
NCT06851663,Ovarian cancer,[68Ga]Ga-NOTA-RT4
NCT06851663,Ovarian cancer,[18F]F-RESCA-T4
NCT06851663,Ovarian cancer,[18F]F-RESCA-RT4
NCT06851663,Prostate cancer,[68Ga]Ga-NOTA-T4
NCT06851663,Prostate cancer,[68Ga]Ga-NOTA-RT4
NCT06851663,Prostate cancer,[18F]F-RESCA-T4
NCT06851663,Prostate cancer,[18F]F-RESCA-RT4
NCT06851663,Urothelial carcinoma,[68Ga]Ga-NOTA-T4
NCT06851663,Urothelial carcinoma,[68Ga]Ga-NOTA-RT4
NCT06851663,Urothelial carcinoma,[18F]F-RESCA-T4
NCT06851663,Urothelial carcinoma,[18F]F-RESCA-RT4
NCT06626256,Metastatic melanoma,aldesleukin
NCT06626256,Metastatic melanoma,cyclophosphamide
NCT06626256,Metastatic melanoma,fludarabine
NCT06626256,Metastatic melanoma,Therapeutic Tumor Infiltrating Lymphocytes
NCT06923709,Proteinuria,amiloride
NCT06653556,Systemic lupus erythematosus,LCAR-AIO T cells
NCT06708156,Myopia,Atropine sulfate eye drops
NCT06708156,Myopia,Atropine sulfate eye drops
NCT07001709,Prostate cancer,Oxycodone oral capsule
NCT07001709,Prostate cancer,Abiraterone Acetate Tablets
NCT06629909,Cirrhosis of liver,Secretome
NCT06623656,Carcinoma,cemiplimab
NCT06623656,Carcinoma,Platinum based chemotherapy
NCT06973356,Autoimmune thrombocytopenic purpura,Anti-CD19/BCMA CAR gene vector injection will be injected intravenously on a one-time basis.
NCT06759909,Atrial fibrillation,Dapagliflozin (DAPA)
NCT06992609,Small cell lung carcinoma,durvalumab
NCT06710756,Gastric carcinoma,[203Pb]Pb-PSV359
NCT06710756,Gastric carcinoma,[212Pb]Pb-PSV359
NCT06710756,Ovarian cancer,[203Pb]Pb-PSV359
NCT06710756,Ovarian cancer,[212Pb]Pb-PSV359
NCT06710756,Pancreatic ductal adenocarcinoma,[203Pb]Pb-PSV359
NCT06710756,Pancreatic ductal adenocarcinoma,[212Pb]Pb-PSV359
NCT06788509,Leukemia,JNJ-75348780
NCT06788509,Leukemia,JNJ-67856633
NCT06788509,Leukemia,JNJ-54179060
NCT06788509,Leukemia,JNJ-64264681
NCT06788509,Leukemia,JNJ-74856665
NCT06788509,Leukemia,JNJ-70218902
NCT06788509,Leukemia,JNJ-64619178
NCT06788509,Lymphoma,JNJ-75348780
NCT06788509,Lymphoma,JNJ-67856633
NCT06788509,Lymphoma,JNJ-54179060
NCT06788509,Lymphoma,JNJ-64264681
NCT06788509,Lymphoma,JNJ-74856665
NCT06788509,Lymphoma,JNJ-70218902
NCT06788509,Lymphoma,JNJ-64619178
NCT06788509,Myelodysplastic syndrome,JNJ-75348780
NCT06788509,Myelodysplastic syndrome,JNJ-67856633
NCT06788509,Myelodysplastic syndrome,JNJ-54179060
NCT06788509,Myelodysplastic syndrome,JNJ-64264681
NCT06788509,Myelodysplastic syndrome,JNJ-74856665
NCT06788509,Myelodysplastic syndrome,JNJ-70218902
NCT06788509,Myelodysplastic syndrome,JNJ-64619178
NCT06834009,Pain,SUZ
NCT06708624,Age-related macular degeneration,FYB201
NCT07113834,Uveitis,adalimumab
NCT07113834,Uveitis,Systemic corticosteroids
NCT06665724,Adult glioblastoma,5-Aminolevulinic acid Hydrochloride (Gliolan®)
NCT07005024,Cancer,Apixaban
NCT07005024,Cancer,Apixaban
NCT07005024,Cancer,No anticoagulation
NCT06925724,Cervical carcinoma,Ivonescimab
NCT06925724,Endometrial cancer,Ivonescimab
NCT06694324,Soft tissue sarcoma,Liposomal Doxorubicin (Doxil)
NCT06694324,Soft tissue sarcoma,Apatinib
NCT06694324,Soft tissue sarcoma,Camrelizumab
NCT06859424,B-cell chronic lymphocytic leukemia,Conditioning Regimen A
NCT06859424,B-cell chronic lymphocytic leukemia,Conditioning Regimen B
NCT06859424,B-cell chronic lymphocytic leukemia,Conditioning Regimen C
NCT06859424,B-cell chronic lymphocytic leukemia,Conditioning Regimen D
NCT06859424,B-cell chronic lymphocytic leukemia,Conditioning Regimen E
NCT06859424,B-cell chronic lymphocytic leukemia,"PTCy (50 mg/kg D3, D4)"
NCT06859424,B-cell chronic lymphocytic leukemia,"PTCy (25 mg/kg D3, D4)"
NCT06859424,B-cell chronic lymphocytic leukemia,Post-transplant Tacrolimus
NCT06859424,B-cell chronic lymphocytic leukemia,Post-transplant Mycophenolate mofetil
NCT06859424,B-cell chronic lymphocytic leukemia,Post-transplant Abatacept
NCT06859424,B-cell chronic lymphocytic leukemia,Post-transplant Ruxolitinib
NCT06859424,B-cell chronic lymphocytic leukemia,Supportive Care: Growth Factors
NCT06859424,B-cell chronic lymphocytic leukemia,Supportive Care: Seizure prophylaxis
NCT06859424,B-cell chronic lymphocytic leukemia,Supportive Care: Prophylaxis against infections
NCT06859424,Lymphoma,Conditioning Regimen A
NCT06859424,Lymphoma,Conditioning Regimen B
NCT06859424,Lymphoma,Conditioning Regimen C
NCT06859424,Lymphoma,Conditioning Regimen D
NCT06859424,Lymphoma,Conditioning Regimen E
NCT06859424,Lymphoma,"PTCy (50 mg/kg D3, D4)"
NCT06859424,Lymphoma,"PTCy (25 mg/kg D3, D4)"
NCT06859424,Lymphoma,Post-transplant Tacrolimus
NCT06859424,Lymphoma,Post-transplant Mycophenolate mofetil
NCT06859424,Lymphoma,Post-transplant Abatacept
NCT06859424,Lymphoma,Post-transplant Ruxolitinib
NCT06859424,Lymphoma,Supportive Care: Growth Factors
NCT06859424,Lymphoma,Supportive Care: Seizure prophylaxis
NCT06859424,Lymphoma,Supportive Care: Prophylaxis against infections
NCT06859424,Myelodysplastic syndrome,Conditioning Regimen A
NCT06859424,Myelodysplastic syndrome,Conditioning Regimen B
NCT06859424,Myelodysplastic syndrome,Conditioning Regimen C
NCT06859424,Myelodysplastic syndrome,Conditioning Regimen D
NCT06859424,Myelodysplastic syndrome,Conditioning Regimen E
NCT06859424,Myelodysplastic syndrome,"PTCy (50 mg/kg D3, D4)"
NCT06859424,Myelodysplastic syndrome,"PTCy (25 mg/kg D3, D4)"
NCT06859424,Myelodysplastic syndrome,Post-transplant Tacrolimus
NCT06859424,Myelodysplastic syndrome,Post-transplant Mycophenolate mofetil
NCT06859424,Myelodysplastic syndrome,Post-transplant Abatacept
NCT06859424,Myelodysplastic syndrome,Post-transplant Ruxolitinib
NCT06859424,Myelodysplastic syndrome,Supportive Care: Growth Factors
NCT06859424,Myelodysplastic syndrome,Supportive Care: Seizure prophylaxis
NCT06859424,Myelodysplastic syndrome,Supportive Care: Prophylaxis against infections
NCT06859424,Myelofibrosis,Conditioning Regimen A
NCT06859424,Myelofibrosis,Conditioning Regimen B
NCT06859424,Myelofibrosis,Conditioning Regimen C
NCT06859424,Myelofibrosis,Conditioning Regimen D
NCT06859424,Myelofibrosis,Conditioning Regimen E
NCT06859424,Myelofibrosis,"PTCy (50 mg/kg D3, D4)"
NCT06859424,Myelofibrosis,"PTCy (25 mg/kg D3, D4)"
NCT06859424,Myelofibrosis,Post-transplant Tacrolimus
NCT06859424,Myelofibrosis,Post-transplant Mycophenolate mofetil
NCT06859424,Myelofibrosis,Post-transplant Abatacept
NCT06859424,Myelofibrosis,Post-transplant Ruxolitinib
NCT06859424,Myelofibrosis,Supportive Care: Growth Factors
NCT06859424,Myelofibrosis,Supportive Care: Seizure prophylaxis
NCT06859424,Myelofibrosis,Supportive Care: Prophylaxis against infections
NCT06859424,Myeloproliferative neoplasm,Conditioning Regimen A
NCT06859424,Myeloproliferative neoplasm,Conditioning Regimen B
NCT06859424,Myeloproliferative neoplasm,Conditioning Regimen C
NCT06859424,Myeloproliferative neoplasm,Conditioning Regimen D
NCT06859424,Myeloproliferative neoplasm,Conditioning Regimen E
NCT06859424,Myeloproliferative neoplasm,"PTCy (50 mg/kg D3, D4)"
NCT06859424,Myeloproliferative neoplasm,"PTCy (25 mg/kg D3, D4)"
NCT06859424,Myeloproliferative neoplasm,Post-transplant Tacrolimus
NCT06859424,Myeloproliferative neoplasm,Post-transplant Mycophenolate mofetil
NCT06859424,Myeloproliferative neoplasm,Post-transplant Abatacept
NCT06859424,Myeloproliferative neoplasm,Post-transplant Ruxolitinib
NCT06859424,Myeloproliferative neoplasm,Supportive Care: Growth Factors
NCT06859424,Myeloproliferative neoplasm,Supportive Care: Seizure prophylaxis
NCT06859424,Myeloproliferative neoplasm,Supportive Care: Prophylaxis against infections
NCT06592924,Prostate cancer,abiraterone
NCT06592924,Prostate cancer,enzalutamide
NCT06592924,Prostate cancer,apalutamide
NCT06592924,Prostate cancer,Darolutamide (BAY
NCT06592924,Prostate cancer,docetaxel
NCT06592924,Prostate cancer,ADT
NCT06704724,Carcinoma,PF-07985045
NCT06713434,Epidermolysis bullosa,ELK-003 (Standarized Amniotic Fluid Secretome Eye Drops)
NCT06952309,Pharyngitis,Intracheal dexmedetomidine
NCT06952309,Pharyngitis,Intravenous lidocaine
NCT06952309,Pharyngitis,Intravenous lidocaine combined with intracheal dexmedetomidine
NCT06866509,Inherited lipid metabolism disorder,Litorvazet Tablet
NCT06866509,Inherited lipid metabolism disorder,Litorvazet Tablet10/20mg
NCT06866509,Inherited lipid metabolism disorder,Litorvazet Tablet
NCT06704009,Wet macular degeneration,NT-101
NCT06704009,Wet macular degeneration,NT-101
NCT07060456,Type 2 diabetes mellitus,HRS953
NCT07060456,Type 2 diabetes mellitus,HRS953
NCT07001956,Rheumatoid arthritis,UTAA91 injection
NCT06643156,Influenza,GP681
NCT06998056,Atopic eczema,ARQ-151 cream
NCT06901609,Heart failure,SGLT2 inhibitor (Dapagliflozin
NCT07105709,Alzheimer disease,GSK4527226
NCT07056556,Non-small cell lung carcinoma,BL-M09D1
NCT07074756,Malignant glioma,Chemotherapy
NCT06732856,Gastric carcinoma,zolbetuximab
NCT06732856,Gastric carcinoma,oxaliplatin
NCT06732856,Gastric carcinoma,docetaxel
NCT06732856,Gastric carcinoma,S-1
NCT06732856,Gastric neoplasm,zolbetuximab
NCT06732856,Gastric neoplasm,oxaliplatin
NCT06732856,Gastric neoplasm,docetaxel
NCT06732856,Gastric neoplasm,S-1
NCT07046156,Overactive bladder,Oxybutynin Cl
NCT07046156,Overactive bladder,propiverine
NCT07046156,Overactive bladder,tolterodine
NCT06819215,Cancer,VB15010
NCT06819215,Malignant pancreatic neoplasm,VB15010
NCT06819215,Neoplasm,VB15010
NCT06819215,Prostate cancer,VB15010
NCT07049185,Esophageal squamous cell carcinoma,QL1706 Plus Celecoxib Group
NCT06802185,Pain,ADA Liquid Filled Capsules (Test Product)
NCT06802185,Pain,ADA Caplets (Reference Product)
NCT06802185,Pain,Advil Liqui-gels (Reference Product)
NCT06946485,Systemic lupus erythematosus,Universal CAR-T (CHT101)
NCT06572085,Cardiac arrest,Butylphthalide and Sodium Chloride Injection
NCT06950385,Classic familial adenomatous polyposis,eRapa (encapsulated rapamycin)
NCT07131085,Myelodysplastic syndrome,Allogeneic TCR-enhanced γδ T cell(QH101)
NCT07131085,Myelodysplastic syndrome,Fludarabine (FLU)
NCT07131085,Myelodysplastic syndrome,Cyclophosphamide (CTX)
NCT06822985,Hepatocellular carcinoma,QL1706
NCT06821685,Preeclampsia,autologous decidual-like NK cells
NCT06917885,Adult glioblastoma,CUE-102
NCT06917885,Malignant glioma,CUE-102
NCT06747585,Esophageal squamous cell carcinoma,ALE.P02
NCT06930885,Atherosclerotic cardiovascular disease,Cardiovascular Polypill
NCT06930885,Atherosclerotic cardiovascular disease,colchicine
NCT06930885,Atherosclerotic cardiovascular disease,Usual Care Group
NCT06978985,Proximal spinal muscular atrophy,risdiplam
NCT06978985,Proximal spinal muscular atrophy,nusinersen Injectable Product
NCT06789185,Inguinal hernia,0.1mg/kg esketamine
NCT06789185,Inguinal hernia,0.2mg/kg esketamine
NCT07041385,Preeclampsia,Aspirin Tablets
NCT07033585,Type 2 diabetes mellitus,Farxiga® (dapagliflozin) + Onglyza® (saxagliptin) + Metformin Oral Mix Treat type
NCT07033585,Type 2 diabetes mellitus,China Import (dapagliflozin) + China Import (saxagliptin) + Metformin Oral Mix Treat type
NCT06685185,Diabetes mellitus,NNC0363-1063
NCT06685185,Diabetes mellitus,insulin degludec
NCT06850285,Lymphoma,chimeric antigen receptor gene modified T cells
NCT06699771,Lymphoma,GCC2005
NCT06699771,Lymphoma,cyclophosphamide
NCT06699771,Lymphoma,fludarabine
NCT06785493,Inflammatory bowel disease,Optimized Treatment (OPT)
NCT06999993,Pain,Sodium hyaluronate jell
NCT06999993,Pain,sodium bicarbonate
NCT06583993,Intrahepatic cholangiocarcinoma,HNF4α srRNA
NCT06609993,Aortic aneurysm,intravenous rescue opioid analgesia using fentanyl
NCT06609993,Aortic aneurysm,intravenous rescue atropine administration
NCT06609993,Aortic aneurysm,intravenous rescue urapidil administration
NCT06609993,Aortic aneurysm,intravenous rescue ephedrine administration
NCT06609993,Aortic aneurysm,concentrate of red blood cells
NCT06609993,Aortic aneurysm,red blood cells autotransfusion
NCT06609993,Aortic aneurysm,primary treatment of postoperative nausea and vomiting (PONV)
NCT06609993,Aortic aneurysm,secondary treatment of postoperative nausea and vomiting (PONV)
NCT06609993,Aortic aneurysm,intraopertative fluid challenge (IFC)
NCT06609993,Aortic aneurysm,postoperative rescue opioid analgesia using morphine
NCT06637371,Asthma,AMG
NCT06584071,Hepatocellular carcinoma,PM8002
NCT06584071,Hepatocellular carcinoma,PM1009
NCT06584071,Hepatocellular carcinoma,atezolizumab
NCT06584071,Hepatocellular carcinoma,bevacizumab
NCT06568471,Hypercholesterolemia,Lerodalcibep
NCT06568471,Metabolic disease,Lerodalcibep
NCT06753071,Benign prostatic hyperplasia,pyridostigmine Oral Tablet
NCT06576271,Systemic lupus erythematosus,GSK4527363
NCT06576271,Systemic lupus erythematosus,belimumab
NCT06672393,Psoriasis,HS-10374
NCT06642493,Dengue disease,Fresh frozen plasma
NCT06916793,Androgenetic alopecia,CKD-843 dose#1
NCT06916793,Androgenetic alopecia,CKD-843 dose#2
NCT06916793,Androgenetic alopecia,Dutasteride Capsules
NCT06642571,Obesity disorder,NNC0519-0130 B
NCT06642571,Obesity disorder,NNC0519-0130 C
NCT07018271,Neutropenia,sulpegfilgrastim
NCT06947993,Atopic eczema,GHZ339
NCT06665971,Eosinophilic esophagitis,Dupilumab
NCT07038278,Soft tissue sarcoma,5-ALA
NCT06769971,Small cell lung carcinoma,Ivonescimab
NCT06769971,Small cell lung carcinoma,Cadonilimab
NCT06769971,Small cell lung carcinoma,etoposide
NCT06769971,Small cell lung carcinoma,carboplatin
NCT06979271,Rheumatoid arthritis,Telitacicept Tofacitinib
NCT06668571,Depressive disorder,ketamine
NCT06733519,Primary biliary cholangitis,nalmefene
NCT06733519,Pruritus,nalmefene
NCT06846541,Psoriasis,Open-Label ESK-001
NCT06846541,Psoriasis,Blinded ESK-001
NCT06733441,Lymphoma,TLN-254
NCT06733441,Lymphoma,TLN-254
NCT06793241,Precursor B-cell acute lymphoblastic leukemia,CD19 B-cell Acute Lymphoblastic Leukemia Targeted CAR T-cells injection
NCT06746441,Endogenous depression,Psilocybin
NCT06771219,Endometrial cancer,SLV-154
NCT06771219,Non-small cell lung carcinoma,SLV-154
NCT06771219,Ovarian cancer,SLV-154
NCT06771219,Sarcoma,SLV-154
NCT06771219,Small cell lung carcinoma,SLV-154
NCT06660719,Ischemic stroke,SP-8203
NCT06643819,Essential hypertension,sacubitril/valsatran(dose maintenance)
NCT06643819,Essential hypertension,sacubitril/valsartan(dose increasing)
NCT06643819,Essential hypertension,valsartan
NCT06902519,Rheumatoid arthritis,GS-0151
NCT06664619,Asthma,Fp/ABS
NCT06664619,Asthma,FP
NCT06664619,Asthma,ABS
NCT06945419,Obesity disorder,LY4086940
NCT06945419,Type 2 diabetes mellitus,LY4086940
NCT07131319,Non-small cell lung carcinoma,"Tislelizumab, Carboplatin, Pemetrexed"
NCT07131319,Non-small cell lung carcinoma,"Tislelizumab, paclitaxel, Carboplatin"
NCT07070219,Lymphoma,CTD402 CAR T Cell Injection
NCT06721819,Delirium,Control
NCT07070518,Endometrial carcinoma,GV20-0251
NCT07070518,Hepatocellular carcinoma,GV20-0251
NCT07070518,Melanoma,GV20-0251
NCT07070518,Non-small cell lung carcinoma,GV20-0251
NCT07070518,Small cell lung carcinoma,GV20-0251
NCT06908018,Dengue disease,rDEN2Δ30-7169
NCT07086118,Cataract,Metoclopramide
NCT07086118,Cataract,dexamethasone
NCT06984718,Hepatocellular carcinoma,AK104+lenvatinib
NCT06984718,Hepatocellular carcinoma,lenvatinib
NCT07088718,Type 2 diabetes mellitus,tirzepatide
NCT07088718,Type 2 diabetes mellitus,dulaglutide
NCT07010419,Non-small cell lung carcinoma,Firmonertinib
NCT07022119,Autosomal dominant polycystic kidney disease,VX-407
NCT06967519,Malaria,Artemether-lumefantrine (AL)
NCT06967519,Malaria,artesunate-amodiaquine (AS-AQ)
NCT06829719,Cancer,TTV DNAemia
NCT06829719,Cancer,Biological tests
NCT06829719,Infectious disease,TTV DNAemia
NCT06829719,Infectious disease,Biological tests
NCT06840119,Cancer,IMC-R117C
NCT06840119,Cancer,Chemotherapy drug
NCT06840119,Cancer,Chemotherapy drug
NCT06840119,Cancer,Kinase inhibitor
NCT06840119,Cancer,Antiangiogenic Agent
NCT06840119,Cancer,Monoclonal antibody
NCT07028632,Parkinson disease,Human Dopaminergic Progenitor Cells
NCT06867432,Hepatocellular carcinoma,Combination Product：t: SIRT-Y90 +HAIC+Atezolizumab + Bevacizumab
NCT06972732,Type 2 diabetes mellitus,metformin
NCT06972732,Type 2 diabetes mellitus,Dapagliflozin/Pioglitazone
NCT06972732,Type 2 diabetes mellitus,Dapagliflozin/Sitagliptin
NCT06977932,Trigeminal neuralgia,Carbarmazepine
NCT06602232,Vitiligo-associated multiple autoimmune disease susceptibility 1,DR-01
NCT07023432,Nonpapillary renal cell carcinoma,belzutifan
NCT07080632,Intracerebral hemorrhage,Calculus bovis sativus (CBS)
NCT07080632,Intracerebral hemorrhage,Natural Calculus Bovis(NCB)
NCT06704152,Myelodysplastic syndrome,SOC + BSB-1001 Dose Escalation Cohort
NCT06704152,Myelodysplastic syndrome,SOC+BSB-1001 Expansion Dose
NCT06706232,Bipolar II disorder,Psilocybin
NCT06706232,Depressive disorder,Psilocybin
NCT07129252,Neuroendocrine neoplasm,CRN09682
NCT06692452,Lymphoma,tazemetostat
NCT06692452,Lymphoma,doxorubicin
NCT06692452,Lymphoma,vincristine
NCT06692452,Lymphoma,prednisone
NCT06692452,Lymphoma,Cytoxan
NCT06692452,Lymphoma,carmustine
NCT06692452,Lymphoma,etoposide
NCT06692452,Lymphoma,cytarabine
NCT06692452,Lymphoma,melphalan
NCT07034742,Gastric adenocarcinoma,Intraperitoneal chemotherapy PLUS systemic chemotherapy
NCT06749470,Endogenous depression,Jieyu Chufan Capsules
NCT06749470,Endogenous depression,Jieyu Chufan Capsules simulant
NCT07052942,Asthma,Inhaled corticosteroid (ICS)
NCT07052942,Asthma,azithromycin
NCT06699342,Atrial fibrillation,Pharmacologic therapy optimized for Atrial Fibrillation management
NCT06874842,Herpes zoster,Low dose antigen and low dose adjuvant of LYB004
NCT06874842,Herpes zoster,Low dose antigen and high dose adjuvant of LYB004
NCT06874842,Herpes zoster,High dose antigen and low dose adjuvant of LYB004
NCT06874842,Herpes zoster,High dose antigen and high dose adjuvant of LYB004
NCT06874842,Herpes zoster,Positive control
NCT06625242,Rheumatoid arthritis,Filgotinib Maleate
NCT07045142,Schizophrenia,atorvastatin
NCT07045142,Schizophrenia,metformin
NCT07117942,Diabetic neuropathy,Fermented Deglycyrrhizinated Licorice (FDGL)
NCT07119970,Myeloproliferative neoplasm,Additional blood sampling
NCT06685042,Dermatomyositis,CAR T cell
NCT06685042,Lupus erythematosus,CAR T cell
NCT07088042,Pulpitis,Limitless Allzyme
NCT07088042,Pulpitis,Oral tablets of Alphintern®
NCT07088042,Pulpitis,Cataflam®
NCT06696742,Childhood bladder carcinoma,Clostridium Butyricum Tablets
NCT06696742,Childhood bladder carcinoma,cisplatin
NCT06620042,Bipolar depression,ketamine
NCT06755671,Constipation disorder,Danning Tablet
NCT06755671,Dyspepsia,Danning Tablet
NCT06771271,Diabetic macular edema,RO7200220
NCT06771271,Diabetic macular edema,ranibizumab
NCT06906471,Prostate cancer,AS1986NS
NCT07013071,Pain,2% Mepivacaine with
NCT07013071,Pain,2% Mepivacaine with
NCT07057271,Type 2 diabetes mellitus,CJC-1134-PC Injection
NCT06625671,Systemic lupus erythematosus,DB-2304
NCT06625671,Systemic lupus erythematosus,prednisone
NCT07126171,Chikungunya,Reduning injection
NCT07126171,Chikungunya,The simulant of Reduning Injection
NCT07110571,Gastric carcinoma,Adebrelimab Injection
NCT07110571,Gastric carcinoma,SHR-A1811 for Injection
NCT07110571,Gastric carcinoma,SHR-A1904 for Injection
NCT07110571,Gastric carcinoma,SHR-8068 Injection
NCT06929156,Type 2 diabetes mellitus,BGM0504
NCT06929156,Type 2 diabetes mellitus,BGM0504
NCT06929156,Type 2 diabetes mellitus,BGM0504
NCT06929156,Type 2 diabetes mellitus,BGM0504
NCT06827756,Ascites,norfloxacin
NCT06827756,Ascites,nitazoxanide
NCT06827756,Ascites,colistin
NCT06764056,Obesity disorder,semaglutide
NCT07077356,Hepatocellular carcinoma,HBV mRNA vaccine
NCT06598956,Myelofibrosis,TQ05105
NCT06932861,Rhabdomyosarcoma,mRNA Tumor Vaccine Therapy
NCT06888661,Proximal spinal muscular atrophy,EXG001-307 injection
NCT06996561,Hernia,nalbuphine Injection
NCT06758661,Inherited lipid metabolism disorder,D352
NCT06758661,Inherited lipid metabolism disorder,D794
NCT06585761,Heart failure,SGLT2 inhibitor
NCT06746961,Esophageal squamous cell carcinoma,QL1706 (bispecific antibody targeting PD-1 and CLTA-4)
NCT06746961,Esophageal squamous cell carcinoma,lenvatinib
NCT06948461,Irritable bowel syndrome,ORAL-LYO-FMT
NCT07074561,Trigeminal neuralgia,CBZ
NCT06992661,Interstitial lung disease,ICF004 inhaled powder
NCT06992661,Interstitial lung disease,Oral Teavigo® capsules
NCT06714461,Psoriatic arthritis,leflunomide
NCT06714461,Rheumatoid arthritis,leflunomide
NCT06730061,Primary biliary cholangitis,elafibranor
NCT07077161,Nonpapillary renal cell carcinoma,cabozantinib
NCT06695598,Type 2 diabetes mellitus,CKD-383
NCT06809998,Osteoarthritis,Corticosteroid Injection -
NCT06925698,Behcet disease,Rivaroxaban plus immunosupression
NCT07120698,Non-small cell lung carcinoma,Sintilimab
NCT06910605,Attention deficit-hyperactivity disorder,"""drug holidays"" (D)"
NCT07124351,Gastric carcinoma,CYTALUX™ (pafolacianine)
NCT06830551,Dry eye syndrome,"administration cord blood based eye drops, standardized to the deliver BDNF."
NCT07117383,Erectile dysfunction,ASP-001
NCT07117383,Erectile dysfunction,Commercial Sildenafil and Sildenafil/Tadalafil Products
NCT06594783,Cirrhosis of liver,Carvedilol alone
NCT06594783,Esophageal varices,Carvedilol alone
NCT06695897,Eosinophilic esophagitis,dupilumab
NCT07052253,Hepatocellular carcinoma,TT-00420 (tinengotinib)
NCT07052253,Hepatocellular carcinoma,AK104
NCT07052253,Hepatocellular carcinoma,AK112
NCT07121153,Obesity disorder,NNC0487-0111 A
NCT06729151,Female sexual dysfunction,Onabotulinum toxin A
NCT06729151,Interstitial cystitis,Onabotulinum toxin A
NCT06609551,Malignant colon neoplasm,6-month adjuvant chemotherapy with
NCT06609551,Malignant colon neoplasm,XELOX intensive treatment group
NCT06987851,Multiple sclerosis,Divozilimab
NCT06999551,Diabetes mellitus,switch NPH to glargin
NCT06856577,Wet macular degeneration,aflibercept
NCT06591351,Ischemic stroke,cilostazol
NCT06591351,Ischemic stroke,clopidogrel
NCT06583551,Bruxism,Botulinum toxin
NCT06583551,Bruxism,Myorel
NCT06651853,Diffuse large B-cell lymphoma,"Large fraction radiotherapy in combined with GM-CSF, Lenalidomide, and Glofitamab"
NCT06988553,Type 2 diabetes mellitus,AZD5004
NCT07000253,Gastric adenocarcinoma,Chemotherapy
NCT07000253,Gastric adenocarcinoma,Targeted Systemic Therapy
NCT07000253,Gastric adenocarcinoma,Immunotherapy
NCT07000253,Gastric carcinoma,Chemotherapy
NCT07000253,Gastric carcinoma,Targeted Systemic Therapy
NCT07000253,Gastric carcinoma,Immunotherapy
NCT06982651,Postpartum depression,MI078
NCT06748053,Asthma,GSK5784283
NCT07048353,Lymphoma,chimeric antigen receptor gene modified T cells
NCT06783153,Childhood bladder carcinoma,rifAXIMin
NCT06783153,Childhood bladder carcinoma,Standard Care Chemoradiation
NCT06783153,Prostate cancer,rifAXIMin
NCT06783153,Prostate cancer,Standard Care Chemoradiation
NCT06783153,Rectum adenocarcinoma,rifAXIMin
NCT06783153,Rectum adenocarcinoma,Standard Care Chemoradiation
NCT06811051,Pharyngitis,Menthol lozenge
NCT06811051,Pharyngitis,Clove lozenge
NCT06649851,Adult glioblastoma,Granulocyte Colony Stimulating Factor (G-CSF)
NCT06872151,Hemorrhoid,Hyaluronic acid and silver sulfadiazine
NCT06614153,Parkinson disease,HRG2010(I)
NCT06614153,Parkinson disease,HRG2010(II)
NCT06614153,Parkinson disease,Sustained-release Carbidopa/Levodopa
NCT06857253,Hyperlipidemia,HRS-1301
NCT06832683,Hypoxemia,sevoflurane
NCT06832683,Hypoxemia,propofol
NCT06832683,Hypoxemia,ketamine
NCT07045805,Gastric carcinoma,QL1706 combined with paclitaxel and bevacizumab
NCT06655883,Insomnia,suvorexant
NCT06708897,B-cell chronic lymphocytic leukemia,ZE
NCT06668805,Turner syndrome,vosoritide Injection
NCT06668805,Turner syndrome,Human Growth Hormone
NCT06854861,Type 1 diabetes mellitus,Insulin lispro
NCT06854861,Type 1 diabetes mellitus,Premixed Lyumjev
NCT06961383,Secondary progressive multiple sclerosis,NG01 - Autologous bone marrow derived human stromal cells
NCT06646497,Aplastic anemia,Allogeneic hematopoietic stem cell transplantation Stem cell source only Bone Marrow
NCT06924697,Diabetes mellitus,Application of GLP-1RAs drugs
NCT06924697,Diabetes mellitus,DPP-4i group
NCT06924697,Nicotine dependence,Application of GLP-1RAs drugs
NCT06924697,Nicotine dependence,DPP-4i group
NCT06930261,"Ocular motor apraxia, Cogan type",LBT-999
NCT06926283,Ewing sarcoma,DXC008
NCT06926283,Prostate cancer,DXC008
NCT06937697,Allergic disease,Test toothpaste
NCT06937697,Allergic disease,Control toothpaste
NCT06834997,Endometriosis,Dronabinol Capsules
NCT06606483,Obesity disorder,MDR-001
NCT07052097,Allergic rhinitis,TQC2938 injection
NCT06850597,Alzheimer disease,dimethyl fumarate
NCT06914297,Endometrial cancer,TQB2450 injection + oral progestin
NCT07022197,Acquired idiopathic inflammatory myopathy,BAFF-R CART
NCT07022197,Myasthenia gravis,BAFF-R CART
NCT06741683,Dengue disease,TDV
NCT07104383,Weight loss,VK2735
NCT07062497,Hernia,Rectus Sheath Block
NCT07062497,Hernia,Rectus Sheath Block with Clonidine
NCT07062497,Pain,Rectus Sheath Block
NCT07062497,Pain,Rectus Sheath Block with Clonidine
NCT06633783,Obesity disorder,semaglutide
NCT06633783,Obesity disorder,semaglutide
NCT06726161,Hepatocellular carcinoma,RYZ801
NCT06910397,Gingivitis,Probiotic Arm
NCT06574997,Retinitis pigmentosa,OCU400
NCT07101783,Obesity disorder,NNC0662-0419
NCT06810583,Leukemia,dalbavancin
NCT06810583,Leukemia,Fluoroquinolone (either ciprofloxacin or levofloxacin at the discretion of the treating clinician)
NCT07077083,Nonpapillary renal cell carcinoma,89Zr-Girentuximab
NCT06645197,Amyotrophic lateral sclerosis,SNUG01
NCT06815497,Ovarian cancer,telmisartan
NCT06629597,Nasopharyngeal carcinoma,YL201
NCT06629597,Nasopharyngeal carcinoma,docetaxel
NCT06629597,Nasopharyngeal carcinoma,capecitabine
NCT06629597,Nasopharyngeal carcinoma,gemcitabine
NCT07093697,Bronchitis,DW5121
NCT07093697,Bronchitis,DW51211
NCT07093697,Bronchitis,DW51212
NCT06594445,Myelodysplastic syndrome,GTB-360
NCT06594445,Myeloid neoplasm,GTB-360
NCT06892145,Systemic lupus erythematosus,MC-1-50
NCT06587347,Cerebrovascular disorder,tirofiban hydrochloride
NCT06587347,Cerebrovascular disorder,Standard medical treatment (SMT)
NCT06587347,Ischemic stroke,tirofiban hydrochloride
NCT06587347,Ischemic stroke,Standard medical treatment (SMT)
NCT06680947,Asthma,610
NCT06680947,Asthma,610
NCT06630845,Metastatic malignant neoplasm,fluorodeoxyglucose F18
NCT06863545,Coronary artery disorder,PCSK9 inhibitors and background lipid-modifying therapy
NCT07024147,B-cell non-Hodgkin lymphoma,JWCAR239
NCT07024147,B-cell non-Hodgkin lymphoma,fludarabine
NCT07024147,B-cell non-Hodgkin lymphoma,cyclophosphamide
NCT07024147,Follicular lymphoma,JWCAR239
NCT07024147,Follicular lymphoma,fludarabine
NCT07024147,Follicular lymphoma,cyclophosphamide
NCT07024147,Mantle cell lymphoma,JWCAR239
NCT07024147,Mantle cell lymphoma,fludarabine
NCT07024147,Mantle cell lymphoma,cyclophosphamide
NCT07024147,Marginal zone lymphoma,JWCAR239
NCT07024147,Marginal zone lymphoma,fludarabine
NCT07024147,Marginal zone lymphoma,cyclophosphamide
NCT06970847,Prostate cancer,64Cu-SAR-bisPSMA
NCT06826547,Diabetes mellitus,Adjustment of insulin doses DAR
NCT06826547,Diabetes mellitus,Adjustment of insulin doses CFT
NCT06695845,Endometrial cancer,zanidatamab
NCT06695845,Gastric carcinoma,zanidatamab
NCT06695845,Gastroesophageal cancer,zanidatamab
NCT06695845,Malignant pancreatic neoplasm,zanidatamab
NCT06695845,Non-small cell lung carcinoma,zanidatamab
NCT06695845,Ovarian cancer,zanidatamab
NCT06695845,Urothelial carcinoma,zanidatamab
NCT07131345,Mesothelioma,iparomlimab and tuvonralimab (Dual PD-1/CTLA-4 blockade) + chemotherapy
NCT06716645,Cough,Robitussin Maximum Strength Cough and Chest Congestion DM
NCT06716645,Cough,Robitussin Maximum Strength Cough and Chest Congestion DM
NCT06716645,Cough,Robitussin Maximum Strength Nighttime Cough DM
NCT06955845,Post-traumatic stress disorder,Selective serotonin reuptake inhibitors
NCT07132645,Neuroendocrine neoplasm,Gallium Ga
NCT06703047,Esophageal squamous cell carcinoma,ATRA+pd-1+chemo
NCT06827977,Constipation disorder,PRIM-DJ2727
NCT06845345,Diabetes mellitus,Mysimba
NCT06845345,Hepatic steatosis,Mysimba
NCT06845345,Metabolic dysfunction-associated steatotic liver disease,Mysimba
NCT06704347,Amyotrophic lateral sclerosis,XT-150
NCT06731647,Pneumothorax,KETOPROFEN(RP19583)
NCT06744777,Dengue disease,ribavirin
NCT06978647,Anti-neutrophil cytoplasmic antibody-associated vasculitis,YTS109 cell
NCT06978647,Antiphospholipid syndrome,YTS109 cell
NCT06978647,Inclusion body myositis,YTS109 cell
NCT06978647,Rheumatoid arthritis,YTS109 cell
NCT06978647,Systemic lupus erythematosus,YTS109 cell
NCT06978647,Systemic sclerosis,YTS109 cell
NCT06692283,Metabolic dysfunction-associated steatohepatitis,denifanstat
NCT06692283,Metabolic dysfunction-associated steatotic liver disease,denifanstat
NCT06665997,Sickle cell disease,Depot medroxyprogesterone acetate (DMPA)
NCT06980597,Systemic lupus erythematosus,OL-108
NCT06980597,Systemic sclerosis,OL-108
NCT06596005,Parkinson disease,TJ0113
NCT07022405,Depressive disorder,Pramipexole Immediate Release
NCT06744205,Influenza,Trivalent (TIV) messenger ribonucleic acid (mRNA) hemagglutinin (HA) Vaccine
NCT06744205,Influenza,TIV mRNA-neuraminidase (NA)
NCT06744205,Influenza,TIV mRNA-HA Vaccine
NCT06744205,Influenza,Quadrivalent Influenza Standard Dose Vaccine
NCT06744205,Influenza,Quadrivalent Influenza Vaccine High Dose
NCT06997497,Colon adenocarcinoma,MK-1084
NCT06997497,Colon adenocarcinoma,oxaliplatin
NCT06997497,Colon adenocarcinoma,Leucovorin/levofolinate calcium
NCT06997497,Colon adenocarcinoma,5-Fluorouracil
NCT06997497,Colon adenocarcinoma,cetuximab
NCT06997497,Colon adenocarcinoma,bevacizumab
NCT06997497,Rectum adenocarcinoma,MK-1084
NCT06997497,Rectum adenocarcinoma,oxaliplatin
NCT06997497,Rectum adenocarcinoma,Leucovorin/levofolinate calcium
NCT06997497,Rectum adenocarcinoma,5-Fluorouracil
NCT06997497,Rectum adenocarcinoma,cetuximab
NCT06997497,Rectum adenocarcinoma,bevacizumab
NCT07035197,Migraine disorder,eptinezumab
NCT06581497,Hepatocellular carcinoma,ICIs
NCT06605105,Endogenous depression,CYB003
NCT07082205,Malaria,Antimalarial monoclonal antibodies
NCT07082205,Malaria,Dihydroartemisinin - Piperaquine (DP)
NCT06946797,Non-small cell lung carcinoma,nivolumab
NCT06946797,Non-small cell lung carcinoma,ipilimumab
NCT06946797,Non-small cell lung carcinoma,carboplatin
NCT06946797,Non-small cell lung carcinoma,paclitaxel
NCT06946797,Non-small cell lung carcinoma,pemetrexed
NCT06946797,Non-small cell lung carcinoma,cisplatin
NCT07086105,Metastatic melanoma,Adze1.C
NCT07001605,Ketamine,ketamine
NCT07019805,Hypotensive disorder,"Standard General Anesthesia Induction Using Propofol, Fentanyl and Midazolam"
NCT06715605,Multiple sclerosis,tolerogenic dendritic cells (tolDC)
NCT06715605,Multiple sclerosis,Standard-of-care
NCT06945705,Non-small cell lung carcinoma,furmonertinib combined with anlotinib
NCT07096297,Myelodysplastic syndrome,luspatercept
NCT07096297,Myelodysplastic syndrome,Darbeopoetin
NCT06598397,Human immunodeficiency virus,Combination NRT
NCT06902805,Osteoarthritis,onabotulinumtoxinA
NCT06720805,Irritable bowel syndrome,Pentabiocel
NCT06572397,Ocular hypertension,H-1337
NCT06671405,Inherited lipid metabolism disorder,AZD0780
NCT06671405,Inherited lipid metabolism disorder,itraconazole
NCT06671405,Inherited lipid metabolism disorder,carbamazepine
NCT06671405,Inherited lipid metabolism disorder,midazolam
NCT06671405,Inherited lipid metabolism disorder,Ethinyl estradiol/levonorgestrel
NCT06737705,Intracerebral hemorrhage,Baritinib
NCT06897605,Anemia,Dapagliflozin (DAPA)
NCT06897605,Anemia,Erythropoiesis Stimulating Agent
NCT06658197,Cerebrovascular disorder,tenecteplase
NCT06658197,Cerebrovascular disorder,alteplase
NCT06658197,Thrombotic disease,tenecteplase
NCT06658197,Thrombotic disease,alteplase
NCT07128797,Metabolic dysfunction-associated steatotic liver disease,B1344
NCT06852105,Dry eye syndrome,3% Diquafosol Sodium Eye Drops
NCT06852105,Dry eye syndrome,0.1% hyaluronic acid
NCT06690697,Nonpapillary renal cell carcinoma,JS004
NCT06690697,Nonpapillary renal cell carcinoma,toripalimab
NCT06690697,Nonpapillary renal cell carcinoma,axitinib
NCT06690697,Nonpapillary renal cell carcinoma,sorafenib
NCT06993597,Glaucoma,Prostaglandin Analogue -Containing IOP-Lowering Therapy
NCT06993597,Glaucoma,Beta Blocker
NCT06793397,Endogenous depression,CYB003
NCT07010497,Carcinoma,irpagratinib
NCT06965998,Thrombotic disease,Full dose rivaroxaban
NCT06965998,Thrombotic disease,Low dose rivaroxaban
NCT07054697,Autism,Homoeopathic medicines
NCT06772597,Obesity disorder,setmelanotide
NCT06772597,Prader-Willi syndrome,setmelanotide
NCT07025005,Peripheral neuropathy,Bortezomib + Lenalidomide + Dexamethasone + Fenofibrate
NCT07025005,Peripheral neuropathy,Bortezomib + Lenalidomide + Dexamethasone
NCT06716905,Metabolic dysfunction-associated steatohepatitis,ACT500 tablets
NCT06716905,Metabolic dysfunction-associated steatohepatitis,ACT500 tablets
NCT06635798,Tetanus,GR2001
NCT06635798,Tetanus,HTIG
NCT07077798,Hepatocellular carcinoma,Sintilimab
NCT07077798,Hepatocellular carcinoma,lenvatinib
NCT06955598,Systemic lupus erythematosus,SHR-2173
NCT06890598,Carcinoma,Olomorasib
NCT06890598,Carcinoma,pembrolizumab
NCT06890598,Carcinoma,durvalumab
NCT06997198,Intellectual disability,Deutetrabenazine Oral Capsule
NCT06673498,Thrombocytopenia,Lusutrombopag combined with recombinant human thrombopoietin
NCT06703398,Melanoma,GC101 TIL
NCT06703398,Melanoma,"dacarbazine, temozolomide, paclitaxel ,platinum or cisplatin"
NCT07033598,Leukemia,pacritinib
NCT07033598,Leukemia,hydroxyurea
NCT07108998,B-cell chronic lymphocytic leukemia,epcoritamab
NCT07010198,Pediatric hepatocellular carcinoma,Measurement Indicators Required for Risk Scoring in HCC Screening Strategies
NCT07010198,Pediatric hepatocellular carcinoma,Follow-Up Monitoring Parameters
NCT06728553,Migraine disorder,MTX101
NCT06882551,Diabetic macular edema,Intravitreal Bevacizumab IVB
NCT06882551,Diabetic macular edema,intravitreal bevacizumab and suprachoroidal triamcinolone acetonide
NCT06587451,Melanoma,JPB898 (Induction and Maintenance)
NCT06587451,Melanoma,Opdivo-EU (Induction)
NCT06587451,Melanoma,Opdivo-US (Induction)
NCT06587451,Melanoma,Yervoy-EU (Induction)
NCT06587451,Melanoma,Opdivo-EU (Maintenance)
NCT06970951,Acquired idiopathic inflammatory myopathy,UTAA91 injection
NCT06970951,Rheumatoid arthritis,UTAA91 injection
NCT06970951,Systemic lupus erythematosus,UTAA91 injection
NCT06970951,Systemic sclerosis,UTAA91 injection
NCT06632951,Urothelial carcinoma,Livmoniplimab
NCT06632951,Urothelial carcinoma,Budigalimab
NCT06632951,Urothelial carcinoma,docetaxel
NCT06632951,Urothelial carcinoma,paclitaxel
NCT06632951,Urothelial carcinoma,docetaxel
NCT06632951,Urothelial carcinoma,paclitaxel
NCT06632951,Urothelial carcinoma,gemcitabine
NCT06810154,Necrotizing enterocolitis,Multi-strain probiotics
NCT06843187,Endogenous depression,lemborexant
NCT06671587,Type 2 diabetes mellitus,iGlarLixi (insulin glargine/lixisenatide)
NCT06671587,Type 2 diabetes mellitus,Gla-100 (insulin glargine)
NCT06999187,Cervical carcinoma,DR-0202
NCT06999187,Endometrial cancer,DR-0202
NCT06999187,Gastric carcinoma,DR-0202
NCT06999187,Ovarian cancer,DR-0202
NCT06999187,Pancreatic ductal adenocarcinoma,DR-0202
NCT06999187,Urothelial carcinoma,DR-0202
NCT06818851,Diabetes mellitus,Henggliflozin
NCT06824051,Obesity disorder,Orforglipron
NCT06903754,Heart failure,With ISGLT2
NCT06851754,Primary ovarian failure,progesterone
NCT06851754,Primary ovarian failure,Estrogen Patch
NCT06893354,Non-small cell lung carcinoma,lorlatinib
NCT06893354,Non-small cell lung carcinoma,lorlatinib plus chemotherapy
NCT07005154,Prostate cancer,ASP5541
NCT07005154,Prostate cancer,prednisone
NCT07005154,Prostate cancer,prednisolone
NCT07005154,Prostate cancer,ABIRATERONE ACETATE
NCT06736054,Prostate adenocarcinoma,Copper
NCT07121751,Infertility disorder,use of combination of recombinant FSH and recombinant LH
NCT07121751,Infertility disorder,higher dose recFSH
NCT07121751,Infertility disorder,unchanged dose
NCT07072351,Gastroesophageal junction adenocarcinoma,SOX Chemotherapy
NCT07072351,Gastroesophageal junction adenocarcinoma,PD-1 inhibitor
NCT06612151,Small cell lung carcinoma,YL201
NCT06612151,Small cell lung carcinoma,topotecan hydrochloride for injection
NCT06742554,Analgesic,Buprenorphine transdermal patch
NCT06742554,Analgesic,tramadol
NCT06664151,Skin cancer,Fluzone Trivalent
NCT06664151,Skin squamous cell carcinoma,Fluzone Trivalent
NCT07014254,Gastric adenocarcinoma,177Lu-CTR-FAPI nuclide-targeted therapy
NCT07014254,Neuroendocrine neoplasm,177Lu-CTR-FAPI nuclide-targeted therapy
NCT07014254,Pancreatic ductal adenocarcinoma,177Lu-CTR-FAPI nuclide-targeted therapy
NCT06673654,Atopic eczema,Ruxolitinib Topical Cream
NCT06673654,Atopic eczema,OPZELURA (Ruxolitinib) Cream
NCT06761651,Cancer,TAVO412
NCT06914154,Diabetes mellitus,tirzepatide
NCT07031154,Non-small cell lung carcinoma,Adebrelimab
NCT07031154,Non-small cell lung carcinoma,Apatinib
NCT06684951,Female infertility,hCG
NCT07128251,Hepatocellular carcinoma,Iparomlimab and Tuvonralimab Injection (QL1706)
NCT07128251,Hepatocellular carcinoma,bevacizumab
NCT06755151,Primary biliary cholangitis,fenofibrate
NCT06832254,Pulpitis,dexamethasone
NCT06732154,Inherited lipid metabolism disorder,HRS-5632
NCT06800651,Autosomal dominant polycystic kidney disease,JMKX003142 will be administered orally
NCT06800651,Autosomal dominant polycystic kidney disease,Plcacebo
NCT06675851,Endogenous depression,WELLBUTRIN SR (Bupropion HCI) Sustained-Release Tablets
NCT06675851,Endogenous depression,GlaxoSmithKline
NCT06694454,Carcinoma,azacytidine
NCT06694454,Carcinoma,carboplatin
NCT06694454,Carcinoma,paclitaxel
NCT06694454,Carcinoma,durvalumab
NCT06694454,Carcinoma,cisplatin
NCT06694454,Carcinoma,gemcitabine
NCT06694454,Carcinoma,pemetrexed
NCT06694454,Non-small cell lung carcinoma,azacytidine
NCT06694454,Non-small cell lung carcinoma,carboplatin
NCT06694454,Non-small cell lung carcinoma,paclitaxel
NCT06694454,Non-small cell lung carcinoma,durvalumab
NCT06694454,Non-small cell lung carcinoma,cisplatin
NCT06694454,Non-small cell lung carcinoma,gemcitabine
NCT06694454,Non-small cell lung carcinoma,pemetrexed
NCT06839053,B-cell chronic lymphocytic leukemia,rituximab
NCT06839053,B-cell chronic lymphocytic leukemia,Sonrotoclax
NCT06839053,B-cell chronic lymphocytic leukemia,zanubrutinib
NCT06839053,Mantle cell lymphoma,rituximab
NCT06839053,Mantle cell lymphoma,Sonrotoclax
NCT06839053,Mantle cell lymphoma,zanubrutinib
NCT07020351,Atopic eczema,LY3454738
NCT06813651,Ischemic stroke,TBO-309
NCT06813651,Ischemic stroke,TBO-309
NCT06813651,Ischemic stroke,TBO-309
NCT07086651,Prostate cancer,enzalutamide
NCT07086651,Prostate cancer,apalutamide
NCT07086651,Prostate carcinoma,enzalutamide
NCT07086651,Prostate carcinoma,apalutamide
NCT06755554,Gastric carcinoma,Endoscopic injection of Indocyanine green
NCT06980454,Cancer,HLX05
NCT06980454,Cancer,EU-Erbitux®
NCT06980454,Cancer,US-Erbitux®
NCT06980454,Cancer,CN-Erbitux®
NCT06703554,Dental caries,Chlorohexidine Mouthwash
NCT06905054,Sclerosing cholangitis,Fenofibrate (drug)
NCT06614751,Endometrial cancer,DAT-2645 tablet
NCT06614751,Endometrial cancer,DAT-2645 tablet
NCT06614751,Gastric carcinoma,DAT-2645 tablet
NCT06614751,Gastric carcinoma,DAT-2645 tablet
NCT06614751,Malignant pancreatic neoplasm,DAT-2645 tablet
NCT06614751,Malignant pancreatic neoplasm,DAT-2645 tablet
NCT06614751,Prostate cancer,DAT-2645 tablet
NCT06614751,Prostate cancer,DAT-2645 tablet
NCT06828354,Ovarian cancer,SHR-A1811
NCT06828354,Ovarian cancer,paclitaxel Injection
NCT06828354,Ovarian cancer,doxorubicin hydrochloride liposome Injection
NCT06828354,Ovarian cancer,Gemcitabine Hydrochloride for Injection
NCT06828354,Ovarian cancer,Topotecan Hydrochloride for Injection
NCT06889454,Polycystic ovary syndrome,GLP-1 receptor agonist
NCT06889454,Polycystic ovary syndrome,Oral contraceptive
NCT06889454,Polycystic ovary syndrome,metformin
NCT06646354,Hypertensive disorder,Ezetimibe/Rosuvastatin/Candesartan/Amlodipine
NCT06646354,Hypertensive disorder,Candesartan/Amlodipine
NCT06646354,Hypertensive disorder,Candesartan/Rosuvastatin/Ezetimibe
NCT06822751,Urinary tract infection,Fosfomycun-trometamol
NCT06928051,COVID-19,S-892216
NCT07095933,Epilepsy,everolimus
NCT07055087,Parkinson disease,Prasinezumab
NCT07055087,Parkinson disease,sodium chloride
NCT06975787,Lupus nephritis,Vonsetamig
NCT06891287,Obesity disorder,PG-102
NCT06642987,Gastric ulcer,Vonoprazan Test
NCT06642987,Gastric ulcer,Vonoprazan Reference
NCT06671054,Rheumatoid arthritis,AP1189
NCT06671054,Rheumatoid arthritis,AP1189
NCT06671054,Rheumatoid arthritis,AP1189
NCT06798454,Primary biliary cholangitis,PVT201
NCT06978933,Hepatocellular carcinoma,ABSK-011
NCT06999733,Neurotrophic keratopathy,KB801
NCT07016633,Metabolic dysfunction-associated steatohepatitis,IMM-H014
NCT06577233,Endometriosis,bupivacaine hydrochloride
NCT06731933,Squamous cell carcinoma,BVEC
NCT06878833,Schizophrenia,LYN-005 (risperidone)
NCT06878833,Schizophrenia,IR Risperidone
NCT06742333,Psoriasis,bimekizumab
NCT06742333,Psoriasis,clobetasol
NCT06598033,Malignant pancreatic neoplasm,VC plus herbal medicine
NCT06769633,Duchenne muscular dystrophy,Givinostat Hydrochloride
NCT06769633,Duchenne muscular dystrophy,Givinostat Hydrochloride - Cohort
NCT06815133,Myasthenia gravis,Zilbrysq
NCT07083154,Dementia,Mazdutide
NCT07083154,Type 2 diabetes mellitus,Mazdutide
NCT06696833,Precursor B-cell acute lymphoblastic leukemia,QH10304-BAL-01
NCT06696833,Precursor B-cell acute lymphoblastic leukemia,fludarabine
NCT06696833,Precursor B-cell acute lymphoblastic leukemia,cyclophosphamide
NCT07037433,Atherosclerotic cardiovascular disease,Maridebart Cafraglutide
NCT07037433,Obesity disorder,Maridebart Cafraglutide
NCT06778733,Female infertility,Clomiphane citrate
NCT06778733,Female infertility,recombinant human Follicle-Stimulating Hormone (r-FSH-alfa)
NCT06765733,Multiple system atrophy,Aleeto
NCT06676033,Leukemia,epcoritamab
NCT06676033,Richter syndrome,epcoritamab
NCT06613633,Non-small cell lung carcinoma,"third-generation EGFR-TKI (Osimertinib, Almonertinib or Furmonertinib)"
NCT06796998,Marginal zone lymphoma,epcoritamab
NCT06581198,Lupus erythematosus,rapcabtagene autoleucel Regimen
NCT06581198,Lupus erythematosus,rapcabtagene autoleucel Regimen
NCT06581198,Lupus nephritis,rapcabtagene autoleucel Regimen
NCT06581198,Lupus nephritis,rapcabtagene autoleucel Regimen
NCT06704633,Heart failure,sacubitril / valsartan Oral Tablet
NCT06969287,Delirium,fluvoxamine
NCT06665087,Malignant colon neoplasm,Ultrafractionated RT and CGA Guided systemic treatment.
NCT06665087,Malignant colon neoplasm,PD-1 antibody
NCT06665087,Malignant colon neoplasm,Chemotherapy (Fluorouracil)
NCT06665087,Malignant colon neoplasm,Chemotherapy (Raltitrexed)
NCT06665087,Malignant colon neoplasm,Chemotherapy (Oxaliplatin)
NCT06665087,Malignant colon neoplasm,Chemotherapy (CPT-11)
NCT06665087,Malignant colon neoplasm,Targeted Therapy (anti-VEGF)
NCT06665087,Malignant colon neoplasm,Targeted Therapy (anti-EGFR)
NCT06665087,Rectal carcinoma,Ultrafractionated RT and CGA Guided systemic treatment.
NCT06665087,Rectal carcinoma,PD-1 antibody
NCT06665087,Rectal carcinoma,Chemotherapy (Fluorouracil)
NCT06665087,Rectal carcinoma,Chemotherapy (Raltitrexed)
NCT06665087,Rectal carcinoma,Chemotherapy (Oxaliplatin)
NCT06665087,Rectal carcinoma,Chemotherapy (CPT-11)
NCT06665087,Rectal carcinoma,Targeted Therapy (anti-VEGF)
NCT06665087,Rectal carcinoma,Targeted Therapy (anti-EGFR)
NCT06577987,Cancer,CID-078 Monotherapy
NCT06577987,Neuroendocrine carcinoma,CID-078 Monotherapy
NCT07077187,Parkinson disease,Rasagiline
NCT07001787,Inherited lipid metabolism disorder,Drug：HS-10510；
NCT07001787,Inherited lipid metabolism disorder,Drug： Rosuvastatin
NCT06936787,Retinitis pigmentosa,IGT001
